<?xml version="1.0" encoding="UTF-8"?><experiments version="1.2" revision="100915" total="53" total-samples="10029" total-assays="9524"><experiment><species>Homo sapiens</species><rawdatafiles available="true"/><processeddatafiles available="false"/><sampleattribute><category>age at death</category><value>31 year</value><value>38 year</value><value>39 year</value><value>40 year</value><value>41 year</value><value>43 year</value><value>44 year</value><value>45 year</value><value>46 year</value><value>48 year</value><value>51 year</value><value>54 year</value><value>55 year</value><value>57 year</value><value>58 year</value><value>59 year</value><value>60 year</value><value>61 year</value><value>63 year</value><value>64 year</value><value>65 year</value><value>67 year</value><value>68 year</value><value>69 year</value><value>70 year</value><value>71 year</value><value>73 year</value></sampleattribute><sampleattribute><category>ethnicity</category><value>caucasian</value></sampleattribute><sampleattribute><category>organism</category><value>Homo sapiens</value></sampleattribute><sampleattribute><category>organism part</category><value>v4 cortex</value></sampleattribute><sampleattribute><category>Patient code</category><value>1</value><value>10</value><value>11</value><value>12</value><value>13</value><value>14</value><value>15</value><value>16</value><value>17</value><value>18</value><value>19</value><value>2</value><value>20</value><value>21</value><value>22</value><value>23</value><value>24</value><value>25</value><value>26</value><value>27</value><value>28</value><value>29</value><value>3</value><value>30</value><value>31</value><value>32</value><value>33</value><value>34</value><value>35</value><value>36</value><value>37</value><value>38</value><value>39</value><value>4</value><value>40</value><value>41</value><value>5</value><value>6</value><value>7</value><value>8</value><value>9</value></sampleattribute><sampleattribute><category>sex</category><value>Female</value><value>Male</value></sampleattribute><experimentalfactor><name>age at death</name><value>31 year</value><value>38 year</value><value>39 year</value><value>40 year</value><value>41 year</value><value>43 year</value><value>44 year</value><value>45 year</value><value>46 year</value><value>48 year</value><value>51 year</value><value>54 year</value><value>55 year</value><value>57 year</value><value>58 year</value><value>59 year</value><value>60 year</value><value>61 year</value><value>63 year</value><value>64 year</value><value>65 year</value><value>67 year</value><value>68 year</value><value>69 year</value><value>70 year</value><value>71 year</value><value>73 year</value></experimentalfactor><experimentalfactor><name>Alchool use or not</name><value>abstinent</value><value>abuse of acohol</value><value>moderate use of alcohol ( 2/d men, 1/d women, elderly)</value><value>more than moderate (3 /d men, 2/d women, elderly)</value><value>n/a</value></experimentalfactor><experimentalfactor><name>disease</name><value>normal</value><value>Sporadic Amyotrophic Lateral Sclerosis</value></experimentalfactor><experimentalfactor><name>Familial anamnesis</name><value>A sister had leukemia, whereas an uncle had Parkinson</value><value>A sister of her mother had MS and died after an ilness period of 10 years at the age of 68</value><value>A son with asthma bronchiale. Brother with back problems.</value><value>brother MS, daughter handicapped</value><value>father died at the age of 49 of hart disease and mother suffered of hypertension</value><value>father died in 1987 of brain tumor and had spinal cord tumors and intestine polyps</value><value>Father died of heart attack.</value><value>Husband died in 13-03-1986 in Switserland of ALS. A nephew of mother's side was paralyzed</value><value>Mother died of cancer</value><value>Mother died of cancer, father of consequences tentamen suicidii</value><value>n/a</value><value>Several cases of Alzheimer in his mother's family</value><value>sister with morbus Reckinhhausen</value></experimentalfactor><experimentalfactor><name>Location of onset</name><value>arm onset</value><value>leg onset</value><value>n/a</value><value>trunk onset</value></experimentalfactor><experimentalfactor><name>Occupation (job)</name><value>Administrator in gardening company, sportive man, Up until 1975 lived with his parents in gardening company and came into contact with different pesticides</value><value>Assistent export manager in office product supplies. At the age of 16 suffered a heavy blow on his head</value><value>computer operator, worked also with chemical substances</value><value>employed in administration</value><value>employed in administration in woodfactory and in past worked as barman</value><value>Employed in agricultural machinery factory. Sportive type. Suffered a severe fall on her buttocks while skating on ice.</value><value>Employed in bike club as secretary. Sportive type, cycled 150 km a day up unill 1994.</value><value>employed in management with stressful job (self report)</value><value>Ex-metal- bank employee</value><value>Head constable of the policeforce in Haarlem</value><value>housewife</value><value>housewife and nurse in old people's nursing home untill 1987</value><value>housewife, previously worked in a taylorshop, wife of painter,/decorator</value><value>In the past contact with lead damps, and dental protheses with 9 amalgam fillings</value><value>n/a</value><value>occupation not known, however patient had been exposed to toxic substances</value><value>Plummer, intensive contact with copper and PVC-glue</value><value>Previously emplyed in the University canteen</value><value>technical architecture head civil servant</value></experimentalfactor><experimentalfactor><name>Other pathologies</name><value>(1989) Anamnesis of Chronic aspecific respiratory disease, hypertsension and adipositas. Uncinate fits (temporal epilepsy). In 1988 Salmonella typhimu</value><value>A lot of stress due to loss of family members/ friends and difficult contact with eldest son</value><value>Adipositas, diabetes mellitus, arthrosis. Amamnesis: womb operaion, and knees and ankles due to arthrosis</value><value>Back pain underwent a laminectomy (L4-L5).As a child also suffered kidney disease during a cold. Bad acnﾎ, rontgen treatment of torax and face. In 1990 facial and bottom cheak infection</value><value>Begin 1990,hallucinations with signs of daementia, change in personality, planning capacity and disorienation. 1990 diagnosis:schizofrenia simplex with loss of intelligence and frontal, cortical atrophy</value><value>Colic pains left side of abdomen, had previously been operated 13 times for similar problem. Suffered hypertension</value><value>diverticulosis since 2nd WW. Benign mammay cyst. Uterus myoma. Melanoma right leg</value><value>Had bronchitis untill 1945, had a period of hypertension during the use of the pill</value><value>In 1976 operated for aneurysma. Post-operational abducensparesis. in 1981 dogbite upperlip. 1983 angina complaints</value><value>In the past frequent migrain headaches.Osteopenia and hypercholesterolemy. Trismus.</value><value>Injured nose (with nosebleeds), due to violent ex-partner. Very stressed due to personal situation, divorce. Previous womb operation.</value><value>Known with hypertension</value><value>known with hypertension since 1960. Hypercholesterolemia and ECG with signs of anteroseptal infarct.</value><value>malaria since 1991 (New-Guinea). Sincs 1990 diabetes type II. 1986 cholecystectomie, 1987 period with hypertension</value><value>n/a</value><value>non-insulin-dependent diabetes, hypertension</value><value>period of alcohol abuse as well as depression period in the past. Suffered stomach ache</value><value>Possible leasion of periferic and central motoric neuron at the spinal level. Known with hypertension</value><value>psoriasis. Motor and car-accident</value><value>Raynaud's attacks</value><value>recidive sinusitis, suffered frequent colds</value><value>Stressful experiences in her life, such as traumatic birth of her son.</value><value>Suffered a heart attack after which he had probmlems of communication. August 1989 operated intestinal carcinoma (stoma was closed in november 1989)</value><value>Suffered atopic eczema as a child (age 2 yrs). 1969 pneumonia. Chronic aspecific respiratory disease</value><value>transposition of n. ulnaris (1988)/in the past suffered some epileptic attacks/ spondylarthrosis deform. C4-C6</value></experimentalfactor><experimentalfactor><name>Post-mortem interval in hours</name><value>10</value><value>3</value><value>4</value><value>5</value><value>5.3</value><value>6</value><value>6.5</value><value>7</value><value>7.5</value><value>8</value><value>9</value></experimentalfactor><experimentalfactor><name>Smoker or non smoker</name><value>n/a</value><value>non smoker</value><value>smoker</value></experimentalfactor><experimentalfactor><name>Survival characteristics</name><value>long term survival more than 6 yrs</value><value>medium term survival up to 6 yrs</value><value>n/a</value><value>short term survival up to 24 months</value></experimentalfactor><experimentalfactor><name>Survival time from date of onset (months)</name><value>11</value><value>13</value><value>130</value><value>18</value><value>20</value><value>22</value><value>23</value><value>27</value><value>29</value><value>30</value><value>31</value><value>38</value><value>42</value><value>43</value><value>48</value><value>49</value><value>52</value><value>60</value><value>7</value><value>71</value><value>72</value><value>90</value><value>96</value><value>n/a</value></experimentalfactor><experimentalfactor><name>Therapy used</name><value>Acetyl cyst.</value><value>antidiabetics, Rastinon, glucophage</value><value>Carbamazepine divitabs, sinaspril, clonazepam, importal, microlax</value><value>Hypertension medication (tagamet, inhibin, trasolan, isoptin). Participated in the Acetyl cyst. trial</value><value>In 1990 infections treated with different antibiotics and a mushroom extract. Vit B injections</value><value>Legendal, Tryptizol</value><value>n/a</value><value>Participated in the Acetyl cyst. trial</value><value>Participated in the n-acetylcysteine trial</value><value>Participated in the n-acetylcysteine trial. Amytriptiline, Scopoderm plasters, Oxygen</value><value>Participated in the n-acetylcysteine trial. Further medication Normison and Laxantia.</value><value>Participated in the n-acetylcysteine trial. Ozazepap when needed</value><value>Renitec (hypertension). participated in the n-acetylcysteine trial</value><value>rilutek</value><value>Rilutek, cream for psoriasis</value><value>rilutek, vit E, Oxazepam, amitriptyline-chloride, acetyl cyst.</value><value>Salazopyrin when needed</value><value>Selokeen, vit C, vit E, Coenzyme q10, vitamax, vit. B complex, superoxyde dismutase.</value><value>theolair retard, temesta, lactulose, codeine, zantac, regla, tranxene, euphiline, morfine hcl</value><value>Tolbutamide, magnesiumsulfate (for cramps), Rilutec, Fluimicil, etc</value><value>Trismus treated with botox injections and irradiation of parotids for excessive saliva</value><value>vit-B complex, vitamine C</value><value>vit. B complex, Aldomet, Tolbutamide, Fluimicil and Lasix</value><value>Vitamin B, Tryptizol, Prednison/Lactulose, Normison and lactulose when needed</value></experimentalfactor><experimentalfactor><name>Vaccination boost</name><value>n/a</value><value>polio vaccine (1992)</value></experimentalfactor><miamescores><reportersequencescore>1</reportersequencescore><protocolscore>1</protocolscore><factorvaluescore>1</factorvaluescore><derivedbioassaydatascore>0</derivedbioassaydatascore><measuredbioassaydatascore>1</measuredbioassaydatascore><overallscore>4</overallscore></miamescores><id>516651</id><accession>E-MTAB-2325</accession><name>Gene expression profiles in motor cortex of Control and Sporadic Amyotrphic Lateral Sclerosis patients</name><experimenttype>transcription profiling by array</experimenttype><releasedate>2015-02-27</releasedate><submissiondate>2014-02-17</submissiondate><lastupdatedate>2014-12-29</lastupdatedate><samples>41</samples><assays>41</assays><arraydesign><id>11853</id><accession>A-AGIL-28</accession><name>Agilent Whole Human Genome Microarray 4x44K 014850 G4112F (85 cols x 532 rows)</name><count>41</count><legacy_id>1316855037</legacy_id></arraydesign><bioassaydatagroup><id/><name>rawDataMatrix</name><bioassaydatacubes>1</bioassaydatacubes><arraydesignprovider/><dataformat>rawDataMatrix</dataformat><bioassays>1</bioassays><isderived>0</isderived></bioassaydatagroup><bioassaydatagroup><id/><name>scan</name><bioassaydatacubes>41</bioassaydatacubes><arraydesignprovider/><dataformat>scan</dataformat><bioassays>41</bioassays><isderived>0</isderived></bioassaydatagroup><provider><contact>Sebastiano Cavallaro</contact><role>submitter</role><email>sebastiano.cavallaro@cnr.it</email></provider><experimentdesign>case control design</experimentdesign><experimentdesign>clinical history design</experimentdesign><description><id/><text>Threshold: 1.0 . Logbase: 2 . Technology: Generic.SingleColor.014850. Normalization: Shift to 75 percentile . Baseline Transformation: median of all samples .</text></description><protocol><id>1101756</id><accession>P-MTAB-37658</accession></protocol><protocol><id>1101757</id><accession>P-MTAB-37657</accession></protocol><protocol><id>1101758</id><accession>P-MTAB-37656</accession></protocol><protocol><id>1101759</id><accession>P-MTAB-37655</accession></protocol><organism>Homo sapiens</organism><files><!--
This section is deprecated and unsupported.
Please use webservice located at:
    http://www.ebi.ac.uk/arrayexpress/xml/files
to obtain detailed information on files available for the experiment.
For more information, please go to:
    http://www.ebi.ac.uk/arrayexpress/help/programmatic_access.html
                --><raw name="E-MTAB-2325.raw.1.zip" count="true" celcount="0"/><idf name="E-MTAB-2325.idf.txt"/><sdrf name="E-MTAB-2325.sdrf.txt"/></files></experiment><experiment><species>Homo sapiens</species><rawdatafiles available="false"/><processeddatafiles available="false"/><sampleattribute><category>organism</category><value>Homo sapiens</value></sampleattribute><sampleattribute><category>patient id</category><value>001-0025</value><value>001-0029</value><value>001-0037</value><value>001-0038</value><value>001-0039</value><value>001-0061</value><value>001-0068</value><value>001-0084</value><value>001-0091</value><value>001-0121</value><value>001-0155</value><value>001-0161</value><value>001-0187</value><value>001-0188</value><value>001-0194</value><value>001-0205</value><value>001-0246</value><value>001-0249</value><value>001-0253</value><value>001-0283</value><value>001-0284</value><value>001-0299</value><value>001-0303</value><value>001-0307</value><value>001-0309</value><value>001-0315</value><value>001-0326</value><value>001-0347</value><value>001-0360</value><value>001-0364</value><value>001-0366</value><value>001-0387</value><value>002-0002</value><value>002-0006</value><value>002-0010</value><value>002-0011</value><value>002-0013</value><value>002-0018</value><value>002-0020</value><value>002-0022</value><value>002-0025</value><value>002-0027</value><value>002-0033</value><value>002-0037</value><value>002-0040</value><value>002-0045</value><value>002-0057</value><value>002-0059</value><value>002-0068</value><value>002-0076</value><value>002-0079</value><value>002-0081</value><value>002-0082</value><value>002-0083</value><value>002-0086</value><value>002-0097</value><value>002-0098</value><value>002-0099</value><value>002-0100</value><value>002-0101</value><value>002-0102</value><value>002-0103</value><value>002-0104</value><value>002-0106</value><value>002-0107</value><value>002-0111</value><value>002-0120</value><value>002-0124</value><value>002-0126</value><value>002-0128</value><value>002-0136</value><value>002-0138</value><value>002-0155</value><value>002-0158</value><value>002-0159</value><value>002-0161</value><value>002-0162</value><value>002-0174</value><value>002-0179</value><value>002-0184</value><value>002-0188</value><value>002-0189</value><value>002-0190</value><value>002-0192</value><value>002-0193</value><value>002-0194</value><value>002-0195</value><value>002-0196</value><value>002-0197</value><value>002-0201</value><value>002-0202</value><value>002-0203</value><value>002-0205</value><value>002-0206</value><value>002-0207</value><value>002-0210</value><value>002-0213</value><value>002-0216</value><value>002-0217</value><value>002-0225</value><value>002-0230</value><value>002-0231</value><value>002-0236</value><value>002-0240</value><value>002-0241</value><value>002-0244</value><value>002-0246</value><value>002-0258</value><value>002-0265</value><value>002-0270</value><value>002-0274</value><value>002-0275</value><value>002-0286</value><value>002-0287</value><value>002-0292</value><value>002-0295</value><value>002-0296</value><value>002-0301</value><value>002-0304</value><value>002-0310</value><value>002-0311</value><value>002-0314</value><value>002-0317</value><value>002-0319</value><value>002-0325</value><value>002-0327</value><value>002-0330</value><value>002-0346</value><value>002-0348</value></sampleattribute><sampleattribute><category>sirs outcomes</category><value>sepsis death</value><value>Septic shock</value><value>Severe Sepsis</value><value>SIRS</value><value>Uncomplicated sepsis</value></sampleattribute><sampleattribute><category>sirs vs sepsis</category><value>sepsis</value><value>SIRS</value></sampleattribute><experimentalfactor><name>patient id</name><value>001-0025</value><value>001-0029</value><value>001-0037</value><value>001-0038</value><value>001-0039</value><value>001-0061</value><value>001-0068</value><value>001-0084</value><value>001-0091</value><value>001-0121</value><value>001-0155</value><value>001-0161</value><value>001-0187</value><value>001-0188</value><value>001-0194</value><value>001-0205</value><value>001-0246</value><value>001-0249</value><value>001-0253</value><value>001-0283</value><value>001-0284</value><value>001-0299</value><value>001-0303</value><value>001-0307</value><value>001-0309</value><value>001-0315</value><value>001-0326</value><value>001-0347</value><value>001-0360</value><value>001-0364</value><value>001-0366</value><value>001-0387</value><value>002-0002</value><value>002-0006</value><value>002-0010</value><value>002-0011</value><value>002-0013</value><value>002-0018</value><value>002-0020</value><value>002-0022</value><value>002-0025</value><value>002-0027</value><value>002-0033</value><value>002-0037</value><value>002-0040</value><value>002-0045</value><value>002-0057</value><value>002-0059</value><value>002-0068</value><value>002-0076</value><value>002-0079</value><value>002-0081</value><value>002-0082</value><value>002-0083</value><value>002-0086</value><value>002-0097</value><value>002-0098</value><value>002-0099</value><value>002-0100</value><value>002-0101</value><value>002-0102</value><value>002-0103</value><value>002-0104</value><value>002-0106</value><value>002-0107</value><value>002-0111</value><value>002-0120</value><value>002-0124</value><value>002-0126</value><value>002-0128</value><value>002-0136</value><value>002-0138</value><value>002-0155</value><value>002-0158</value><value>002-0159</value><value>002-0161</value><value>002-0162</value><value>002-0174</value><value>002-0179</value><value>002-0184</value><value>002-0188</value><value>002-0189</value><value>002-0190</value><value>002-0192</value><value>002-0193</value><value>002-0194</value><value>002-0195</value><value>002-0196</value><value>002-0197</value><value>002-0201</value><value>002-0202</value><value>002-0203</value><value>002-0205</value><value>002-0206</value><value>002-0207</value><value>002-0210</value><value>002-0213</value><value>002-0216</value><value>002-0217</value><value>002-0225</value><value>002-0230</value><value>002-0231</value><value>002-0236</value><value>002-0240</value><value>002-0241</value><value>002-0244</value><value>002-0246</value><value>002-0258</value><value>002-0265</value><value>002-0270</value><value>002-0274</value><value>002-0275</value><value>002-0286</value><value>002-0287</value><value>002-0292</value><value>002-0295</value><value>002-0296</value><value>002-0301</value><value>002-0304</value><value>002-0310</value><value>002-0311</value><value>002-0314</value><value>002-0317</value><value>002-0319</value><value>002-0325</value><value>002-0327</value><value>002-0330</value><value>002-0346</value><value>002-0348</value></experimentalfactor><experimentalfactor><name>sirs outcomes</name><value>sepsis death</value><value>Septic shock</value><value>Severe Sepsis</value><value>SIRS</value><value>Uncomplicated sepsis</value></experimentalfactor><experimentalfactor><name>sirs vs sepsis</name><value>sepsis</value><value>SIRS</value></experimentalfactor><minseqescores><experimentdesignscore>1</experimentdesignscore><protocolscore>1</protocolscore><factorvaluescore>1</factorvaluescore><derivedbioassaydatascore>0</derivedbioassaydatascore><measuredbioassaydatascore>1</measuredbioassaydatascore><overallscore>4</overallscore></minseqescores><id>518031</id><accession>E-GEOD-63042</accession><secondaryaccession>SRP050000</secondaryaccession><secondaryaccession>GSE63042</secondaryaccession><name>An integrated transcriptome and expressed variant analysis of sepsis survival and death</name><experimenttype>RNA-seq of coding RNA</experimenttype><releasedate>2015-01-01</releasedate><lastupdatedate>2015-01-28</lastupdatedate><samples>129</samples><assays>129</assays><provider><contact>Neil A Miller</contact><role/><email/></provider><provider><contact>Raymond J Langley</contact><role/><email/></provider><provider><contact>Raymond J Langley</contact><role>submitter</role><email>rlangley@lrri.org</email></provider><description><id/><text>Background: Sepsis, a leading cause of morbidity and mortality, is not a homogeneous disease but rather a syndrome encompassing many heterogeneous pathophysiologies. Patient factors including genetics predispose to poor outcomes, though current clinical characterizations fail to identify those at greatest risk of progression and mortality. Results: The Community Acquired Pneumonia and Sepsis Outcome Diagnostic study enrolled 1,152 subjects with suspected sepsis. We sequenced peripheral blood RNA of 129 representative subjects with systemic inflammatory response syndrome (SIRS) or sepsis (infection with SIRS), including 78 sepsis survivors and 28 sepsis nonsurvivors, who had previously undergone plasma proteomic and metabolomic profiling. The expression of 338 genes differed between subjects with SIRS and those with sepsis, primarily reflective of immune activation in sepsis. The expression of 1,238 genes differed with sepsis outcome: Nonsurvivors had lower expression of many immune function-related genes. Functional genetic variants associated with sepsis mortality were sought based on a common disease – rare variant hypothesis. VPS9D1, whose expression was increased in sepsis survivors, had a higher burden of missense variants in sepsis survivors, and these were associated with altered expression of 3,799 genes, primarily reflecting Golgi and endosome biology. Conclusions: Host response in sepsis survivors – activation of immune response-related genes – was muted in sepsis nonsurvivors. The association of sepsis survival with robust immune response and presence of missense variants in VPS9D1 warrants replication and further functional studies. We sequenced peripheral blood RNA of 129 representative subjects with systemic inflammatory response syndrome (SIRS, n=23) or sepsis (infection with SIRS), including 78 sepsis survivors and 28 sepsis nonsurvivors, who had previously undergone plasma proteomic and metabolomic profiling.</text></description><protocol><id>1108507</id><accession>P-GSE63042-1</accession></protocol><organism>Homo sapiens</organism><files><!--
This section is deprecated and unsupported.
Please use webservice located at:
    http://www.ebi.ac.uk/arrayexpress/xml/files
to obtain detailed information on files available for the experiment.
For more information, please go to:
    http://www.ebi.ac.uk/arrayexpress/help/programmatic_access.html
                --><idf name="E-GEOD-63042.idf.txt"/><sdrf name="E-GEOD-63042.sdrf.txt"/></files></experiment><experiment><species>Homo sapiens</species><rawdatafiles available="false"/><processeddatafiles available="false"/><sampleattribute><category>age</category><value>15</value><value>16</value><value>17</value><value>18</value><value>20</value><value>22</value><value>24</value><value>27</value><value>28</value><value>29</value><value>30</value><value>31</value><value>33</value><value>36</value><value>38</value><value>39</value><value>47</value><value>49</value><value>52</value><value>56</value><value>60</value></sampleattribute><sampleattribute><category>aligned.reads.picard</category><value>14009235</value><value>21602464</value><value>23819131</value><value>26677747</value><value>26764492</value><value>27996353</value><value>36285419</value><value>36680597</value><value>37271753</value><value>38299573</value><value>39374242</value><value>39989410</value><value>42088917</value><value>43809852</value><value>45359064</value><value>45506260</value><value>52392755</value><value>53015802</value><value>53472673</value><value>53620215</value><value>54642554</value><value>61929295</value><value>64358619</value><value>84218275</value></sampleattribute><sampleattribute><category>at.dropout.picard</category><value>12.484056</value><value>16.320927</value><value>17.520306</value><value>18.404535</value><value>18.733352</value><value>19.238169</value><value>20.398705</value><value>20.49268</value><value>21.240025</value><value>21.714036</value><value>21.981844</value><value>24.58006</value><value>25.250158</value><value>25.586988</value><value>25.816095</value><value>25.876523</value><value>26.507544</value><value>26.508086</value><value>27.422884</value><value>27.518531</value><value>29.584314</value><value>30.928684</value><value>33.18674</value><value>33.235931</value></sampleattribute><sampleattribute><category>brainbank</category><value>ATP</value><value>NICHD</value></sampleattribute><sampleattribute><category>brainid</category><value>AN00493</value><value>AN01570</value><value>AN01971</value><value>AN02987</value><value>AN03632</value><value>AN04682</value><value>AN07444</value><value>AN08043</value><value>AN08161</value><value>AN08166</value><value>AN08677</value><value>AN08792</value><value>AN09714</value><value>AN10833</value><value>AN12137</value><value>AN12457</value><value>AN13295</value><value>AN14757</value><value>AN17425</value><value>AN19760</value><value>UMB4590</value><value>UMB4842</value><value>UMB5079</value><value>UMB5278</value></sampleattribute><sampleattribute><category>coding.bases.picard</category><value>1026287819</value><value>1120380572</value><value>1163882243</value><value>1179031182</value><value>1208816699</value><value>1256516035</value><value>1279178541</value><value>1318635297</value><value>1388493945</value><value>1450472979</value><value>1513643620</value><value>1827033959</value><value>369250054</value><value>407890700</value><value>587501039</value><value>627114981</value><value>662440925</value><value>702818287</value><value>783309516</value><value>827846853</value><value>875666592</value><value>971886645</value><value>978687230</value><value>988975069</value></sampleattribute><sampleattribute><category>diagnosis</category><value>ASD</value><value>CTL</value></sampleattribute><sampleattribute><category>gc.dropout.picard</category><value>0.000411</value><value>0.059879</value><value>0.068047</value><value>0.138467</value><value>0.147311</value><value>0.234574</value><value>0.247464</value><value>0.343162</value><value>0.364098</value><value>0.437608</value><value>0.541477</value><value>0.542003</value><value>0.584005</value><value>0.635361</value><value>0.883464</value><value>1.209633</value><value>1.48112</value><value>1.529695</value><value>1.704897</value><value>1.745625</value><value>1.926078</value><value>2.008445</value><value>2.109142</value><value>2.207123</value></sampleattribute><sampleattribute><category>hq.aligned.reads.picard</category><value>12298443</value><value>20148125</value><value>21766665</value><value>24598667</value><value>24833347</value><value>25895921</value><value>32949428</value><value>33813136</value><value>34033845</value><value>34376877</value><value>35730549</value><value>35878279</value><value>39007710</value><value>40502727</value><value>40938207</value><value>42050951</value><value>47286926</value><value>49006770</value><value>49011686</value><value>49351156</value><value>50421547</value><value>57724758</value><value>60194702</value><value>77408176</value></sampleattribute><sampleattribute><category>intergenic.bases.picard</category><value>145385398</value><value>154582868</value><value>166317514</value><value>176079327</value><value>188945820</value><value>193289139</value><value>222508090</value><value>250537903</value><value>251305460</value><value>261644497</value><value>265918897</value><value>266201054</value><value>272254377</value><value>276209287</value><value>295936578</value><value>317955216</value><value>327328755</value><value>345401006</value><value>351245444</value><value>383405202</value><value>384559944</value><value>440686054</value><value>633414121</value><value>707908936</value></sampleattribute><sampleattribute><category>intronic.bases.picard</category><value>1026654593</value><value>1027660089</value><value>1276495682</value><value>1416654269</value><value>1455524346</value><value>1462609241</value><value>1472794507</value><value>1509111144</value><value>1714218211</value><value>1922767554</value><value>1959276248</value><value>2007211250</value><value>2047071120</value><value>2201517866</value><value>2505050452</value><value>2887561281</value><value>3403006316</value><value>474899394</value><value>757149793</value><value>859937444</value><value>908579543</value><value>954566349</value><value>975637636</value><value>985011596</value></sampleattribute><sampleattribute><category>median.3prime.bias.picard</category><value>0.624652</value><value>0.645537</value><value>0.692505</value><value>0.698454</value><value>0.714718</value><value>0.717227</value><value>0.725846</value><value>0.728013</value><value>0.728795</value><value>0.735198</value><value>0.735531</value><value>0.738806</value><value>0.740362</value><value>0.742371</value><value>0.748535</value><value>0.754858</value><value>0.75744</value><value>0.757907</value><value>0.758689</value><value>0.758754</value><value>0.75935</value><value>0.76372</value><value>0.764301</value><value>0.764958</value></sampleattribute><sampleattribute><category>median.5prime.bias.picard</category><value>0.412661</value><value>0.420976</value><value>0.449296</value><value>0.449714</value><value>0.450031</value><value>0.450107</value><value>0.451317</value><value>0.453488</value><value>0.454784</value><value>0.454812</value><value>0.454813</value><value>0.456012</value><value>0.456507</value><value>0.458133</value><value>0.458689</value><value>0.461482</value><value>0.462606</value><value>0.463211</value><value>0.468214</value><value>0.469228</value><value>0.47135</value><value>0.476451</value><value>0.490352</value><value>0.506708</value></sampleattribute><sampleattribute><category>median.5to3prime.bias.picard</category><value>0.568229</value><value>0.58198</value><value>0.585323</value><value>0.587971</value><value>0.594834</value><value>0.599055</value><value>0.603934</value><value>0.608376</value><value>0.614396</value><value>0.615196</value><value>0.617553</value><value>0.620901</value><value>0.62359</value><value>0.624815</value><value>0.628312</value><value>0.636392</value><value>0.639601</value><value>0.645283</value><value>0.648227</value><value>0.651819</value><value>0.654083</value><value>0.655312</value><value>0.659333</value><value>0.669651</value></sampleattribute><sampleattribute><category>median.cv.coverage.picard</category><value>0.489994</value><value>0.495822</value><value>0.498845</value><value>0.50918</value><value>0.509791</value><value>0.514579</value><value>0.515141</value><value>0.515967</value><value>0.516626</value><value>0.521915</value><value>0.52525</value><value>0.530111</value><value>0.53213</value><value>0.536172</value><value>0.536375</value><value>0.536986</value><value>0.540069</value><value>0.542408</value><value>0.544495</value><value>0.546166</value><value>0.558868</value><value>0.57253</value><value>0.5855</value><value>0.672936</value></sampleattribute><sampleattribute><category>organism</category><value>Homo sapiens</value></sampleattribute><sampleattribute><category>pf.all.bases.picard</category><value>1400830353</value><value>2160114475</value><value>2381776441</value><value>2667612889</value><value>2676307143</value><value>2799474872</value><value>3628330699</value><value>3667850200</value><value>3726947653</value><value>3829742695</value><value>3937184301</value><value>3998687269</value><value>4208626438</value><value>4380656349</value><value>4535639256</value><value>4550389520</value><value>5238958678</value><value>5301270119</value><value>5346972506</value><value>5361714476</value><value>5463948661</value><value>6192566687</value><value>6435460250</value><value>8421328282</value></sampleattribute><sampleattribute><category>pmi</category><value>12</value><value>13</value><value>16</value><value>17.83</value><value>19</value><value>20.3</value><value>21.08</value><value>21.33</value><value>21.47</value><value>22.12</value><value>23.23</value><value>23.25</value><value>23.83</value><value>25.47</value><value>26.16</value><value>26.5</value><value>30.75</value><value>30.8</value><value>31.5</value><value>32.92</value><value>39.15</value><value>43.25</value><value>6.75</value><value>8.3</value></sampleattribute><sampleattribute><category>primarycauseofdeath</category><value>  </value><value>Airway obstruction</value><value>Asphyxia</value><value>Aspiration</value><value>cancer</value><value>Cardiac Arrest</value><value>Drowning</value><value>gastrointestinal bleeding</value><value>Head Trauma</value><value>heart attack</value><value>Multisystem Failure</value><value>pancreatic cancer</value><value>Seizure disorder</value><value>Seizure Suspected</value><value>Unknown</value></sampleattribute><sampleattribute><category>propexonicreads.htsc</category><value>0.199289699821407</value><value>0.199491483715109</value><value>0.205380943772731</value><value>0.206035839916563</value><value>0.211381126899055</value><value>0.218807793509352</value><value>0.222355227667841</value><value>0.227599593037691</value><value>0.230517918601934</value><value>0.23200673943566</value><value>0.236222916424395</value><value>0.241850412605494</value><value>0.247112907702278</value><value>0.247944635871419</value><value>0.250729310342743</value><value>0.268190590703174</value><value>0.269084059244469</value><value>0.283788958310798</value><value>0.291545269337683</value><value>0.298174687069412</value><value>0.316050793386682</value><value>0.322754433526967</value><value>0.326368486910971</value><value>0.342817813861959</value></sampleattribute><sampleattribute><category>regionid</category><value>ba41-42-22</value></sampleattribute><sampleattribute><category>rin</category><value>1.8</value><value>2.9</value><value>5.1</value><value>6</value><value>6.1</value><value>6.3</value><value>6.4</value><value>7.1</value><value>7.2</value><value>7.3</value><value>7.8</value><value>7.9</value><value>8</value><value>8.1</value><value>8.2</value><value>8.3</value><value>8.6</value></sampleattribute><sampleattribute><category>secondarycauseofdeath</category><value>  </value><value>Alcohol intoxication</value><value>Associated with seizure disorder</value><value>Colorectal spread through abdomen</value><value>CP; Seizure Disorder</value><value>Dilated Cardiomyopathy; Morbid Obesity</value><value>Hanging</value><value>heart disease</value><value>Pneumonitis</value><value>Respiratory Arrest</value><value>SUDEP</value></sampleattribute><sampleattribute><category>Sex</category><value>female</value><value>male</value></sampleattribute><sampleattribute><category>totalreads.picard</category><value>14009235</value><value>21602464</value><value>23819131</value><value>26677747</value><value>26764492</value><value>27996353</value><value>36285419</value><value>36680597</value><value>37271753</value><value>38299573</value><value>39374242</value><value>39989410</value><value>42088917</value><value>43809852</value><value>45359064</value><value>45506260</value><value>52392755</value><value>53015802</value><value>53472673</value><value>53620215</value><value>54642554</value><value>61929295</value><value>64358619</value><value>84218275</value></sampleattribute><sampleattribute><category>utr.bases.picard</category><value>1074079230</value><value>1151872810</value><value>1161321487</value><value>1285458462</value><value>1292786624</value><value>1312933668</value><value>1475004428</value><value>1479357646</value><value>1495560716</value><value>1632881234</value><value>1672809200</value><value>1694136856</value><value>1752586185</value><value>1828034374</value><value>1852483312</value><value>1884703079</value><value>2305527744</value><value>2557873886</value><value>402098037</value><value>574331115</value><value>804222528</value><value>830338432</value><value>831540131</value><value>954701435</value></sampleattribute><experimentalfactor><name>age</name><value>15</value><value>16</value><value>17</value><value>18</value><value>20</value><value>22</value><value>24</value><value>27</value><value>28</value><value>29</value><value>30</value><value>31</value><value>33</value><value>36</value><value>38</value><value>39</value><value>47</value><value>49</value><value>52</value><value>56</value><value>60</value></experimentalfactor><experimentalfactor><name>aligned.reads.picard</name><value>14009235</value><value>21602464</value><value>23819131</value><value>26677747</value><value>26764492</value><value>27996353</value><value>36285419</value><value>36680597</value><value>37271753</value><value>38299573</value><value>39374242</value><value>39989410</value><value>42088917</value><value>43809852</value><value>45359064</value><value>45506260</value><value>52392755</value><value>53015802</value><value>53472673</value><value>53620215</value><value>54642554</value><value>61929295</value><value>64358619</value><value>84218275</value></experimentalfactor><experimentalfactor><name>at.dropout.picard</name><value>12.484056</value><value>16.320927</value><value>17.520306</value><value>18.404535</value><value>18.733352</value><value>19.238169</value><value>20.398705</value><value>20.49268</value><value>21.240025</value><value>21.714036</value><value>21.981844</value><value>24.58006</value><value>25.250158</value><value>25.586988</value><value>25.816095</value><value>25.876523</value><value>26.507544</value><value>26.508086</value><value>27.422884</value><value>27.518531</value><value>29.584314</value><value>30.928684</value><value>33.18674</value><value>33.235931</value></experimentalfactor><experimentalfactor><name>brainbank</name><value>ATP</value><value>NICHD</value></experimentalfactor><experimentalfactor><name>brainid</name><value>AN00493</value><value>AN01570</value><value>AN01971</value><value>AN02987</value><value>AN03632</value><value>AN04682</value><value>AN07444</value><value>AN08043</value><value>AN08161</value><value>AN08166</value><value>AN08677</value><value>AN08792</value><value>AN09714</value><value>AN10833</value><value>AN12137</value><value>AN12457</value><value>AN13295</value><value>AN14757</value><value>AN17425</value><value>AN19760</value><value>UMB4590</value><value>UMB4842</value><value>UMB5079</value><value>UMB5278</value></experimentalfactor><experimentalfactor><name>coding.bases.picard</name><value>1026287819</value><value>1120380572</value><value>1163882243</value><value>1179031182</value><value>1208816699</value><value>1256516035</value><value>1279178541</value><value>1318635297</value><value>1388493945</value><value>1450472979</value><value>1513643620</value><value>1827033959</value><value>369250054</value><value>407890700</value><value>587501039</value><value>627114981</value><value>662440925</value><value>702818287</value><value>783309516</value><value>827846853</value><value>875666592</value><value>971886645</value><value>978687230</value><value>988975069</value></experimentalfactor><experimentalfactor><name>diagnosis</name><value>ASD</value><value>CTL</value></experimentalfactor><experimentalfactor><name>gc.dropout.picard</name><value>0.000411</value><value>0.059879</value><value>0.068047</value><value>0.138467</value><value>0.147311</value><value>0.234574</value><value>0.247464</value><value>0.343162</value><value>0.364098</value><value>0.437608</value><value>0.541477</value><value>0.542003</value><value>0.584005</value><value>0.635361</value><value>0.883464</value><value>1.209633</value><value>1.48112</value><value>1.529695</value><value>1.704897</value><value>1.745625</value><value>1.926078</value><value>2.008445</value><value>2.109142</value><value>2.207123</value></experimentalfactor><experimentalfactor><name>hq.aligned.reads.picard</name><value>12298443</value><value>20148125</value><value>21766665</value><value>24598667</value><value>24833347</value><value>25895921</value><value>32949428</value><value>33813136</value><value>34033845</value><value>34376877</value><value>35730549</value><value>35878279</value><value>39007710</value><value>40502727</value><value>40938207</value><value>42050951</value><value>47286926</value><value>49006770</value><value>49011686</value><value>49351156</value><value>50421547</value><value>57724758</value><value>60194702</value><value>77408176</value></experimentalfactor><experimentalfactor><name>intergenic.bases.picard</name><value>145385398</value><value>154582868</value><value>166317514</value><value>176079327</value><value>188945820</value><value>193289139</value><value>222508090</value><value>250537903</value><value>251305460</value><value>261644497</value><value>265918897</value><value>266201054</value><value>272254377</value><value>276209287</value><value>295936578</value><value>317955216</value><value>327328755</value><value>345401006</value><value>351245444</value><value>383405202</value><value>384559944</value><value>440686054</value><value>633414121</value><value>707908936</value></experimentalfactor><experimentalfactor><name>intronic.bases.picard</name><value>1026654593</value><value>1027660089</value><value>1276495682</value><value>1416654269</value><value>1455524346</value><value>1462609241</value><value>1472794507</value><value>1509111144</value><value>1714218211</value><value>1922767554</value><value>1959276248</value><value>2007211250</value><value>2047071120</value><value>2201517866</value><value>2505050452</value><value>2887561281</value><value>3403006316</value><value>474899394</value><value>757149793</value><value>859937444</value><value>908579543</value><value>954566349</value><value>975637636</value><value>985011596</value></experimentalfactor><experimentalfactor><name>median.3prime.bias.picard</name><value>0.624652</value><value>0.645537</value><value>0.692505</value><value>0.698454</value><value>0.714718</value><value>0.717227</value><value>0.725846</value><value>0.728013</value><value>0.728795</value><value>0.735198</value><value>0.735531</value><value>0.738806</value><value>0.740362</value><value>0.742371</value><value>0.748535</value><value>0.754858</value><value>0.75744</value><value>0.757907</value><value>0.758689</value><value>0.758754</value><value>0.75935</value><value>0.76372</value><value>0.764301</value><value>0.764958</value></experimentalfactor><experimentalfactor><name>median.5prime.bias.picard</name><value>0.412661</value><value>0.420976</value><value>0.449296</value><value>0.449714</value><value>0.450031</value><value>0.450107</value><value>0.451317</value><value>0.453488</value><value>0.454784</value><value>0.454812</value><value>0.454813</value><value>0.456012</value><value>0.456507</value><value>0.458133</value><value>0.458689</value><value>0.461482</value><value>0.462606</value><value>0.463211</value><value>0.468214</value><value>0.469228</value><value>0.47135</value><value>0.476451</value><value>0.490352</value><value>0.506708</value></experimentalfactor><experimentalfactor><name>median.5to3prime.bias.picard</name><value>0.568229</value><value>0.58198</value><value>0.585323</value><value>0.587971</value><value>0.594834</value><value>0.599055</value><value>0.603934</value><value>0.608376</value><value>0.614396</value><value>0.615196</value><value>0.617553</value><value>0.620901</value><value>0.62359</value><value>0.624815</value><value>0.628312</value><value>0.636392</value><value>0.639601</value><value>0.645283</value><value>0.648227</value><value>0.651819</value><value>0.654083</value><value>0.655312</value><value>0.659333</value><value>0.669651</value></experimentalfactor><experimentalfactor><name>median.cv.coverage.picard</name><value>0.489994</value><value>0.495822</value><value>0.498845</value><value>0.50918</value><value>0.509791</value><value>0.514579</value><value>0.515141</value><value>0.515967</value><value>0.516626</value><value>0.521915</value><value>0.52525</value><value>0.530111</value><value>0.53213</value><value>0.536172</value><value>0.536375</value><value>0.536986</value><value>0.540069</value><value>0.542408</value><value>0.544495</value><value>0.546166</value><value>0.558868</value><value>0.57253</value><value>0.5855</value><value>0.672936</value></experimentalfactor><experimentalfactor><name>pf.all.bases.picard</name><value>1400830353</value><value>2160114475</value><value>2381776441</value><value>2667612889</value><value>2676307143</value><value>2799474872</value><value>3628330699</value><value>3667850200</value><value>3726947653</value><value>3829742695</value><value>3937184301</value><value>3998687269</value><value>4208626438</value><value>4380656349</value><value>4535639256</value><value>4550389520</value><value>5238958678</value><value>5301270119</value><value>5346972506</value><value>5361714476</value><value>5463948661</value><value>6192566687</value><value>6435460250</value><value>8421328282</value></experimentalfactor><experimentalfactor><name>pmi</name><value>12</value><value>13</value><value>16</value><value>17.83</value><value>19</value><value>20.3</value><value>21.08</value><value>21.33</value><value>21.47</value><value>22.12</value><value>23.23</value><value>23.25</value><value>23.83</value><value>25.47</value><value>26.16</value><value>26.5</value><value>30.75</value><value>30.8</value><value>31.5</value><value>32.92</value><value>39.15</value><value>43.25</value><value>6.75</value><value>8.3</value></experimentalfactor><experimentalfactor><name>primarycauseofdeath</name><value>Airway obstruction</value><value>Asphyxia</value><value>Aspiration</value><value>cancer</value><value>Cardiac Arrest</value><value>Drowning</value><value>gastrointestinal bleeding</value><value>Head Trauma</value><value>heart attack</value><value>Multisystem Failure</value><value>not specified</value><value>pancreatic cancer</value><value>Seizure disorder</value><value>Seizure Suspected</value><value>Unknown</value></experimentalfactor><experimentalfactor><name>propexonicreads.htsc</name><value>0.199289699821407</value><value>0.199491483715109</value><value>0.205380943772731</value><value>0.206035839916563</value><value>0.211381126899055</value><value>0.218807793509352</value><value>0.222355227667841</value><value>0.227599593037691</value><value>0.230517918601934</value><value>0.23200673943566</value><value>0.236222916424395</value><value>0.241850412605494</value><value>0.247112907702278</value><value>0.247944635871419</value><value>0.250729310342743</value><value>0.268190590703174</value><value>0.269084059244469</value><value>0.283788958310798</value><value>0.291545269337683</value><value>0.298174687069412</value><value>0.316050793386682</value><value>0.322754433526967</value><value>0.326368486910971</value><value>0.342817813861959</value></experimentalfactor><experimentalfactor><name>rin</name><value>1.8</value><value>2.9</value><value>5.1</value><value>6</value><value>6.1</value><value>6.3</value><value>6.4</value><value>7.1</value><value>7.2</value><value>7.3</value><value>7.8</value><value>7.9</value><value>8</value><value>8.1</value><value>8.2</value><value>8.3</value><value>8.6</value></experimentalfactor><experimentalfactor><name>secondarycauseofdeath</name><value>Alcohol intoxication</value><value>Associated with seizure disorder</value><value>Colorectal spread through abdomen</value><value>CP; Seizure Disorder</value><value>Dilated Cardiomyopathy; Morbid Obesity</value><value>Hanging</value><value>heart disease</value><value>not specified</value><value>Pneumonitis</value><value>Respiratory Arrest</value><value>SUDEP</value></experimentalfactor><experimentalfactor><name>Sex</name><value>female</value><value>male</value></experimentalfactor><experimentalfactor><name>totalreads.picard</name><value>14009235</value><value>21602464</value><value>23819131</value><value>26677747</value><value>26764492</value><value>27996353</value><value>36285419</value><value>36680597</value><value>37271753</value><value>38299573</value><value>39374242</value><value>39989410</value><value>42088917</value><value>43809852</value><value>45359064</value><value>45506260</value><value>52392755</value><value>53015802</value><value>53472673</value><value>53620215</value><value>54642554</value><value>61929295</value><value>64358619</value><value>84218275</value></experimentalfactor><experimentalfactor><name>utr.bases.picard</name><value>1074079230</value><value>1151872810</value><value>1161321487</value><value>1285458462</value><value>1292786624</value><value>1312933668</value><value>1475004428</value><value>1479357646</value><value>1495560716</value><value>1632881234</value><value>1672809200</value><value>1694136856</value><value>1752586185</value><value>1828034374</value><value>1852483312</value><value>1884703079</value><value>2305527744</value><value>2557873886</value><value>402098037</value><value>574331115</value><value>804222528</value><value>830338432</value><value>831540131</value><value>954701435</value></experimentalfactor><minseqescores><experimentdesignscore>1</experimentdesignscore><protocolscore>1</protocolscore><factorvaluescore>1</factorvaluescore><derivedbioassaydatascore>0</derivedbioassaydatascore><measuredbioassaydatascore>1</measuredbioassaydatascore><overallscore>4</overallscore></minseqescores><id>516970</id><accession>E-GEOD-64018</accession><secondaryaccession>GSE64018</secondaryaccession><name>RNA-seq of autistic and control cortex</name><experimenttype>RNA-seq of coding RNA</experimenttype><releasedate>2014-12-09</releasedate><lastupdatedate>2015-01-02</lastupdatedate><samples>24</samples><assays>24</assays><provider><contact>Neelroop N Parikshak</contact><role/><email/></provider><provider><contact>Daniel H Geschwind</contact><role/><email/></provider><provider><contact>Neelroop Parikshak</contact><role>submitter</role><email>geo@ncbi.nlm.nih.gov</email></provider><description><id/><text>Purpose: The goal of this study was to assess the status of splicing changes in microexons in the cortex of individuals with autism. Methods: We performed RiboZero Gold (rRNA depleted) 50bp PE RNA-seq in a larger set of case and control samples to define 12 autism and 12 control samples showing the greatest global differential gene expression change. These samples, which show differential expression of the splicing regulator SRRM4, were used to evaluate global splicing changes. Results: Within these samples, 126 of 504 (30%) detected alternative microexons display a mean ΔPSI &gt; 10 between ASD and control subjects of which 113 (90%) also display neural-differential regulation. By contrast, only 825 of 15,405 (5.4%) longer (i.e. &gt;27 nt) exons show such misregulation, of which 285 (35%) correspond to neural-regulated exons. Notably, we also observe significantly higher correlations between microexon inclusion and nSR100 mRNA expression levels across the stratified ASD samples and controls, for those microexons regulated by nSR100 relative to those microexons that are not regulated by this factor (p=1.4×10-7, Wilcoxon Sum Rank test). Conclusions: These data suggest microexon regulation is a potentially important mechanism underlying ASD and likely other neurodevelopmental disorders 12 case samples representing a more extreme autism gene expression signature and 12 representative controls; raw data have been submitted to dbGaP</text></description><protocol><id>1104017</id><accession>P-GSE64018-1</accession></protocol><organism>Homo sapiens</organism><files><!--
This section is deprecated and unsupported.
Please use webservice located at:
    http://www.ebi.ac.uk/arrayexpress/xml/files
to obtain detailed information on files available for the experiment.
For more information, please go to:
    http://www.ebi.ac.uk/arrayexpress/help/programmatic_access.html
                --><idf name="E-GEOD-64018.idf.txt"/><sdrf name="E-GEOD-64018.sdrf.txt"/></files></experiment><experiment><species>Homo sapiens</species><rawdatafiles available="true"/><processeddatafiles available="true"/><sampleattribute><category>cell line</category><value>Calu-3 2B4</value></sampleattribute><sampleattribute><category>infection</category><value>LoCoV</value><value>Mock  Infected</value></sampleattribute><sampleattribute><category>organism</category><value>Homo sapiens</value></sampleattribute><experimentalfactor><name>INFECTION</name><value>LoCoV</value><value>Mock  Infected</value></experimentalfactor><experimentalfactor><name>TIME</name><value>0h</value><value>12h</value><value>18h</value><value>24h</value><value>3h</value><value>7h</value></experimentalfactor><miamescores><reportersequencescore>1</reportersequencescore><protocolscore>1</protocolscore><factorvaluescore>1</factorvaluescore><derivedbioassaydatascore>1</derivedbioassaydatascore><measuredbioassaydatascore>1</measuredbioassaydatascore><overallscore>5</overallscore></miamescores><id>497307</id><accession>E-GEOD-56677</accession><secondaryaccession>GSE56677</secondaryaccession><name>Cytokine stimulation systems approach demonstrates differences in innate and pro-inflammatory host responses between genetically distinct MERS-CoV isolates</name><experimenttype>transcription profiling by array</experimenttype><releasedate>2014-08-31</releasedate><lastupdatedate>2014-09-07</lastupdatedate><samples>33</samples><assays>33</assays><arraydesign><id>25466</id><accession>A-GEOD-17077</accession><name>Agilent-039494 SurePrint G3 Human GE v2 8x60K Microarray 039381 (Probe Name version)</name><count>33</count></arraydesign><bioassaydatagroup><id/><name>rawData</name><bioassaydatacubes>33</bioassaydatacubes><arraydesignprovider/><dataformat>rawData</dataformat><bioassays>33</bioassays><isderived>0</isderived></bioassaydatagroup><bioassaydatagroup><id/><name>normalization</name><bioassaydatacubes>33</bioassaydatacubes><arraydesignprovider/><dataformat>normalization</dataformat><bioassays>33</bioassays><isderived>0</isderived></bioassaydatagroup><bioassaydatagroup><id/><name>processedData</name><bioassaydatacubes>33</bioassaydatacubes><arraydesignprovider/><dataformat>processedData</dataformat><bioassays>33</bioassays><isderived>0</isderived></bioassaydatagroup><provider><contact>Pavel Sova</contact><role/><email/></provider><provider><contact>Michael Katze</contact><role>submitter</role><email>data@viromics.washington.edu</email></provider><provider><contact>Victoria Carter</contact><role/><email/></provider><provider><contact>Michael G Katze</contact><role/><email/></provider><provider><contact>Jennifer Tisoncik-Go</contact><role/><email/></provider><provider><contact>Chris Williams</contact><role/><email/></provider><provider><contact>Ralph S Baric</contact><role/><email/></provider><provider><contact>Christian Selinger</contact><role/><email/></provider><provider><contact>Jean Chang</contact><role/><email/></provider><provider><contact>Vineet D Menachery</contact><role/><email/></provider><description><id/><text>Background: The recent emergence of a novel coronavirus in the Middle East (designated MERS-CoV) is a reminder of the zoonotic potential of coronaviruses and the severe disease these etiologic agents can cause in humans. Clinical features of Middle East respiratory syndrome (MERS) include severe acute pneumonia and renal failure that is highly reminiscent of severe acute respiratory syndrome (SARS) caused by SARS-CoV. The host response is a key component of highly pathogenic respiratory virus infection. Here, we computationally analyzed gene expression changes in a human airway epithelial cell line infected with two genetically distinct MERS-CoV strains obtained from human patients, MERS-CoV-EMC (designated EMC) and MERS-CoV-London (designated LoCoV).   Results: Using topological techniques, such as persistence homology and filtered clustering, we characterized the host response system to the different MERS-CoVs, with LoCoV inducing early kinetic changes, between 3 and 12 hours post infection, compared to EMC. Robust transcriptional changes distinguished the two MERS-CoV strains predominantly at the late time points. Combining statistical analysis of infection and cytokine-stimulated treatment transcriptomics, we identified differential innate and pro-inflammatory responses between the two virus strains, including up-regulation of extracellular remodeling genes following LoCoV infection and differential pro-inflammatory responses between the two strains.   Conclusions: These transcriptional differences may be the result of amino acid differences in viral proteins known to modulate innate immunity against MERS infection. Triplicate wells of Calu-3 2B4 cells were infected with Human Coronavirus EMC 2012 (HCoV-EMC) or time-matched mock infected.  Cells were harvested at 0, 3, 7, 12, 18 and 24 hours post-infection (hpi), RNA extracted and transcriptomics analyzed by microarray.</text></description><protocol><id>1070971</id><accession>P-GSE56677-2</accession></protocol><protocol><id>1070965</id><accession>P-GSE56677-1</accession></protocol><protocol><id>1070966</id><accession>P-GSE56677-7</accession></protocol><protocol><id>1070968</id><accession>P-GSE56677-5</accession></protocol><protocol><id>1070967</id><accession>P-GSE56677-6</accession></protocol><protocol><id>1070970</id><accession>P-GSE56677-3</accession></protocol><protocol><id>1070969</id><accession>P-GSE56677-4</accession></protocol><organism>Homo sapiens</organism><files><!--
This section is deprecated and unsupported.
Please use webservice located at:
    http://www.ebi.ac.uk/arrayexpress/xml/files
to obtain detailed information on files available for the experiment.
For more information, please go to:
    http://www.ebi.ac.uk/arrayexpress/help/programmatic_access.html
                --><raw name="E-GEOD-56677.raw.1.zip E-GEOD-56677.raw.2.zip E-GEOD-56677.raw.3.zip" count="true" celcount="0"/><fgem name="E-GEOD-56677.processed.1.zip" available="true"/><idf name="E-GEOD-56677.idf.txt"/><sdrf name="E-GEOD-56677.sdrf.txt"/></files></experiment><experiment><species>Homo sapiens</species><rawdatafiles available="false"/><processeddatafiles available="true"/><sampleattribute><category>cell line</category><value>A549</value></sampleattribute><sampleattribute><category>cell type</category><value>human  lung epithelial cells</value></sampleattribute><sampleattribute><category>organism</category><value>Homo sapiens</value></sampleattribute><sampleattribute><category>treated with</category><value>NT</value><value>ppp5RNA</value></sampleattribute><experimentalfactor><name>TIME</name><value>1 hr</value><value>12 hrs</value><value>2 hrs</value><value>24 hrs</value><value>4 hrs</value><value>48 hrs</value><value>6 hrs</value><value>8 hrs</value></experimentalfactor><experimentalfactor><name>TREATED WITH</name><value>NT</value><value>ppp5RNA</value></experimentalfactor><miamescores><reportersequencescore>1</reportersequencescore><protocolscore>1</protocolscore><factorvaluescore>1</factorvaluescore><derivedbioassaydatascore>1</derivedbioassaydatascore><measuredbioassaydatascore>1</measuredbioassaydatascore><overallscore>5</overallscore></miamescores><id>489329</id><accession>E-GEOD-60573</accession><secondaryaccession>GSE60573</secondaryaccession><name>Systems Analysis of a RIG-I Agonist Inducing Broad Spectrum Inhibition of Virus Infectivity [Kinetic]</name><experimenttype>transcription profiling by array</experimenttype><releasedate>2014-08-21</releasedate><lastupdatedate>2014-08-22</lastupdatedate><samples>11</samples><assays>11</assays><arraydesign><id>7604</id><accession>A-GEOD-10558</accession><name>Illumina HumanHT-12 V4.0 expression beadchip</name><count>11</count><legacy_id>2501282336</legacy_id></arraydesign><bioassaydatagroup><id/><name>normalization</name><bioassaydatacubes>11</bioassaydatacubes><arraydesignprovider/><dataformat>normalization</dataformat><bioassays>11</bioassays><isderived>0</isderived></bioassaydatagroup><bioassaydatagroup><id/><name>processedData</name><bioassaydatacubes>11</bioassaydatacubes><arraydesignprovider/><dataformat>processedData</dataformat><bioassays>11</bioassays><isderived>0</isderived></bioassaydatagroup><bibliography><accession>23633948</accession><authors>Goulet ML, Olagnier D, Xu Z, Paz S, Belgnaoui SM, Lafferty EI, Janelle V, Arguello M, Paquet M, Ghneim K, Richards S, Smith A, Wilkinson P, Cameron M, Kalinke U, Qureshi S, Lamarre A, Haddad EK, Sekaly RP, Peri S, Balachandran S, Lin R, Hiscott J</authors><title>Systems analysis of a RIG-I agonist inducing broad spectrum inhibition of virus infectivity.</title><doi>10.1371/journal.ppat.1003298</doi></bibliography><provider><contact>Marilene Paquet</contact><role/><email/></provider><provider><contact>Suzanne Paz</contact><role/><email/></provider><provider><contact>Alain Lamarre</contact><role/><email/></provider><provider><contact>Meztli Arguello</contact><role/><email/></provider><provider><contact>Marie-Line Goulet</contact><role/><email/></provider><provider><contact>John Hiscott</contact><role>submitter</role><email>jhiscott@vgtifl.org</email></provider><provider><contact>David Olagnier</contact><role/><email/></provider><provider><contact>Stephanie Richards</contact><role/><email/></provider><provider><contact>Rongtuan Lin</contact><role/><email/></provider><provider><contact>Elias K Haddad</contact><role/><email/></provider><provider><contact>Peter Wilkinson</contact><role/><email/></provider><provider><contact>Khader Ghneim</contact><role/><email/></provider><provider><contact>Zhengyun Xu</contact><role/><email/></provider><provider><contact>Mark Cameron</contact><role/><email/></provider><provider><contact>Valérie Janelle</contact><role/><email/></provider><provider><contact>Erin I Lafferty</contact><role/><email/></provider><provider><contact>Suraj Peri</contact><role/><email/></provider><provider><contact>Ulrich Kalinke</contact><role/><email/></provider><provider><contact>S M Belgnaoui</contact><role/><email/></provider><provider><contact>Salman Qureshi</contact><role/><email/></provider><provider><contact>Andrew Smith</contact><role/><email/></provider><provider><contact>John Hiscott</contact><role/><email/></provider><provider><contact>Siddharth Balachandran</contact><role/><email/></provider><provider><contact>Rafick P Sekaly</contact><role/><email/></provider><description><id/><text>The RIG-I like receptor pathway is stimulated during RNA virus infection by interaction between cytosolic RIG-I and viral RNA structures that contain short hairpin dsRNA and 5’ triphosphate (5’ppp) terminal structure. In the present study, an RNA agonist of RIG-I was synthesized in vitro and shown to stimulate RIG-I-dependent antiviral responses at concentrations in the picomolar range. In human lung epithelial A549 cells, 5’pppRNA specifically stimulated multiple parameters of the innate antiviral response, including IRF3, IRF7 and STAT1 activation, andinduction of inflammatory and interferon stimulated genes - hallmarks of a fully functional antiviral response. Evaluation of the magnitude and duration of gene expression by transcriptional profiling identified a robust, sustained and diversified antiviral and inflammatory response characterized by enhanced pathogen recognition and interferon (IFN)signaling. Bioinformatics analysis further identified a transcriptional signature uniquely induced by 5’pppRNA, and not by IFNα-2bthat included a constellation of IRF7 and NF-kB target genes capable of mobilizing multiple arms of the innate and adaptive immune response. Treatment of primary PBMCs or lung epithelial A549 cells with 5’pppRNA provided significant protection against a spectrum of RNA and DNA viruses. In C57Bl/6 mice, intravenous administration of 5’pppRNA protected animals from a lethal challenge with H1N1 Influenza, reduced virus titers in mouse lungs and protected animals from virus-induced pneumonia. Strikingly, the RIG-I-specific transcriptional response afforded partial protection from influenza challenge, even in the absence of type I interferon signaling. This systems approach providestranscriptional, biochemical, and in vivo analysis of the antiviral efficacy of 5’pppRNA and highlights the therapeutic potential associated with the use of RIG-I agonists as broad spectrum antiviral agents. Kinetic analysis of A549 cells treated with 5'pppRNA and analyzed at 1h, 2h, 4h, 6h, 8h, 12h, 24h or 48h.</text></description><protocol><id>1062795</id><accession>P-GSE60573-7</accession></protocol><protocol><id>1062797</id><accession>P-GSE60573-5</accession></protocol><protocol><id>1062796</id><accession>P-GSE60573-6</accession></protocol><protocol><id>1062798</id><accession>P-GSE60573-3</accession></protocol><protocol><id>1062799</id><accession>P-GSE60573-4</accession></protocol><protocol><id>1062794</id><accession>P-GSE60573-1</accession></protocol><protocol><id>1062800</id><accession>P-GSE60573-2</accession></protocol><organism>Homo sapiens</organism><files><!--
This section is deprecated and unsupported.
Please use webservice located at:
    http://www.ebi.ac.uk/arrayexpress/xml/files
to obtain detailed information on files available for the experiment.
For more information, please go to:
    http://www.ebi.ac.uk/arrayexpress/help/programmatic_access.html
                --><fgem name="E-GEOD-60573.processed.1.zip" available="true"/><idf name="E-GEOD-60573.idf.txt"/><sdrf name="E-GEOD-60573.sdrf.txt"/></files></experiment><experiment><species>Homo sapiens</species><rawdatafiles available="false"/><processeddatafiles available="true"/><sampleattribute><category>cell line</category><value>A549</value></sampleattribute><sampleattribute><category>cell type</category><value>human  lung epithelial cells</value></sampleattribute><sampleattribute><category>organism</category><value>Homo sapiens</value></sampleattribute><sampleattribute><category>treated with</category><value>IFN_2b_100</value><value>IFN_2b_1000</value><value>none (media)</value><value>ppp5RNA</value><value>RNAiMax</value></sampleattribute><experimentalfactor><name>TIME</name><value>24 hrs</value><value>6 hrs</value></experimentalfactor><experimentalfactor><name>TREATED WITH</name><value>IFN_2b_100</value><value>IFN_2b_1000</value><value>none (media)</value><value>ppp5RNA</value><value>RNAiMax</value></experimentalfactor><miamescores><reportersequencescore>1</reportersequencescore><protocolscore>1</protocolscore><factorvaluescore>1</factorvaluescore><derivedbioassaydatascore>1</derivedbioassaydatascore><measuredbioassaydatascore>1</measuredbioassaydatascore><overallscore>5</overallscore></miamescores><id>490315</id><accession>E-GEOD-60572</accession><secondaryaccession>GSE60572</secondaryaccession><name>Systems Analysis of a RIG-I Agonist Inducing Broad Spectrum Inhibition of Virus Infectivity [comparison]</name><experimenttype>transcription profiling by array</experimenttype><releasedate>2014-08-21</releasedate><lastupdatedate>2014-08-26</lastupdatedate><samples>24</samples><assays>24</assays><arraydesign><id>7604</id><accession>A-GEOD-10558</accession><name>Illumina HumanHT-12 V4.0 expression beadchip</name><count>24</count><legacy_id>2501282336</legacy_id></arraydesign><bioassaydatagroup><id/><name>normalization</name><bioassaydatacubes>24</bioassaydatacubes><arraydesignprovider/><dataformat>normalization</dataformat><bioassays>24</bioassays><isderived>0</isderived></bioassaydatagroup><bioassaydatagroup><id/><name>processedData</name><bioassaydatacubes>24</bioassaydatacubes><arraydesignprovider/><dataformat>processedData</dataformat><bioassays>24</bioassays><isderived>0</isderived></bioassaydatagroup><bibliography><accession>23633948</accession><authors>Goulet ML, Olagnier D, Xu Z, Paz S, Belgnaoui SM, Lafferty EI, Janelle V, Arguello M, Paquet M, Ghneim K, Richards S, Smith A, Wilkinson P, Cameron M, Kalinke U, Qureshi S, Lamarre A, Haddad EK, Sekaly RP, Peri S, Balachandran S, Lin R, Hiscott J</authors><title>Systems analysis of a RIG-I agonist inducing broad spectrum inhibition of virus infectivity.</title><doi>10.1371/journal.ppat.1003298</doi></bibliography><provider><contact>Rafick P Sekaly</contact><role/><email/></provider><provider><contact>John Hiscott</contact><role>submitter</role><email>jhiscott@vgtifl.org</email></provider><provider><contact>Meztli Arguello</contact><role/><email/></provider><provider><contact>Salman Qureshi</contact><role/><email/></provider><provider><contact>Zhengyun Xu</contact><role/><email/></provider><provider><contact>Rongtuan Lin</contact><role/><email/></provider><provider><contact>Siddharth Balachandran</contact><role/><email/></provider><provider><contact>Andrew Smith</contact><role/><email/></provider><provider><contact>S M Belgnaoui</contact><role/><email/></provider><provider><contact>Elias K Haddad</contact><role/><email/></provider><provider><contact>John Hiscott</contact><role/><email/></provider><provider><contact>Marie-Line Goulet</contact><role/><email/></provider><provider><contact>Suraj Peri</contact><role/><email/></provider><provider><contact>Peter Wilkinson</contact><role/><email/></provider><provider><contact>Valérie Janelle</contact><role/><email/></provider><provider><contact>Stephanie Richards</contact><role/><email/></provider><provider><contact>Khader Ghneim</contact><role/><email/></provider><provider><contact>Alain Lamarre</contact><role/><email/></provider><provider><contact>Marilene Paquet</contact><role/><email/></provider><provider><contact>Suzanne Paz</contact><role/><email/></provider><provider><contact>Ulrich Kalinke</contact><role/><email/></provider><provider><contact>David Olagnier</contact><role/><email/></provider><provider><contact>Erin I Lafferty</contact><role/><email/></provider><provider><contact>Mark Cameron</contact><role/><email/></provider><description><id/><text>The RIG-I like receptor pathway is stimulated during RNA virus infection by interaction between cytosolic RIG-I and viral RNA structures that contain short hairpin dsRNA and 5’ triphosphate (5’ppp) terminal structure. In the present study, an RNA agonist of RIG-I was synthesized in vitro and shown to stimulate RIG-I-dependent antiviral responses at concentrations in the picomolar range. In human lung epithelial A549 cells, 5’pppRNA specifically stimulated multiple parameters of the innate antiviral response, including IRF3, IRF7 and STAT1 activation, andinduction of inflammatory and interferon stimulated genes - hallmarks of a fully functional antiviral response. Evaluation of the magnitude and duration of gene expression by transcriptional profiling identified a robust, sustained and diversified antiviral and inflammatory response characterized by enhanced pathogen recognition and interferon (IFN)signaling. Bioinformatics analysis further identified a transcriptional signature uniquely induced by 5’pppRNA, and not by IFNα-2bthat included a constellation of IRF7 and NF-kB target genes capable of mobilizing multiple arms of the innate and adaptive immune response. Treatment of primary PBMCs or lung epithelial A549 cells with 5’pppRNA provided significant protection against a spectrum of RNA and DNA viruses. In C57Bl/6 mice, intravenous administration of 5’pppRNA protected animals from a lethal challenge with H1N1 Influenza, reduced virus titers in mouse lungs and protected animals from virus-induced pneumonia. Strikingly, the RIG-I-specific transcriptional response afforded partial protection from influenza challenge, even in the absence of type I interferon signaling. This systems approach providestranscriptional, biochemical, and in vivo analysis of the antiviral efficacy of 5’pppRNA and highlights the therapeutic potential associated with the use of RIG-I agonists as broad spectrum antiviral agents. A549 cells were either non-treated, treated with RNAiMax only, transfected with 5'pppRNA, or treated with IFNa-2b and analysed at 6h or 24h.</text></description><protocol><id>1063787</id><accession>P-GSE60572-1</accession></protocol><protocol><id>1063790</id><accession>P-GSE60572-5</accession></protocol><protocol><id>1063791</id><accession>P-GSE60572-4</accession></protocol><protocol><id>1063792</id><accession>P-GSE60572-3</accession></protocol><protocol><id>1063793</id><accession>P-GSE60572-2</accession></protocol><protocol><id>1063788</id><accession>P-GSE60572-7</accession></protocol><protocol><id>1063789</id><accession>P-GSE60572-6</accession></protocol><organism>Homo sapiens</organism><files><!--
This section is deprecated and unsupported.
Please use webservice located at:
    http://www.ebi.ac.uk/arrayexpress/xml/files
to obtain detailed information on files available for the experiment.
For more information, please go to:
    http://www.ebi.ac.uk/arrayexpress/help/programmatic_access.html
                --><fgem name="E-GEOD-60572.processed.1.zip" available="true"/><idf name="E-GEOD-60572.idf.txt"/><sdrf name="E-GEOD-60572.sdrf.txt"/></files></experiment><experiment><species>Homo sapiens</species><rawdatafiles available="true"/><processeddatafiles available="true"/><sampleattribute><category>cell type</category><value>mononuclear cell</value></sampleattribute><sampleattribute><category>diagnosis</category><value>Healthy volunteer</value><value>Septic shock</value><value>Severe Sepsis</value></sampleattribute><sampleattribute><category>organism</category><value>Homo sapiens</value></sampleattribute><sampleattribute><category>outcome</category><value>alive</value><value>dead</value><value>Healthy volunteer</value></sampleattribute><experimentalfactor><name>DIAGNOSIS</name><value>Healthy volunteer</value><value>Septic shock</value><value>Severe Sepsis</value></experimentalfactor><experimentalfactor><name>OUTCOME</name><value>alive</value><value>dead</value><value>Healthy volunteer</value></experimentalfactor><experimentalfactor><name>TIME</name><value>D0 (at the time of sepsis diagnosis)</value><value>D7 (7 days after diagnosis)</value><value>not specified</value></experimentalfactor><miamescores><reportersequencescore>1</reportersequencescore><protocolscore>1</protocolscore><factorvaluescore>1</factorvaluescore><derivedbioassaydatascore>1</derivedbioassaydatascore><measuredbioassaydatascore>1</measuredbioassaydatascore><overallscore>5</overallscore></miamescores><id>462353</id><accession>E-GEOD-48080</accession><secondaryaccession>GSE48080</secondaryaccession><name>Gene expression in peripheral mononuclear cells from septic patients secondary to community acquired pneumonia: patterns of gene expression and outcomes</name><experimenttype>transcription profiling by array</experimenttype><releasedate>2014-06-20</releasedate><lastupdatedate>2014-06-28</lastupdatedate><samples>23</samples><assays>23</assays><arraydesign><id>11853</id><accession>A-AGIL-28</accession><name>Agilent Whole Human Genome Microarray 4x44K 014850 G4112F (85 cols x 532 rows)</name><count>23</count><legacy_id>1316855037</legacy_id></arraydesign><bioassaydatagroup><id/><name>rawData</name><bioassaydatacubes>23</bioassaydatacubes><arraydesignprovider/><dataformat>rawData</dataformat><bioassays>23</bioassays><isderived>0</isderived></bioassaydatagroup><bioassaydatagroup><id/><name>normalization</name><bioassaydatacubes>23</bioassaydatacubes><arraydesignprovider/><dataformat>normalization</dataformat><bioassays>23</bioassays><isderived>0</isderived></bioassaydatagroup><bioassaydatagroup><id/><name>processedData</name><bioassaydatacubes>23</bioassaydatacubes><arraydesignprovider/><dataformat>processedData</dataformat><bioassays>23</bioassays><isderived>0</isderived></bioassaydatagroup><bibliography><accession>24667684</accession><authors>Severino P, Silva E, Baggio-Zappia GL, Brunialti MK, Nucci LA, Rigato O Jr, da Silva ID, Machado FR, Salomao R</authors><title>Patterns of gene expression in peripheral blood mononuclear cells and outcomes from patients with sepsis secondary to community acquired pneumonia.</title><doi>10.1371/journal.pone.0091886</doi></bibliography><provider><contact>Giovana L Baggio-Zappia</contact><role/><email/></provider><provider><contact>Eliézer Silva</contact><role/><email/></provider><provider><contact>Reinaldo Salomao</contact><role/><email/></provider><provider><contact>Milena K Brunialti</contact><role/><email/></provider><provider><contact>Otelo Rigato Junior</contact><role/><email/></provider><provider><contact>Flávia R Machado</contact><role/><email/></provider><provider><contact>Ismael D Guerreiro da Silva</contact><role/><email/></provider><provider><contact>Patricia Severino</contact><role/><email/></provider><provider><contact>Patricia Severino</contact><role>submitter</role><email>psever@einstein.br</email></provider><description><id/><text>Sepsis is defined as a systemic inflammatory response secondary to a proven or suspected infection. Mechanisms governing this inflammatory response have been shown to be complex and dynamic, involving cross-talking among diverse signaling pathways. However, current knowledge on mechanisms underlying sepsis is far from providing a complete picture of the syndrome, justifying additional efforts that might add to this scenario. Microarray-based expression profiling is a powerful approach for the investigation of complex clinical conditions such as sepsis: the analysis of gene transcription at the genome level potentially avoids results derived from biased assumptions. In this study we investigate whole-genome gene expression profiles of mononuclear cells from survivor and non-survivor septic patients. Blood samples were collected at the time of sepsis diagnosis and seven days later, allowing us to evaluate the role of biological processes or genes possibly involved in patient recovery. Aiming to circumvent, at least partially, the heterogeneity of septic patients we included only patients admitted with sepsis caused by community-acquired pneumonia. Global gene expression profiling allowed us to characterize early sepsis, as compared to healthy individuals. Our results corroborate literature reports on inflammation response in the early stages of sepsis but highlight great heterogeneity in gene expression during sepsis progress. Additionally, global gene expression in the early stage was also able to distinguish sepsis from septic shock and correlated with patient outcome. Differences in oxidative stress seem to be associated with clinical outcome, since significant differences in the expression profile of related genes were observed between survivors and non-survivors at the time of patient enrollment (early sepsis). However, our results substantiate current knowledge supporting that sepsis syndrome development is indeed multifaceted. Although the initial infection of enrolled patients was pneumonia, seven days later gene expression profiles seemed to be characteristic of each patient, common gene expression changes distinguishing survivors from non-survivors. This result could be associated with the underlying health status of each one of them, with complications due to sepsis itself as well as with distinct timing for response to treatment. In this study we investigate whole-genome gene expression profiles of mononuclear cells from survivor (n=5)  and non-survivor (n=5) septic patients, as well as from 3 healthy controls. Blood samples were collected at the time of sepsis diagnosis and seven days later, allowing us to evaluate the role of biological processes or genes possibly involved in patient recovery. Aiming to circumvent, at least partially, the heterogeneity of septic patients we included only patients admitted with sepsis caused by community-acquired pneumonia.</text></description><protocol><id>1038346</id><accession>P-GSE48080-6</accession></protocol><protocol><id>1038348</id><accession>P-GSE48080-4</accession></protocol><protocol><id>1038347</id><accession>P-GSE48080-5</accession></protocol><protocol><id>1038349</id><accession>P-GSE48080-3</accession></protocol><protocol><id>1038350</id><accession>P-GSE48080-2</accession></protocol><protocol><id>1038345</id><accession>P-GSE48080-1</accession></protocol><organism>Homo sapiens</organism><files><!--
This section is deprecated and unsupported.
Please use webservice located at:
    http://www.ebi.ac.uk/arrayexpress/xml/files
to obtain detailed information on files available for the experiment.
For more information, please go to:
    http://www.ebi.ac.uk/arrayexpress/help/programmatic_access.html
                --><raw name="E-GEOD-48080.raw.1.zip E-GEOD-48080.raw.2.zip" count="true" celcount="0"/><fgem name="E-GEOD-48080.processed.1.zip" available="true"/><idf name="E-GEOD-48080.idf.txt"/><sdrf name="E-GEOD-48080.sdrf.txt"/></files></experiment><experiment><species>Homo sapiens</species><rawdatafiles available="true"/><processeddatafiles available="true"/><sampleattribute><category>adjuvant therapy</category><value>no</value><value>unknown</value><value>yes</value></sampleattribute><sampleattribute><category>age</category><value>36</value><value>39</value><value>39.5397260273973</value><value>40</value><value>41</value><value>42</value><value>43.7698630136986</value><value>44</value><value>44.6630136986301</value><value>45</value><value>45.2219178082192</value><value>46</value><value>46.0328767123288</value><value>46.3287671232877</value><value>47</value><value>47.5506849315069</value><value>48</value><value>48.4027397260274</value><value>49</value><value>50</value><value>50.9123287671233</value><value>50.9424657534247</value><value>51</value><value>51.7369863013699</value><value>51.9890410958904</value><value>52</value><value>53</value><value>53.5643835616438</value><value>53.7424657534247</value><value>53.9972602739726</value><value>54</value><value>54.2931506849315</value><value>54.4794520547945</value><value>54.5753424657534</value><value>55</value><value>55.9890410958904</value><value>56</value><value>56.0849315068493</value><value>56.2328767123288</value><value>56.9643835616438</value><value>57</value><value>57.0986301369863</value><value>57.3945205479452</value><value>58</value><value>58.3205479452055</value><value>58.6356164383562</value><value>59</value><value>59.6520547945205</value><value>59.972602739726</value><value>60</value><value>60.5068493150685</value><value>61</value><value>61.2739726027397</value><value>61.3315068493151</value><value>62</value><value>62.1205479452055</value><value>62.4383561643836</value><value>62.8438356164384</value><value>62.8986301369863</value><value>63</value><value>63.6602739726027</value><value>63.7178082191781</value><value>64</value><value>64.013698630137</value><value>64.7506849315069</value><value>64.8794520547945</value><value>65</value><value>65.4493150684931</value><value>66</value><value>66.1479452054794</value><value>66.2712328767123</value><value>66.4602739726027</value><value>66.9178082191781</value><value>67</value><value>67.2739726027397</value><value>67.8438356164384</value><value>68</value><value>68.0849315068493</value><value>68.2904109589041</value><value>68.5178082191781</value><value>69</value><value>70</value><value>71</value><value>71.1835616438356</value><value>71.9150684931507</value><value>72</value><value>72.241095890411</value><value>73</value><value>74</value><value>75</value><value>75.5095890410959</value><value>76</value><value>78.8876712328767</value><value>80.9506849315069</value><value>81</value><value>82</value></sampleattribute><sampleattribute><category>alcohol use</category><value>no</value><value>yes</value></sampleattribute><sampleattribute><category>anastomotic leak</category><value>no</value><value>yes</value></sampleattribute><sampleattribute><category>arrhythmia</category><value>no</value><value>yes</value></sampleattribute><sampleattribute><category>death at fu</category><value>no</value><value>yes</value></sampleattribute><sampleattribute><category>disease state</category><value>esophageal squamous cell carcinoma</value></sampleattribute><sampleattribute><category>n stage</category><value>N0</value><value>N1</value><value>N2</value><value>N3</value></sampleattribute><sampleattribute><category>organism</category><value>Homo sapiens</value></sampleattribute><sampleattribute><category>organism part</category><value>cancer tissue from patient 10</value><value>cancer tissue from patient 101</value><value>cancer tissue from patient 102</value><value>cancer tissue from patient 106</value><value>cancer tissue from patient 108</value><value>cancer tissue from patient 11</value><value>cancer tissue from patient 112</value><value>cancer tissue from patient 117</value><value>cancer tissue from patient 119</value><value>cancer tissue from patient 12</value><value>cancer tissue from patient 120</value><value>cancer tissue from patient 122</value><value>cancer tissue from patient 129</value><value>cancer tissue from patient 13</value><value>cancer tissue from patient 131</value><value>cancer tissue from patient 132</value><value>cancer tissue from patient 134</value><value>cancer tissue from patient 135</value><value>cancer tissue from patient 136</value><value>cancer tissue from patient 142</value><value>cancer tissue from patient 146</value><value>cancer tissue from patient 148</value><value>cancer tissue from patient 201</value><value>cancer tissue from patient 205</value><value>cancer tissue from patient 206</value><value>cancer tissue from patient 207</value><value>cancer tissue from patient 208</value><value>cancer tissue from patient 210</value><value>cancer tissue from patient 211</value><value>cancer tissue from patient 212</value><value>cancer tissue from patient 214</value><value>cancer tissue from patient 215</value><value>cancer tissue from patient 216</value><value>cancer tissue from patient 217</value><value>cancer tissue from patient 218</value><value>cancer tissue from patient 219</value><value>cancer tissue from patient 220</value><value>cancer tissue from patient 221</value><value>cancer tissue from patient 222</value><value>cancer tissue from patient 223</value><value>cancer tissue from patient 224</value><value>cancer tissue from patient 225</value><value>cancer tissue from patient 226</value><value>cancer tissue from patient 227</value><value>cancer tissue from patient 228</value><value>cancer tissue from patient 229</value><value>cancer tissue from patient 23</value><value>cancer tissue from patient 231</value><value>cancer tissue from patient 234</value><value>cancer tissue from patient 236</value><value>cancer tissue from patient 239</value><value>cancer tissue from patient 241</value><value>cancer tissue from patient 243</value><value>cancer tissue from patient 245</value><value>cancer tissue from patient 246</value><value>cancer tissue from patient 247</value><value>cancer tissue from patient 249</value><value>cancer tissue from patient 25</value><value>cancer tissue from patient 251</value><value>cancer tissue from patient 253</value><value>cancer tissue from patient 256</value><value>cancer tissue from patient 258</value><value>cancer tissue from patient 259</value><value>cancer tissue from patient 26</value><value>cancer tissue from patient 260</value><value>cancer tissue from patient 261</value><value>cancer tissue from patient 262</value><value>cancer tissue from patient 264</value><value>cancer tissue from patient 265</value><value>cancer tissue from patient 266</value><value>cancer tissue from patient 268</value><value>cancer tissue from patient 269</value><value>cancer tissue from patient 27</value><value>cancer tissue from patient 273</value><value>cancer tissue from patient 274</value><value>cancer tissue from patient 275</value><value>cancer tissue from patient 277</value><value>cancer tissue from patient 279</value><value>cancer tissue from patient 28</value><value>cancer tissue from patient 280</value><value>cancer tissue from patient 281</value><value>cancer tissue from patient 284</value><value>cancer tissue from patient 285</value><value>cancer tissue from patient 287</value><value>cancer tissue from patient 288</value><value>cancer tissue from patient 29</value><value>cancer tissue from patient 290</value><value>cancer tissue from patient 297</value><value>cancer tissue from patient 30</value><value>cancer tissue from patient 302</value><value>cancer tissue from patient 303</value><value>cancer tissue from patient 305</value><value>cancer tissue from patient 306</value><value>cancer tissue from patient 308</value><value>cancer tissue from patient 309</value><value>cancer tissue from patient 31</value><value>cancer tissue from patient 311</value><value>cancer tissue from patient 312</value><value>cancer tissue from patient 315</value><value>cancer tissue from patient 316</value><value>cancer tissue from patient 317</value><value>cancer tissue from patient 318</value><value>cancer tissue from patient 319</value><value>cancer tissue from patient 32</value><value>cancer tissue from patient 321</value><value>cancer tissue from patient 322</value><value>cancer tissue from patient 324</value><value>cancer tissue from patient 325</value><value>cancer tissue from patient 326</value><value>cancer tissue from patient 330</value><value>cancer tissue from patient 331</value><value>cancer tissue from patient 333</value><value>cancer tissue from patient 334</value><value>cancer tissue from patient 337</value><value>cancer tissue from patient 338</value><value>cancer tissue from patient 340</value><value>cancer tissue from patient 341</value><value>cancer tissue from patient 342</value><value>cancer tissue from patient 347</value><value>cancer tissue from patient 353</value><value>cancer tissue from patient 355</value><value>cancer tissue from patient 36</value><value>cancer tissue from patient 361</value><value>cancer tissue from patient 362</value><value>cancer tissue from patient 365</value><value>cancer tissue from patient 366</value><value>cancer tissue from patient 367</value><value>cancer tissue from patient 370</value><value>cancer tissue from patient 371</value><value>cancer tissue from patient 373</value><value>cancer tissue from patient 374</value><value>cancer tissue from patient 375</value><value>cancer tissue from patient 376</value><value>cancer tissue from patient 378</value><value>cancer tissue from patient 380</value><value>cancer tissue from patient 381</value><value>cancer tissue from patient 382</value><value>cancer tissue from patient 385</value><value>cancer tissue from patient 391</value><value>cancer tissue from patient 392</value><value>cancer tissue from patient 393</value><value>cancer tissue from patient 396</value><value>cancer tissue from patient 398</value><value>cancer tissue from patient 4</value><value>cancer tissue from patient 400</value><value>cancer tissue from patient 402</value><value>cancer tissue from patient 403</value><value>cancer tissue from patient 404</value><value>cancer tissue from patient 405</value><value>cancer tissue from patient 406</value><value>cancer tissue from patient 407</value><value>cancer tissue from patient 408</value><value>cancer tissue from patient 409</value><value>cancer tissue from patient 42</value><value>cancer tissue from patient 45</value><value>cancer tissue from patient 46</value><value>cancer tissue from patient 49</value><value>cancer tissue from patient 51</value><value>cancer tissue from patient 52</value><value>cancer tissue from patient 6</value><value>cancer tissue from patient 60</value><value>cancer tissue from patient 61</value><value>cancer tissue from patient 68</value><value>cancer tissue from patient 7</value><value>cancer tissue from patient 71</value><value>cancer tissue from patient 73</value><value>cancer tissue from patient 74</value><value>cancer tissue from patient 76</value><value>cancer tissue from patient 77</value><value>cancer tissue from patient 79</value><value>cancer tissue from patient 80</value><value>cancer tissue from patient 81</value><value>cancer tissue from patient 87</value><value>cancer tissue from patient 9</value><value>cancer tissue from patient 91</value><value>cancer tissue from patient 92</value><value>cancer tissue from patient 94</value><value>cancer tissue from patient 96</value><value>cancer tissue from patient 97</value><value>normal tissue from patient 10</value><value>normal tissue from patient 101</value><value>normal tissue from patient 102</value><value>normal tissue from patient 106</value><value>normal tissue from patient 108</value><value>normal tissue from patient 11</value><value>normal tissue from patient 112</value><value>normal tissue from patient 117</value><value>normal tissue from patient 119</value><value>normal tissue from patient 12</value><value>normal tissue from patient 120</value><value>normal tissue from patient 122</value><value>normal tissue from patient 129</value><value>normal tissue from patient 13</value><value>normal tissue from patient 131</value><value>normal tissue from patient 132</value><value>normal tissue from patient 134</value><value>normal tissue from patient 135</value><value>normal tissue from patient 136</value><value>normal tissue from patient 142</value><value>normal tissue from patient 146</value><value>normal tissue from patient 148</value><value>normal tissue from patient 201</value><value>normal tissue from patient 205</value><value>normal tissue from patient 206</value><value>normal tissue from patient 207</value><value>normal tissue from patient 208</value><value>normal tissue from patient 210</value><value>normal tissue from patient 211</value><value>normal tissue from patient 212</value><value>normal tissue from patient 214</value><value>normal tissue from patient 215</value><value>normal tissue from patient 216</value><value>normal tissue from patient 217</value><value>normal tissue from patient 218</value><value>normal tissue from patient 219</value><value>normal tissue from patient 220</value><value>normal tissue from patient 221</value><value>normal tissue from patient 222</value><value>normal tissue from patient 223</value><value>normal tissue from patient 224</value><value>normal tissue from patient 225</value><value>normal tissue from patient 226</value><value>normal tissue from patient 227</value><value>normal tissue from patient 228</value><value>normal tissue from patient 229</value><value>normal tissue from patient 23</value><value>normal tissue from patient 231</value><value>normal tissue from patient 234</value><value>normal tissue from patient 236</value><value>normal tissue from patient 239</value><value>normal tissue from patient 241</value><value>normal tissue from patient 243</value><value>normal tissue from patient 245</value><value>normal tissue from patient 246</value><value>normal tissue from patient 247</value><value>normal tissue from patient 249</value><value>normal tissue from patient 25</value><value>normal tissue from patient 251</value><value>normal tissue from patient 253</value><value>normal tissue from patient 256</value><value>normal tissue from patient 258</value><value>normal tissue from patient 259</value><value>normal tissue from patient 26</value><value>normal tissue from patient 260</value><value>normal tissue from patient 261</value><value>normal tissue from patient 262</value><value>normal tissue from patient 264</value><value>normal tissue from patient 265</value><value>normal tissue from patient 266</value><value>normal tissue from patient 268</value><value>normal tissue from patient 269</value><value>normal tissue from patient 27</value><value>normal tissue from patient 273</value><value>normal tissue from patient 274</value><value>normal tissue from patient 275</value><value>normal tissue from patient 277</value><value>normal tissue from patient 279</value><value>normal tissue from patient 28</value><value>normal tissue from patient 280</value><value>normal tissue from patient 281</value><value>normal tissue from patient 284</value><value>normal tissue from patient 285</value><value>normal tissue from patient 287</value><value>normal tissue from patient 288</value><value>normal tissue from patient 29</value><value>normal tissue from patient 290</value><value>normal tissue from patient 297</value><value>normal tissue from patient 30</value><value>normal tissue from patient 302</value><value>normal tissue from patient 303</value><value>normal tissue from patient 305</value><value>normal tissue from patient 306</value><value>normal tissue from patient 308</value><value>normal tissue from patient 309</value><value>normal tissue from patient 31</value><value>normal tissue from patient 311</value><value>normal tissue from patient 312</value><value>normal tissue from patient 315</value><value>normal tissue from patient 316</value><value>normal tissue from patient 317</value><value>normal tissue from patient 318</value><value>normal tissue from patient 319</value><value>normal tissue from patient 32</value><value>normal tissue from patient 321</value><value>normal tissue from patient 322</value><value>normal tissue from patient 324</value><value>normal tissue from patient 325</value><value>normal tissue from patient 326</value><value>normal tissue from patient 330</value><value>normal tissue from patient 331</value><value>normal tissue from patient 333</value><value>normal tissue from patient 334</value><value>normal tissue from patient 337</value><value>normal tissue from patient 338</value><value>normal tissue from patient 340</value><value>normal tissue from patient 341</value><value>normal tissue from patient 342</value><value>normal tissue from patient 347</value><value>normal tissue from patient 353</value><value>normal tissue from patient 355</value><value>normal tissue from patient 36</value><value>normal tissue from patient 361</value><value>normal tissue from patient 362</value><value>normal tissue from patient 365</value><value>normal tissue from patient 366</value><value>normal tissue from patient 367</value><value>normal tissue from patient 370</value><value>normal tissue from patient 371</value><value>normal tissue from patient 373</value><value>normal tissue from patient 374</value><value>normal tissue from patient 375</value><value>normal tissue from patient 376</value><value>normal tissue from patient 378</value><value>normal tissue from patient 380</value><value>normal tissue from patient 381</value><value>normal tissue from patient 382</value><value>normal tissue from patient 385</value><value>normal tissue from patient 391</value><value>normal tissue from patient 392</value><value>normal tissue from patient 393</value><value>normal tissue from patient 396</value><value>normal tissue from patient 398</value><value>normal tissue from patient 4</value><value>normal tissue from patient 400</value><value>normal tissue from patient 402</value><value>normal tissue from patient 403</value><value>normal tissue from patient 404</value><value>normal tissue from patient 405</value><value>normal tissue from patient 406</value><value>normal tissue from patient 407</value><value>normal tissue from patient 408</value><value>normal tissue from patient 409</value><value>normal tissue from patient 42</value><value>normal tissue from patient 45</value><value>normal tissue from patient 46</value><value>normal tissue from patient 49</value><value>normal tissue from patient 51</value><value>normal tissue from patient 52</value><value>normal tissue from patient 6</value><value>normal tissue from patient 60</value><value>normal tissue from patient 61</value><value>normal tissue from patient 68</value><value>normal tissue from patient 7</value><value>normal tissue from patient 71</value><value>normal tissue from patient 73</value><value>normal tissue from patient 74</value><value>normal tissue from patient 76</value><value>normal tissue from patient 77</value><value>normal tissue from patient 79</value><value>normal tissue from patient 80</value><value>normal tissue from patient 81</value><value>normal tissue from patient 87</value><value>normal tissue from patient 9</value><value>normal tissue from patient 91</value><value>normal tissue from patient 92</value><value>normal tissue from patient 94</value><value>normal tissue from patient 96</value><value>normal tissue from patient 97</value></sampleattribute><sampleattribute><category>patient id</category><value>ec10</value><value>ec101</value><value>ec102</value><value>ec106</value><value>ec108</value><value>ec11</value><value>ec112</value><value>ec117</value><value>ec119</value><value>ec12</value><value>ec120</value><value>ec122</value><value>ec129</value><value>ec13</value><value>ec131</value><value>ec132</value><value>ec134</value><value>ec135</value><value>ec136</value><value>ec142</value><value>ec146</value><value>ec148</value><value>ec201</value><value>ec205</value><value>ec206</value><value>ec207</value><value>ec208</value><value>ec210</value><value>ec211</value><value>ec212</value><value>ec214</value><value>ec215</value><value>ec216</value><value>ec217</value><value>ec218</value><value>ec219</value><value>ec220</value><value>ec221</value><value>ec222</value><value>ec223</value><value>ec224</value><value>ec225</value><value>ec226</value><value>ec227</value><value>ec228</value><value>ec229</value><value>ec23</value><value>ec231</value><value>ec234</value><value>ec236</value><value>ec239</value><value>ec241</value><value>ec243</value><value>ec245</value><value>ec246</value><value>ec247</value><value>ec249</value><value>ec25</value><value>ec251</value><value>ec253</value><value>ec256</value><value>ec258</value><value>ec259</value><value>ec26</value><value>ec260</value><value>ec261</value><value>ec262</value><value>ec264</value><value>ec265</value><value>ec266</value><value>ec268</value><value>ec269</value><value>ec27</value><value>ec273</value><value>ec274</value><value>ec275</value><value>ec277</value><value>ec279</value><value>ec28</value><value>ec280</value><value>ec281</value><value>ec284</value><value>ec285</value><value>ec287</value><value>ec288</value><value>ec29</value><value>ec290</value><value>ec297</value><value>ec30</value><value>ec302</value><value>ec303</value><value>ec305</value><value>ec306</value><value>ec308</value><value>ec309</value><value>ec31</value><value>ec311</value><value>ec312</value><value>ec315</value><value>ec316</value><value>ec317</value><value>ec318</value><value>ec319</value><value>ec32</value><value>ec321</value><value>ec322</value><value>ec324</value><value>ec325</value><value>ec326</value><value>ec330</value><value>ec331</value><value>ec333</value><value>ec334</value><value>ec337</value><value>ec338</value><value>ec340</value><value>ec341</value><value>ec342</value><value>ec347</value><value>ec353</value><value>ec355</value><value>ec36</value><value>ec361</value><value>ec362</value><value>ec365</value><value>ec366</value><value>ec367</value><value>ec370</value><value>ec371</value><value>ec373</value><value>ec374</value><value>ec375</value><value>ec376</value><value>ec378</value><value>ec380</value><value>ec381</value><value>ec382</value><value>ec385</value><value>ec391</value><value>ec392</value><value>ec393</value><value>ec396</value><value>ec398</value><value>ec4</value><value>ec400</value><value>ec402</value><value>ec403</value><value>ec404</value><value>ec405</value><value>ec406</value><value>ec407</value><value>ec408</value><value>ec409</value><value>ec42</value><value>ec45</value><value>ec46</value><value>ec49</value><value>ec51</value><value>ec52</value><value>ec6</value><value>ec60</value><value>ec61</value><value>ec68</value><value>ec7</value><value>ec71</value><value>ec73</value><value>ec74</value><value>ec76</value><value>ec77</value><value>ec79</value><value>ec80</value><value>ec81</value><value>ec87</value><value>ec9</value><value>ec91</value><value>ec92</value><value>ec94</value><value>ec96</value><value>ec97</value></sampleattribute><sampleattribute><category>pneumonia</category><value>no</value><value>yes</value></sampleattribute><sampleattribute><category>Sex</category><value>female</value><value>male</value></sampleattribute><sampleattribute><category>survival timemonths</category><value>0.1</value><value>0.633333333333333</value><value>1.43333333333333</value><value>1.66666666666667</value><value>10.0333333333333</value><value>10.2</value><value>10.4666666666667</value><value>10.5666666666667</value><value>10.9666666666667</value><value>11</value><value>11.0666666666667</value><value>11.4</value><value>11.5</value><value>11.6333333333333</value><value>12</value><value>12.2333333333333</value><value>12.5666666666667</value><value>13</value><value>13.1666666666667</value><value>13.4666666666667</value><value>14.3666666666667</value><value>15.4333333333333</value><value>15.6</value><value>15.8666666666667</value><value>16.0333333333333</value><value>16.8333333333333</value><value>17.4333333333333</value><value>17.5</value><value>17.9</value><value>18.0666666666667</value><value>19.1666666666667</value><value>19.2</value><value>19.2666666666667</value><value>21.2333333333333</value><value>21.2666666666667</value><value>21.4333333333333</value><value>21.5333333333333</value><value>21.9333333333333</value><value>22.1333333333333</value><value>22.4</value><value>22.7</value><value>23.1333333333333</value><value>23.2666666666667</value><value>24.4</value><value>24.4333333333333</value><value>24.4666666666667</value><value>24.6666666666667</value><value>24.8</value><value>25.1666666666667</value><value>25.4666666666667</value><value>25.7333333333333</value><value>26.5</value><value>27.5666666666667</value><value>29.7</value><value>29.8666666666667</value><value>3.83333333333333</value><value>31.5</value><value>32.0666666666667</value><value>32.2</value><value>32.4666666666667</value><value>34.1666666666667</value><value>34.6666666666667</value><value>35.0333333333333</value><value>36.3</value><value>37.1666666666667</value><value>38.5333333333333</value><value>39.1666666666667</value><value>39.5</value><value>39.8333333333333</value><value>4.2</value><value>4.36666666666667</value><value>4.9</value><value>42.0333333333333</value><value>44.9333333333333</value><value>45.8333333333333</value><value>47.1666666666667</value><value>47.9333333333333</value><value>48.0333333333333</value><value>48.4333333333333</value><value>48.7666666666667</value><value>49.4333333333333</value><value>5.06666666666667</value><value>5.7</value><value>5.83333333333333</value><value>50.1666666666667</value><value>50.6</value><value>51.1</value><value>51.2</value><value>51.3</value><value>52.0333333333333</value><value>52.7</value><value>52.9333333333333</value><value>54.1</value><value>54.7333333333333</value><value>55.2666666666667</value><value>55.6666666666667</value><value>56.1333333333333</value><value>56.2333333333333</value><value>56.6333333333333</value><value>57.2333333333333</value><value>57.2666666666667</value><value>57.3666666666667</value><value>57.5333333333333</value><value>57.6</value><value>57.7333333333333</value><value>58.2</value><value>59.1333333333333</value><value>6</value><value>6.2</value><value>6.26666666666667</value><value>6.33333333333333</value><value>6.63333333333333</value><value>6.66666666666667</value><value>60.2</value><value>60.3</value><value>60.5</value><value>60.5666666666667</value><value>60.6333333333333</value><value>60.7333333333333</value><value>60.7666666666667</value><value>60.9</value><value>60.9666666666667</value><value>61</value><value>61.2</value><value>61.3</value><value>61.3333333333333</value><value>61.3666666666667</value><value>61.6</value><value>61.8333333333333</value><value>61.9</value><value>61.9333333333333</value><value>62.4666666666667</value><value>62.8666666666667</value><value>62.9333333333333</value><value>62.9666666666667</value><value>63.0666666666667</value><value>63.2666666666667</value><value>63.4</value><value>63.5333333333333</value><value>64</value><value>64.1333333333333</value><value>65.1666666666667</value><value>65.2666666666667</value><value>65.5</value><value>65.8666666666667</value><value>68</value><value>68.2</value><value>68.6</value><value>68.7</value><value>69.6333333333333</value><value>69.9666666666667</value><value>7.8</value><value>70.0666666666667</value><value>72.1333333333333</value><value>72.5333333333333</value><value>72.6333333333333</value><value>8.26666666666667</value><value>8.36666666666667</value><value>8.46666666666667</value><value>8.5</value><value>8.53333333333333</value><value>8.76666666666667</value><value>9</value><value>9.03333333333333</value><value>9.76666666666667</value></sampleattribute><sampleattribute><category>t stage</category><value>T1</value><value>T2</value><value>T3</value><value>T4</value></sampleattribute><sampleattribute><category>tnm stage</category><value>I</value><value>II</value><value>III</value></sampleattribute><sampleattribute><category>tobacco use</category><value>no</value><value>yes</value></sampleattribute><sampleattribute><category>tumor grade</category><value>moderately</value><value>poorly</value><value>well</value></sampleattribute><sampleattribute><category>tumor loation</category><value>lower</value><value>middle</value><value>upper</value></sampleattribute><experimentalfactor><name>ADJUVANT THERAPY</name><value>no</value><value>unknown</value><value>yes</value></experimentalfactor><experimentalfactor><name>AGE</name><value>36</value><value>39</value><value>39.5397260273973</value><value>40</value><value>41</value><value>42</value><value>43.7698630136986</value><value>44</value><value>44.6630136986301</value><value>45</value><value>45.2219178082192</value><value>46</value><value>46.0328767123288</value><value>46.3287671232877</value><value>47</value><value>47.5506849315069</value><value>48</value><value>48.4027397260274</value><value>49</value><value>50</value><value>50.9123287671233</value><value>50.9424657534247</value><value>51</value><value>51.7369863013699</value><value>51.9890410958904</value><value>52</value><value>53</value><value>53.5643835616438</value><value>53.7424657534247</value><value>53.9972602739726</value><value>54</value><value>54.2931506849315</value><value>54.4794520547945</value><value>54.5753424657534</value><value>55</value><value>55.9890410958904</value><value>56</value><value>56.0849315068493</value><value>56.2328767123288</value><value>56.9643835616438</value><value>57</value><value>57.0986301369863</value><value>57.3945205479452</value><value>58</value><value>58.3205479452055</value><value>58.6356164383562</value><value>59</value><value>59.6520547945205</value><value>59.972602739726</value><value>60</value><value>60.5068493150685</value><value>61</value><value>61.2739726027397</value><value>61.3315068493151</value><value>62</value><value>62.1205479452055</value><value>62.4383561643836</value><value>62.8438356164384</value><value>62.8986301369863</value><value>63</value><value>63.6602739726027</value><value>63.7178082191781</value><value>64</value><value>64.013698630137</value><value>64.7506849315069</value><value>64.8794520547945</value><value>65</value><value>65.4493150684931</value><value>66</value><value>66.1479452054794</value><value>66.2712328767123</value><value>66.4602739726027</value><value>66.9178082191781</value><value>67</value><value>67.2739726027397</value><value>67.8438356164384</value><value>68</value><value>68.0849315068493</value><value>68.2904109589041</value><value>68.5178082191781</value><value>69</value><value>70</value><value>71</value><value>71.1835616438356</value><value>71.9150684931507</value><value>72</value><value>72.241095890411</value><value>73</value><value>74</value><value>75</value><value>75.5095890410959</value><value>76</value><value>78.8876712328767</value><value>80.9506849315069</value><value>81</value><value>82</value></experimentalfactor><experimentalfactor><name>ALCOHOL USE</name><value>no</value><value>yes</value></experimentalfactor><experimentalfactor><name>ANASTOMOTIC LEAK</name><value>no</value><value>yes</value></experimentalfactor><experimentalfactor><name>ARRHYTHMIA</name><value>no</value><value>yes</value></experimentalfactor><experimentalfactor><name>DEATH AT FU</name><value>no</value><value>yes</value></experimentalfactor><experimentalfactor><name>N STAGE</name><value>N0</value><value>N1</value><value>N2</value><value>N3</value></experimentalfactor><experimentalfactor><name>ORGANISM PART</name><value>cancer tissue from patient 10</value><value>cancer tissue from patient 101</value><value>cancer tissue from patient 102</value><value>cancer tissue from patient 106</value><value>cancer tissue from patient 108</value><value>cancer tissue from patient 11</value><value>cancer tissue from patient 112</value><value>cancer tissue from patient 117</value><value>cancer tissue from patient 119</value><value>cancer tissue from patient 12</value><value>cancer tissue from patient 120</value><value>cancer tissue from patient 122</value><value>cancer tissue from patient 129</value><value>cancer tissue from patient 13</value><value>cancer tissue from patient 131</value><value>cancer tissue from patient 132</value><value>cancer tissue from patient 134</value><value>cancer tissue from patient 135</value><value>cancer tissue from patient 136</value><value>cancer tissue from patient 142</value><value>cancer tissue from patient 146</value><value>cancer tissue from patient 148</value><value>cancer tissue from patient 201</value><value>cancer tissue from patient 205</value><value>cancer tissue from patient 206</value><value>cancer tissue from patient 207</value><value>cancer tissue from patient 208</value><value>cancer tissue from patient 210</value><value>cancer tissue from patient 211</value><value>cancer tissue from patient 212</value><value>cancer tissue from patient 214</value><value>cancer tissue from patient 215</value><value>cancer tissue from patient 216</value><value>cancer tissue from patient 217</value><value>cancer tissue from patient 218</value><value>cancer tissue from patient 219</value><value>cancer tissue from patient 220</value><value>cancer tissue from patient 221</value><value>cancer tissue from patient 222</value><value>cancer tissue from patient 223</value><value>cancer tissue from patient 224</value><value>cancer tissue from patient 225</value><value>cancer tissue from patient 226</value><value>cancer tissue from patient 227</value><value>cancer tissue from patient 228</value><value>cancer tissue from patient 229</value><value>cancer tissue from patient 23</value><value>cancer tissue from patient 231</value><value>cancer tissue from patient 234</value><value>cancer tissue from patient 236</value><value>cancer tissue from patient 239</value><value>cancer tissue from patient 241</value><value>cancer tissue from patient 243</value><value>cancer tissue from patient 245</value><value>cancer tissue from patient 246</value><value>cancer tissue from patient 247</value><value>cancer tissue from patient 249</value><value>cancer tissue from patient 25</value><value>cancer tissue from patient 251</value><value>cancer tissue from patient 253</value><value>cancer tissue from patient 256</value><value>cancer tissue from patient 258</value><value>cancer tissue from patient 259</value><value>cancer tissue from patient 26</value><value>cancer tissue from patient 260</value><value>cancer tissue from patient 261</value><value>cancer tissue from patient 262</value><value>cancer tissue from patient 264</value><value>cancer tissue from patient 265</value><value>cancer tissue from patient 266</value><value>cancer tissue from patient 268</value><value>cancer tissue from patient 269</value><value>cancer tissue from patient 27</value><value>cancer tissue from patient 273</value><value>cancer tissue from patient 274</value><value>cancer tissue from patient 275</value><value>cancer tissue from patient 277</value><value>cancer tissue from patient 279</value><value>cancer tissue from patient 28</value><value>cancer tissue from patient 280</value><value>cancer tissue from patient 281</value><value>cancer tissue from patient 284</value><value>cancer tissue from patient 285</value><value>cancer tissue from patient 287</value><value>cancer tissue from patient 288</value><value>cancer tissue from patient 29</value><value>cancer tissue from patient 290</value><value>cancer tissue from patient 297</value><value>cancer tissue from patient 30</value><value>cancer tissue from patient 302</value><value>cancer tissue from patient 303</value><value>cancer tissue from patient 305</value><value>cancer tissue from patient 306</value><value>cancer tissue from patient 308</value><value>cancer tissue from patient 309</value><value>cancer tissue from patient 31</value><value>cancer tissue from patient 311</value><value>cancer tissue from patient 312</value><value>cancer tissue from patient 315</value><value>cancer tissue from patient 316</value><value>cancer tissue from patient 317</value><value>cancer tissue from patient 318</value><value>cancer tissue from patient 319</value><value>cancer tissue from patient 32</value><value>cancer tissue from patient 321</value><value>cancer tissue from patient 322</value><value>cancer tissue from patient 324</value><value>cancer tissue from patient 325</value><value>cancer tissue from patient 326</value><value>cancer tissue from patient 330</value><value>cancer tissue from patient 331</value><value>cancer tissue from patient 333</value><value>cancer tissue from patient 334</value><value>cancer tissue from patient 337</value><value>cancer tissue from patient 338</value><value>cancer tissue from patient 340</value><value>cancer tissue from patient 341</value><value>cancer tissue from patient 342</value><value>cancer tissue from patient 347</value><value>cancer tissue from patient 353</value><value>cancer tissue from patient 355</value><value>cancer tissue from patient 36</value><value>cancer tissue from patient 361</value><value>cancer tissue from patient 362</value><value>cancer tissue from patient 365</value><value>cancer tissue from patient 366</value><value>cancer tissue from patient 367</value><value>cancer tissue from patient 370</value><value>cancer tissue from patient 371</value><value>cancer tissue from patient 373</value><value>cancer tissue from patient 374</value><value>cancer tissue from patient 375</value><value>cancer tissue from patient 376</value><value>cancer tissue from patient 378</value><value>cancer tissue from patient 380</value><value>cancer tissue from patient 381</value><value>cancer tissue from patient 382</value><value>cancer tissue from patient 385</value><value>cancer tissue from patient 391</value><value>cancer tissue from patient 392</value><value>cancer tissue from patient 393</value><value>cancer tissue from patient 396</value><value>cancer tissue from patient 398</value><value>cancer tissue from patient 4</value><value>cancer tissue from patient 400</value><value>cancer tissue from patient 402</value><value>cancer tissue from patient 403</value><value>cancer tissue from patient 404</value><value>cancer tissue from patient 405</value><value>cancer tissue from patient 406</value><value>cancer tissue from patient 407</value><value>cancer tissue from patient 408</value><value>cancer tissue from patient 409</value><value>cancer tissue from patient 42</value><value>cancer tissue from patient 45</value><value>cancer tissue from patient 46</value><value>cancer tissue from patient 49</value><value>cancer tissue from patient 51</value><value>cancer tissue from patient 52</value><value>cancer tissue from patient 6</value><value>cancer tissue from patient 60</value><value>cancer tissue from patient 61</value><value>cancer tissue from patient 68</value><value>cancer tissue from patient 7</value><value>cancer tissue from patient 71</value><value>cancer tissue from patient 73</value><value>cancer tissue from patient 74</value><value>cancer tissue from patient 76</value><value>cancer tissue from patient 77</value><value>cancer tissue from patient 79</value><value>cancer tissue from patient 80</value><value>cancer tissue from patient 81</value><value>cancer tissue from patient 87</value><value>cancer tissue from patient 9</value><value>cancer tissue from patient 91</value><value>cancer tissue from patient 92</value><value>cancer tissue from patient 94</value><value>cancer tissue from patient 96</value><value>cancer tissue from patient 97</value><value>normal tissue from patient 10</value><value>normal tissue from patient 101</value><value>normal tissue from patient 102</value><value>normal tissue from patient 106</value><value>normal tissue from patient 108</value><value>normal tissue from patient 11</value><value>normal tissue from patient 112</value><value>normal tissue from patient 117</value><value>normal tissue from patient 119</value><value>normal tissue from patient 12</value><value>normal tissue from patient 120</value><value>normal tissue from patient 122</value><value>normal tissue from patient 129</value><value>normal tissue from patient 13</value><value>normal tissue from patient 131</value><value>normal tissue from patient 132</value><value>normal tissue from patient 134</value><value>normal tissue from patient 135</value><value>normal tissue from patient 136</value><value>normal tissue from patient 142</value><value>normal tissue from patient 146</value><value>normal tissue from patient 148</value><value>normal tissue from patient 201</value><value>normal tissue from patient 205</value><value>normal tissue from patient 206</value><value>normal tissue from patient 207</value><value>normal tissue from patient 208</value><value>normal tissue from patient 210</value><value>normal tissue from patient 211</value><value>normal tissue from patient 212</value><value>normal tissue from patient 214</value><value>normal tissue from patient 215</value><value>normal tissue from patient 216</value><value>normal tissue from patient 217</value><value>normal tissue from patient 218</value><value>normal tissue from patient 219</value><value>normal tissue from patient 220</value><value>normal tissue from patient 221</value><value>normal tissue from patient 222</value><value>normal tissue from patient 223</value><value>normal tissue from patient 224</value><value>normal tissue from patient 225</value><value>normal tissue from patient 226</value><value>normal tissue from patient 227</value><value>normal tissue from patient 228</value><value>normal tissue from patient 229</value><value>normal tissue from patient 23</value><value>normal tissue from patient 231</value><value>normal tissue from patient 234</value><value>normal tissue from patient 236</value><value>normal tissue from patient 239</value><value>normal tissue from patient 241</value><value>normal tissue from patient 243</value><value>normal tissue from patient 245</value><value>normal tissue from patient 246</value><value>normal tissue from patient 247</value><value>normal tissue from patient 249</value><value>normal tissue from patient 25</value><value>normal tissue from patient 251</value><value>normal tissue from patient 253</value><value>normal tissue from patient 256</value><value>normal tissue from patient 258</value><value>normal tissue from patient 259</value><value>normal tissue from patient 26</value><value>normal tissue from patient 260</value><value>normal tissue from patient 261</value><value>normal tissue from patient 262</value><value>normal tissue from patient 264</value><value>normal tissue from patient 265</value><value>normal tissue from patient 266</value><value>normal tissue from patient 268</value><value>normal tissue from patient 269</value><value>normal tissue from patient 27</value><value>normal tissue from patient 273</value><value>normal tissue from patient 274</value><value>normal tissue from patient 275</value><value>normal tissue from patient 277</value><value>normal tissue from patient 279</value><value>normal tissue from patient 28</value><value>normal tissue from patient 280</value><value>normal tissue from patient 281</value><value>normal tissue from patient 284</value><value>normal tissue from patient 285</value><value>normal tissue from patient 287</value><value>normal tissue from patient 288</value><value>normal tissue from patient 29</value><value>normal tissue from patient 290</value><value>normal tissue from patient 297</value><value>normal tissue from patient 30</value><value>normal tissue from patient 302</value><value>normal tissue from patient 303</value><value>normal tissue from patient 305</value><value>normal tissue from patient 306</value><value>normal tissue from patient 308</value><value>normal tissue from patient 309</value><value>normal tissue from patient 31</value><value>normal tissue from patient 311</value><value>normal tissue from patient 312</value><value>normal tissue from patient 315</value><value>normal tissue from patient 316</value><value>normal tissue from patient 317</value><value>normal tissue from patient 318</value><value>normal tissue from patient 319</value><value>normal tissue from patient 32</value><value>normal tissue from patient 321</value><value>normal tissue from patient 322</value><value>normal tissue from patient 324</value><value>normal tissue from patient 325</value><value>normal tissue from patient 326</value><value>normal tissue from patient 330</value><value>normal tissue from patient 331</value><value>normal tissue from patient 333</value><value>normal tissue from patient 334</value><value>normal tissue from patient 337</value><value>normal tissue from patient 338</value><value>normal tissue from patient 340</value><value>normal tissue from patient 341</value><value>normal tissue from patient 342</value><value>normal tissue from patient 347</value><value>normal tissue from patient 353</value><value>normal tissue from patient 355</value><value>normal tissue from patient 36</value><value>normal tissue from patient 361</value><value>normal tissue from patient 362</value><value>normal tissue from patient 365</value><value>normal tissue from patient 366</value><value>normal tissue from patient 367</value><value>normal tissue from patient 370</value><value>normal tissue from patient 371</value><value>normal tissue from patient 373</value><value>normal tissue from patient 374</value><value>normal tissue from patient 375</value><value>normal tissue from patient 376</value><value>normal tissue from patient 378</value><value>normal tissue from patient 380</value><value>normal tissue from patient 381</value><value>normal tissue from patient 382</value><value>normal tissue from patient 385</value><value>normal tissue from patient 391</value><value>normal tissue from patient 392</value><value>normal tissue from patient 393</value><value>normal tissue from patient 396</value><value>normal tissue from patient 398</value><value>normal tissue from patient 4</value><value>normal tissue from patient 400</value><value>normal tissue from patient 402</value><value>normal tissue from patient 403</value><value>normal tissue from patient 404</value><value>normal tissue from patient 405</value><value>normal tissue from patient 406</value><value>normal tissue from patient 407</value><value>normal tissue from patient 408</value><value>normal tissue from patient 409</value><value>normal tissue from patient 42</value><value>normal tissue from patient 45</value><value>normal tissue from patient 46</value><value>normal tissue from patient 49</value><value>normal tissue from patient 51</value><value>normal tissue from patient 52</value><value>normal tissue from patient 6</value><value>normal tissue from patient 60</value><value>normal tissue from patient 61</value><value>normal tissue from patient 68</value><value>normal tissue from patient 7</value><value>normal tissue from patient 71</value><value>normal tissue from patient 73</value><value>normal tissue from patient 74</value><value>normal tissue from patient 76</value><value>normal tissue from patient 77</value><value>normal tissue from patient 79</value><value>normal tissue from patient 80</value><value>normal tissue from patient 81</value><value>normal tissue from patient 87</value><value>normal tissue from patient 9</value><value>normal tissue from patient 91</value><value>normal tissue from patient 92</value><value>normal tissue from patient 94</value><value>normal tissue from patient 96</value><value>normal tissue from patient 97</value></experimentalfactor><experimentalfactor><name>PATIENT ID</name><value>ec10</value><value>ec101</value><value>ec102</value><value>ec106</value><value>ec108</value><value>ec11</value><value>ec112</value><value>ec117</value><value>ec119</value><value>ec12</value><value>ec120</value><value>ec122</value><value>ec129</value><value>ec13</value><value>ec131</value><value>ec132</value><value>ec134</value><value>ec135</value><value>ec136</value><value>ec142</value><value>ec146</value><value>ec148</value><value>ec201</value><value>ec205</value><value>ec206</value><value>ec207</value><value>ec208</value><value>ec210</value><value>ec211</value><value>ec212</value><value>ec214</value><value>ec215</value><value>ec216</value><value>ec217</value><value>ec218</value><value>ec219</value><value>ec220</value><value>ec221</value><value>ec222</value><value>ec223</value><value>ec224</value><value>ec225</value><value>ec226</value><value>ec227</value><value>ec228</value><value>ec229</value><value>ec23</value><value>ec231</value><value>ec234</value><value>ec236</value><value>ec239</value><value>ec241</value><value>ec243</value><value>ec245</value><value>ec246</value><value>ec247</value><value>ec249</value><value>ec25</value><value>ec251</value><value>ec253</value><value>ec256</value><value>ec258</value><value>ec259</value><value>ec26</value><value>ec260</value><value>ec261</value><value>ec262</value><value>ec264</value><value>ec265</value><value>ec266</value><value>ec268</value><value>ec269</value><value>ec27</value><value>ec273</value><value>ec274</value><value>ec275</value><value>ec277</value><value>ec279</value><value>ec28</value><value>ec280</value><value>ec281</value><value>ec284</value><value>ec285</value><value>ec287</value><value>ec288</value><value>ec29</value><value>ec290</value><value>ec297</value><value>ec30</value><value>ec302</value><value>ec303</value><value>ec305</value><value>ec306</value><value>ec308</value><value>ec309</value><value>ec31</value><value>ec311</value><value>ec312</value><value>ec315</value><value>ec316</value><value>ec317</value><value>ec318</value><value>ec319</value><value>ec32</value><value>ec321</value><value>ec322</value><value>ec324</value><value>ec325</value><value>ec326</value><value>ec330</value><value>ec331</value><value>ec333</value><value>ec334</value><value>ec337</value><value>ec338</value><value>ec340</value><value>ec341</value><value>ec342</value><value>ec347</value><value>ec353</value><value>ec355</value><value>ec36</value><value>ec361</value><value>ec362</value><value>ec365</value><value>ec366</value><value>ec367</value><value>ec370</value><value>ec371</value><value>ec373</value><value>ec374</value><value>ec375</value><value>ec376</value><value>ec378</value><value>ec380</value><value>ec381</value><value>ec382</value><value>ec385</value><value>ec391</value><value>ec392</value><value>ec393</value><value>ec396</value><value>ec398</value><value>ec4</value><value>ec400</value><value>ec402</value><value>ec403</value><value>ec404</value><value>ec405</value><value>ec406</value><value>ec407</value><value>ec408</value><value>ec409</value><value>ec42</value><value>ec45</value><value>ec46</value><value>ec49</value><value>ec51</value><value>ec52</value><value>ec6</value><value>ec60</value><value>ec61</value><value>ec68</value><value>ec7</value><value>ec71</value><value>ec73</value><value>ec74</value><value>ec76</value><value>ec77</value><value>ec79</value><value>ec80</value><value>ec81</value><value>ec87</value><value>ec9</value><value>ec91</value><value>ec92</value><value>ec94</value><value>ec96</value><value>ec97</value></experimentalfactor><experimentalfactor><name>PNEUMONIA</name><value>no</value><value>yes</value></experimentalfactor><experimentalfactor><name>SEX</name><value>female</value><value>male</value></experimentalfactor><experimentalfactor><name>SURVIVAL TIMEMONTHS</name><value>0.1</value><value>0.633333333333333</value><value>1.43333333333333</value><value>1.66666666666667</value><value>10.0333333333333</value><value>10.2</value><value>10.4666666666667</value><value>10.5666666666667</value><value>10.9666666666667</value><value>11</value><value>11.0666666666667</value><value>11.4</value><value>11.5</value><value>11.6333333333333</value><value>12</value><value>12.2333333333333</value><value>12.5666666666667</value><value>13</value><value>13.1666666666667</value><value>13.4666666666667</value><value>14.3666666666667</value><value>15.4333333333333</value><value>15.6</value><value>15.8666666666667</value><value>16.0333333333333</value><value>16.8333333333333</value><value>17.4333333333333</value><value>17.5</value><value>17.9</value><value>18.0666666666667</value><value>19.1666666666667</value><value>19.2</value><value>19.2666666666667</value><value>21.2333333333333</value><value>21.2666666666667</value><value>21.4333333333333</value><value>21.5333333333333</value><value>21.9333333333333</value><value>22.1333333333333</value><value>22.4</value><value>22.7</value><value>23.1333333333333</value><value>23.2666666666667</value><value>24.4</value><value>24.4333333333333</value><value>24.4666666666667</value><value>24.6666666666667</value><value>24.8</value><value>25.1666666666667</value><value>25.4666666666667</value><value>25.7333333333333</value><value>26.5</value><value>27.5666666666667</value><value>29.7</value><value>29.8666666666667</value><value>3.83333333333333</value><value>31.5</value><value>32.0666666666667</value><value>32.2</value><value>32.4666666666667</value><value>34.1666666666667</value><value>34.6666666666667</value><value>35.0333333333333</value><value>36.3</value><value>37.1666666666667</value><value>38.5333333333333</value><value>39.1666666666667</value><value>39.5</value><value>39.8333333333333</value><value>4.2</value><value>4.36666666666667</value><value>4.9</value><value>42.0333333333333</value><value>44.9333333333333</value><value>45.8333333333333</value><value>47.1666666666667</value><value>47.9333333333333</value><value>48.0333333333333</value><value>48.4333333333333</value><value>48.7666666666667</value><value>49.4333333333333</value><value>5.06666666666667</value><value>5.7</value><value>5.83333333333333</value><value>50.1666666666667</value><value>50.6</value><value>51.1</value><value>51.2</value><value>51.3</value><value>52.0333333333333</value><value>52.7</value><value>52.9333333333333</value><value>54.1</value><value>54.7333333333333</value><value>55.2666666666667</value><value>55.6666666666667</value><value>56.1333333333333</value><value>56.2333333333333</value><value>56.6333333333333</value><value>57.2333333333333</value><value>57.2666666666667</value><value>57.3666666666667</value><value>57.5333333333333</value><value>57.6</value><value>57.7333333333333</value><value>58.2</value><value>59.1333333333333</value><value>6</value><value>6.2</value><value>6.26666666666667</value><value>6.33333333333333</value><value>6.63333333333333</value><value>6.66666666666667</value><value>60.2</value><value>60.3</value><value>60.5</value><value>60.5666666666667</value><value>60.6333333333333</value><value>60.7333333333333</value><value>60.7666666666667</value><value>60.9</value><value>60.9666666666667</value><value>61</value><value>61.2</value><value>61.3</value><value>61.3333333333333</value><value>61.3666666666667</value><value>61.6</value><value>61.8333333333333</value><value>61.9</value><value>61.9333333333333</value><value>62.4666666666667</value><value>62.8666666666667</value><value>62.9333333333333</value><value>62.9666666666667</value><value>63.0666666666667</value><value>63.2666666666667</value><value>63.4</value><value>63.5333333333333</value><value>64</value><value>64.1333333333333</value><value>65.1666666666667</value><value>65.2666666666667</value><value>65.5</value><value>65.8666666666667</value><value>68</value><value>68.2</value><value>68.6</value><value>68.7</value><value>69.6333333333333</value><value>69.9666666666667</value><value>7.8</value><value>70.0666666666667</value><value>72.1333333333333</value><value>72.5333333333333</value><value>72.6333333333333</value><value>8.26666666666667</value><value>8.36666666666667</value><value>8.46666666666667</value><value>8.5</value><value>8.53333333333333</value><value>8.76666666666667</value><value>9</value><value>9.03333333333333</value><value>9.76666666666667</value></experimentalfactor><experimentalfactor><name>T STAGE</name><value>T1</value><value>T2</value><value>T3</value><value>T4</value></experimentalfactor><experimentalfactor><name>TNM STAGE</name><value>I</value><value>II</value><value>III</value></experimentalfactor><experimentalfactor><name>TOBACCO USE</name><value>no</value><value>yes</value></experimentalfactor><experimentalfactor><name>TUMOR GRADE</name><value>moderately</value><value>poorly</value><value>well</value></experimentalfactor><experimentalfactor><name>TUMOR LOATION</name><value>lower</value><value>middle</value><value>upper</value></experimentalfactor><miamescores><reportersequencescore>1</reportersequencescore><protocolscore>0</protocolscore><factorvaluescore>1</factorvaluescore><derivedbioassaydatascore>1</derivedbioassaydatascore><measuredbioassaydatascore>1</measuredbioassaydatascore><overallscore>4</overallscore></miamescores><id>413268</id><accession>E-GEOD-53625</accession><secondaryaccession>GSE53625</secondaryaccession><name>LncRNA profile study reveals a three-lncRNA signature associated with the survival of esophageal squamous cell carcinoma patients</name><experimenttype>transcription profiling by array</experimenttype><releasedate>2014-03-07</releasedate><lastupdatedate>2014-06-03</lastupdatedate><samples>358</samples><assays>358</assays><arraydesign><id>28493</id><accession>A-GEOD-18109</accession><name>CBC Homo sapiens lncRNA + mRNA microarray V2.0</name><count>358</count></arraydesign><bioassaydatagroup><id/><name>rawData</name><bioassaydatacubes>358</bioassaydatacubes><arraydesignprovider/><dataformat>rawData</dataformat><bioassays>358</bioassays><isderived>0</isderived></bioassaydatagroup><bioassaydatagroup><id/><name>normalization</name><bioassaydatacubes>358</bioassaydatacubes><arraydesignprovider/><dataformat>normalization</dataformat><bioassays>358</bioassays><isderived>0</isderived></bioassaydatagroup><bioassaydatagroup><id/><name>processedData</name><bioassaydatacubes>358</bioassaydatacubes><arraydesignprovider/><dataformat>processedData</dataformat><bioassays>358</bioassays><isderived>0</isderived></bioassaydatagroup><bibliography><accession>24522499</accession><authors>Li J, Chen Z, Tian L, Zhou C, He MY, Gao Y, Wang S, Zhou F, Shi S, Feng X, Sun N, Liu Z, Skogerboe G, Dong J, Yao R, Zhao Y, Sun J, Zhang B, Yu Y, Shi X, Luo M, Shao K, Li N, Qiu B, Tan F, Chen R, He J</authors><title>LncRNA profile study reveals a three-lncRNA signature associated with the survival of patients with oesophageal squamous cell carcinoma.</title><doi>10.1136/gutjnl-2013-305806</doi></bibliography><provider><contact>Jiagen Li</contact><role>submitter</role><email>jiagen.li@hotmail.com</email></provider><description><id/><text>This SuperSeries is composed of the SubSeries listed below. Refer to individual Series</text></description><protocol><id>978877</id><accession>P-GSE53625-7</accession></protocol><protocol><id>978872</id><accession>P-GSE53625-5</accession></protocol><protocol><id>978876</id><accession>P-GSE53625-6</accession></protocol><protocol><id>235758</id><accession>  </accession></protocol><protocol><id>978874</id><accession>P-GSE53625-3</accession></protocol><protocol><id>978873</id><accession>P-GSE53625-4</accession></protocol><protocol><id>978871</id><accession>P-GSE53625-1</accession></protocol><protocol><id>978875</id><accession>P-GSE53625-2</accession></protocol><organism>Homo sapiens</organism><files><!--
This section is deprecated and unsupported.
Please use webservice located at:
    http://www.ebi.ac.uk/arrayexpress/xml/files
to obtain detailed information on files available for the experiment.
For more information, please go to:
    http://www.ebi.ac.uk/arrayexpress/help/programmatic_access.html
                --><raw name="E-GEOD-53625.raw.10.zip E-GEOD-53625.raw.11.zip E-GEOD-53625.raw.12.zip E-GEOD-53625.raw.13.zip E-GEOD-53625.raw.14.zip E-GEOD-53625.raw.15.zip E-GEOD-53625.raw.16.zip E-GEOD-53625.raw.17.zip E-GEOD-53625.raw.18.zip E-GEOD-53625.raw.19.zip E-GEOD-53625.raw.1.zip E-GEOD-53625.raw.20.zip E-GEOD-53625.raw.21.zip E-GEOD-53625.raw.22.zip E-GEOD-53625.raw.23.zip E-GEOD-53625.raw.24.zip E-GEOD-53625.raw.25.zip E-GEOD-53625.raw.26.zip E-GEOD-53625.raw.27.zip E-GEOD-53625.raw.28.zip E-GEOD-53625.raw.29.zip E-GEOD-53625.raw.2.zip E-GEOD-53625.raw.30.zip E-GEOD-53625.raw.31.zip E-GEOD-53625.raw.32.zip E-GEOD-53625.raw.33.zip E-GEOD-53625.raw.34.zip E-GEOD-53625.raw.35.zip E-GEOD-53625.raw.36.zip E-GEOD-53625.raw.37.zip E-GEOD-53625.raw.38.zip E-GEOD-53625.raw.39.zip E-GEOD-53625.raw.3.zip E-GEOD-53625.raw.40.zip E-GEOD-53625.raw.41.zip E-GEOD-53625.raw.42.zip E-GEOD-53625.raw.43.zip E-GEOD-53625.raw.44.zip E-GEOD-53625.raw.45.zip E-GEOD-53625.raw.46.zip E-GEOD-53625.raw.47.zip E-GEOD-53625.raw.48.zip E-GEOD-53625.raw.49.zip E-GEOD-53625.raw.4.zip E-GEOD-53625.raw.50.zip E-GEOD-53625.raw.51.zip E-GEOD-53625.raw.52.zip E-GEOD-53625.raw.53.zip E-GEOD-53625.raw.54.zip E-GEOD-53625.raw.55.zip E-GEOD-53625.raw.56.zip E-GEOD-53625.raw.57.zip E-GEOD-53625.raw.58.zip E-GEOD-53625.raw.59.zip E-GEOD-53625.raw.5.zip E-GEOD-53625.raw.60.zip E-GEOD-53625.raw.61.zip E-GEOD-53625.raw.62.zip E-GEOD-53625.raw.63.zip E-GEOD-53625.raw.64.zip E-GEOD-53625.raw.65.zip E-GEOD-53625.raw.66.zip E-GEOD-53625.raw.67.zip E-GEOD-53625.raw.68.zip E-GEOD-53625.raw.69.zip E-GEOD-53625.raw.6.zip E-GEOD-53625.raw.70.zip E-GEOD-53625.raw.71.zip E-GEOD-53625.raw.72.zip E-GEOD-53625.raw.7.zip E-GEOD-53625.raw.8.zip E-GEOD-53625.raw.9.zip" count="true" celcount="0"/><fgem name="E-GEOD-53625.processed.1.zip" available="true"/><idf name="E-GEOD-53625.idf.txt"/><sdrf name="E-GEOD-53625.sdrf.txt"/></files></experiment><experiment><species>Homo sapiens</species><rawdatafiles available="true"/><processeddatafiles available="true"/><sampleattribute><category>adjuvant therapy</category><value>no</value><value>unknown</value><value>yes</value></sampleattribute><sampleattribute><category>age</category><value>36</value><value>39</value><value>40</value><value>41</value><value>42</value><value>44</value><value>45</value><value>46</value><value>47</value><value>48</value><value>49</value><value>50</value><value>51</value><value>52</value><value>53</value><value>54</value><value>55</value><value>56</value><value>57</value><value>58</value><value>59</value><value>60</value><value>61</value><value>62</value><value>63</value><value>64</value><value>65</value><value>66</value><value>67</value><value>68</value><value>69</value><value>70</value><value>71</value><value>72</value><value>73</value><value>74</value><value>75</value><value>76</value><value>82</value></sampleattribute><sampleattribute><category>alcohol use</category><value>no</value><value>yes</value></sampleattribute><sampleattribute><category>anastomotic leak</category><value>no</value><value>yes</value></sampleattribute><sampleattribute><category>arrhythmia</category><value>no</value><value>yes</value></sampleattribute><sampleattribute><category>death at fu</category><value>no</value><value>yes</value></sampleattribute><sampleattribute><category>disease state</category><value>esophageal squamous cell carcinoma</value></sampleattribute><sampleattribute><category>n stage</category><value>N0</value><value>N1</value><value>N2</value><value>N3</value></sampleattribute><sampleattribute><category>organism</category><value>Homo sapiens</value></sampleattribute><sampleattribute><category>organism part</category><value>cancer tissue from patient 10</value><value>cancer tissue from patient 101</value><value>cancer tissue from patient 102</value><value>cancer tissue from patient 106</value><value>cancer tissue from patient 108</value><value>cancer tissue from patient 11</value><value>cancer tissue from patient 112</value><value>cancer tissue from patient 117</value><value>cancer tissue from patient 119</value><value>cancer tissue from patient 12</value><value>cancer tissue from patient 120</value><value>cancer tissue from patient 122</value><value>cancer tissue from patient 129</value><value>cancer tissue from patient 13</value><value>cancer tissue from patient 131</value><value>cancer tissue from patient 132</value><value>cancer tissue from patient 134</value><value>cancer tissue from patient 135</value><value>cancer tissue from patient 136</value><value>cancer tissue from patient 142</value><value>cancer tissue from patient 146</value><value>cancer tissue from patient 148</value><value>cancer tissue from patient 201</value><value>cancer tissue from patient 205</value><value>cancer tissue from patient 206</value><value>cancer tissue from patient 207</value><value>cancer tissue from patient 208</value><value>cancer tissue from patient 210</value><value>cancer tissue from patient 211</value><value>cancer tissue from patient 212</value><value>cancer tissue from patient 214</value><value>cancer tissue from patient 215</value><value>cancer tissue from patient 216</value><value>cancer tissue from patient 217</value><value>cancer tissue from patient 218</value><value>cancer tissue from patient 219</value><value>cancer tissue from patient 220</value><value>cancer tissue from patient 221</value><value>cancer tissue from patient 222</value><value>cancer tissue from patient 223</value><value>cancer tissue from patient 224</value><value>cancer tissue from patient 225</value><value>cancer tissue from patient 226</value><value>cancer tissue from patient 227</value><value>cancer tissue from patient 228</value><value>cancer tissue from patient 229</value><value>cancer tissue from patient 23</value><value>cancer tissue from patient 231</value><value>cancer tissue from patient 234</value><value>cancer tissue from patient 236</value><value>cancer tissue from patient 239</value><value>cancer tissue from patient 241</value><value>cancer tissue from patient 243</value><value>cancer tissue from patient 245</value><value>cancer tissue from patient 246</value><value>cancer tissue from patient 247</value><value>cancer tissue from patient 249</value><value>cancer tissue from patient 25</value><value>cancer tissue from patient 251</value><value>cancer tissue from patient 253</value><value>cancer tissue from patient 256</value><value>cancer tissue from patient 258</value><value>cancer tissue from patient 259</value><value>cancer tissue from patient 26</value><value>cancer tissue from patient 260</value><value>cancer tissue from patient 261</value><value>cancer tissue from patient 262</value><value>cancer tissue from patient 264</value><value>cancer tissue from patient 265</value><value>cancer tissue from patient 266</value><value>cancer tissue from patient 268</value><value>cancer tissue from patient 269</value><value>cancer tissue from patient 27</value><value>cancer tissue from patient 273</value><value>cancer tissue from patient 274</value><value>cancer tissue from patient 275</value><value>cancer tissue from patient 277</value><value>cancer tissue from patient 279</value><value>cancer tissue from patient 28</value><value>cancer tissue from patient 280</value><value>cancer tissue from patient 281</value><value>cancer tissue from patient 284</value><value>cancer tissue from patient 285</value><value>cancer tissue from patient 287</value><value>cancer tissue from patient 288</value><value>cancer tissue from patient 29</value><value>cancer tissue from patient 290</value><value>cancer tissue from patient 297</value><value>cancer tissue from patient 30</value><value>cancer tissue from patient 31</value><value>cancer tissue from patient 32</value><value>cancer tissue from patient 36</value><value>cancer tissue from patient 4</value><value>cancer tissue from patient 42</value><value>cancer tissue from patient 45</value><value>cancer tissue from patient 46</value><value>cancer tissue from patient 49</value><value>cancer tissue from patient 51</value><value>cancer tissue from patient 52</value><value>cancer tissue from patient 6</value><value>cancer tissue from patient 60</value><value>cancer tissue from patient 61</value><value>cancer tissue from patient 68</value><value>cancer tissue from patient 7</value><value>cancer tissue from patient 71</value><value>cancer tissue from patient 73</value><value>cancer tissue from patient 74</value><value>cancer tissue from patient 76</value><value>cancer tissue from patient 77</value><value>cancer tissue from patient 79</value><value>cancer tissue from patient 80</value><value>cancer tissue from patient 81</value><value>cancer tissue from patient 87</value><value>cancer tissue from patient 9</value><value>cancer tissue from patient 91</value><value>cancer tissue from patient 92</value><value>cancer tissue from patient 94</value><value>cancer tissue from patient 96</value><value>cancer tissue from patient 97</value><value>normal tissue from patient 10</value><value>normal tissue from patient 101</value><value>normal tissue from patient 102</value><value>normal tissue from patient 106</value><value>normal tissue from patient 108</value><value>normal tissue from patient 11</value><value>normal tissue from patient 112</value><value>normal tissue from patient 117</value><value>normal tissue from patient 119</value><value>normal tissue from patient 12</value><value>normal tissue from patient 120</value><value>normal tissue from patient 122</value><value>normal tissue from patient 129</value><value>normal tissue from patient 13</value><value>normal tissue from patient 131</value><value>normal tissue from patient 132</value><value>normal tissue from patient 134</value><value>normal tissue from patient 135</value><value>normal tissue from patient 136</value><value>normal tissue from patient 142</value><value>normal tissue from patient 146</value><value>normal tissue from patient 148</value><value>normal tissue from patient 201</value><value>normal tissue from patient 205</value><value>normal tissue from patient 206</value><value>normal tissue from patient 207</value><value>normal tissue from patient 208</value><value>normal tissue from patient 210</value><value>normal tissue from patient 211</value><value>normal tissue from patient 212</value><value>normal tissue from patient 214</value><value>normal tissue from patient 215</value><value>normal tissue from patient 216</value><value>normal tissue from patient 217</value><value>normal tissue from patient 218</value><value>normal tissue from patient 219</value><value>normal tissue from patient 220</value><value>normal tissue from patient 221</value><value>normal tissue from patient 222</value><value>normal tissue from patient 223</value><value>normal tissue from patient 224</value><value>normal tissue from patient 225</value><value>normal tissue from patient 226</value><value>normal tissue from patient 227</value><value>normal tissue from patient 228</value><value>normal tissue from patient 229</value><value>normal tissue from patient 23</value><value>normal tissue from patient 231</value><value>normal tissue from patient 234</value><value>normal tissue from patient 236</value><value>normal tissue from patient 239</value><value>normal tissue from patient 241</value><value>normal tissue from patient 243</value><value>normal tissue from patient 245</value><value>normal tissue from patient 246</value><value>normal tissue from patient 247</value><value>normal tissue from patient 249</value><value>normal tissue from patient 25</value><value>normal tissue from patient 251</value><value>normal tissue from patient 253</value><value>normal tissue from patient 256</value><value>normal tissue from patient 258</value><value>normal tissue from patient 259</value><value>normal tissue from patient 26</value><value>normal tissue from patient 260</value><value>normal tissue from patient 261</value><value>normal tissue from patient 262</value><value>normal tissue from patient 264</value><value>normal tissue from patient 265</value><value>normal tissue from patient 266</value><value>normal tissue from patient 268</value><value>normal tissue from patient 269</value><value>normal tissue from patient 27</value><value>normal tissue from patient 273</value><value>normal tissue from patient 274</value><value>normal tissue from patient 275</value><value>normal tissue from patient 277</value><value>normal tissue from patient 279</value><value>normal tissue from patient 28</value><value>normal tissue from patient 280</value><value>normal tissue from patient 281</value><value>normal tissue from patient 284</value><value>normal tissue from patient 285</value><value>normal tissue from patient 287</value><value>normal tissue from patient 288</value><value>normal tissue from patient 29</value><value>normal tissue from patient 290</value><value>normal tissue from patient 297</value><value>normal tissue from patient 30</value><value>normal tissue from patient 31</value><value>normal tissue from patient 32</value><value>normal tissue from patient 36</value><value>normal tissue from patient 4</value><value>normal tissue from patient 42</value><value>normal tissue from patient 45</value><value>normal tissue from patient 46</value><value>normal tissue from patient 49</value><value>normal tissue from patient 51</value><value>normal tissue from patient 52</value><value>normal tissue from patient 6</value><value>normal tissue from patient 60</value><value>normal tissue from patient 61</value><value>normal tissue from patient 68</value><value>normal tissue from patient 7</value><value>normal tissue from patient 71</value><value>normal tissue from patient 73</value><value>normal tissue from patient 74</value><value>normal tissue from patient 76</value><value>normal tissue from patient 77</value><value>normal tissue from patient 79</value><value>normal tissue from patient 80</value><value>normal tissue from patient 81</value><value>normal tissue from patient 87</value><value>normal tissue from patient 9</value><value>normal tissue from patient 91</value><value>normal tissue from patient 92</value><value>normal tissue from patient 94</value><value>normal tissue from patient 96</value><value>normal tissue from patient 97</value></sampleattribute><sampleattribute><category>patient id</category><value>ec10</value><value>ec101</value><value>ec102</value><value>ec106</value><value>ec108</value><value>ec11</value><value>ec112</value><value>ec117</value><value>ec119</value><value>ec12</value><value>ec120</value><value>ec122</value><value>ec129</value><value>ec13</value><value>ec131</value><value>ec132</value><value>ec134</value><value>ec135</value><value>ec136</value><value>ec142</value><value>ec146</value><value>ec148</value><value>ec201</value><value>ec205</value><value>ec206</value><value>ec207</value><value>ec208</value><value>ec210</value><value>ec211</value><value>ec212</value><value>ec214</value><value>ec215</value><value>ec216</value><value>ec217</value><value>ec218</value><value>ec219</value><value>ec220</value><value>ec221</value><value>ec222</value><value>ec223</value><value>ec224</value><value>ec225</value><value>ec226</value><value>ec227</value><value>ec228</value><value>ec229</value><value>ec23</value><value>ec231</value><value>ec234</value><value>ec236</value><value>ec239</value><value>ec241</value><value>ec243</value><value>ec245</value><value>ec246</value><value>ec247</value><value>ec249</value><value>ec25</value><value>ec251</value><value>ec253</value><value>ec256</value><value>ec258</value><value>ec259</value><value>ec26</value><value>ec260</value><value>ec261</value><value>ec262</value><value>ec264</value><value>ec265</value><value>ec266</value><value>ec268</value><value>ec269</value><value>ec27</value><value>ec273</value><value>ec274</value><value>ec275</value><value>ec277</value><value>ec279</value><value>ec28</value><value>ec280</value><value>ec281</value><value>ec284</value><value>ec285</value><value>ec287</value><value>ec288</value><value>ec29</value><value>ec290</value><value>ec297</value><value>ec30</value><value>ec31</value><value>ec32</value><value>ec36</value><value>ec4</value><value>ec42</value><value>ec45</value><value>ec46</value><value>ec49</value><value>ec51</value><value>ec52</value><value>ec6</value><value>ec60</value><value>ec61</value><value>ec68</value><value>ec7</value><value>ec71</value><value>ec73</value><value>ec74</value><value>ec76</value><value>ec77</value><value>ec79</value><value>ec80</value><value>ec81</value><value>ec87</value><value>ec9</value><value>ec91</value><value>ec92</value><value>ec94</value><value>ec96</value><value>ec97</value></sampleattribute><sampleattribute><category>pneumonia</category><value>no</value><value>yes</value></sampleattribute><sampleattribute><category>Sex</category><value>female</value><value>male</value></sampleattribute><sampleattribute><category>survival timemonths</category><value>0.1</value><value>0.633333333333333</value><value>1.43333333333333</value><value>10.0333333333333</value><value>10.4666666666667</value><value>10.5666666666667</value><value>11</value><value>11.5</value><value>12</value><value>12.2333333333333</value><value>12.5666666666667</value><value>13</value><value>13.4666666666667</value><value>14.3666666666667</value><value>15.4333333333333</value><value>15.6</value><value>15.8666666666667</value><value>16.8333333333333</value><value>17.4333333333333</value><value>17.5</value><value>19.2</value><value>19.2666666666667</value><value>21.2333333333333</value><value>21.2666666666667</value><value>21.4333333333333</value><value>21.5333333333333</value><value>21.9333333333333</value><value>22.1333333333333</value><value>22.4</value><value>22.7</value><value>23.1333333333333</value><value>23.2666666666667</value><value>24.4</value><value>24.4333333333333</value><value>24.6666666666667</value><value>24.8</value><value>25.1666666666667</value><value>25.7333333333333</value><value>26.5</value><value>27.5666666666667</value><value>3.83333333333333</value><value>31.5</value><value>32.2</value><value>32.4666666666667</value><value>34.1666666666667</value><value>34.6666666666667</value><value>35.0333333333333</value><value>37.1666666666667</value><value>38.5333333333333</value><value>4.2</value><value>4.9</value><value>42.0333333333333</value><value>45.8333333333333</value><value>47.1666666666667</value><value>48.7666666666667</value><value>5.06666666666667</value><value>5.83333333333333</value><value>56.2333333333333</value><value>59.1333333333333</value><value>6.2</value><value>6.33333333333333</value><value>6.63333333333333</value><value>6.66666666666667</value><value>60.2</value><value>60.3</value><value>60.5</value><value>60.5666666666667</value><value>60.6333333333333</value><value>60.7333333333333</value><value>60.7666666666667</value><value>60.9</value><value>60.9666666666667</value><value>61</value><value>61.2</value><value>61.3</value><value>61.3333333333333</value><value>61.3666666666667</value><value>61.6</value><value>61.8333333333333</value><value>61.9</value><value>61.9333333333333</value><value>62.4666666666667</value><value>62.8666666666667</value><value>62.9333333333333</value><value>62.9666666666667</value><value>63.0666666666667</value><value>63.2666666666667</value><value>63.4</value><value>63.5333333333333</value><value>64</value><value>64.1333333333333</value><value>65.1666666666667</value><value>65.2666666666667</value><value>65.5</value><value>65.8666666666667</value><value>68</value><value>68.2</value><value>68.6</value><value>68.7</value><value>69.6333333333333</value><value>69.9666666666667</value><value>7.8</value><value>70.0666666666667</value><value>72.1333333333333</value><value>72.5333333333333</value><value>72.6333333333333</value><value>8.26666666666667</value><value>8.36666666666667</value><value>8.53333333333333</value><value>9</value><value>9.03333333333333</value><value>9.76666666666667</value></sampleattribute><sampleattribute><category>t stage</category><value>T1</value><value>T2</value><value>T3</value><value>T4</value></sampleattribute><sampleattribute><category>tnm stage</category><value>I</value><value>II</value><value>III</value></sampleattribute><sampleattribute><category>tobacco use</category><value>no</value><value>yes</value></sampleattribute><sampleattribute><category>tumor grade</category><value>moderately</value><value>poorly</value><value>well</value></sampleattribute><sampleattribute><category>tumor loation</category><value>lower</value><value>middle</value><value>upper</value></sampleattribute><experimentalfactor><name>ADJUVANT THERAPY</name><value>no</value><value>unknown</value><value>yes</value></experimentalfactor><experimentalfactor><name>AGE</name><value>36</value><value>39</value><value>40</value><value>41</value><value>42</value><value>44</value><value>45</value><value>46</value><value>47</value><value>48</value><value>49</value><value>50</value><value>51</value><value>52</value><value>53</value><value>54</value><value>55</value><value>56</value><value>57</value><value>58</value><value>59</value><value>60</value><value>61</value><value>62</value><value>63</value><value>64</value><value>65</value><value>66</value><value>67</value><value>68</value><value>69</value><value>70</value><value>71</value><value>72</value><value>73</value><value>74</value><value>75</value><value>76</value><value>82</value></experimentalfactor><experimentalfactor><name>ALCOHOL USE</name><value>no</value><value>yes</value></experimentalfactor><experimentalfactor><name>ANASTOMOTIC LEAK</name><value>no</value><value>yes</value></experimentalfactor><experimentalfactor><name>ARRHYTHMIA</name><value>no</value><value>yes</value></experimentalfactor><experimentalfactor><name>DEATH AT FU</name><value>no</value><value>yes</value></experimentalfactor><experimentalfactor><name>N STAGE</name><value>N0</value><value>N1</value><value>N2</value><value>N3</value></experimentalfactor><experimentalfactor><name>ORGANISM PART</name><value>cancer tissue from patient 10</value><value>cancer tissue from patient 101</value><value>cancer tissue from patient 102</value><value>cancer tissue from patient 106</value><value>cancer tissue from patient 108</value><value>cancer tissue from patient 11</value><value>cancer tissue from patient 112</value><value>cancer tissue from patient 117</value><value>cancer tissue from patient 119</value><value>cancer tissue from patient 12</value><value>cancer tissue from patient 120</value><value>cancer tissue from patient 122</value><value>cancer tissue from patient 129</value><value>cancer tissue from patient 13</value><value>cancer tissue from patient 131</value><value>cancer tissue from patient 132</value><value>cancer tissue from patient 134</value><value>cancer tissue from patient 135</value><value>cancer tissue from patient 136</value><value>cancer tissue from patient 142</value><value>cancer tissue from patient 146</value><value>cancer tissue from patient 148</value><value>cancer tissue from patient 201</value><value>cancer tissue from patient 205</value><value>cancer tissue from patient 206</value><value>cancer tissue from patient 207</value><value>cancer tissue from patient 208</value><value>cancer tissue from patient 210</value><value>cancer tissue from patient 211</value><value>cancer tissue from patient 212</value><value>cancer tissue from patient 214</value><value>cancer tissue from patient 215</value><value>cancer tissue from patient 216</value><value>cancer tissue from patient 217</value><value>cancer tissue from patient 218</value><value>cancer tissue from patient 219</value><value>cancer tissue from patient 220</value><value>cancer tissue from patient 221</value><value>cancer tissue from patient 222</value><value>cancer tissue from patient 223</value><value>cancer tissue from patient 224</value><value>cancer tissue from patient 225</value><value>cancer tissue from patient 226</value><value>cancer tissue from patient 227</value><value>cancer tissue from patient 228</value><value>cancer tissue from patient 229</value><value>cancer tissue from patient 23</value><value>cancer tissue from patient 231</value><value>cancer tissue from patient 234</value><value>cancer tissue from patient 236</value><value>cancer tissue from patient 239</value><value>cancer tissue from patient 241</value><value>cancer tissue from patient 243</value><value>cancer tissue from patient 245</value><value>cancer tissue from patient 246</value><value>cancer tissue from patient 247</value><value>cancer tissue from patient 249</value><value>cancer tissue from patient 25</value><value>cancer tissue from patient 251</value><value>cancer tissue from patient 253</value><value>cancer tissue from patient 256</value><value>cancer tissue from patient 258</value><value>cancer tissue from patient 259</value><value>cancer tissue from patient 26</value><value>cancer tissue from patient 260</value><value>cancer tissue from patient 261</value><value>cancer tissue from patient 262</value><value>cancer tissue from patient 264</value><value>cancer tissue from patient 265</value><value>cancer tissue from patient 266</value><value>cancer tissue from patient 268</value><value>cancer tissue from patient 269</value><value>cancer tissue from patient 27</value><value>cancer tissue from patient 273</value><value>cancer tissue from patient 274</value><value>cancer tissue from patient 275</value><value>cancer tissue from patient 277</value><value>cancer tissue from patient 279</value><value>cancer tissue from patient 28</value><value>cancer tissue from patient 280</value><value>cancer tissue from patient 281</value><value>cancer tissue from patient 284</value><value>cancer tissue from patient 285</value><value>cancer tissue from patient 287</value><value>cancer tissue from patient 288</value><value>cancer tissue from patient 29</value><value>cancer tissue from patient 290</value><value>cancer tissue from patient 297</value><value>cancer tissue from patient 30</value><value>cancer tissue from patient 31</value><value>cancer tissue from patient 32</value><value>cancer tissue from patient 36</value><value>cancer tissue from patient 4</value><value>cancer tissue from patient 42</value><value>cancer tissue from patient 45</value><value>cancer tissue from patient 46</value><value>cancer tissue from patient 49</value><value>cancer tissue from patient 51</value><value>cancer tissue from patient 52</value><value>cancer tissue from patient 6</value><value>cancer tissue from patient 60</value><value>cancer tissue from patient 61</value><value>cancer tissue from patient 68</value><value>cancer tissue from patient 7</value><value>cancer tissue from patient 71</value><value>cancer tissue from patient 73</value><value>cancer tissue from patient 74</value><value>cancer tissue from patient 76</value><value>cancer tissue from patient 77</value><value>cancer tissue from patient 79</value><value>cancer tissue from patient 80</value><value>cancer tissue from patient 81</value><value>cancer tissue from patient 87</value><value>cancer tissue from patient 9</value><value>cancer tissue from patient 91</value><value>cancer tissue from patient 92</value><value>cancer tissue from patient 94</value><value>cancer tissue from patient 96</value><value>cancer tissue from patient 97</value><value>normal tissue from patient 10</value><value>normal tissue from patient 101</value><value>normal tissue from patient 102</value><value>normal tissue from patient 106</value><value>normal tissue from patient 108</value><value>normal tissue from patient 11</value><value>normal tissue from patient 112</value><value>normal tissue from patient 117</value><value>normal tissue from patient 119</value><value>normal tissue from patient 12</value><value>normal tissue from patient 120</value><value>normal tissue from patient 122</value><value>normal tissue from patient 129</value><value>normal tissue from patient 13</value><value>normal tissue from patient 131</value><value>normal tissue from patient 132</value><value>normal tissue from patient 134</value><value>normal tissue from patient 135</value><value>normal tissue from patient 136</value><value>normal tissue from patient 142</value><value>normal tissue from patient 146</value><value>normal tissue from patient 148</value><value>normal tissue from patient 201</value><value>normal tissue from patient 205</value><value>normal tissue from patient 206</value><value>normal tissue from patient 207</value><value>normal tissue from patient 208</value><value>normal tissue from patient 210</value><value>normal tissue from patient 211</value><value>normal tissue from patient 212</value><value>normal tissue from patient 214</value><value>normal tissue from patient 215</value><value>normal tissue from patient 216</value><value>normal tissue from patient 217</value><value>normal tissue from patient 218</value><value>normal tissue from patient 219</value><value>normal tissue from patient 220</value><value>normal tissue from patient 221</value><value>normal tissue from patient 222</value><value>normal tissue from patient 223</value><value>normal tissue from patient 224</value><value>normal tissue from patient 225</value><value>normal tissue from patient 226</value><value>normal tissue from patient 227</value><value>normal tissue from patient 228</value><value>normal tissue from patient 229</value><value>normal tissue from patient 23</value><value>normal tissue from patient 231</value><value>normal tissue from patient 234</value><value>normal tissue from patient 236</value><value>normal tissue from patient 239</value><value>normal tissue from patient 241</value><value>normal tissue from patient 243</value><value>normal tissue from patient 245</value><value>normal tissue from patient 246</value><value>normal tissue from patient 247</value><value>normal tissue from patient 249</value><value>normal tissue from patient 25</value><value>normal tissue from patient 251</value><value>normal tissue from patient 253</value><value>normal tissue from patient 256</value><value>normal tissue from patient 258</value><value>normal tissue from patient 259</value><value>normal tissue from patient 26</value><value>normal tissue from patient 260</value><value>normal tissue from patient 261</value><value>normal tissue from patient 262</value><value>normal tissue from patient 264</value><value>normal tissue from patient 265</value><value>normal tissue from patient 266</value><value>normal tissue from patient 268</value><value>normal tissue from patient 269</value><value>normal tissue from patient 27</value><value>normal tissue from patient 273</value><value>normal tissue from patient 274</value><value>normal tissue from patient 275</value><value>normal tissue from patient 277</value><value>normal tissue from patient 279</value><value>normal tissue from patient 28</value><value>normal tissue from patient 280</value><value>normal tissue from patient 281</value><value>normal tissue from patient 284</value><value>normal tissue from patient 285</value><value>normal tissue from patient 287</value><value>normal tissue from patient 288</value><value>normal tissue from patient 29</value><value>normal tissue from patient 290</value><value>normal tissue from patient 297</value><value>normal tissue from patient 30</value><value>normal tissue from patient 31</value><value>normal tissue from patient 32</value><value>normal tissue from patient 36</value><value>normal tissue from patient 4</value><value>normal tissue from patient 42</value><value>normal tissue from patient 45</value><value>normal tissue from patient 46</value><value>normal tissue from patient 49</value><value>normal tissue from patient 51</value><value>normal tissue from patient 52</value><value>normal tissue from patient 6</value><value>normal tissue from patient 60</value><value>normal tissue from patient 61</value><value>normal tissue from patient 68</value><value>normal tissue from patient 7</value><value>normal tissue from patient 71</value><value>normal tissue from patient 73</value><value>normal tissue from patient 74</value><value>normal tissue from patient 76</value><value>normal tissue from patient 77</value><value>normal tissue from patient 79</value><value>normal tissue from patient 80</value><value>normal tissue from patient 81</value><value>normal tissue from patient 87</value><value>normal tissue from patient 9</value><value>normal tissue from patient 91</value><value>normal tissue from patient 92</value><value>normal tissue from patient 94</value><value>normal tissue from patient 96</value><value>normal tissue from patient 97</value></experimentalfactor><experimentalfactor><name>PATIENT ID</name><value>ec10</value><value>ec101</value><value>ec102</value><value>ec106</value><value>ec108</value><value>ec11</value><value>ec112</value><value>ec117</value><value>ec119</value><value>ec12</value><value>ec120</value><value>ec122</value><value>ec129</value><value>ec13</value><value>ec131</value><value>ec132</value><value>ec134</value><value>ec135</value><value>ec136</value><value>ec142</value><value>ec146</value><value>ec148</value><value>ec201</value><value>ec205</value><value>ec206</value><value>ec207</value><value>ec208</value><value>ec210</value><value>ec211</value><value>ec212</value><value>ec214</value><value>ec215</value><value>ec216</value><value>ec217</value><value>ec218</value><value>ec219</value><value>ec220</value><value>ec221</value><value>ec222</value><value>ec223</value><value>ec224</value><value>ec225</value><value>ec226</value><value>ec227</value><value>ec228</value><value>ec229</value><value>ec23</value><value>ec231</value><value>ec234</value><value>ec236</value><value>ec239</value><value>ec241</value><value>ec243</value><value>ec245</value><value>ec246</value><value>ec247</value><value>ec249</value><value>ec25</value><value>ec251</value><value>ec253</value><value>ec256</value><value>ec258</value><value>ec259</value><value>ec26</value><value>ec260</value><value>ec261</value><value>ec262</value><value>ec264</value><value>ec265</value><value>ec266</value><value>ec268</value><value>ec269</value><value>ec27</value><value>ec273</value><value>ec274</value><value>ec275</value><value>ec277</value><value>ec279</value><value>ec28</value><value>ec280</value><value>ec281</value><value>ec284</value><value>ec285</value><value>ec287</value><value>ec288</value><value>ec29</value><value>ec290</value><value>ec297</value><value>ec30</value><value>ec31</value><value>ec32</value><value>ec36</value><value>ec4</value><value>ec42</value><value>ec45</value><value>ec46</value><value>ec49</value><value>ec51</value><value>ec52</value><value>ec6</value><value>ec60</value><value>ec61</value><value>ec68</value><value>ec7</value><value>ec71</value><value>ec73</value><value>ec74</value><value>ec76</value><value>ec77</value><value>ec79</value><value>ec80</value><value>ec81</value><value>ec87</value><value>ec9</value><value>ec91</value><value>ec92</value><value>ec94</value><value>ec96</value><value>ec97</value></experimentalfactor><experimentalfactor><name>PNEUMONIA</name><value>no</value><value>yes</value></experimentalfactor><experimentalfactor><name>SEX</name><value>female</value><value>male</value></experimentalfactor><experimentalfactor><name>SURVIVAL TIMEMONTHS</name><value>0.1</value><value>0.633333333333333</value><value>1.43333333333333</value><value>10.0333333333333</value><value>10.4666666666667</value><value>10.5666666666667</value><value>11</value><value>11.5</value><value>12</value><value>12.2333333333333</value><value>12.5666666666667</value><value>13</value><value>13.4666666666667</value><value>14.3666666666667</value><value>15.4333333333333</value><value>15.6</value><value>15.8666666666667</value><value>16.8333333333333</value><value>17.4333333333333</value><value>17.5</value><value>19.2</value><value>19.2666666666667</value><value>21.2333333333333</value><value>21.2666666666667</value><value>21.4333333333333</value><value>21.5333333333333</value><value>21.9333333333333</value><value>22.1333333333333</value><value>22.4</value><value>22.7</value><value>23.1333333333333</value><value>23.2666666666667</value><value>24.4</value><value>24.4333333333333</value><value>24.6666666666667</value><value>24.8</value><value>25.1666666666667</value><value>25.7333333333333</value><value>26.5</value><value>27.5666666666667</value><value>3.83333333333333</value><value>31.5</value><value>32.2</value><value>32.4666666666667</value><value>34.1666666666667</value><value>34.6666666666667</value><value>35.0333333333333</value><value>37.1666666666667</value><value>38.5333333333333</value><value>4.2</value><value>4.9</value><value>42.0333333333333</value><value>45.8333333333333</value><value>47.1666666666667</value><value>48.7666666666667</value><value>5.06666666666667</value><value>5.83333333333333</value><value>56.2333333333333</value><value>59.1333333333333</value><value>6.2</value><value>6.33333333333333</value><value>6.63333333333333</value><value>6.66666666666667</value><value>60.2</value><value>60.3</value><value>60.5</value><value>60.5666666666667</value><value>60.6333333333333</value><value>60.7333333333333</value><value>60.7666666666667</value><value>60.9</value><value>60.9666666666667</value><value>61</value><value>61.2</value><value>61.3</value><value>61.3333333333333</value><value>61.3666666666667</value><value>61.6</value><value>61.8333333333333</value><value>61.9</value><value>61.9333333333333</value><value>62.4666666666667</value><value>62.8666666666667</value><value>62.9333333333333</value><value>62.9666666666667</value><value>63.0666666666667</value><value>63.2666666666667</value><value>63.4</value><value>63.5333333333333</value><value>64</value><value>64.1333333333333</value><value>65.1666666666667</value><value>65.2666666666667</value><value>65.5</value><value>65.8666666666667</value><value>68</value><value>68.2</value><value>68.6</value><value>68.7</value><value>69.6333333333333</value><value>69.9666666666667</value><value>7.8</value><value>70.0666666666667</value><value>72.1333333333333</value><value>72.5333333333333</value><value>72.6333333333333</value><value>8.26666666666667</value><value>8.36666666666667</value><value>8.53333333333333</value><value>9</value><value>9.03333333333333</value><value>9.76666666666667</value></experimentalfactor><experimentalfactor><name>T STAGE</name><value>T1</value><value>T2</value><value>T3</value><value>T4</value></experimentalfactor><experimentalfactor><name>TNM STAGE</name><value>I</value><value>II</value><value>III</value></experimentalfactor><experimentalfactor><name>TOBACCO USE</name><value>no</value><value>yes</value></experimentalfactor><experimentalfactor><name>TUMOR GRADE</name><value>moderately</value><value>poorly</value><value>well</value></experimentalfactor><experimentalfactor><name>TUMOR LOATION</name><value>lower</value><value>middle</value><value>upper</value></experimentalfactor><miamescores><reportersequencescore>1</reportersequencescore><protocolscore>0</protocolscore><factorvaluescore>1</factorvaluescore><derivedbioassaydatascore>1</derivedbioassaydatascore><measuredbioassaydatascore>1</measuredbioassaydatascore><overallscore>4</overallscore></miamescores><id>414250</id><accession>E-GEOD-53624</accession><secondaryaccession>GSE53624</secondaryaccession><name>LncRNA profile study reveals a three-lncRNA signature associated with the survival of esophageal squamous cell carcinoma patients (original)</name><experimenttype>transcription profiling by array</experimenttype><releasedate>2014-03-07</releasedate><lastupdatedate>2014-06-03</lastupdatedate><samples>238</samples><assays>238</assays><arraydesign><id>28493</id><accession>A-GEOD-18109</accession><name>CBC Homo sapiens lncRNA + mRNA microarray V2.0</name><count>238</count></arraydesign><bioassaydatagroup><id/><name>rawData</name><bioassaydatacubes>238</bioassaydatacubes><arraydesignprovider/><dataformat>rawData</dataformat><bioassays>238</bioassays><isderived>0</isderived></bioassaydatagroup><bioassaydatagroup><id/><name>normalization</name><bioassaydatacubes>238</bioassaydatacubes><arraydesignprovider/><dataformat>normalization</dataformat><bioassays>238</bioassays><isderived>0</isderived></bioassaydatagroup><bioassaydatagroup><id/><name>processedData</name><bioassaydatacubes>238</bioassaydatacubes><arraydesignprovider/><dataformat>processedData</dataformat><bioassays>238</bioassays><isderived>0</isderived></bioassaydatagroup><bibliography><accession>24522499</accession><authors>Li J, Chen Z, Tian L, Zhou C, He MY, Gao Y, Wang S, Zhou F, Shi S, Feng X, Sun N, Liu Z, Skogerboe G, Dong J, Yao R, Zhao Y, Sun J, Zhang B, Yu Y, Shi X, Luo M, Shao K, Li N, Qiu B, Tan F, Chen R, He J</authors><title>LncRNA profile study reveals a three-lncRNA signature associated with the survival of patients with oesophageal squamous cell carcinoma.</title><doi>10.1136/gutjnl-2013-305806</doi></bibliography><provider><contact>Jiagen Li</contact><role>submitter</role><email>jiagen.li@hotmail.com</email></provider><provider><contact>J Li</contact><role/><email/></provider><provider><contact>Z Chen</contact><role/><email/></provider><provider><contact>L Tian</contact><role/><email/></provider><description><id/><text>Objective: Globally, esophageal cancer is among the most deadly cancer forms. Long non-coding RNAs (lncRNA) are frequently found to have important regulatory roles. We aim to assess the lncRNA expression profile of esophageal squamous cell carcinoma (ESCC) and identify prognosis related lncRNAs. Design: LncRNA expression profiles were studied by microarray in paired tumor and normal tissues from 119 ESCC patients, and validated by qRT-PCR. The 119 patients were subsequently divided randomly into training (n=60) and test (n=59) groups. A prognostic signature was developed from the training group using a random forest supervised classification algorithm and a nearest shrunken centroid algorithm, and validated in test group and further in an independent cohort (n=60). The independence of the signature in survival prediction was evaluated by Multivariable Cox regression analysis. Results: LncRNAs showed significantly altered expression in ESCC tissues. From the training group, we identified a three-lncRNA signature (including the lncRNAs ENST00000435885•1, XLOC_013014, and ENST00000547963•1) which classified the patients into two groups with significantly different overall survival (median survival 19•2 months vs. not reached, p&lt;0•0001). The signature was applied to the test group (median survival 21•5 months vs. not reached, p=0•0030) and independent cohort (median survival 25•8 months vs. not reached, p=0•0187) and showed similar prognostic values in both. Multivariable Cox regression analysis showed that the signature was an independent prognostic factor for ESCC patients. Stratified analysis suggested that the signature was prognostic within clinical stages. Conclusions: Our results suggest that the three-lncRNA signature can serve as a novel biomarker for the prognosis of ESCC patients. Application of it allows for more accurate survival prediction. The lncRNA expression profiles of cancer and adjacent normal tissues form 119 ESCC patients were studied by microarray and an lncRNA signature that can perdict the survival of ESCC patients was identified.</text></description><protocol><id>979754</id><accession>P-GSE53624-4</accession></protocol><protocol><id>979753</id><accession>P-GSE53624-5</accession></protocol><protocol><id>979755</id><accession>P-GSE53624-2</accession></protocol><protocol><id>979756</id><accession>P-GSE53624-3</accession></protocol><protocol><id>979750</id><accession>P-GSE53624-1</accession></protocol><protocol><id>979752</id><accession>P-GSE53624-6</accession></protocol><protocol><id>979751</id><accession>P-GSE53624-7</accession></protocol><organism>Homo sapiens</organism><files><!--
This section is deprecated and unsupported.
Please use webservice located at:
    http://www.ebi.ac.uk/arrayexpress/xml/files
to obtain detailed information on files available for the experiment.
For more information, please go to:
    http://www.ebi.ac.uk/arrayexpress/help/programmatic_access.html
                --><raw name="E-GEOD-53624.raw.10.zip E-GEOD-53624.raw.11.zip E-GEOD-53624.raw.12.zip E-GEOD-53624.raw.13.zip E-GEOD-53624.raw.14.zip E-GEOD-53624.raw.15.zip E-GEOD-53624.raw.16.zip E-GEOD-53624.raw.17.zip E-GEOD-53624.raw.18.zip E-GEOD-53624.raw.19.zip E-GEOD-53624.raw.1.zip E-GEOD-53624.raw.20.zip E-GEOD-53624.raw.21.zip E-GEOD-53624.raw.22.zip E-GEOD-53624.raw.23.zip E-GEOD-53624.raw.24.zip E-GEOD-53624.raw.25.zip E-GEOD-53624.raw.26.zip E-GEOD-53624.raw.27.zip E-GEOD-53624.raw.28.zip E-GEOD-53624.raw.29.zip E-GEOD-53624.raw.2.zip E-GEOD-53624.raw.30.zip E-GEOD-53624.raw.31.zip E-GEOD-53624.raw.32.zip E-GEOD-53624.raw.33.zip E-GEOD-53624.raw.34.zip E-GEOD-53624.raw.35.zip E-GEOD-53624.raw.36.zip E-GEOD-53624.raw.37.zip E-GEOD-53624.raw.38.zip E-GEOD-53624.raw.39.zip E-GEOD-53624.raw.3.zip E-GEOD-53624.raw.40.zip E-GEOD-53624.raw.41.zip E-GEOD-53624.raw.42.zip E-GEOD-53624.raw.43.zip E-GEOD-53624.raw.44.zip E-GEOD-53624.raw.45.zip E-GEOD-53624.raw.46.zip E-GEOD-53624.raw.47.zip E-GEOD-53624.raw.48.zip E-GEOD-53624.raw.4.zip E-GEOD-53624.raw.5.zip E-GEOD-53624.raw.6.zip E-GEOD-53624.raw.7.zip E-GEOD-53624.raw.8.zip E-GEOD-53624.raw.9.zip" count="true" celcount="0"/><fgem name="E-GEOD-53624.processed.1.zip" available="true"/><idf name="E-GEOD-53624.idf.txt"/><sdrf name="E-GEOD-53624.sdrf.txt"/></files></experiment><experiment><species>Homo sapiens</species><rawdatafiles available="true"/><processeddatafiles available="true"/><sampleattribute><category>adjuvant therapy</category><value>no</value><value>unknown</value><value>yes</value></sampleattribute><sampleattribute><category>age</category><value>39.5397260273973</value><value>43.7698630136986</value><value>44.6630136986301</value><value>45.2219178082192</value><value>46.0328767123288</value><value>46.3287671232877</value><value>47.5506849315069</value><value>48.4027397260274</value><value>50.9123287671233</value><value>50.9424657534247</value><value>51</value><value>51.7369863013699</value><value>51.9890410958904</value><value>53.5643835616438</value><value>53.7424657534247</value><value>53.9972602739726</value><value>54.2931506849315</value><value>54.4794520547945</value><value>54.5753424657534</value><value>55.9890410958904</value><value>56</value><value>56.0849315068493</value><value>56.2328767123288</value><value>56.9643835616438</value><value>57.0986301369863</value><value>57.3945205479452</value><value>58.3205479452055</value><value>58.6356164383562</value><value>59.6520547945205</value><value>59.972602739726</value><value>60.5068493150685</value><value>61.2739726027397</value><value>61.3315068493151</value><value>62.1205479452055</value><value>62.4383561643836</value><value>62.8438356164384</value><value>62.8986301369863</value><value>63.6602739726027</value><value>63.7178082191781</value><value>64.013698630137</value><value>64.7506849315069</value><value>64.8794520547945</value><value>65.4493150684931</value><value>66.1479452054794</value><value>66.2712328767123</value><value>66.4602739726027</value><value>66.9178082191781</value><value>67.2739726027397</value><value>67.8438356164384</value><value>68.0849315068493</value><value>68.2904109589041</value><value>68.5178082191781</value><value>71.1835616438356</value><value>71.9150684931507</value><value>72.241095890411</value><value>75.5095890410959</value><value>78.8876712328767</value><value>80.9506849315069</value><value>81</value></sampleattribute><sampleattribute><category>alcohol use</category><value>no</value><value>yes</value></sampleattribute><sampleattribute><category>anastomotic leak</category><value>no</value><value>yes</value></sampleattribute><sampleattribute><category>arrhythmia</category><value>no</value><value>yes</value></sampleattribute><sampleattribute><category>death at fu</category><value>no</value><value>yes</value></sampleattribute><sampleattribute><category>disease state</category><value>esophageal squamous cell carcinoma</value></sampleattribute><sampleattribute><category>n stage</category><value>N0</value><value>N1</value><value>N2</value><value>N3</value></sampleattribute><sampleattribute><category>organism</category><value>Homo sapiens</value></sampleattribute><sampleattribute><category>organism part</category><value>cancer tissue from patient 302</value><value>cancer tissue from patient 303</value><value>cancer tissue from patient 305</value><value>cancer tissue from patient 306</value><value>cancer tissue from patient 308</value><value>cancer tissue from patient 309</value><value>cancer tissue from patient 311</value><value>cancer tissue from patient 312</value><value>cancer tissue from patient 315</value><value>cancer tissue from patient 316</value><value>cancer tissue from patient 317</value><value>cancer tissue from patient 318</value><value>cancer tissue from patient 319</value><value>cancer tissue from patient 321</value><value>cancer tissue from patient 322</value><value>cancer tissue from patient 324</value><value>cancer tissue from patient 325</value><value>cancer tissue from patient 326</value><value>cancer tissue from patient 330</value><value>cancer tissue from patient 331</value><value>cancer tissue from patient 333</value><value>cancer tissue from patient 334</value><value>cancer tissue from patient 337</value><value>cancer tissue from patient 338</value><value>cancer tissue from patient 340</value><value>cancer tissue from patient 341</value><value>cancer tissue from patient 342</value><value>cancer tissue from patient 347</value><value>cancer tissue from patient 353</value><value>cancer tissue from patient 355</value><value>cancer tissue from patient 361</value><value>cancer tissue from patient 362</value><value>cancer tissue from patient 365</value><value>cancer tissue from patient 366</value><value>cancer tissue from patient 367</value><value>cancer tissue from patient 370</value><value>cancer tissue from patient 371</value><value>cancer tissue from patient 373</value><value>cancer tissue from patient 374</value><value>cancer tissue from patient 375</value><value>cancer tissue from patient 376</value><value>cancer tissue from patient 378</value><value>cancer tissue from patient 380</value><value>cancer tissue from patient 381</value><value>cancer tissue from patient 382</value><value>cancer tissue from patient 385</value><value>cancer tissue from patient 391</value><value>cancer tissue from patient 392</value><value>cancer tissue from patient 393</value><value>cancer tissue from patient 396</value><value>cancer tissue from patient 398</value><value>cancer tissue from patient 400</value><value>cancer tissue from patient 402</value><value>cancer tissue from patient 403</value><value>cancer tissue from patient 404</value><value>cancer tissue from patient 405</value><value>cancer tissue from patient 406</value><value>cancer tissue from patient 407</value><value>cancer tissue from patient 408</value><value>cancer tissue from patient 409</value><value>normal tissue from patient 302</value><value>normal tissue from patient 303</value><value>normal tissue from patient 305</value><value>normal tissue from patient 306</value><value>normal tissue from patient 308</value><value>normal tissue from patient 309</value><value>normal tissue from patient 311</value><value>normal tissue from patient 312</value><value>normal tissue from patient 315</value><value>normal tissue from patient 316</value><value>normal tissue from patient 317</value><value>normal tissue from patient 318</value><value>normal tissue from patient 319</value><value>normal tissue from patient 321</value><value>normal tissue from patient 322</value><value>normal tissue from patient 324</value><value>normal tissue from patient 325</value><value>normal tissue from patient 326</value><value>normal tissue from patient 330</value><value>normal tissue from patient 331</value><value>normal tissue from patient 333</value><value>normal tissue from patient 334</value><value>normal tissue from patient 337</value><value>normal tissue from patient 338</value><value>normal tissue from patient 340</value><value>normal tissue from patient 341</value><value>normal tissue from patient 342</value><value>normal tissue from patient 347</value><value>normal tissue from patient 353</value><value>normal tissue from patient 355</value><value>normal tissue from patient 361</value><value>normal tissue from patient 362</value><value>normal tissue from patient 365</value><value>normal tissue from patient 366</value><value>normal tissue from patient 367</value><value>normal tissue from patient 370</value><value>normal tissue from patient 371</value><value>normal tissue from patient 373</value><value>normal tissue from patient 374</value><value>normal tissue from patient 375</value><value>normal tissue from patient 376</value><value>normal tissue from patient 378</value><value>normal tissue from patient 380</value><value>normal tissue from patient 381</value><value>normal tissue from patient 382</value><value>normal tissue from patient 385</value><value>normal tissue from patient 391</value><value>normal tissue from patient 392</value><value>normal tissue from patient 393</value><value>normal tissue from patient 396</value><value>normal tissue from patient 398</value><value>normal tissue from patient 400</value><value>normal tissue from patient 402</value><value>normal tissue from patient 403</value><value>normal tissue from patient 404</value><value>normal tissue from patient 405</value><value>normal tissue from patient 406</value><value>normal tissue from patient 407</value><value>normal tissue from patient 408</value><value>normal tissue from patient 409</value></sampleattribute><sampleattribute><category>patient id</category><value>ec302</value><value>ec303</value><value>ec305</value><value>ec306</value><value>ec308</value><value>ec309</value><value>ec311</value><value>ec312</value><value>ec315</value><value>ec316</value><value>ec317</value><value>ec318</value><value>ec319</value><value>ec321</value><value>ec322</value><value>ec324</value><value>ec325</value><value>ec326</value><value>ec330</value><value>ec331</value><value>ec333</value><value>ec334</value><value>ec337</value><value>ec338</value><value>ec340</value><value>ec341</value><value>ec342</value><value>ec347</value><value>ec353</value><value>ec355</value><value>ec361</value><value>ec362</value><value>ec365</value><value>ec366</value><value>ec367</value><value>ec370</value><value>ec371</value><value>ec373</value><value>ec374</value><value>ec375</value><value>ec376</value><value>ec378</value><value>ec380</value><value>ec381</value><value>ec382</value><value>ec385</value><value>ec391</value><value>ec392</value><value>ec393</value><value>ec396</value><value>ec398</value><value>ec400</value><value>ec402</value><value>ec403</value><value>ec404</value><value>ec405</value><value>ec406</value><value>ec407</value><value>ec408</value><value>ec409</value></sampleattribute><sampleattribute><category>pneumonia</category><value>no</value><value>yes</value></sampleattribute><sampleattribute><category>Sex</category><value>female</value><value>male</value></sampleattribute><sampleattribute><category>survival timemonths</category><value>1.66666666666667</value><value>10.2</value><value>10.9666666666667</value><value>11.0666666666667</value><value>11.4</value><value>11.6333333333333</value><value>13</value><value>13.1666666666667</value><value>16.0333333333333</value><value>17.9</value><value>18.0666666666667</value><value>19.1666666666667</value><value>24.4666666666667</value><value>25.1666666666667</value><value>25.4666666666667</value><value>29.7</value><value>29.8666666666667</value><value>32.0666666666667</value><value>36.3</value><value>39.1666666666667</value><value>39.5</value><value>39.8333333333333</value><value>4.36666666666667</value><value>44.9333333333333</value><value>47.9333333333333</value><value>48.0333333333333</value><value>48.4333333333333</value><value>49.4333333333333</value><value>5.7</value><value>50.1666666666667</value><value>50.6</value><value>51.1</value><value>51.2</value><value>51.3</value><value>52.0333333333333</value><value>52.7</value><value>52.9333333333333</value><value>54.1</value><value>54.7333333333333</value><value>55.2666666666667</value><value>55.6666666666667</value><value>56.1333333333333</value><value>56.6333333333333</value><value>57.2333333333333</value><value>57.2666666666667</value><value>57.3666666666667</value><value>57.5333333333333</value><value>57.6</value><value>57.7333333333333</value><value>58.2</value><value>6</value><value>6.26666666666667</value><value>6.63333333333333</value><value>8.46666666666667</value><value>8.5</value><value>8.76666666666667</value></sampleattribute><sampleattribute><category>t stage</category><value>T1</value><value>T2</value><value>T3</value><value>T4</value></sampleattribute><sampleattribute><category>tnm stage</category><value>I</value><value>II</value><value>III</value></sampleattribute><sampleattribute><category>tobacco use</category><value>no</value><value>yes</value></sampleattribute><sampleattribute><category>tumor grade</category><value>moderately</value><value>poorly</value><value>well</value></sampleattribute><sampleattribute><category>tumor loation</category><value>lower</value><value>middle</value><value>upper</value></sampleattribute><experimentalfactor><name>ADJUVANT THERAPY</name><value>no</value><value>unknown</value><value>yes</value></experimentalfactor><experimentalfactor><name>AGE</name><value>39.5397260273973</value><value>43.7698630136986</value><value>44.6630136986301</value><value>45.2219178082192</value><value>46.0328767123288</value><value>46.3287671232877</value><value>47.5506849315069</value><value>48.4027397260274</value><value>50.9123287671233</value><value>50.9424657534247</value><value>51</value><value>51.7369863013699</value><value>51.9890410958904</value><value>53.5643835616438</value><value>53.7424657534247</value><value>53.9972602739726</value><value>54.2931506849315</value><value>54.4794520547945</value><value>54.5753424657534</value><value>55.9890410958904</value><value>56</value><value>56.0849315068493</value><value>56.2328767123288</value><value>56.9643835616438</value><value>57.0986301369863</value><value>57.3945205479452</value><value>58.3205479452055</value><value>58.6356164383562</value><value>59.6520547945205</value><value>59.972602739726</value><value>60.5068493150685</value><value>61.2739726027397</value><value>61.3315068493151</value><value>62.1205479452055</value><value>62.4383561643836</value><value>62.8438356164384</value><value>62.8986301369863</value><value>63.6602739726027</value><value>63.7178082191781</value><value>64.013698630137</value><value>64.7506849315069</value><value>64.8794520547945</value><value>65.4493150684931</value><value>66.1479452054794</value><value>66.2712328767123</value><value>66.4602739726027</value><value>66.9178082191781</value><value>67.2739726027397</value><value>67.8438356164384</value><value>68.0849315068493</value><value>68.2904109589041</value><value>68.5178082191781</value><value>71.1835616438356</value><value>71.9150684931507</value><value>72.241095890411</value><value>75.5095890410959</value><value>78.8876712328767</value><value>80.9506849315069</value><value>81</value></experimentalfactor><experimentalfactor><name>ALCOHOL USE</name><value>no</value><value>yes</value></experimentalfactor><experimentalfactor><name>ANASTOMOTIC LEAK</name><value>no</value><value>yes</value></experimentalfactor><experimentalfactor><name>ARRHYTHMIA</name><value>no</value><value>yes</value></experimentalfactor><experimentalfactor><name>DEATH AT FU</name><value>no</value><value>yes</value></experimentalfactor><experimentalfactor><name>N STAGE</name><value>N0</value><value>N1</value><value>N2</value><value>N3</value></experimentalfactor><experimentalfactor><name>ORGANISM PART</name><value>cancer tissue from patient 302</value><value>cancer tissue from patient 303</value><value>cancer tissue from patient 305</value><value>cancer tissue from patient 306</value><value>cancer tissue from patient 308</value><value>cancer tissue from patient 309</value><value>cancer tissue from patient 311</value><value>cancer tissue from patient 312</value><value>cancer tissue from patient 315</value><value>cancer tissue from patient 316</value><value>cancer tissue from patient 317</value><value>cancer tissue from patient 318</value><value>cancer tissue from patient 319</value><value>cancer tissue from patient 321</value><value>cancer tissue from patient 322</value><value>cancer tissue from patient 324</value><value>cancer tissue from patient 325</value><value>cancer tissue from patient 326</value><value>cancer tissue from patient 330</value><value>cancer tissue from patient 331</value><value>cancer tissue from patient 333</value><value>cancer tissue from patient 334</value><value>cancer tissue from patient 337</value><value>cancer tissue from patient 338</value><value>cancer tissue from patient 340</value><value>cancer tissue from patient 341</value><value>cancer tissue from patient 342</value><value>cancer tissue from patient 347</value><value>cancer tissue from patient 353</value><value>cancer tissue from patient 355</value><value>cancer tissue from patient 361</value><value>cancer tissue from patient 362</value><value>cancer tissue from patient 365</value><value>cancer tissue from patient 366</value><value>cancer tissue from patient 367</value><value>cancer tissue from patient 370</value><value>cancer tissue from patient 371</value><value>cancer tissue from patient 373</value><value>cancer tissue from patient 374</value><value>cancer tissue from patient 375</value><value>cancer tissue from patient 376</value><value>cancer tissue from patient 378</value><value>cancer tissue from patient 380</value><value>cancer tissue from patient 381</value><value>cancer tissue from patient 382</value><value>cancer tissue from patient 385</value><value>cancer tissue from patient 391</value><value>cancer tissue from patient 392</value><value>cancer tissue from patient 393</value><value>cancer tissue from patient 396</value><value>cancer tissue from patient 398</value><value>cancer tissue from patient 400</value><value>cancer tissue from patient 402</value><value>cancer tissue from patient 403</value><value>cancer tissue from patient 404</value><value>cancer tissue from patient 405</value><value>cancer tissue from patient 406</value><value>cancer tissue from patient 407</value><value>cancer tissue from patient 408</value><value>cancer tissue from patient 409</value><value>normal tissue from patient 302</value><value>normal tissue from patient 303</value><value>normal tissue from patient 305</value><value>normal tissue from patient 306</value><value>normal tissue from patient 308</value><value>normal tissue from patient 309</value><value>normal tissue from patient 311</value><value>normal tissue from patient 312</value><value>normal tissue from patient 315</value><value>normal tissue from patient 316</value><value>normal tissue from patient 317</value><value>normal tissue from patient 318</value><value>normal tissue from patient 319</value><value>normal tissue from patient 321</value><value>normal tissue from patient 322</value><value>normal tissue from patient 324</value><value>normal tissue from patient 325</value><value>normal tissue from patient 326</value><value>normal tissue from patient 330</value><value>normal tissue from patient 331</value><value>normal tissue from patient 333</value><value>normal tissue from patient 334</value><value>normal tissue from patient 337</value><value>normal tissue from patient 338</value><value>normal tissue from patient 340</value><value>normal tissue from patient 341</value><value>normal tissue from patient 342</value><value>normal tissue from patient 347</value><value>normal tissue from patient 353</value><value>normal tissue from patient 355</value><value>normal tissue from patient 361</value><value>normal tissue from patient 362</value><value>normal tissue from patient 365</value><value>normal tissue from patient 366</value><value>normal tissue from patient 367</value><value>normal tissue from patient 370</value><value>normal tissue from patient 371</value><value>normal tissue from patient 373</value><value>normal tissue from patient 374</value><value>normal tissue from patient 375</value><value>normal tissue from patient 376</value><value>normal tissue from patient 378</value><value>normal tissue from patient 380</value><value>normal tissue from patient 381</value><value>normal tissue from patient 382</value><value>normal tissue from patient 385</value><value>normal tissue from patient 391</value><value>normal tissue from patient 392</value><value>normal tissue from patient 393</value><value>normal tissue from patient 396</value><value>normal tissue from patient 398</value><value>normal tissue from patient 400</value><value>normal tissue from patient 402</value><value>normal tissue from patient 403</value><value>normal tissue from patient 404</value><value>normal tissue from patient 405</value><value>normal tissue from patient 406</value><value>normal tissue from patient 407</value><value>normal tissue from patient 408</value><value>normal tissue from patient 409</value></experimentalfactor><experimentalfactor><name>PATIENT ID</name><value>ec302</value><value>ec303</value><value>ec305</value><value>ec306</value><value>ec308</value><value>ec309</value><value>ec311</value><value>ec312</value><value>ec315</value><value>ec316</value><value>ec317</value><value>ec318</value><value>ec319</value><value>ec321</value><value>ec322</value><value>ec324</value><value>ec325</value><value>ec326</value><value>ec330</value><value>ec331</value><value>ec333</value><value>ec334</value><value>ec337</value><value>ec338</value><value>ec340</value><value>ec341</value><value>ec342</value><value>ec347</value><value>ec353</value><value>ec355</value><value>ec361</value><value>ec362</value><value>ec365</value><value>ec366</value><value>ec367</value><value>ec370</value><value>ec371</value><value>ec373</value><value>ec374</value><value>ec375</value><value>ec376</value><value>ec378</value><value>ec380</value><value>ec381</value><value>ec382</value><value>ec385</value><value>ec391</value><value>ec392</value><value>ec393</value><value>ec396</value><value>ec398</value><value>ec400</value><value>ec402</value><value>ec403</value><value>ec404</value><value>ec405</value><value>ec406</value><value>ec407</value><value>ec408</value><value>ec409</value></experimentalfactor><experimentalfactor><name>PNEUMONIA</name><value>no</value><value>yes</value></experimentalfactor><experimentalfactor><name>SEX</name><value>female</value><value>male</value></experimentalfactor><experimentalfactor><name>SURVIVAL TIMEMONTHS</name><value>1.66666666666667</value><value>10.2</value><value>10.9666666666667</value><value>11.0666666666667</value><value>11.4</value><value>11.6333333333333</value><value>13</value><value>13.1666666666667</value><value>16.0333333333333</value><value>17.9</value><value>18.0666666666667</value><value>19.1666666666667</value><value>24.4666666666667</value><value>25.1666666666667</value><value>25.4666666666667</value><value>29.7</value><value>29.8666666666667</value><value>32.0666666666667</value><value>36.3</value><value>39.1666666666667</value><value>39.5</value><value>39.8333333333333</value><value>4.36666666666667</value><value>44.9333333333333</value><value>47.9333333333333</value><value>48.0333333333333</value><value>48.4333333333333</value><value>49.4333333333333</value><value>5.7</value><value>50.1666666666667</value><value>50.6</value><value>51.1</value><value>51.2</value><value>51.3</value><value>52.0333333333333</value><value>52.7</value><value>52.9333333333333</value><value>54.1</value><value>54.7333333333333</value><value>55.2666666666667</value><value>55.6666666666667</value><value>56.1333333333333</value><value>56.6333333333333</value><value>57.2333333333333</value><value>57.2666666666667</value><value>57.3666666666667</value><value>57.5333333333333</value><value>57.6</value><value>57.7333333333333</value><value>58.2</value><value>6</value><value>6.26666666666667</value><value>6.63333333333333</value><value>8.46666666666667</value><value>8.5</value><value>8.76666666666667</value></experimentalfactor><experimentalfactor><name>T STAGE</name><value>T1</value><value>T2</value><value>T3</value><value>T4</value></experimentalfactor><experimentalfactor><name>TNM STAGE</name><value>I</value><value>II</value><value>III</value></experimentalfactor><experimentalfactor><name>TOBACCO USE</name><value>no</value><value>yes</value></experimentalfactor><experimentalfactor><name>TUMOR GRADE</name><value>moderately</value><value>poorly</value><value>well</value></experimentalfactor><experimentalfactor><name>TUMOR LOATION</name><value>lower</value><value>middle</value><value>upper</value></experimentalfactor><miamescores><reportersequencescore>1</reportersequencescore><protocolscore>1</protocolscore><factorvaluescore>1</factorvaluescore><derivedbioassaydatascore>1</derivedbioassaydatascore><measuredbioassaydatascore>1</measuredbioassaydatascore><overallscore>5</overallscore></miamescores><id>413264</id><accession>E-GEOD-53622</accession><secondaryaccession>GSE53622</secondaryaccession><name>LncRNA profile study reveals a three-lncRNA signature associated with the survival of esophageal squamous cell carcinoma patients (independent set)</name><experimenttype>transcription profiling by array</experimenttype><releasedate>2014-03-07</releasedate><lastupdatedate>2014-06-03</lastupdatedate><samples>120</samples><assays>120</assays><arraydesign><id>28493</id><accession>A-GEOD-18109</accession><name>CBC Homo sapiens lncRNA + mRNA microarray V2.0</name><count>120</count></arraydesign><bioassaydatagroup><id/><name>rawData</name><bioassaydatacubes>120</bioassaydatacubes><arraydesignprovider/><dataformat>rawData</dataformat><bioassays>120</bioassays><isderived>0</isderived></bioassaydatagroup><bioassaydatagroup><id/><name>normalization</name><bioassaydatacubes>120</bioassaydatacubes><arraydesignprovider/><dataformat>normalization</dataformat><bioassays>120</bioassays><isderived>0</isderived></bioassaydatagroup><bioassaydatagroup><id/><name>processedData</name><bioassaydatacubes>120</bioassaydatacubes><arraydesignprovider/><dataformat>processedData</dataformat><bioassays>120</bioassays><isderived>0</isderived></bioassaydatagroup><bibliography><accession>24522499</accession><authors>Li J, Chen Z, Tian L, Zhou C, He MY, Gao Y, Wang S, Zhou F, Shi S, Feng X, Sun N, Liu Z, Skogerboe G, Dong J, Yao R, Zhao Y, Sun J, Zhang B, Yu Y, Shi X, Luo M, Shao K, Li N, Qiu B, Tan F, Chen R, He J</authors><title>LncRNA profile study reveals a three-lncRNA signature associated with the survival of patients with oesophageal squamous cell carcinoma.</title><doi>10.1136/gutjnl-2013-305806</doi></bibliography><provider><contact>L Tian</contact><role/><email/></provider><provider><contact>Z Chen</contact><role/><email/></provider><provider><contact>J Li</contact><role/><email/></provider><provider><contact>Jiagen Li</contact><role>submitter</role><email>jiagen.li@hotmail.com</email></provider><description><id/><text>Objective: Globally, esophageal cancer is among the most deadly cancer forms. Long non-coding RNAs (lncRNA) are frequently found to have important regulatory roles. We aim to assess the lncRNA expression profile of esophageal squamous cell carcinoma (ESCC) and identify prognosis related lncRNAs. Design: LncRNA expression profiles were studied by microarray in paired tumor and normal tissues from 119 ESCC patients, and validated by qRT-PCR. The 119 patients were subsequently divided randomly into training (n=60) and test (n=59) groups. A prognostic signature was developed from the training group using a random forest supervised classification algorithm and a nearest shrunken centroid algorithm, and validated in test group and further in an independent cohort (n=60). The independence of the signature in survival prediction was evaluated by Multivariable Cox regression analysis. Results: LncRNAs showed significantly altered expression in ESCC tissues. From the training group, we identified a three-lncRNA signature (including the lncRNAs ENST00000435885•1, XLOC_013014, and ENST00000547963•1) which classified the patients into two groups with significantly different overall survival (median survival 19•2 months vs. not reached, p&lt;0•0001). The signature was applied to the test group (median survival 21•5 months vs. not reached, p=0•0030) and independent cohort (median survival 25•8 months vs. not reached, p=0•0187) and showed similar prognostic values in both. Multivariable Cox regression analysis showed that the signature was an independent prognostic factor for ESCC patients. Stratified analysis suggested that the signature was prognostic within clinical stages. Conclusions: Our results suggest that the three-lncRNA signature can serve as a novel biomarker for the prognosis of ESCC patients. Application of it allows for more accurate survival prediction. The lncRNA expression profiles of cancer and adjacent normal tissues form 119 ESCC patients were studied by microarray and an lncRNA signature that can perdict the survival of ESCC patients was identified.</text></description><protocol><id>978847</id><accession>P-GSE53622-4</accession></protocol><protocol><id>978846</id><accession>P-GSE53622-5</accession></protocol><protocol><id>978849</id><accession>P-GSE53622-2</accession></protocol><protocol><id>978848</id><accession>P-GSE53622-3</accession></protocol><protocol><id>978845</id><accession>P-GSE53622-1</accession></protocol><organism>Homo sapiens</organism><files><!--
This section is deprecated and unsupported.
Please use webservice located at:
    http://www.ebi.ac.uk/arrayexpress/xml/files
to obtain detailed information on files available for the experiment.
For more information, please go to:
    http://www.ebi.ac.uk/arrayexpress/help/programmatic_access.html
                --><raw name="E-GEOD-53622.raw.10.zip E-GEOD-53622.raw.11.zip E-GEOD-53622.raw.12.zip E-GEOD-53622.raw.13.zip E-GEOD-53622.raw.14.zip E-GEOD-53622.raw.15.zip E-GEOD-53622.raw.16.zip E-GEOD-53622.raw.17.zip E-GEOD-53622.raw.18.zip E-GEOD-53622.raw.19.zip E-GEOD-53622.raw.1.zip E-GEOD-53622.raw.20.zip E-GEOD-53622.raw.21.zip E-GEOD-53622.raw.22.zip E-GEOD-53622.raw.23.zip E-GEOD-53622.raw.24.zip E-GEOD-53622.raw.25.zip E-GEOD-53622.raw.2.zip E-GEOD-53622.raw.3.zip E-GEOD-53622.raw.4.zip E-GEOD-53622.raw.5.zip E-GEOD-53622.raw.6.zip E-GEOD-53622.raw.7.zip E-GEOD-53622.raw.8.zip E-GEOD-53622.raw.9.zip" count="true" celcount="0"/><fgem name="E-GEOD-53622.processed.1.zip" available="true"/><idf name="E-GEOD-53622.idf.txt"/><sdrf name="E-GEOD-53622.sdrf.txt"/></files></experiment><experiment><species>Homo sapiens</species><rawdatafiles available="false"/><processeddatafiles available="true"/><sampleattribute><category>cell line</category><value>PPC-1</value></sampleattribute><sampleattribute><category>cell type</category><value>primary prostatic tumor cells</value></sampleattribute><sampleattribute><category>genotype</category><value>control cells (shGFP)</value><value>lacking NWD1 expression (sh184)</value><value>lacking NWD1 expression (sh3922)</value></sampleattribute><sampleattribute><category>organism</category><value>Homo sapiens</value></sampleattribute><experimentalfactor><name>GENOTYPE</name><value>control cells (shGFP)</value><value>lacking NWD1 expression (sh184)</value><value>lacking NWD1 expression (sh3922)</value></experimentalfactor><miamescores><reportersequencescore>1</reportersequencescore><protocolscore>0</protocolscore><factorvaluescore>1</factorvaluescore><derivedbioassaydatascore>1</derivedbioassaydatascore><measuredbioassaydatascore>1</measuredbioassaydatascore><overallscore>4</overallscore></miamescores><id>410277</id><accession>E-GEOD-53115</accession><secondaryaccession>GSE53115</secondaryaccession><name>The novel NLR-related protein NWD1 is associated with prostate cancer progression and impacts androgen receptor signaling</name><experimenttype>transcription profiling by array</experimenttype><releasedate>2014-03-07</releasedate><lastupdatedate>2014-06-03</lastupdatedate><samples>6</samples><assays>6</assays><arraydesign><id>12299</id><accession>A-MEXP-1173</accession><name>Illumina HumanWG-6 v3.0 Expression BeadChip</name><count>6</count><legacy_id>1633118223</legacy_id></arraydesign><bioassaydatagroup><id/><name>normalization</name><bioassaydatacubes>6</bioassaydatacubes><arraydesignprovider/><dataformat>normalization</dataformat><bioassays>6</bioassays><isderived>0</isderived></bioassaydatagroup><bioassaydatagroup><id/><name>processedData</name><bioassaydatacubes>6</bioassaydatacubes><arraydesignprovider/><dataformat>processedData</dataformat><bioassays>6</bioassays><isderived>0</isderived></bioassaydatagroup><provider><contact>Ricardo Correa</contact><role/><email/></provider><provider><contact>Roy M Williams</contact><role>submitter</role><email>royw@burnham.org</email></provider><provider><contact>John Reed</contact><role/><email/></provider><description><id/><text>Characterization of NWD1; a novel NLR-related protein and further correlate it as a putative Prostate Cancer marker.  NLRs (NACHT and Leucine Rich Repeat domain containing proteins) constitute a major subfamily of innate immunity proteins  mostly acting as cytosolic pattern recognition receptors (PRRs), involved in the detection of cytoplasmic pathogen-associated molecular patterns (PAMPs) and endogenous danger signals. The recognition of the signals initiates a variety of host defense pathways through the activation of NF-kappaB, stress kinases, interferon response factors (IRFs) and/or inflammatory caspases. Despite the importance in host immune response, deregulation on NLR activities has been described in a variety of maladies, including chronic inflammation and cancer predisposition. For instance, NOD1 was one of the first NLR members shown to possibly play a role in tumorigenesis, since NOD1 stimulation induces apoptosis in MCF-7 breast carcinoma cells, and NOD1-/- MCF-7 cells generate larger tumors after injection in SCID mice. Mice deficient in NLR member NLRP3, and/or its interacting partners ASC or caspase-1, are also shown to be more susceptible to colitis-associated cancer (CAC). Polymorphisms along NLR genes NOD1 and NOD2 have also been correlated with altered cancer risk. NOD1 SNPs have been associated with gastric cancer, lymphoma, ovarian, prostate, and lung cancer due to the recognition of H. pylori (etiologic agent in gastric cancer and MALT lymphoma), C. trachomatis (putative etiologic agent in ovarian cancer), P. acnes (possible causative agent in PCa) and C. pneumonia (plausible etiological agent in lung cancer) as NOD1 ligands. Particularly, NOD1 and NOD2 have been shown to be fully operative in prostate epithelial cells and, in cooperation with TLRs, may elicit immune response during PCa progression. To access a tissue-specific gene expression profile for NWD1, quantitative PCR analysis was performed using a normalized cDNA panel derived from 48 human tissues (TissueScan Tissue qPCR Array, Origene). Two apparently independent expression patterns were detected, respectively related to neurological related organs (brain, pituitary and retina) and male reproductive system (prostate, epididymis and testis), where the highest mRNA levels was observed in prostate tissue. Results were confirmed using a second set of NWD1-specific qPCR primers (data not shown). Moreover, a similar expression pattern was virtually observed using the SAGE database from the Cancer Genome Anatomy Project (CGAP) of the National Cancer Institute (not shown).  Comparative gene expression microarray data was analyzed systematically by Ingenuity Pathway Analysis (IPA) to set up potential networks based on NWD1 regulated genes. The eventual participation of NWD1 in signaling transduction pathways was further examined by microarray analysis (Human WG-6v3 Expression BeadChip, Illumina) comparing the expression profile of PPC-1 cells lacking NWD1 expression (sh184 &amp; sh3922) versus control cells  (shGFP). According to the differential expression profile that was generated and analyzed by the Ingenuity PathwaysTM software (IPA version 7.1, Ingenuity Systems), NWD1 is presumably associated with biological networks related, for instance, to tissue morphology, organogenesis, cancer and neurological diseases .</text></description><protocol><id>974935</id><accession>P-GSE53115-4</accession></protocol><protocol><id>974936</id><accession>P-GSE53115-3</accession></protocol><protocol><id>974937</id><accession>P-GSE53115-2</accession></protocol><protocol><id>974933</id><accession>P-GSE53115-1</accession></protocol><protocol><id>974934</id><accession>P-GSE53115-5</accession></protocol><organism>Homo sapiens</organism><files><!--
This section is deprecated and unsupported.
Please use webservice located at:
    http://www.ebi.ac.uk/arrayexpress/xml/files
to obtain detailed information on files available for the experiment.
For more information, please go to:
    http://www.ebi.ac.uk/arrayexpress/help/programmatic_access.html
                --><fgem name="E-GEOD-53115.processed.1.zip" available="true"/><idf name="E-GEOD-53115.idf.txt"/><sdrf name="E-GEOD-53115.sdrf.txt"/></files></experiment><experiment><species>Homo sapiens</species><rawdatafiles available="true"/><processeddatafiles available="true"/><sampleattribute><category>organism</category><value>Homo sapiens</value></sampleattribute><sampleattribute><category>organism part</category><value>bronchoalveolar lavage</value></sampleattribute><sampleattribute><category>subject id</category><value>UG1138</value><value>UG1142</value><value>UG1165</value><value>UG1166</value><value>UG1168</value><value>UG1169</value><value>UG1171</value><value>UG1175</value><value>UG1176</value><value>UG1186</value><value>UG1194</value><value>UG1197</value><value>UG1200</value><value>UG1216</value><value>UG1222</value><value>UG1242</value><value>UG1243</value><value>UG1254</value><value>UG1262</value><value>UG1266</value><value>UG1289</value><value>UG1290</value><value>UG1292</value><value>UG1325</value><value>UG1328</value><value>UG1360</value><value>UG1397</value><value>UG1416</value><value>UG1420</value><value>UG1424</value><value>UG1435</value><value>UG1436</value><value>UG1438</value><value>UG1442</value><value>UG1454</value><value>UG1472</value><value>UG1477</value><value>UG1483</value><value>UG1488</value><value>UG1492</value><value>UG1499</value><value>UG1500</value><value>UG1550</value><value>UG1555</value><value>UG1563</value><value>UG1571</value><value>UG1586</value><value>UG1601</value><value>UG1618</value><value>UG1623</value><value>UG1628</value><value>UG1634</value><value>UG1640</value><value>UG1651</value><value>UG1652</value><value>UG1674</value><value>UG1689</value><value>UG1690</value><value>UG1705</value><value>UG1711</value></sampleattribute><sampleattribute><category>subject status</category><value>Ugandan HIV-infected patients with pneumonia</value></sampleattribute><experimentalfactor><name>SUBJECT ID</name><value>UG1138</value><value>UG1142</value><value>UG1165</value><value>UG1166</value><value>UG1168</value><value>UG1169</value><value>UG1171</value><value>UG1175</value><value>UG1176</value><value>UG1186</value><value>UG1194</value><value>UG1197</value><value>UG1200</value><value>UG1216</value><value>UG1222</value><value>UG1242</value><value>UG1243</value><value>UG1254</value><value>UG1262</value><value>UG1266</value><value>UG1289</value><value>UG1290</value><value>UG1292</value><value>UG1325</value><value>UG1328</value><value>UG1360</value><value>UG1397</value><value>UG1416</value><value>UG1420</value><value>UG1424</value><value>UG1435</value><value>UG1436</value><value>UG1438</value><value>UG1442</value><value>UG1454</value><value>UG1472</value><value>UG1477</value><value>UG1483</value><value>UG1488</value><value>UG1492</value><value>UG1499</value><value>UG1500</value><value>UG1550</value><value>UG1555</value><value>UG1563</value><value>UG1571</value><value>UG1586</value><value>UG1601</value><value>UG1618</value><value>UG1623</value><value>UG1628</value><value>UG1634</value><value>UG1640</value><value>UG1651</value><value>UG1652</value><value>UG1674</value><value>UG1689</value><value>UG1690</value><value>UG1705</value><value>UG1711</value></experimentalfactor><miamescores><reportersequencescore>1</reportersequencescore><protocolscore>1</protocolscore><factorvaluescore>1</factorvaluescore><derivedbioassaydatascore>1</derivedbioassaydatascore><measuredbioassaydatascore>1</measuredbioassaydatascore><overallscore>5</overallscore></miamescores><id>406419</id><accession>E-GEOD-52791</accession><secondaryaccession>GSE52791</secondaryaccession><name>The Lung Microbiome of HIV-infected Pneumonia Patients in Sub-Saharan Africa</name><experimenttype>other</experimenttype><releasedate>2014-02-20</releasedate><lastupdatedate>2014-06-03</lastupdatedate><samples>60</samples><assays>60</assays><arraydesign><id>27701</id><accession>A-GEOD-18000</accession><name>[PhyloChip] Affymetrix G2 PhyloChip (Nov2013v)</name><count>60</count></arraydesign><bioassaydatagroup><id/><name>rawData</name><bioassaydatacubes>60</bioassaydatacubes><arraydesignprovider/><dataformat>rawData</dataformat><bioassays>60</bioassays><isderived>0</isderived></bioassaydatagroup><bioassaydatagroup><id/><name>normalization</name><bioassaydatacubes>60</bioassaydatacubes><arraydesignprovider/><dataformat>normalization</dataformat><bioassays>60</bioassays><isderived>0</isderived></bioassaydatagroup><bioassaydatagroup><id/><name>processedData</name><bioassaydatacubes>60</bioassaydatacubes><arraydesignprovider/><dataformat>processedData</dataformat><bioassays>60</bioassays><isderived>0</isderived></bioassaydatagroup><provider><contact>Susan V Lynch</contact><role/><email/></provider><provider><contact>Shoko Iwai</contact><role>submitter</role><email>shoko.iwai@ucsf.edu</email></provider><provider><contact>Laurence Huang</contact><role/><email/></provider><provider><contact>Shoko Iwai</contact><role/><email/></provider><description><id/><text>Sub-Saharan Africa represents 69% of the total number of individuals living with HIV infection worldwide and 72% of AIDS deaths globally. Pulmonary infection is a common and frequently fatal complication, though little is known regarding the lower airway microbiome composition of this population. Our objectives were to characterize the lower airway microbiome of Ugandan HIV-infected patients with pneumonia, to determine relationships with demographic, clinical, immunological, and microbiological variables and to compare the composition and predicted metagenome of these communities to a comparable cohort of patients in the US (San Francisco). Bronchoalveolar lavage samples from a cohort of 60 Ugandan HIV-infected patients with acute pneumonia were collected. Amplified 16S ribosomal RNA was profiled and aforementioned relationships examined. Ugandan airway microbiome composition and predicted metagenomic function were compared to US HIV-infected pneumonia patients. Among the most common bacterial pulmonary pathogens, Pseudomonas aeruginosa was most prevalent in the Ugandan cohort. Patients with a richer and more diverse airway microbiome exhibited lower bacterial burden, enrichment of members of the Lachnospiraceae and sulfur-reducing bacteria and reduced expression of TNF-alpha and matrix metalloproteinase-9. Compared to San Franciscan patients, Ugandan airway microbiome were significantly richer, and compositionally distinct with predicted metagenomes that encoded a multitude of distinct pathogenic pathways e.g secretion systems. Ugandan pneumonia-associated airway microbiome is compositionally and functionally distinct from those detected in comparable patients in developed countries, a feature which may contribute to adverse outcomes in this population.  Please note that the data from the comparable cohort of patients in the USUS data was published as supplemental material of PMID: 22760045 but not submitted to GEO  The 'patient_info.txt' contains 12 clinical, 7 immunological and 3 microbiological variables for each patient. The G2 PhyloChip microarray platform (commercially available from Second Genome, Inc.) was used to profile bacteria in lower airway samples from 60 subjects</text></description><protocol><id>968024</id><accession>P-GSE52791-2</accession></protocol><protocol><id>968023</id><accession>P-GSE52791-3</accession></protocol><protocol><id>968022</id><accession>P-GSE52791-4</accession></protocol><protocol><id>968021</id><accession>P-GSE52791-5</accession></protocol><protocol><id>968019</id><accession>P-GSE52791-1</accession></protocol><protocol><id>968020</id><accession>P-GSE52791-6</accession></protocol><organism>Homo sapiens</organism><files><!--
This section is deprecated and unsupported.
Please use webservice located at:
    http://www.ebi.ac.uk/arrayexpress/xml/files
to obtain detailed information on files available for the experiment.
For more information, please go to:
    http://www.ebi.ac.uk/arrayexpress/help/programmatic_access.html
                --><raw name="E-GEOD-52791.raw.1.zip E-GEOD-52791.raw.2.zip" count="true" celcount="0"/><fgem name="E-GEOD-52791.processed.1.zip" available="true"/><idf name="E-GEOD-52791.idf.txt"/><sdrf name="E-GEOD-52791.sdrf.txt"/></files></experiment><experiment><species>Homo sapiens</species><rawdatafiles available="false"/><processeddatafiles available="true"/><sampleattribute><category>cell type</category><value>  </value><value>CD14</value><value>CD15</value><value>CD4</value><value>CD8</value><value>PBMC</value></sampleattribute><sampleattribute><category>disease state</category><value>  </value><value>Active Sarcoid</value><value>Active sarcoidosis</value><value>Baseline</value><value>control</value><value>Lung Cancer</value><value>Non-active sarcoidosis</value><value>pneumonia</value><value>Sarcoid</value><value>TB</value></sampleattribute><sampleattribute><category>ethnicity</category><value>  </value><value>Afro-Carribbean</value><value>Black</value><value>Caucasian</value><value>Central Asia</value><value>Indian subcontinent</value><value>Middle Eastern</value><value>None</value><value>SE Asian</value><value>White</value></sampleattribute><sampleattribute><category>organism</category><value>Homo sapiens</value></sampleattribute><sampleattribute><category>organism part</category><value>  </value><value>whole blood</value></sampleattribute><sampleattribute><category>response</category><value>  </value><value>Good-response</value><value>Inadequate</value><value>Pre-treatment</value></sampleattribute><sampleattribute><category>sex</category><value>  </value><value>female</value><value>male</value><value>None</value></sampleattribute><sampleattribute><category>subject</category><value>  </value><value>2010</value><value>2018</value><value>2099</value><value>2100</value><value>2101</value><value>2102</value><value>2105</value><value>2121</value><value>2132</value><value>2140</value><value>6009</value><value>6011</value></sampleattribute><sampleattribute><category>time d</category><value>  </value><value>1</value><value>2</value><value>3</value></sampleattribute><sampleattribute><category>treament</category><value>  </value><value>immunosuppressive treatment</value><value>Pre-treatment</value></sampleattribute><experimentalfactor><name>CELL TYPE</name><value>CD14</value><value>CD15</value><value>CD4</value><value>CD8</value><value>not specified</value><value>PBMC</value></experimentalfactor><experimentalfactor><name>DISEASE STATE</name><value>Active Sarcoid</value><value>Active sarcoidosis</value><value>Baseline</value><value>control</value><value>Lung Cancer</value><value>Non-active sarcoidosis</value><value>not specified</value><value>pneumonia</value><value>Sarcoid</value><value>TB</value></experimentalfactor><experimentalfactor><name>ETHNICITY</name><value>Afro-Carribbean</value><value>Black</value><value>Caucasian</value><value>Central Asia</value><value>Indian subcontinent</value><value>Middle Eastern</value><value>None</value><value>not specified</value><value>SE Asian</value><value>White</value></experimentalfactor><experimentalfactor><name>RESPONSE</name><value>Good-response</value><value>Inadequate</value><value>not specified</value><value>Pre-treatment</value></experimentalfactor><experimentalfactor><name>SEX</name><value>female</value><value>male</value><value>None</value><value>not specified</value></experimentalfactor><experimentalfactor><name>SUBJECT</name><value>2010</value><value>2018</value><value>2099</value><value>2100</value><value>2101</value><value>2102</value><value>2105</value><value>2121</value><value>2132</value><value>2140</value><value>6009</value><value>6011</value><value>not specified</value></experimentalfactor><experimentalfactor><name>TIME D</name><value>1</value><value>2</value><value>3</value><value>not specified</value></experimentalfactor><experimentalfactor><name>TREAMENT</name><value>immunosuppressive treatment</value><value>not specified</value><value>Pre-treatment</value></experimentalfactor><experimentalfactor><name>TREATMENT</name><value>not specified</value><value>Pre-treatment</value><value>Treated with antibiotic</value></experimentalfactor><miamescores><reportersequencescore>1</reportersequencescore><protocolscore>0</protocolscore><factorvaluescore>1</factorvaluescore><derivedbioassaydatascore>1</derivedbioassaydatascore><measuredbioassaydatascore>1</measuredbioassaydatascore><overallscore>4</overallscore></miamescores><id>366342</id><accession>E-GEOD-42834</accession><secondaryaccession>GSE42834</secondaryaccession><name>Human whole blood microarray study to compare patients with tuberculosis, sarcoidosis, pneumonia, and lung cancer</name><experimenttype>transcription profiling by array</experimenttype><releasedate>2013-10-31</releasedate><lastupdatedate>2014-06-02</lastupdatedate><samples>356</samples><assays>356</assays><arraydesign><id>7604</id><accession>A-GEOD-10558</accession><name>Illumina HumanHT-12 V4.0 expression beadchip</name><count>356</count><legacy_id>2501282336</legacy_id></arraydesign><bioassaydatagroup><id/><name>normalization</name><bioassaydatacubes>356</bioassaydatacubes><arraydesignprovider/><dataformat>normalization</dataformat><bioassays>356</bioassays><isderived>0</isderived></bioassaydatagroup><bioassaydatagroup><id/><name>processedData</name><bioassaydatacubes>356</bioassaydatacubes><arraydesignprovider/><dataformat>processedData</dataformat><bioassays>356</bioassays><isderived>0</isderived></bioassaydatagroup><provider><contact>Chloe Bloom</contact><role>submitter</role><email>cbloom@nimr.mrc.ac.uk</email></provider><description><id/><text>This SuperSeries is composed of the SubSeries listed below. Refer to individual Series</text></description><protocol><id>900383</id><accession>P-GSE42834-11</accession></protocol><protocol><id>900388</id><accession>P-GSE42834-10</accession></protocol><protocol><id>900387</id><accession>P-GSE42834-16</accession></protocol><protocol><id>900390</id><accession>P-GSE42834-4</accession></protocol><protocol><id>900380</id><accession>P-GSE42834-3</accession></protocol><protocol><id>900382</id><accession>P-GSE42834-17</accession></protocol><protocol><id>900376</id><accession>P-GSE42834-2</accession></protocol><protocol><id>900378</id><accession>P-GSE42834-1</accession></protocol><protocol><id>900381</id><accession>P-GSE42834-12</accession></protocol><protocol><id>900379</id><accession>P-GSE42834-13</accession></protocol><protocol><id>900386</id><accession>P-GSE42834-14</accession></protocol><protocol><id>900385</id><accession>P-GSE42834-15</accession></protocol><protocol><id>900377</id><accession>P-GSE42834-9</accession></protocol><protocol><id>900384</id><accession>P-GSE42834-8</accession></protocol><protocol><id>900391</id><accession>P-GSE42834-7</accession></protocol><protocol><id>900392</id><accession>P-GSE42834-6</accession></protocol><protocol><id>900389</id><accession>P-GSE42834-5</accession></protocol><organism>Homo sapiens</organism><files><!--
This section is deprecated and unsupported.
Please use webservice located at:
    http://www.ebi.ac.uk/arrayexpress/xml/files
to obtain detailed information on files available for the experiment.
For more information, please go to:
    http://www.ebi.ac.uk/arrayexpress/help/programmatic_access.html
                --><fgem name="E-GEOD-42834.processed.1.zip" available="true"/><idf name="E-GEOD-42834.idf.txt"/><sdrf name="E-GEOD-42834.sdrf.txt"/></files></experiment><experiment><species>Homo sapiens</species><rawdatafiles available="false"/><processeddatafiles available="true"/><sampleattribute><category>organism</category><value>Homo sapiens</value></sampleattribute><sampleattribute><category>response</category><value>Good-response</value><value>Inadequate</value><value>Pre-treatment</value></sampleattribute><sampleattribute><category>subject</category><value>2010</value><value>2018</value><value>2099</value><value>2100</value><value>2140</value><value>6009</value><value>6011</value></sampleattribute><sampleattribute><category>time d</category><value>1</value><value>2</value><value>3</value></sampleattribute><sampleattribute><category>treament</category><value>immunosuppressive treatment</value><value>Pre-treatment</value></sampleattribute><experimentalfactor><name>RESPONSE</name><value>Good-response</value><value>Inadequate</value><value>Pre-treatment</value></experimentalfactor><experimentalfactor><name>SUBJECT</name><value>2010</value><value>2018</value><value>2099</value><value>2100</value><value>2140</value><value>6009</value><value>6011</value></experimentalfactor><experimentalfactor><name>TIME D</name><value>1</value><value>2</value><value>3</value></experimentalfactor><experimentalfactor><name>TREAMENT</name><value>immunosuppressive treatment</value><value>Pre-treatment</value></experimentalfactor><miamescores><reportersequencescore>1</reportersequencescore><protocolscore>0</protocolscore><factorvaluescore>1</factorvaluescore><derivedbioassaydatascore>1</derivedbioassaydatascore><measuredbioassaydatascore>1</measuredbioassaydatascore><overallscore>4</overallscore></miamescores><id>366303</id><accession>E-GEOD-42831</accession><secondaryaccession>GSE42831</secondaryaccession><name>Human whole blood microarray study to compare patients with tuberculosis, sarcoidosis, pneumonia, and lung cancer (sarcoidosis)</name><experimenttype>transcription profiling by array</experimenttype><releasedate>2013-10-31</releasedate><lastupdatedate>2014-06-02</lastupdatedate><samples>17</samples><assays>17</assays><arraydesign><id>7604</id><accession>A-GEOD-10558</accession><name>Illumina HumanHT-12 V4.0 expression beadchip</name><count>17</count><legacy_id>2501282336</legacy_id></arraydesign><bioassaydatagroup><id/><name>normalization</name><bioassaydatacubes>17</bioassaydatacubes><arraydesignprovider/><dataformat>normalization</dataformat><bioassays>17</bioassays><isderived>0</isderived></bioassaydatagroup><bioassaydatagroup><id/><name>processedData</name><bioassaydatacubes>17</bioassaydatacubes><arraydesignprovider/><dataformat>processedData</dataformat><bioassays>17</bioassays><isderived>0</isderived></bioassaydatagroup><provider><contact>Anne O’Garra</contact><role/><email/></provider><provider><contact>Phillip Vanhems</contact><role/><email/></provider><provider><contact>Makoto Miyara</contact><role/><email/></provider><provider><contact>Guy Gorochov</contact><role/><email/></provider><provider><contact>Robert J Wilkinson</contact><role/><email/></provider><provider><contact>Fotini Rozakeas</contact><role/><email/></provider><provider><contact>Ling-pei Ho</contact><role/><email/></provider><provider><contact>Yvonne West</contact><role/><email/></provider><provider><contact>Katalin A Wilkinson</contact><role/><email/></provider><provider><contact>Rama Vancheeswaran</contact><role/><email/></provider><provider><contact>Mitra Saadatian</contact><role/><email/></provider><provider><contact>Marc Lipman</contact><role/><email/></provider><provider><contact>Mel Wickremasinghe</contact><role/><email/></provider><provider><contact>Christine M Graham</contact><role/><email/></provider><provider><contact>Damien Chaussabel</contact><role/><email/></provider><provider><contact>Diane Bouvry</contact><role/><email/></provider><provider><contact>Chloe I Bloom</contact><role/><email/></provider><provider><contact>Yuanyuan Wang</contact><role/><email/></provider><provider><contact>Matthew R Berry</contact><role/><email/></provider><provider><contact>Derek Blankenship</contact><role/><email/></provider><provider><contact>Valeyre Dominique</contact><role/><email/></provider><provider><contact>Zhaohui Xu</contact><role/><email/></provider><provider><contact>Chloe Bloom</contact><role>submitter</role><email>cbloom@nimr.mrc.ac.uk</email></provider><provider><contact>Huw Beynon</contact><role/><email/></provider><provider><contact>Virginia Pascual</contact><role/><email/></provider><provider><contact>Jacques Banchereau</contact><role/><email/></provider><provider><contact>Paul S Redford</contact><role/><email/></provider><description><id/><text>This study used whole blood transcriptional signatures from patients with sarcoidosis before and during immunosuppressive treatment There were 7 pneumonia patients, the same patients were sampled before and after their treatment</text></description><protocol><id>900115</id><accession>P-GSE42831-5</accession></protocol><protocol><id>900117</id><accession>P-GSE42831-4</accession></protocol><protocol><id>900113</id><accession>P-GSE42831-7</accession></protocol><protocol><id>900114</id><accession>P-GSE42831-6</accession></protocol><protocol><id>900112</id><accession>P-GSE42831-1</accession></protocol><protocol><id>900118</id><accession>P-GSE42831-3</accession></protocol><protocol><id>900116</id><accession>P-GSE42831-2</accession></protocol><organism>Homo sapiens</organism><files><!--
This section is deprecated and unsupported.
Please use webservice located at:
    http://www.ebi.ac.uk/arrayexpress/xml/files
to obtain detailed information on files available for the experiment.
For more information, please go to:
    http://www.ebi.ac.uk/arrayexpress/help/programmatic_access.html
                --><fgem name="E-GEOD-42831.processed.1.zip" available="true"/><idf name="E-GEOD-42831.idf.txt"/><sdrf name="E-GEOD-42831.sdrf.txt"/></files></experiment><experiment><species>Homo sapiens</species><rawdatafiles available="false"/><processeddatafiles available="true"/><sampleattribute><category>disease state</category><value>Active Sarcoid</value><value>Baseline</value><value>control</value><value>Lung Cancer</value><value>Non-active sarcoidosis</value><value>TB</value></sampleattribute><sampleattribute><category>ethnicity</category><value>Afro-Carribbean</value><value>Caucasian</value><value>Indian subcontinent</value><value>Middle Eastern</value></sampleattribute><sampleattribute><category>organism</category><value>Homo sapiens</value></sampleattribute><sampleattribute><category>organism part</category><value>whole blood</value></sampleattribute><sampleattribute><category>sex</category><value>female</value><value>male</value><value>None</value></sampleattribute><experimentalfactor><name>DISEASE STATE</name><value>Active Sarcoid</value><value>Baseline</value><value>control</value><value>Lung Cancer</value><value>Non-active sarcoidosis</value><value>TB</value></experimentalfactor><experimentalfactor><name>ETHNICITY</name><value>Afro-Carribbean</value><value>Caucasian</value><value>Indian subcontinent</value><value>Middle Eastern</value></experimentalfactor><experimentalfactor><name>SEX</name><value>female</value><value>male</value><value>None</value></experimentalfactor><miamescores><reportersequencescore>1</reportersequencescore><protocolscore>0</protocolscore><factorvaluescore>1</factorvaluescore><derivedbioassaydatascore>1</derivedbioassaydatascore><measuredbioassaydatascore>1</measuredbioassaydatascore><overallscore>4</overallscore></miamescores><id>366307</id><accession>E-GEOD-42830</accession><secondaryaccession>GSE42830</secondaryaccession><name>Human whole blood microarray study to compare patients with tuberculosis, sarcoidosis, pneumonia, and lung cancer (training)</name><experimenttype>transcription profiling by array</experimenttype><releasedate>2013-10-31</releasedate><lastupdatedate>2014-06-02</lastupdatedate><samples>95</samples><assays>95</assays><arraydesign><id>7604</id><accession>A-GEOD-10558</accession><name>Illumina HumanHT-12 V4.0 expression beadchip</name><count>95</count><legacy_id>2501282336</legacy_id></arraydesign><bioassaydatagroup><id/><name>normalization</name><bioassaydatacubes>95</bioassaydatacubes><arraydesignprovider/><dataformat>normalization</dataformat><bioassays>95</bioassays><isderived>0</isderived></bioassaydatagroup><bioassaydatagroup><id/><name>processedData</name><bioassaydatacubes>95</bioassaydatacubes><arraydesignprovider/><dataformat>processedData</dataformat><bioassays>95</bioassays><isderived>0</isderived></bioassaydatagroup><provider><contact>Paul S Redford</contact><role/><email/></provider><provider><contact>Yvonne West</contact><role/><email/></provider><provider><contact>Zhaohui Xu</contact><role/><email/></provider><provider><contact>Phillip Vanhems</contact><role/><email/></provider><provider><contact>Ling-pei Ho</contact><role/><email/></provider><provider><contact>Makoto Miyara</contact><role/><email/></provider><provider><contact>Rama Vancheeswaran</contact><role/><email/></provider><provider><contact>Christine M Graham</contact><role/><email/></provider><provider><contact>Derek Blankenship</contact><role/><email/></provider><provider><contact>Marc Lipman</contact><role/><email/></provider><provider><contact>Yuanyuan Wang</contact><role/><email/></provider><provider><contact>Anne O’Garra</contact><role/><email/></provider><provider><contact>Damien Chaussabel</contact><role/><email/></provider><provider><contact>Mitra Saadatian</contact><role/><email/></provider><provider><contact>Huw Beynon</contact><role/><email/></provider><provider><contact>Guy Gorochov</contact><role/><email/></provider><provider><contact>Robert J Wilkinson</contact><role/><email/></provider><provider><contact>Matthew R Berry</contact><role/><email/></provider><provider><contact>Fotini Rozakeas</contact><role/><email/></provider><provider><contact>Virginia Pascual</contact><role/><email/></provider><provider><contact>Valeyre Dominique</contact><role/><email/></provider><provider><contact>Chloe Bloom</contact><role>submitter</role><email>cbloom@nimr.mrc.ac.uk</email></provider><provider><contact>Katalin A Wilkinson</contact><role/><email/></provider><provider><contact>Jacques Banchereau</contact><role/><email/></provider><provider><contact>Mel Wickremasinghe</contact><role/><email/></provider><provider><contact>Chloe I Bloom</contact><role/><email/></provider><provider><contact>Diane Bouvry</contact><role/><email/></provider><description><id/><text>This study used whole blood transcriptional signatures from patients with tuberculosis compared to those with similar pulmonary diseases, sarcoidosis, pneumonia and primary lung cancer. TB and sarcoidosis had similar signatures that were distinct from pneumonia and lung cancer. There were 16 TB, 25 sarcoidosis, 8 pneumonia, 8 lung cancer and 38 healthy controls</text></description><protocol><id>900143</id><accession>P-GSE42830-2</accession></protocol><protocol><id>900138</id><accession>P-GSE42830-1</accession></protocol><protocol><id>900142</id><accession>P-GSE42830-4</accession></protocol><protocol><id>900144</id><accession>P-GSE42830-3</accession></protocol><protocol><id>900140</id><accession>P-GSE42830-6</accession></protocol><protocol><id>900141</id><accession>P-GSE42830-5</accession></protocol><protocol><id>900139</id><accession>P-GSE42830-7</accession></protocol><organism>Homo sapiens</organism><files><!--
This section is deprecated and unsupported.
Please use webservice located at:
    http://www.ebi.ac.uk/arrayexpress/xml/files
to obtain detailed information on files available for the experiment.
For more information, please go to:
    http://www.ebi.ac.uk/arrayexpress/help/programmatic_access.html
                --><fgem name="E-GEOD-42830.processed.1.zip" available="true"/><idf name="E-GEOD-42830.idf.txt"/><sdrf name="E-GEOD-42830.sdrf.txt"/></files></experiment><experiment><species>Homo sapiens</species><rawdatafiles available="false"/><processeddatafiles available="true"/><sampleattribute><category>disease state</category><value>pneumonia</value></sampleattribute><sampleattribute><category>organism</category><value>Homo sapiens</value></sampleattribute><sampleattribute><category>organism part</category><value>whole blood</value></sampleattribute><sampleattribute><category>subject</category><value>2101</value><value>2102</value><value>2105</value><value>2121</value><value>2132</value></sampleattribute><experimentalfactor><name>SUBJECT</name><value>2101</value><value>2102</value><value>2105</value><value>2121</value><value>2132</value></experimentalfactor><experimentalfactor><name>TREATMENT</name><value>Pre-treatment</value><value>Treated with antibiotic</value></experimentalfactor><miamescores><reportersequencescore>1</reportersequencescore><protocolscore>0</protocolscore><factorvaluescore>1</factorvaluescore><derivedbioassaydatascore>1</derivedbioassaydatascore><measuredbioassaydatascore>1</measuredbioassaydatascore><overallscore>4</overallscore></miamescores><id>366302</id><accession>E-GEOD-42827</accession><secondaryaccession>GSE42827</secondaryaccession><name>Human whole blood microarray study to compare patients with tuberculosis, sarcoidosis, pneumonia, and lung cancer (pneumonia treated)</name><experimenttype>transcription profiling by array</experimenttype><releasedate>2013-10-31</releasedate><lastupdatedate>2014-06-02</lastupdatedate><samples>10</samples><assays>10</assays><arraydesign><id>7604</id><accession>A-GEOD-10558</accession><name>Illumina HumanHT-12 V4.0 expression beadchip</name><count>10</count><legacy_id>2501282336</legacy_id></arraydesign><bioassaydatagroup><id/><name>normalization</name><bioassaydatacubes>10</bioassaydatacubes><arraydesignprovider/><dataformat>normalization</dataformat><bioassays>10</bioassays><isderived>0</isderived></bioassaydatagroup><bioassaydatagroup><id/><name>processedData</name><bioassaydatacubes>10</bioassaydatacubes><arraydesignprovider/><dataformat>processedData</dataformat><bioassays>10</bioassays><isderived>0</isderived></bioassaydatagroup><provider><contact>Jacques Banchereau</contact><role/><email/></provider><provider><contact>Fotini Rozakeas</contact><role/><email/></provider><provider><contact>Rama Vancheeswaran</contact><role/><email/></provider><provider><contact>Phillip Vanhems</contact><role/><email/></provider><provider><contact>Chloe I Bloom</contact><role/><email/></provider><provider><contact>Paul S Redford</contact><role/><email/></provider><provider><contact>Ling-pei Ho</contact><role/><email/></provider><provider><contact>Mel Wickremasinghe</contact><role/><email/></provider><provider><contact>Valeyre Dominique</contact><role/><email/></provider><provider><contact>Robert J Wilkinson</contact><role/><email/></provider><provider><contact>Katalin A Wilkinson</contact><role/><email/></provider><provider><contact>Virginia Pascual</contact><role/><email/></provider><provider><contact>Chloe Bloom</contact><role>submitter</role><email>cbloom@nimr.mrc.ac.uk</email></provider><provider><contact>Huw Beynon</contact><role/><email/></provider><provider><contact>Matthew R Berry</contact><role/><email/></provider><provider><contact>Makoto Miyara</contact><role/><email/></provider><provider><contact>Mitra Saadatian</contact><role/><email/></provider><provider><contact>Anne O’Garra</contact><role/><email/></provider><provider><contact>Yuanyuan Wang</contact><role/><email/></provider><provider><contact>Yvonne West</contact><role/><email/></provider><provider><contact>Zhaohui Xu</contact><role/><email/></provider><provider><contact>Damien Chaussabel</contact><role/><email/></provider><provider><contact>Marc Lipman</contact><role/><email/></provider><provider><contact>Christine M Graham</contact><role/><email/></provider><provider><contact>Diane Bouvry</contact><role/><email/></provider><provider><contact>Guy Gorochov</contact><role/><email/></provider><provider><contact>Derek Blankenship</contact><role/><email/></provider><description><id/><text>This study used whole blood transcriptional signatures from patients with pneumonia before and after succesful antibiotic treatment There were 5 pneumonia patients, the same patients were sampled before and after their treatment</text></description><protocol><id>900110</id><accession>P-GSE42827-2</accession></protocol><protocol><id>900106</id><accession>P-GSE42827-1</accession></protocol><protocol><id>900109</id><accession>P-GSE42827-4</accession></protocol><protocol><id>900111</id><accession>P-GSE42827-3</accession></protocol><protocol><id>900107</id><accession>P-GSE42827-6</accession></protocol><protocol><id>900108</id><accession>P-GSE42827-5</accession></protocol><protocol><id>900105</id><accession>P-GSE42827-7</accession></protocol><organism>Homo sapiens</organism><files><!--
This section is deprecated and unsupported.
Please use webservice located at:
    http://www.ebi.ac.uk/arrayexpress/xml/files
to obtain detailed information on files available for the experiment.
For more information, please go to:
    http://www.ebi.ac.uk/arrayexpress/help/programmatic_access.html
                --><fgem name="E-GEOD-42827.processed.1.zip" available="true"/><idf name="E-GEOD-42827.idf.txt"/><sdrf name="E-GEOD-42827.sdrf.txt"/></files></experiment><experiment><species>Homo sapiens</species><rawdatafiles available="false"/><processeddatafiles available="true"/><sampleattribute><category>disease state</category><value>Active Sarcoid</value><value>control</value><value>Lung Cancer</value><value>Non-active sarcoidosis</value><value>pneumonia</value><value>TB</value></sampleattribute><sampleattribute><category>ethnicity</category><value>Black</value><value>Indian subcontinent</value><value>Middle Eastern</value><value>SE Asian</value><value>White</value></sampleattribute><sampleattribute><category>organism</category><value>Homo sapiens</value></sampleattribute><sampleattribute><category>organism part</category><value>whole blood</value></sampleattribute><sampleattribute><category>sex</category><value>female</value><value>male</value></sampleattribute><experimentalfactor><name>DISEASE STATE</name><value>Active Sarcoid</value><value>control</value><value>Lung Cancer</value><value>Non-active sarcoidosis</value><value>pneumonia</value><value>TB</value></experimentalfactor><experimentalfactor><name>ETHNICITY</name><value>Black</value><value>Indian subcontinent</value><value>Middle Eastern</value><value>SE Asian</value><value>White</value></experimentalfactor><experimentalfactor><name>SEX</name><value>female</value><value>male</value></experimentalfactor><miamescores><reportersequencescore>1</reportersequencescore><protocolscore>0</protocolscore><factorvaluescore>1</factorvaluescore><derivedbioassaydatascore>1</derivedbioassaydatascore><measuredbioassaydatascore>1</measuredbioassaydatascore><overallscore>4</overallscore></miamescores><id>366308</id><accession>E-GEOD-42826</accession><secondaryaccession>GSE42826</secondaryaccession><name>Human whole blood microarray study to compare patients with tuberculosis, sarcoidosis, pneumonia, and lung cancer (test)</name><experimenttype>transcription profiling by array</experimenttype><releasedate>2013-10-31</releasedate><lastupdatedate>2014-06-02</lastupdatedate><samples>102</samples><assays>102</assays><arraydesign><id>7604</id><accession>A-GEOD-10558</accession><name>Illumina HumanHT-12 V4.0 expression beadchip</name><count>102</count><legacy_id>2501282336</legacy_id></arraydesign><bioassaydatagroup><id/><name>normalization</name><bioassaydatacubes>102</bioassaydatacubes><arraydesignprovider/><dataformat>normalization</dataformat><bioassays>102</bioassays><isderived>0</isderived></bioassaydatagroup><bioassaydatagroup><id/><name>processedData</name><bioassaydatacubes>102</bioassaydatacubes><arraydesignprovider/><dataformat>processedData</dataformat><bioassays>102</bioassays><isderived>0</isderived></bioassaydatagroup><provider><contact>Makoto Miyara</contact><role/><email/></provider><provider><contact>Robert J Wilkinson</contact><role/><email/></provider><provider><contact>Valeyre Dominique</contact><role/><email/></provider><provider><contact>Christine M Graham</contact><role/><email/></provider><provider><contact>Virginia Pascual</contact><role/><email/></provider><provider><contact>Mel Wickremasinghe</contact><role/><email/></provider><provider><contact>Ling-pei Ho</contact><role/><email/></provider><provider><contact>Chloe I Bloom</contact><role/><email/></provider><provider><contact>Mitra Saadatian</contact><role/><email/></provider><provider><contact>Zhaohui Xu</contact><role/><email/></provider><provider><contact>Paul S Redford</contact><role/><email/></provider><provider><contact>Guy Gorochov</contact><role/><email/></provider><provider><contact>Derek Blankenship</contact><role/><email/></provider><provider><contact>Yuanyuan Wang</contact><role/><email/></provider><provider><contact>Yvonne West</contact><role/><email/></provider><provider><contact>Katalin A Wilkinson</contact><role/><email/></provider><provider><contact>Huw Beynon</contact><role/><email/></provider><provider><contact>Chloe Bloom</contact><role>submitter</role><email>cbloom@nimr.mrc.ac.uk</email></provider><provider><contact>Fotini Rozakeas</contact><role/><email/></provider><provider><contact>Jacques Banchereau</contact><role/><email/></provider><provider><contact>Damien Chaussabel</contact><role/><email/></provider><provider><contact>Phillip Vanhems</contact><role/><email/></provider><provider><contact>Matthew R Berry</contact><role/><email/></provider><provider><contact>Rama Vancheeswaran</contact><role/><email/></provider><provider><contact>Diane Bouvry</contact><role/><email/></provider><provider><contact>Anne O’Garra</contact><role/><email/></provider><provider><contact>Marc Lipman</contact><role/><email/></provider><description><id/><text>This study used whole blood transcriptional signatures from patients with tuberculosis compared to those with similar pulmonary diseases, sarcoidosis, pneumonia and primary lung cancer. TB and sarcoidosis had similar signatures that were distinct from pneumonia and lung cancer. There were 11 TB, 25 sarcoidosis, 6 pneumonia, 8 lung cancer and 52 healthy controls</text></description><protocol><id>900149</id><accession>P-GSE42826-4</accession></protocol><protocol><id>900148</id><accession>P-GSE42826-5</accession></protocol><protocol><id>900151</id><accession>P-GSE42826-2</accession></protocol><protocol><id>900150</id><accession>P-GSE42826-3</accession></protocol><protocol><id>900147</id><accession>P-GSE42826-6</accession></protocol><protocol><id>900145</id><accession>P-GSE42826-7</accession></protocol><protocol><id>900146</id><accession>P-GSE42826-1</accession></protocol><organism>Homo sapiens</organism><files><!--
This section is deprecated and unsupported.
Please use webservice located at:
    http://www.ebi.ac.uk/arrayexpress/xml/files
to obtain detailed information on files available for the experiment.
For more information, please go to:
    http://www.ebi.ac.uk/arrayexpress/help/programmatic_access.html
                --><fgem name="E-GEOD-42826.processed.1.zip" available="true"/><idf name="E-GEOD-42826.idf.txt"/><sdrf name="E-GEOD-42826.sdrf.txt"/></files></experiment><experiment><species>Homo sapiens</species><rawdatafiles available="false"/><processeddatafiles available="true"/><sampleattribute><category>disease state</category><value>Active sarcoidosis</value><value>control</value><value>Non-active sarcoidosis</value><value>TB</value></sampleattribute><sampleattribute><category>ethnicity</category><value>Black</value><value>Central Asia</value><value>Indian subcontinent</value><value>None</value><value>White</value></sampleattribute><sampleattribute><category>organism</category><value>Homo sapiens</value></sampleattribute><sampleattribute><category>organism part</category><value>whole blood</value></sampleattribute><sampleattribute><category>sex</category><value>female</value><value>male</value><value>None</value></sampleattribute><experimentalfactor><name>DISEASE STATE</name><value>Active sarcoidosis</value><value>control</value><value>Non-active sarcoidosis</value><value>TB</value></experimentalfactor><experimentalfactor><name>ETHNICITY</name><value>Black</value><value>Central Asia</value><value>Indian subcontinent</value><value>None</value><value>White</value></experimentalfactor><experimentalfactor><name>SEX</name><value>female</value><value>male</value><value>None</value></experimentalfactor><miamescores><reportersequencescore>1</reportersequencescore><protocolscore>0</protocolscore><factorvaluescore>1</factorvaluescore><derivedbioassaydatascore>1</derivedbioassaydatascore><measuredbioassaydatascore>1</measuredbioassaydatascore><overallscore>4</overallscore></miamescores><id>366301</id><accession>E-GEOD-42825</accession><secondaryaccession>GSE42825</secondaryaccession><name>Human whole blood microarray study to compare patients with tuberculosis, sarcoidosis, pneumonia, and lung cancer (validation)</name><experimenttype>transcription profiling by array</experimenttype><releasedate>2013-10-31</releasedate><lastupdatedate>2014-06-02</lastupdatedate><samples>42</samples><assays>42</assays><arraydesign><id>7604</id><accession>A-GEOD-10558</accession><name>Illumina HumanHT-12 V4.0 expression beadchip</name><count>42</count><legacy_id>2501282336</legacy_id></arraydesign><bioassaydatagroup><id/><name>normalization</name><bioassaydatacubes>42</bioassaydatacubes><arraydesignprovider/><dataformat>normalization</dataformat><bioassays>42</bioassays><isderived>0</isderived></bioassaydatagroup><bioassaydatagroup><id/><name>processedData</name><bioassaydatacubes>42</bioassaydatacubes><arraydesignprovider/><dataformat>processedData</dataformat><bioassays>42</bioassays><isderived>0</isderived></bioassaydatagroup><provider><contact>Damien Chaussabel</contact><role/><email/></provider><provider><contact>Virginia Pascual</contact><role/><email/></provider><provider><contact>Derek Blankenship</contact><role/><email/></provider><provider><contact>Chloe Bloom</contact><role>submitter</role><email>cbloom@nimr.mrc.ac.uk</email></provider><provider><contact>Marc Lipman</contact><role/><email/></provider><provider><contact>Mitra Saadatian</contact><role/><email/></provider><provider><contact>Diane Bouvry</contact><role/><email/></provider><provider><contact>Mel Wickremasinghe</contact><role/><email/></provider><provider><contact>Robert J Wilkinson</contact><role/><email/></provider><provider><contact>Guy Gorochov</contact><role/><email/></provider><provider><contact>Makoto Miyara</contact><role/><email/></provider><provider><contact>Katalin A Wilkinson</contact><role/><email/></provider><provider><contact>Anne O’Garra</contact><role/><email/></provider><provider><contact>Rama Vancheeswaran</contact><role/><email/></provider><provider><contact>Yvonne West</contact><role/><email/></provider><provider><contact>Chloe I Bloom</contact><role/><email/></provider><provider><contact>Jacques Banchereau</contact><role/><email/></provider><provider><contact>Zhaohui Xu</contact><role/><email/></provider><provider><contact>Matthew R Berry</contact><role/><email/></provider><provider><contact>Paul S Redford</contact><role/><email/></provider><provider><contact>Ling-pei Ho</contact><role/><email/></provider><provider><contact>Valeyre Dominique</contact><role/><email/></provider><provider><contact>Phillip Vanhems</contact><role/><email/></provider><provider><contact>Huw Beynon</contact><role/><email/></provider><provider><contact>Christine M Graham</contact><role/><email/></provider><provider><contact>Yuanyuan Wang</contact><role/><email/></provider><provider><contact>Fotini Rozakeas</contact><role/><email/></provider><description><id/><text>This study used whole blood transcriptional signatures from patients with tuberculosis, sarcoidosis and healthy controls. There were 8 TB, 11 sarcoidosis and 23 healthy controls</text></description><protocol><id>900098</id><accession>P-GSE42825-1</accession></protocol><protocol><id>900103</id><accession>P-GSE42825-2</accession></protocol><protocol><id>900099</id><accession>P-GSE42825-7</accession></protocol><protocol><id>900101</id><accession>P-GSE42825-5</accession></protocol><protocol><id>900100</id><accession>P-GSE42825-6</accession></protocol><protocol><id>900104</id><accession>P-GSE42825-3</accession></protocol><protocol><id>900102</id><accession>P-GSE42825-4</accession></protocol><organism>Homo sapiens</organism><files><!--
This section is deprecated and unsupported.
Please use webservice located at:
    http://www.ebi.ac.uk/arrayexpress/xml/files
to obtain detailed information on files available for the experiment.
For more information, please go to:
    http://www.ebi.ac.uk/arrayexpress/help/programmatic_access.html
                --><fgem name="E-GEOD-42825.processed.1.zip" available="true"/><idf name="E-GEOD-42825.idf.txt"/><sdrf name="E-GEOD-42825.sdrf.txt"/></files></experiment><experiment><species>Homo sapiens</species><rawdatafiles available="true"/><processeddatafiles available="true"/><sampleattribute><category>age at excision years</category><value>39</value><value>42</value><value>43</value><value>44</value><value>46</value><value>47</value><value>48</value><value>49</value><value>51</value><value>52</value><value>53</value><value>54</value><value>55</value><value>56</value><value>57</value><value>58</value><value>59</value><value>60</value><value>61</value><value>62</value><value>63</value><value>64</value><value>65</value><value>66</value><value>67</value><value>68</value><value>69</value><value>70</value><value>71</value><value>72</value><value>73</value><value>74</value><value>76</value><value>77</value><value>79</value><value>80</value><value>81</value><value>NA</value></sampleattribute><sampleattribute><category>ajcc uicc stage</category><value>IA</value><value>IB</value><value>II</value><value>IIA</value><value>IIB</value></sampleattribute><sampleattribute><category>biosample confirmed diagnosis</category><value>  </value><value>adenocarcinoma</value><value>Bronchiolo-alveolar adenocarcinoma</value><value>clear cell adenocarcinoma</value><value>Mucinous adenocarcinoma</value><value>Non-Small Cell Carcinoma</value><value>Non-small Cell Carcinoma</value><value>Non-small cell carcinoma</value><value>squamous cell carcinoma</value></sampleattribute><sampleattribute><category>biosample confirmed sub-diagnosis</category><value>  </value><value>Acute leukemia</value><value>adenocarcinoma</value><value>Bronchiolo-alveolar adenocarcinoma</value><value>squamous cell carcinoma</value><value>Squamous cell carcinoma, keratinizing</value></sampleattribute><sampleattribute><category>bmi</category><value>0</value><value>17.50561501</value><value>17.578125</value><value>17.63085399</value><value>17.90123457</value><value>18.36547291</value><value>18.51851852</value><value>18.9370029</value><value>19.03114187</value><value>19.10009183</value><value>19.47340663</value><value>19.72103697</value><value>20.07774787</value><value>20.07960128</value><value>20.17455375</value><value>20.2020202</value><value>20.24489796</value><value>20.28479857</value><value>20.3125</value><value>20.97117202</value><value>21.10726644</value><value>21.30681818</value><value>21.383942</value><value>21.51385851</value><value>21.77755334</value><value>21.79944511</value><value>21.96712018</value><value>21.97133586</value><value>22.03856749</value><value>22.09317005</value><value>22.14532872</value><value>22.22222222</value><value>22.34351559</value><value>22.5981405</value><value>22.64086462</value><value>22.64219297</value><value>22.85714286</value><value>22.9719382</value><value>23.01117686</value><value>23.14725512</value><value>23.14814815</value><value>23.23345618</value><value>23.32341806</value><value>23.4375</value><value>23.51020408</value><value>23.52941176</value><value>23.53036634</value><value>23.72281065</value><value>23.87511478</value><value>23.88946281</value><value>24.00548697</value><value>24.11150746</value><value>24.21229339</value><value>24.22145329</value><value>24.38271605</value><value>24.44180209</value><value>24.4646016</value><value>24.48979592</value><value>24.6097337</value><value>24.61810377</value><value>24.74093729</value><value>24.77209671</value><value>24.8015873</value><value>24.81632653</value><value>24.96800974</value><value>24.97398543</value><value>24.97704316</value><value>25.05930703</value><value>25.07619305</value><value>25.34435262</value><value>25.35154137</value><value>25.40170132</value><value>25.48476454</value><value>25.55932916</value><value>25.6543724</value><value>25.69706994</value><value>25.71166208</value><value>25.82644628</value><value>26.0261749</value><value>26.12244898</value><value>26.171875</value><value>26.25958475</value><value>26.34649403</value><value>26.36560303</value><value>26.44628099</value><value>26.47210744</value><value>26.57312925</value><value>26.7299275</value><value>26.79493802</value><value>26.81221871</value><value>26.88093499</value><value>27.04164413</value><value>27.10204082</value><value>27.14158239</value><value>27.17063157</value><value>27.42857143</value><value>27.44059917</value><value>27.47252747</value><value>27.6816609</value><value>27.71768524</value><value>27.96801606</value><value>28.04037814</value><value>28.3446712</value><value>28.3530572</value><value>28.37370242</value><value>28.39372634</value><value>28.40550436</value><value>28.7132112</value><value>28.73174689</value><value>28.88888889</value><value>29.03673779</value><value>29.3877551</value><value>29.64268547</value><value>29.7210791</value><value>30.0838291</value><value>30.42719786</value><value>31.14186851</value><value>31.22130395</value><value>31.31456612</value><value>31.37798917</value><value>31.69907016</value><value>31.77393186</value><value>33.9100346</value><value>34.25605536</value><value>34.92767916</value><value>35.01277966</value><value>39.46352484</value><value>NA</value></sampleattribute><sampleattribute><category>clinical diagnosis patient</category><value>  </value><value>Acute duodenal ulcer (Status Past), Acute gastritis with hemorrhage (Status Past), Squamous cell carcinoma of the lung (Status New)</value><value>Adenocarcinoma of lung (Status New)</value><value>Adenocarcinoma of the lung (Status New)</value><value>Alcoholism (Status Ongoing), Large cell carcinoma of the lung (Status New)</value><value>Alkylosing spondylitis (Status Ongoing), Squamous cell carcinoma of the lung (Status Ongoing)</value><value>Angina (Status Ongoing), Arteriopathy (Status Ongoing), Adenocarcinoma of the lung (Status New)</value><value>Appendicitis with appendectomy (Status Past), Tonsillitis with tonsillectomy (Status Past), Squamous cell carcinoma of the lung (Status New)</value><value>Appendicitis with appendectomy (Status Past), Viral hepatitis a (Status Past), Gastric ulcer (Status Recurrent), Thyroidectomy (Status Past), Adenocarcinoma of the lung (Status New)</value><value>Arterial hypertension (Status Ongoing), Adenocarcinoma of the lung (Status New)</value><value>Arterial hypertension (Status Ongoing), Squamous cell carcinoma of the lung (Status New)</value><value>Arterial hypertension (Status Ongoing), Squamous cell carcinoma, keratinizing of the lung (Status New)</value><value>Arthritis (Status Past), Squamous cell carcinoma, keratinizing of the lung (Status New)</value><value>Bronchiolo-alveolar adenocarcinoma of the lung (Status New)</value><value>Bronchitis (Status Ongoing), Ischemic cardiomyopathy (Status Ongoing), Squamous cell carcinoma of the upper lobe of right lung (Status New)</value><value>Cancer of the bladder (Status Past), Adenocarcinoma of the lung (Status New)</value><value>Cancer of the head and neck (Status ), Adenocarcinoma of the lung (Status New)</value><value>Cancer of the lung (Status New), Gastroesophageal reflux disease (Status Ongoing), Hypertension (Status Ongoing), Laparotomy for liver injury (Status Past), Hemorrhoids (Status Past), Adenocarcinoma of the lung (Status New)</value><value>Cancer of the lung (Status New), Hypertension (Status Ongoing), Nocardia pnemonia (Status Past), Chronic obstructive pulmonary disease (Status Ongoing), Squamous cell carcinoma of the lung (Status New)</value><value>Car accident with multiple injuries (Status Past), Coma  (as a result of car accident) (Status Past), Adenocarcinoma of the lung (Status New)</value><value>Chronic bronchitis (Status Ongoing), Adenocarcinoma of the lung (Status New)</value><value>Chronic bronchitis (Status Ongoing), Gastritis (Status Ongoing), Squamous cell carcinoma of the lung (Status New)</value><value>Chronic bronchitis (Status Ongoing), Hypertension (Status Ongoing), Adenocarcinoma of the lung (Status New)</value><value>Chronic bronchitis (Status Ongoing), Squamous cell carcinoma of the lung (Status New)</value><value>Chronic bronchitis (Status Ongoing), Squamous cell carcinoma, keratinizing of the lung (Status New)</value><value>Chronic bronchitis (Status Ongoing), Squamous cell carcinoma, large cell, non-keratinizing of the lung (Status New)</value><value>Chronic obstructive pulmonary disease (Status Ongoing), Hypertension (Status Ongoing), Squamous cell carcinoma of the lung (Status New)</value><value>Chronic obstructive pulmonary disease (Status Ongoing), Squamous cell carcinoma of the lung (Status New)</value><value>Chronic pancreatitis  (Status Ongoing), Adenocarcinoma of the lung (Status New)</value><value>Coronary artery disease (Status Ongoing), Diabetes  (Status Ongoing), Gastritis (Status Ongoing), Squamous cell carcinoma of the lung (Status New)</value><value>Coronary atherosclerosis     (Status Ongoing), Simple chronic bronchitis (Status Ongoing), Squamous cell carcinoma  of the lung (Status New)</value><value>Coronary atherosclerosis    (Status Ongoing), Essential hypertension (Status Ongoing), Malignant neoplasm of lip (Status Past), Squamous cell carcinoma  of the lung (Status New)</value><value>Diabetes  (Status Ongoing), Squamous cell carcinoma of the lung (Status New)</value><value>Diabetes (Status Ongoing), High blood pressure (Status Ongoing), Bronchiolo-alveolar adenocarcinoma of the lung (Status New)</value><value>Duodenal ulcer  (Status Past), Essential hypertension (Status Ongoing), Squamous cell carcinoma of the lung (Status New)</value><value>Duodenal ulcer (Status Ongoing), Squamous cell carcinoma of the lung (Status New)</value><value>Duodenal ulcer (Status Past), Squamous cell carcinoma of the lung (Status New)</value><value>Essential hypertension  (Status Ongoing), Adenocarcinoma of the lung (Status New)</value><value>Essential hypertension (Status Ongoing), Chronic bronchitis (Status Ongoing), Squamous cell carcinoma of the lung (Status New)</value><value>Essential hypertension (Status Ongoing), Simple chronic bronchitis (Status Ongoing), Squamous cell carcinoma of the lung (Status New)</value><value>Essential hypertension (Status Ongoing), Squamous cell carcinoma, keratinizing of the lung (Status New)</value><value>Essential hypertension (Status Ongoing), Squamous cell carcinoma, keratinizing of the skin (Status New)</value><value>Gastric ulcer (Status Ongoing), Adenocarcinoma of the lung (Status New)</value><value>Gastritis (Status Past), Adenocarcinoma of the lung (Status New)</value><value>Hypertension (Status Ongoing), Chronic bronchitis (Status Ongoing), Adenocarcinoma of the lung (Status New)</value><value>Hypertension (Status Ongoing), Chronic bronchitis (Status Ongoing), Bronchiolo-alveolar adenocarcinoma of the lung (Status New)</value><value>Hypertension (Status Ongoing), Chronic cholecystitis  (Status Ongoing), Adenocarcinoma of the lung (Status New)</value><value>Hypertension (Status Ongoing), Diabetes (Status Ongoing), Adenocarcinoma of the lung (Status New)</value><value>Hypertension (Status Ongoing), Gastritis (Status Ongoing), Adenocarcinoma of the lung (Status New)</value><value>Hypertension (Status Ongoing), Nodular goiter (Status Ongoing), Bronchiolo-alveolar adenocarcinoma of the lung (Status New)</value><value>Hypertension (Status Ongoing), Squamous cell carcinoma of the lung (Status New)</value><value>Hypertension (Status Ongoing), Squamous cell carcinoma, keratinizing of the lung (Status New)</value><value>Ischemic and dismethabolic cardiopathy (Status Ongoing), Carcinoma of the lung (Status New)</value><value>Ischemic heart disease (Status Ongoing), Hypertension (Status Ongoing), Colorectal cancer (Status ), Adenocarcinoma of the lung (Status New)</value><value>Large cell carcinoma of the lung (Status New)</value><value>Malignant neoplasm of the lung (Status New)</value><value>Obesity   (Status Ongoing), Adenocarcinoma of the lung (Status New)</value><value>Obesity (Status Ongoing), Adenocarcinoma of the lung (Status New)</value><value>Obesity (Status Ongoing), Chronic bronchitis (Status Ongoing), Squamous cell carcinoma of the lung (Status New)</value><value>Obesity (Status Ongoing), Clear cell adenocarcinoma of the lung (Status New)</value><value>Pneumonia (Status New), Adenocarcinoma of lung (Status New)</value><value>Simple chronic bronchitis   (Status Ongoing), Alveolar adenocarcinoma of the lung (Status New)</value><value>Simple chronic bronchitis   (Status Ongoing), Unspecified gastritis and gastroduodenitis  (Status Ongoing), Duodenal ulcer  (Status Past), Squamous cell carcinoma of the lung (Status New)</value><value>Simple chronic bronchitis  (Status Ongoing), Adenocarcinoma of the lung (Status New)</value><value>Simple chronic bronchitis  (Status Ongoing), Unspecified gastritis and gastroduodenitis    (Status Ongoing), Adenocarcinoma of the lung (Status New)</value><value>Simple chronic bronchitis (Status Ongoing), Squamous cell carcinoma of the lung (Status New)</value><value>Squamous cell carcinoma of the lung (Status New)</value><value>Squamous cell carcinoma, keratinizing of the lung (Status New)</value><value>Squamous cell carcinoma, large cell, non-keratinizing of the lung (Status New)</value><value>Unspecified gastritis and gastroduodenitis    (Status Ongoing), Coronary atherosclerosis (Status Ongoing), Squamous cell carcinoma of the lung (Status New)</value><value>Unspecified gastritis and gastroduodenitis (Status Ongoing), Adenocarcinoma of the lung (Status New)</value><value>Unspecified gastritis and gastroduodenitis (Status Ongoing), Squamous cell carcinoma of the lung (Status New)</value></sampleattribute><sampleattribute><category>clinical diagnosis specimen</category><value>Adenocarcinoma of Lung</value><value>Adenocarcinoma of the Lung</value><value>Alveolar adenocarcinoma of the lung</value><value>Bronchioloalveolar Adenocarcinoma of the Lung</value><value>Carcinoma of the Lung</value><value>Clear cell adenocarcinoma of the lung</value><value>Large cell carcinoma of the lung</value><value>Malignant neoplasm of the lung</value><value>Papillary adenocarcinoma of the right lower lung lobe</value><value>Squamous Cell Carcinoma of the Lung</value><value>Squamous cell carcinoma of the upper lobe of right lung</value><value>Squamous cell carcinoma, keratinizing of the lung</value><value>Squamous cell carcinoma, keratinizing of the skin</value><value>Squamous cell carcinoma, large cell, non-keratinizing of the lung</value></sampleattribute><sampleattribute><category>ethnicity</category><value>Asian/Pacific Islander</value><value>Caucasian</value><value>NA</value><value>White</value></sampleattribute><sampleattribute><category>excision year</category><value>  </value><value>2002</value><value>2003</value><value>2004</value><value>2005</value><value>2006</value><value>2007</value><value>2008</value><value>2009</value><value>2010</value><value>2011</value><value>NA</value></sampleattribute><sampleattribute><category>height cm</category><value>0</value><value>149</value><value>150</value><value>151</value><value>153</value><value>155</value><value>156</value><value>157</value><value>158</value><value>160</value><value>161</value><value>162</value><value>163</value><value>164</value><value>165</value><value>167</value><value>168</value><value>169</value><value>170</value><value>172</value><value>173</value><value>174</value><value>175</value><value>176</value><value>177</value><value>178</value><value>179</value><value>180</value><value>182</value><value>184</value><value>185</value><value>187</value><value>190</value><value>NA</value></sampleattribute><sampleattribute><category>organism</category><value>Homo sapiens</value></sampleattribute><sampleattribute><category>organism part</category><value>Bronchus Tumor</value><value>Lung Diseased</value><value>Lung Normal</value><value>Lung Tumor</value></sampleattribute><sampleattribute><category>rin</category><value>10</value><value>7</value><value>7.13</value><value>7.25</value><value>7.279631</value><value>7.3</value><value>7.31</value><value>7.35</value><value>7.38</value><value>7.45</value><value>7.49</value><value>7.5</value><value>7.6</value><value>7.62</value><value>7.66</value><value>7.67</value><value>7.67513</value><value>7.693396</value><value>7.7</value><value>7.81</value><value>7.87</value><value>7.881437</value><value>7.9</value><value>7.95</value><value>8</value><value>8.00742</value><value>8.03</value><value>8.04</value><value>8.05</value><value>8.07</value><value>8.09</value><value>8.1</value><value>8.14</value><value>8.15</value><value>8.19</value><value>8.2</value><value>8.21</value><value>8.231344</value><value>8.24</value><value>8.3</value><value>8.36</value><value>8.39</value><value>8.397932</value><value>8.462233</value><value>8.49</value><value>8.5</value><value>8.51</value><value>8.58</value><value>8.6</value><value>8.61</value><value>8.623299</value><value>8.69</value><value>8.693336</value><value>8.7</value><value>8.74</value><value>8.78</value><value>8.79</value><value>8.8</value><value>8.834855</value><value>8.84</value><value>8.85</value><value>8.881916</value><value>8.89</value><value>8.9</value><value>8.938609</value><value>8.94</value><value>8.96</value><value>8.99</value><value>9</value><value>9.004557</value><value>9.011824</value><value>9.04</value><value>9.072135</value><value>9.1</value><value>9.13</value><value>9.137592</value><value>9.2</value><value>9.21</value><value>9.23</value><value>9.25</value><value>9.254594</value><value>9.29</value><value>9.3</value><value>9.33</value><value>9.35</value><value>9.37</value><value>9.4</value><value>9.400192</value><value>9.41</value><value>9.42</value><value>9.46</value><value>9.5</value><value>9.51</value><value>9.54</value><value>9.599208</value><value>9.64965</value><value>9.65</value><value>9.66</value><value>9.68</value><value>9.7</value><value>9.74118</value><value>9.8</value><value>9.86</value><value>9.878584</value><value>9.89</value><value>9.9</value><value>9.95</value><value>9.97</value><value>9.99</value><value>N/A</value></sampleattribute><sampleattribute><category>sample recovery type</category><value>Surgical</value></sampleattribute><sampleattribute><category>sbv challenge gold standard</category><value>AC1</value><value>AC2</value><value>SCC1</value><value>SCC2</value></sampleattribute><sampleattribute><category>sex</category><value>  </value><value>female</value><value>male</value></sampleattribute><sampleattribute><category>smoking dose cigarettes/day</category><value>0</value><value>10</value><value>11-20</value><value>15</value><value>2-3</value><value>20</value><value>24</value><value>25</value><value>30</value><value>35</value><value>40</value><value>5-8</value><value>6-7</value><value>60</value><value>NA</value></sampleattribute><sampleattribute><category>smoking duration years</category><value>  </value><value>0</value><value>10</value><value>15</value><value>2</value><value>20</value><value>23</value><value>25</value><value>27</value><value>30</value><value>31-40</value><value>34</value><value>35</value><value>36</value><value>37</value><value>39</value><value>40</value><value>44</value><value>45</value><value>48</value><value>50</value><value>52</value><value>58</value><value>8</value><value>&gt;20</value><value>NA</value></sampleattribute><sampleattribute><category>smoking status</category><value>  </value><value>Current Use</value><value>NA</value><value>Never Used</value><value>Occasional Use</value><value>Previous Use</value></sampleattribute><sampleattribute><category>tnm stage</category><value>T1aN1M0</value><value>T1bN0M0</value><value>T1bN1M0</value><value>T1bNXM0</value><value>T1bNXMX</value><value>T1N0M0</value><value>T1N1M0</value><value>T1N1MX</value><value>T1N2M0</value><value>T1NXM0</value><value>T1NXMX</value><value>T2aN0M0</value><value>T2aN0MX</value><value>T2aN1M0</value><value>T2aNXM0</value><value>T2bN0M0</value><value>T2bN1M0</value><value>T2bNXM0</value><value>T2N0M0</value><value>T2N0MX</value><value>T2N1M0</value><value>T2N1MX</value><value>T2NXM0</value><value>T2NXMX</value><value>T3N0M0</value><value>T3N0MX</value><value>T3NXM0</value><value>T3NXMX</value></sampleattribute><sampleattribute><category>tumor grade</category><value>  </value><value>G2</value><value>Moderate to poorly differentiated</value><value>Moderately differentiated</value><value>Poorly differentiated</value><value>Well differentiated</value><value>Well to moderately differentiated</value></sampleattribute><sampleattribute><category>weight kg</category><value>0</value><value>100</value><value>105</value><value>138</value><value>45</value><value>46</value><value>47</value><value>48</value><value>50</value><value>51</value><value>52</value><value>53</value><value>55</value><value>56</value><value>58</value><value>60</value><value>61</value><value>62</value><value>63</value><value>64</value><value>65</value><value>66</value><value>67</value><value>68</value><value>69</value><value>70</value><value>71</value><value>72</value><value>73</value><value>74</value><value>75</value><value>76</value><value>78</value><value>79</value><value>80</value><value>82</value><value>83</value><value>84</value><value>85</value><value>86</value><value>87</value><value>89</value><value>90</value><value>91</value><value>92</value><value>94</value><value>95</value><value>97</value><value>98</value><value>99</value><value>NA</value></sampleattribute><experimentalfactor><name>AGE AT EXCISION YEARS</name><value>39</value><value>42</value><value>43</value><value>44</value><value>46</value><value>47</value><value>48</value><value>49</value><value>51</value><value>52</value><value>53</value><value>54</value><value>55</value><value>56</value><value>57</value><value>58</value><value>59</value><value>60</value><value>61</value><value>62</value><value>63</value><value>64</value><value>65</value><value>66</value><value>67</value><value>68</value><value>69</value><value>70</value><value>71</value><value>72</value><value>73</value><value>74</value><value>76</value><value>77</value><value>79</value><value>80</value><value>81</value><value>NA</value></experimentalfactor><experimentalfactor><name>AJCC UICC STAGE</name><value>IA</value><value>IB</value><value>II</value><value>IIA</value><value>IIB</value></experimentalfactor><experimentalfactor><name>BIOSAMPLE CONFIRMED DIAGNOSIS</name><value>adenocarcinoma</value><value>Bronchiolo-alveolar adenocarcinoma</value><value>clear cell adenocarcinoma</value><value>Mucinous adenocarcinoma</value><value>Non-Small Cell Carcinoma</value><value>Non-small Cell Carcinoma</value><value>Non-small cell carcinoma</value><value>not specified</value><value>squamous cell carcinoma</value></experimentalfactor><experimentalfactor><name>BIOSAMPLE CONFIRMED SUB-DIAGNOSIS</name><value>Acute leukemia</value><value>adenocarcinoma</value><value>Bronchiolo-alveolar adenocarcinoma</value><value>not specified</value><value>squamous cell carcinoma</value><value>Squamous cell carcinoma, keratinizing</value></experimentalfactor><experimentalfactor><name>BMI</name><value>0</value><value>17.50561501</value><value>17.578125</value><value>17.63085399</value><value>17.90123457</value><value>18.36547291</value><value>18.51851852</value><value>18.9370029</value><value>19.03114187</value><value>19.10009183</value><value>19.47340663</value><value>19.72103697</value><value>20.07774787</value><value>20.07960128</value><value>20.17455375</value><value>20.2020202</value><value>20.24489796</value><value>20.28479857</value><value>20.3125</value><value>20.97117202</value><value>21.10726644</value><value>21.30681818</value><value>21.383942</value><value>21.51385851</value><value>21.77755334</value><value>21.79944511</value><value>21.96712018</value><value>21.97133586</value><value>22.03856749</value><value>22.09317005</value><value>22.14532872</value><value>22.22222222</value><value>22.34351559</value><value>22.5981405</value><value>22.64086462</value><value>22.64219297</value><value>22.85714286</value><value>22.9719382</value><value>23.01117686</value><value>23.14725512</value><value>23.14814815</value><value>23.23345618</value><value>23.32341806</value><value>23.4375</value><value>23.51020408</value><value>23.52941176</value><value>23.53036634</value><value>23.72281065</value><value>23.87511478</value><value>23.88946281</value><value>24.00548697</value><value>24.11150746</value><value>24.21229339</value><value>24.22145329</value><value>24.38271605</value><value>24.44180209</value><value>24.4646016</value><value>24.48979592</value><value>24.6097337</value><value>24.61810377</value><value>24.74093729</value><value>24.77209671</value><value>24.8015873</value><value>24.81632653</value><value>24.96800974</value><value>24.97398543</value><value>24.97704316</value><value>25.05930703</value><value>25.07619305</value><value>25.34435262</value><value>25.35154137</value><value>25.40170132</value><value>25.48476454</value><value>25.55932916</value><value>25.6543724</value><value>25.69706994</value><value>25.71166208</value><value>25.82644628</value><value>26.0261749</value><value>26.12244898</value><value>26.171875</value><value>26.25958475</value><value>26.34649403</value><value>26.36560303</value><value>26.44628099</value><value>26.47210744</value><value>26.57312925</value><value>26.7299275</value><value>26.79493802</value><value>26.81221871</value><value>26.88093499</value><value>27.04164413</value><value>27.10204082</value><value>27.14158239</value><value>27.17063157</value><value>27.42857143</value><value>27.44059917</value><value>27.47252747</value><value>27.6816609</value><value>27.71768524</value><value>27.96801606</value><value>28.04037814</value><value>28.3446712</value><value>28.3530572</value><value>28.37370242</value><value>28.39372634</value><value>28.40550436</value><value>28.7132112</value><value>28.73174689</value><value>28.88888889</value><value>29.03673779</value><value>29.3877551</value><value>29.64268547</value><value>29.7210791</value><value>30.0838291</value><value>30.42719786</value><value>31.14186851</value><value>31.22130395</value><value>31.31456612</value><value>31.37798917</value><value>31.69907016</value><value>31.77393186</value><value>33.9100346</value><value>34.25605536</value><value>34.92767916</value><value>35.01277966</value><value>39.46352484</value><value>NA</value></experimentalfactor><experimentalfactor><name>CLINICAL DIAGNOSIS PATIENT</name><value>Acute duodenal ulcer (Status Past), Acute gastritis with hemorrhage (Status Past), Squamous cell carcinoma of the lung (Status New)</value><value>Adenocarcinoma of lung (Status New)</value><value>Adenocarcinoma of the lung (Status New)</value><value>Alcoholism (Status Ongoing), Large cell carcinoma of the lung (Status New)</value><value>Alkylosing spondylitis (Status Ongoing), Squamous cell carcinoma of the lung (Status Ongoing)</value><value>Angina (Status Ongoing), Arteriopathy (Status Ongoing), Adenocarcinoma of the lung (Status New)</value><value>Appendicitis with appendectomy (Status Past), Tonsillitis with tonsillectomy (Status Past), Squamous cell carcinoma of the lung (Status New)</value><value>Appendicitis with appendectomy (Status Past), Viral hepatitis a (Status Past), Gastric ulcer (Status Recurrent), Thyroidectomy (Status Past), Adenocarcinoma of the lung (Status New)</value><value>Arterial hypertension (Status Ongoing), Adenocarcinoma of the lung (Status New)</value><value>Arterial hypertension (Status Ongoing), Squamous cell carcinoma of the lung (Status New)</value><value>Arterial hypertension (Status Ongoing), Squamous cell carcinoma, keratinizing of the lung (Status New)</value><value>Arthritis (Status Past), Squamous cell carcinoma, keratinizing of the lung (Status New)</value><value>Bronchiolo-alveolar adenocarcinoma of the lung (Status New)</value><value>Bronchitis (Status Ongoing), Ischemic cardiomyopathy (Status Ongoing), Squamous cell carcinoma of the upper lobe of right lung (Status New)</value><value>Cancer of the bladder (Status Past), Adenocarcinoma of the lung (Status New)</value><value>Cancer of the head and neck (Status ), Adenocarcinoma of the lung (Status New)</value><value>Cancer of the lung (Status New), Gastroesophageal reflux disease (Status Ongoing), Hypertension (Status Ongoing), Laparotomy for liver injury (Status Past), Hemorrhoids (Status Past), Adenocarcinoma of the lung (Status New)</value><value>Cancer of the lung (Status New), Hypertension (Status Ongoing), Nocardia pnemonia (Status Past), Chronic obstructive pulmonary disease (Status Ongoing), Squamous cell carcinoma of the lung (Status New)</value><value>Car accident with multiple injuries (Status Past), Coma  (as a result of car accident) (Status Past), Adenocarcinoma of the lung (Status New)</value><value>Chronic bronchitis (Status Ongoing), Adenocarcinoma of the lung (Status New)</value><value>Chronic bronchitis (Status Ongoing), Gastritis (Status Ongoing), Squamous cell carcinoma of the lung (Status New)</value><value>Chronic bronchitis (Status Ongoing), Hypertension (Status Ongoing), Adenocarcinoma of the lung (Status New)</value><value>Chronic bronchitis (Status Ongoing), Squamous cell carcinoma of the lung (Status New)</value><value>Chronic bronchitis (Status Ongoing), Squamous cell carcinoma, keratinizing of the lung (Status New)</value><value>Chronic bronchitis (Status Ongoing), Squamous cell carcinoma, large cell, non-keratinizing of the lung (Status New)</value><value>Chronic obstructive pulmonary disease (Status Ongoing), Hypertension (Status Ongoing), Squamous cell carcinoma of the lung (Status New)</value><value>Chronic obstructive pulmonary disease (Status Ongoing), Squamous cell carcinoma of the lung (Status New)</value><value>Chronic pancreatitis  (Status Ongoing), Adenocarcinoma of the lung (Status New)</value><value>Coronary artery disease (Status Ongoing), Diabetes  (Status Ongoing), Gastritis (Status Ongoing), Squamous cell carcinoma of the lung (Status New)</value><value>Coronary atherosclerosis     (Status Ongoing), Simple chronic bronchitis (Status Ongoing), Squamous cell carcinoma  of the lung (Status New)</value><value>Coronary atherosclerosis    (Status Ongoing), Essential hypertension (Status Ongoing), Malignant neoplasm of lip (Status Past), Squamous cell carcinoma  of the lung (Status New)</value><value>Diabetes  (Status Ongoing), Squamous cell carcinoma of the lung (Status New)</value><value>Diabetes (Status Ongoing), High blood pressure (Status Ongoing), Bronchiolo-alveolar adenocarcinoma of the lung (Status New)</value><value>Duodenal ulcer  (Status Past), Essential hypertension (Status Ongoing), Squamous cell carcinoma of the lung (Status New)</value><value>Duodenal ulcer (Status Ongoing), Squamous cell carcinoma of the lung (Status New)</value><value>Duodenal ulcer (Status Past), Squamous cell carcinoma of the lung (Status New)</value><value>Essential hypertension  (Status Ongoing), Adenocarcinoma of the lung (Status New)</value><value>Essential hypertension (Status Ongoing), Chronic bronchitis (Status Ongoing), Squamous cell carcinoma of the lung (Status New)</value><value>Essential hypertension (Status Ongoing), Simple chronic bronchitis (Status Ongoing), Squamous cell carcinoma of the lung (Status New)</value><value>Essential hypertension (Status Ongoing), Squamous cell carcinoma, keratinizing of the lung (Status New)</value><value>Essential hypertension (Status Ongoing), Squamous cell carcinoma, keratinizing of the skin (Status New)</value><value>Gastric ulcer (Status Ongoing), Adenocarcinoma of the lung (Status New)</value><value>Gastritis (Status Past), Adenocarcinoma of the lung (Status New)</value><value>Hypertension (Status Ongoing), Chronic bronchitis (Status Ongoing), Adenocarcinoma of the lung (Status New)</value><value>Hypertension (Status Ongoing), Chronic bronchitis (Status Ongoing), Bronchiolo-alveolar adenocarcinoma of the lung (Status New)</value><value>Hypertension (Status Ongoing), Chronic cholecystitis  (Status Ongoing), Adenocarcinoma of the lung (Status New)</value><value>Hypertension (Status Ongoing), Diabetes (Status Ongoing), Adenocarcinoma of the lung (Status New)</value><value>Hypertension (Status Ongoing), Gastritis (Status Ongoing), Adenocarcinoma of the lung (Status New)</value><value>Hypertension (Status Ongoing), Nodular goiter (Status Ongoing), Bronchiolo-alveolar adenocarcinoma of the lung (Status New)</value><value>Hypertension (Status Ongoing), Squamous cell carcinoma of the lung (Status New)</value><value>Hypertension (Status Ongoing), Squamous cell carcinoma, keratinizing of the lung (Status New)</value><value>Ischemic and dismethabolic cardiopathy (Status Ongoing), Carcinoma of the lung (Status New)</value><value>Ischemic heart disease (Status Ongoing), Hypertension (Status Ongoing), Colorectal cancer (Status ), Adenocarcinoma of the lung (Status New)</value><value>Large cell carcinoma of the lung (Status New)</value><value>Malignant neoplasm of the lung (Status New)</value><value>not specified</value><value>Obesity   (Status Ongoing), Adenocarcinoma of the lung (Status New)</value><value>Obesity (Status Ongoing), Adenocarcinoma of the lung (Status New)</value><value>Obesity (Status Ongoing), Chronic bronchitis (Status Ongoing), Squamous cell carcinoma of the lung (Status New)</value><value>Obesity (Status Ongoing), Clear cell adenocarcinoma of the lung (Status New)</value><value>Pneumonia (Status New), Adenocarcinoma of lung (Status New)</value><value>Simple chronic bronchitis   (Status Ongoing), Alveolar adenocarcinoma of the lung (Status New)</value><value>Simple chronic bronchitis   (Status Ongoing), Unspecified gastritis and gastroduodenitis  (Status Ongoing), Duodenal ulcer  (Status Past), Squamous cell carcinoma of the lung (Status New)</value><value>Simple chronic bronchitis  (Status Ongoing), Adenocarcinoma of the lung (Status New)</value><value>Simple chronic bronchitis  (Status Ongoing), Unspecified gastritis and gastroduodenitis    (Status Ongoing), Adenocarcinoma of the lung (Status New)</value><value>Simple chronic bronchitis (Status Ongoing), Squamous cell carcinoma of the lung (Status New)</value><value>Squamous cell carcinoma of the lung (Status New)</value><value>Squamous cell carcinoma, keratinizing of the lung (Status New)</value><value>Squamous cell carcinoma, large cell, non-keratinizing of the lung (Status New)</value><value>Unspecified gastritis and gastroduodenitis    (Status Ongoing), Coronary atherosclerosis (Status Ongoing), Squamous cell carcinoma of the lung (Status New)</value><value>Unspecified gastritis and gastroduodenitis (Status Ongoing), Adenocarcinoma of the lung (Status New)</value><value>Unspecified gastritis and gastroduodenitis (Status Ongoing), Squamous cell carcinoma of the lung (Status New)</value></experimentalfactor><experimentalfactor><name>CLINICAL DIAGNOSIS SPECIMEN</name><value>Adenocarcinoma of Lung</value><value>Adenocarcinoma of the Lung</value><value>Alveolar adenocarcinoma of the lung</value><value>Bronchioloalveolar Adenocarcinoma of the Lung</value><value>Carcinoma of the Lung</value><value>Clear cell adenocarcinoma of the lung</value><value>Large cell carcinoma of the lung</value><value>Malignant neoplasm of the lung</value><value>Papillary adenocarcinoma of the right lower lung lobe</value><value>Squamous Cell Carcinoma of the Lung</value><value>Squamous cell carcinoma of the upper lobe of right lung</value><value>Squamous cell carcinoma, keratinizing of the lung</value><value>Squamous cell carcinoma, keratinizing of the skin</value><value>Squamous cell carcinoma, large cell, non-keratinizing of the lung</value></experimentalfactor><experimentalfactor><name>ETHNICITY</name><value>Asian/Pacific Islander</value><value>Caucasian</value><value>NA</value><value>White</value></experimentalfactor><experimentalfactor><name>EXCISION YEAR</name><value>2002</value><value>2003</value><value>2004</value><value>2005</value><value>2006</value><value>2007</value><value>2008</value><value>2009</value><value>2010</value><value>2011</value><value>NA</value><value>not specified</value></experimentalfactor><experimentalfactor><name>HEIGHT CM</name><value>0</value><value>149</value><value>150</value><value>151</value><value>153</value><value>155</value><value>156</value><value>157</value><value>158</value><value>160</value><value>161</value><value>162</value><value>163</value><value>164</value><value>165</value><value>167</value><value>168</value><value>169</value><value>170</value><value>172</value><value>173</value><value>174</value><value>175</value><value>176</value><value>177</value><value>178</value><value>179</value><value>180</value><value>182</value><value>184</value><value>185</value><value>187</value><value>190</value><value>NA</value></experimentalfactor><experimentalfactor><name>ORGANISM PART</name><value>Bronchus Tumor</value><value>Lung Diseased</value><value>Lung Normal</value><value>Lung Tumor</value></experimentalfactor><experimentalfactor><name>RIN</name><value>10</value><value>7</value><value>7.13</value><value>7.25</value><value>7.279631</value><value>7.3</value><value>7.31</value><value>7.35</value><value>7.38</value><value>7.45</value><value>7.49</value><value>7.5</value><value>7.6</value><value>7.62</value><value>7.66</value><value>7.67</value><value>7.67513</value><value>7.693396</value><value>7.7</value><value>7.81</value><value>7.87</value><value>7.881437</value><value>7.9</value><value>7.95</value><value>8</value><value>8.00742</value><value>8.03</value><value>8.04</value><value>8.05</value><value>8.07</value><value>8.09</value><value>8.1</value><value>8.14</value><value>8.15</value><value>8.19</value><value>8.2</value><value>8.21</value><value>8.231344</value><value>8.24</value><value>8.3</value><value>8.36</value><value>8.39</value><value>8.397932</value><value>8.462233</value><value>8.49</value><value>8.5</value><value>8.51</value><value>8.58</value><value>8.6</value><value>8.61</value><value>8.623299</value><value>8.69</value><value>8.693336</value><value>8.7</value><value>8.74</value><value>8.78</value><value>8.79</value><value>8.8</value><value>8.834855</value><value>8.84</value><value>8.85</value><value>8.881916</value><value>8.89</value><value>8.9</value><value>8.938609</value><value>8.94</value><value>8.96</value><value>8.99</value><value>9</value><value>9.004557</value><value>9.011824</value><value>9.04</value><value>9.072135</value><value>9.1</value><value>9.13</value><value>9.137592</value><value>9.2</value><value>9.21</value><value>9.23</value><value>9.25</value><value>9.254594</value><value>9.29</value><value>9.3</value><value>9.33</value><value>9.35</value><value>9.37</value><value>9.4</value><value>9.400192</value><value>9.41</value><value>9.42</value><value>9.46</value><value>9.5</value><value>9.51</value><value>9.54</value><value>9.599208</value><value>9.64965</value><value>9.65</value><value>9.66</value><value>9.68</value><value>9.7</value><value>9.74118</value><value>9.8</value><value>9.86</value><value>9.878584</value><value>9.89</value><value>9.9</value><value>9.95</value><value>9.97</value><value>9.99</value><value>N/A</value></experimentalfactor><experimentalfactor><name>SBV CHALLENGE GOLD STANDARD</name><value>AC1</value><value>AC2</value><value>SCC1</value><value>SCC2</value></experimentalfactor><experimentalfactor><name>SEX</name><value>female</value><value>male</value><value>not specified</value></experimentalfactor><experimentalfactor><name>SMOKING DOSE CIGARETTES/DAY</name><value>0</value><value>10</value><value>11-20</value><value>15</value><value>2-3</value><value>20</value><value>24</value><value>25</value><value>30</value><value>35</value><value>40</value><value>5-8</value><value>6-7</value><value>60</value><value>NA</value></experimentalfactor><experimentalfactor><name>SMOKING DURATION YEARS</name><value>0</value><value>10</value><value>15</value><value>2</value><value>20</value><value>23</value><value>25</value><value>27</value><value>30</value><value>31-40</value><value>34</value><value>35</value><value>36</value><value>37</value><value>39</value><value>40</value><value>44</value><value>45</value><value>48</value><value>50</value><value>52</value><value>58</value><value>8</value><value>&gt;20</value><value>NA</value><value>not specified</value></experimentalfactor><experimentalfactor><name>SMOKING STATUS</name><value>Current Use</value><value>NA</value><value>Never Used</value><value>not specified</value><value>Occasional Use</value><value>Previous Use</value></experimentalfactor><experimentalfactor><name>TNM STAGE</name><value>T1aN1M0</value><value>T1bN0M0</value><value>T1bN1M0</value><value>T1bNXM0</value><value>T1bNXMX</value><value>T1N0M0</value><value>T1N1M0</value><value>T1N1MX</value><value>T1N2M0</value><value>T1NXM0</value><value>T1NXMX</value><value>T2aN0M0</value><value>T2aN0MX</value><value>T2aN1M0</value><value>T2aNXM0</value><value>T2bN0M0</value><value>T2bN1M0</value><value>T2bNXM0</value><value>T2N0M0</value><value>T2N0MX</value><value>T2N1M0</value><value>T2N1MX</value><value>T2NXM0</value><value>T2NXMX</value><value>T3N0M0</value><value>T3N0MX</value><value>T3NXM0</value><value>T3NXMX</value></experimentalfactor><experimentalfactor><name>TUMOR GRADE</name><value>G2</value><value>Moderate to poorly differentiated</value><value>Moderately differentiated</value><value>not specified</value><value>Poorly differentiated</value><value>Well differentiated</value><value>Well to moderately differentiated</value></experimentalfactor><experimentalfactor><name>WEIGHT KG</name><value>0</value><value>100</value><value>105</value><value>138</value><value>45</value><value>46</value><value>47</value><value>48</value><value>50</value><value>51</value><value>52</value><value>53</value><value>55</value><value>56</value><value>58</value><value>60</value><value>61</value><value>62</value><value>63</value><value>64</value><value>65</value><value>66</value><value>67</value><value>68</value><value>69</value><value>70</value><value>71</value><value>72</value><value>73</value><value>74</value><value>75</value><value>76</value><value>78</value><value>79</value><value>80</value><value>82</value><value>83</value><value>84</value><value>85</value><value>86</value><value>87</value><value>89</value><value>90</value><value>91</value><value>92</value><value>94</value><value>95</value><value>97</value><value>98</value><value>99</value><value>NA</value></experimentalfactor><miamescores><reportersequencescore>1</reportersequencescore><protocolscore>0</protocolscore><factorvaluescore>1</factorvaluescore><derivedbioassaydatascore>1</derivedbioassaydatascore><measuredbioassaydatascore>1</measuredbioassaydatascore><overallscore>4</overallscore></miamescores><id>358291</id><accession>E-GEOD-43580</accession><secondaryaccession>GSE43580</secondaryaccession><name>SBV - Gene Expression Profiles of Lung Cancer Tumors - Adenocarcinomas and Squamous Cell Carcinomas</name><experimenttype>transcription profiling by array</experimenttype><releasedate>2013-10-18</releasedate><lastupdatedate>2014-06-02</lastupdatedate><samples>150</samples><assays>150</assays><arraydesign><id>11119</id><accession>A-AFFY-44</accession><name>Affymetrix GeneChip Human Genome U133 Plus 2.0 [HG-U133_Plus_2]</name><count>150</count><legacy_id>405156763</legacy_id></arraydesign><bioassaydatagroup><id/><name>rawData</name><bioassaydatacubes>150</bioassaydatacubes><arraydesignprovider/><dataformat>rawData</dataformat><bioassays>150</bioassays><isderived>0</isderived></bioassaydatagroup><bioassaydatagroup><id/><name>normalization</name><bioassaydatacubes>150</bioassaydatacubes><arraydesignprovider/><dataformat>normalization</dataformat><bioassays>150</bioassays><isderived>0</isderived></bioassaydatagroup><bioassaydatagroup><id/><name>processedData</name><bioassaydatacubes>150</bioassaydatacubes><arraydesignprovider/><dataformat>processedData</dataformat><bioassays>150</bioassays><isderived>0</isderived></bioassaydatagroup><bibliography><accession>23966112</accession><authors>Tarca AL, Lauria M, Unger M, Bilal E, Boue S, Kumar Dey K, Hoeng J, Koeppl H, Martin F, Meyer P, Nandy P, Norel R, Peitsch M, Rice JJ, Romero R, Stolovitzky G, Talikka M, Xiang Y, Zechner C, IMPROVER DSC Collaborators</authors><title>Strengths and limitations of microarray-based phenotype prediction: lessons learned from the IMPROVER Diagnostic Signature Challenge.</title><doi>10.1093/bioinformatics/btt492</doi></bibliography><provider><contact>Marja Talikka</contact><role/><email/></provider><provider><contact>Julia Hoeng</contact><role/><email/></provider><provider><contact>Sam Ansari</contact><role>submitter</role><email>sam.ansari@pmi.com</email></provider><provider><contact>Walter Schlage</contact><role/><email/></provider><provider><contact>Stephanie Boue</contact><role/><email/></provider><provider><contact>Manuel C Peitsch</contact><role/><email/></provider><provider><contact>Florian Martin</contact><role/><email/></provider><provider><contact>Sam Ansari</contact><role/><email/></provider><provider><contact>Yang Xiang</contact><role/><email/></provider><description><id/><text>This dataset encompassing the profiles of 150 lung cancer tumors was developed to serve as test dataset in the SBV IMPROVER Diagnostic Signature Challenge (sbvimprover.com). The aim of this subchallenge was to verify that it is possible to extract a robust diagnostic signature from gene expression data that can identify stages of different types of lung cancer. Participants were asked to develop and submit a classifier that can stratify lung cancer patients in one of four groups – Stage 1 of Adenocarcinoma (AC Stage 1), Stage 2 of Adenocarcinoma (AC Stage 2), Stage 1 of Squamous cell carcinoma (SCC Stage 1) or Stage 2 of Squamous cell carcinoma (SCC Stage 2). The classifier could be built by using any publicly available gene expression data with related histopathological information and was tested on the independent dataset described here. 150 non-small cell lung cancer tumors (adenocarcinoma, AC and squamous cell carcinoma, SCC) of stages I and II were collected by surgical resection from patients who have provided consent. Adenosquamous and large cell tumor samples were excluded. The number of smokers and non-smokers was balanced: there were 41 AC1 (adenocarcinoma stage I), 36 AC2, 34 SCC1, and 39 SCC2 samples. Study pathologists at each of the seven sites (Lebanon, Republic of Moldova, Romania, Russian Federation, Ukraine, Vietnam and United States of America) reviewed both the tumor permanent sections and the frozen sections of the samples. Clinical information was also collected about tumor staging, history of prior cancers, lymph node involvement by lymph node sampling/dissection, smoking history, age, gender.</text></description><protocol><id>886480</id><accession>P-GSE43580-1</accession></protocol><protocol><id>886481</id><accession>P-GSE43580-7</accession></protocol><protocol><id>886482</id><accession>P-GSE43580-6</accession></protocol><protocol><id>886486</id><accession>P-GSE43580-3</accession></protocol><protocol><id>886484</id><accession>P-GSE43580-2</accession></protocol><protocol><id>886483</id><accession>P-GSE43580-5</accession></protocol><protocol><id>886485</id><accession>P-GSE43580-4</accession></protocol><organism>Homo sapiens</organism><files><!--
This section is deprecated and unsupported.
Please use webservice located at:
    http://www.ebi.ac.uk/arrayexpress/xml/files
to obtain detailed information on files available for the experiment.
For more information, please go to:
    http://www.ebi.ac.uk/arrayexpress/help/programmatic_access.html
                --><raw name="E-GEOD-43580.raw.1.zip E-GEOD-43580.raw.2.zip E-GEOD-43580.raw.3.zip E-GEOD-43580.raw.4.zip" count="true" celcount="0"/><fgem name="E-GEOD-43580.processed.1.zip" available="true"/><idf name="E-GEOD-43580.idf.txt"/><sdrf name="E-GEOD-43580.sdrf.txt"/></files></experiment><experiment><species>Homo sapiens</species><rawdatafiles available="true"/><processeddatafiles available="true"/><sampleattribute><category>age</category><value>11 females and 6 males</value><value>26</value><value>52</value><value>53</value><value>55</value><value>63</value><value>64</value><value>67</value><value>68</value><value>75</value><value>80</value><value>85</value></sampleattribute><sampleattribute><category>angiography</category><value>  </value><value>Done*</value><value>ND</value></sampleattribute><sampleattribute><category>associated diseses</category><value>  </value><value>After operation of subarachinoid hemorrage, artificial cardiac pacing, fracture of femur neck and dementia developped during treatment</value><value>Diabetes miiitus</value><value>Diabetes miiitus, hypertension, pneumonia</value><value>hypertension</value><value>Hypertension, prostata hypertrophy</value><value>Juvenile idiopathic arthritis</value><value>Optic disc vasculitis, sterid induced diabetes miiitus</value><value>Pneumonia induced by candida, congestive heart failure</value><value>Scleroderma, interstitial pneumonia</value><value>Scleroderma, steroid induced diabetes miiitus</value><value>Steroid-induced diabetes miiitus</value></sampleattribute><sampleattribute><category>clinical manifestation</category><value>  </value><value>Abdominal pain,hematiuria</value><value>Arthritis, fever (38～39℃), erythema nodosum, mononeuritis multiplex</value><value>Arthritis, hematuria, proteinuria</value><value>Fever of 38～39℃, myalgia, arthralgia, uveitis</value><value>Fever, arthralgia, myalgia, nephritis, leg ulcer</value><value>Fever, arthritis, body weight loss,interstitial pneumonia, peripheral nerve disturbance,dementia</value><value>Fever, arthritis, body weight loss,interstitialpneumonia, peripheral nerve disturbance</value><value>Fever, body weight loss, mononeuritis multiplex</value><value>Fever, nephritis, interstitial pneumonia</value><value>Fever, nephritis, mononeuritis multiplex</value><value>Fever, ulcers of both legs</value><value>Subsided all symptom except peripheral neuropathy</value></sampleattribute><sampleattribute><category>creatinine mg/dl</category><value>  </value><value>0.43</value><value>0.54</value><value>0.6</value><value>0.64</value><value>0.67</value><value>0.74</value><value>1.12</value><value>1.5➝1.6</value><value>2</value><value>2.52</value><value>3.12</value><value>9.2</value></sampleattribute><sampleattribute><category>crp mg/dl</category><value>  </value><value>0.7</value><value>1.0</value><value>1.5</value><value>12.0</value><value>2.0</value><value>4.6</value><value>4.9</value><value>5.3</value><value>5.6</value><value>6.0➝0.1</value><value>7.0</value><value>9.0</value></sampleattribute><sampleattribute><category>disaese activity bvas 2003 persistent/worse</category><value>  </value><value>0/0</value><value>0/10</value><value>0/6</value><value>2/10</value><value>2/11</value><value>2/2</value><value>3/0</value><value>3/6</value><value>3/8</value><value>6/0</value><value>6/12</value><value>7/0</value></sampleattribute><sampleattribute><category>disease status</category><value>healthy controls without any identified diseases</value><value>Microscopic polyangiitis (MPA)</value></sampleattribute><sampleattribute><category>duration of disease</category><value>  </value><value>1 month</value><value>1 year</value><value>1 year and 6 months</value><value>10 days</value><value>15 months</value><value>2 months</value><value>22 years</value><value>3 months</value><value>4 months after treatment</value><value>5 years</value><value>6 years</value></sampleattribute><sampleattribute><category>histological findings of renal specimen</category><value>  </value><value>cGN</value><value>Diffuse mesangial proliferative GN with crescent formation</value><value>no precise information was obtained</value><value>―</value></sampleattribute><sampleattribute><category>interstitial pneumonia</category><value>  </value><value>absent</value><value>present</value><value>Present with bilateral pleural effusion</value></sampleattribute><sampleattribute><category>mpo-anca u/ml</category><value>  </value><value>12</value><value>123</value><value>180</value><value>195</value><value>23</value><value>249➝negative</value><value>304</value><value>40</value><value>412</value><value>79</value><value>89</value><value>negative</value></sampleattribute><sampleattribute><category>organism</category><value>Homo sapiens</value></sampleattribute><sampleattribute><category>pr3-anca u/ml</category><value>  </value><value>ND</value><value>negative</value></sampleattribute><sampleattribute><category>renal biopsy</category><value>  </value><value>Done</value><value>ND</value></sampleattribute><sampleattribute><category>sex</category><value>avg. 42.1</value><value>female</value><value>male</value></sampleattribute><sampleattribute><category>wbc  /mm3</category><value>  </value><value>10100</value><value>12000</value><value>13000</value><value>13300</value><value>13600</value><value>4600</value><value>6200</value><value>7000</value><value>7200</value><value>7900</value><value>8000</value><value>8900</value></sampleattribute><experimentalfactor><name>AGE</name><value>11 females and 6 males</value><value>26</value><value>52</value><value>53</value><value>55</value><value>63</value><value>64</value><value>67</value><value>68</value><value>75</value><value>80</value><value>85</value></experimentalfactor><experimentalfactor><name>ANGIOGRAPHY</name><value>Done*</value><value>ND</value><value>not specified</value></experimentalfactor><experimentalfactor><name>ASSOCIATED DISESES</name><value>After operation of subarachinoid hemorrage, artificial cardiac pacing, fracture of femur neck and dementia developped during treatment</value><value>Diabetes miiitus</value><value>Diabetes miiitus, hypertension, pneumonia</value><value>hypertension</value><value>Hypertension, prostata hypertrophy</value><value>Juvenile idiopathic arthritis</value><value>not specified</value><value>Optic disc vasculitis, sterid induced diabetes miiitus</value><value>Pneumonia induced by candida, congestive heart failure</value><value>Scleroderma, interstitial pneumonia</value><value>Scleroderma, steroid induced diabetes miiitus</value><value>Steroid-induced diabetes miiitus</value></experimentalfactor><experimentalfactor><name>CLINICAL MANIFESTATION</name><value>Abdominal pain,hematiuria</value><value>Arthritis, fever (38～39℃), erythema nodosum, mononeuritis multiplex</value><value>Arthritis, hematuria, proteinuria</value><value>Fever of 38～39℃, myalgia, arthralgia, uveitis</value><value>Fever, arthralgia, myalgia, nephritis, leg ulcer</value><value>Fever, arthritis, body weight loss,interstitial pneumonia, peripheral nerve disturbance,dementia</value><value>Fever, arthritis, body weight loss,interstitialpneumonia, peripheral nerve disturbance</value><value>Fever, body weight loss, mononeuritis multiplex</value><value>Fever, nephritis, interstitial pneumonia</value><value>Fever, nephritis, mononeuritis multiplex</value><value>Fever, ulcers of both legs</value><value>not specified</value><value>Subsided all symptom except peripheral neuropathy</value></experimentalfactor><experimentalfactor><name>CREATININE MG/DL</name><value>0.43</value><value>0.54</value><value>0.6</value><value>0.64</value><value>0.67</value><value>0.74</value><value>1.12</value><value>1.5➝1.6</value><value>2</value><value>2.52</value><value>3.12</value><value>9.2</value><value>not specified</value></experimentalfactor><experimentalfactor><name>CRP MG/DL</name><value>0.7</value><value>1.0</value><value>1.5</value><value>12.0</value><value>2.0</value><value>4.6</value><value>4.9</value><value>5.3</value><value>5.6</value><value>6.0➝0.1</value><value>7.0</value><value>9.0</value><value>not specified</value></experimentalfactor><experimentalfactor><name>DISAESE ACTIVITY BVAS 2003 PERSISTENT/WORSE</name><value>0/0</value><value>0/10</value><value>0/6</value><value>2/10</value><value>2/11</value><value>2/2</value><value>3/0</value><value>3/6</value><value>3/8</value><value>6/0</value><value>6/12</value><value>7/0</value><value>not specified</value></experimentalfactor><experimentalfactor><name>DISEASE STATUS</name><value>healthy controls without any identified diseases</value><value>Microscopic polyangiitis (MPA)</value></experimentalfactor><experimentalfactor><name>DURATION OF DISEASE</name><value>1 month</value><value>1 year</value><value>1 year and 6 months</value><value>10 days</value><value>15 months</value><value>2 months</value><value>22 years</value><value>3 months</value><value>4 months after treatment</value><value>5 years</value><value>6 years</value><value>not specified</value></experimentalfactor><experimentalfactor><name>HISTOLOGICAL FINDINGS OF RENAL SPECIMEN</name><value>cGN</value><value>Diffuse mesangial proliferative GN with crescent formation</value><value>no precise information was obtained</value><value>not specified</value><value>―</value></experimentalfactor><experimentalfactor><name>INTERSTITIAL PNEUMONIA</name><value>absent</value><value>not specified</value><value>present</value><value>Present with bilateral pleural effusion</value></experimentalfactor><experimentalfactor><name>MPO-ANCA U/ML</name><value>12</value><value>123</value><value>180</value><value>195</value><value>23</value><value>249➝negative</value><value>304</value><value>40</value><value>412</value><value>79</value><value>89</value><value>negative</value><value>not specified</value></experimentalfactor><experimentalfactor><name>PR3-ANCA U/ML</name><value>ND</value><value>negative</value><value>not specified</value></experimentalfactor><experimentalfactor><name>RENAL BIOPSY</name><value>Done</value><value>ND</value><value>not specified</value></experimentalfactor><experimentalfactor><name>SEX</name><value>avg. 42.1</value><value>female</value><value>male</value></experimentalfactor><experimentalfactor><name>TREATMENT</name><value>IVCY, PSL50mg/d➝PSL20mg/d</value><value>mPSL 500mg/d for 3 days, CY 100mg/d, renal dialysis</value><value>mPSL 500mg/d for 3 days, CyA 70mg/d</value><value>mPSL500mg/d for 3 days➝ 22.5mg/d</value><value>not specified</value><value>PSL 10mg/d, aspirine 100mg/d</value><value>PSL 40mg/d➝PSL 12.5mg/d</value><value>PSL 50mg/d</value><value>PSL10mg/d, CY 75mg/d</value><value>PSL20mg/d. CY 50mg/d</value><value>PSL30mg/d, AZA 50mg/d</value><value>PSL50mg/d, CY 150mg/d, mPSL (200mg) pulse with 3 days</value></experimentalfactor><experimentalfactor><name>WBC  /MM3</name><value>10100</value><value>12000</value><value>13000</value><value>13300</value><value>13600</value><value>4600</value><value>6200</value><value>7000</value><value>7200</value><value>7900</value><value>8000</value><value>8900</value><value>not specified</value></experimentalfactor><miamescores><reportersequencescore>1</reportersequencescore><protocolscore>1</protocolscore><factorvaluescore>1</factorvaluescore><derivedbioassaydatascore>1</derivedbioassaydatascore><measuredbioassaydatascore>1</measuredbioassaydatascore><overallscore>5</overallscore></miamescores><id>335267</id><accession>E-GEOD-41744</accession><secondaryaccession>GSE41744</secondaryaccession><name>Ficolin-1 is upregulated in leukocytes and glomeruli from microscopic polyangiitis patients</name><experimenttype>transcription profiling by array</experimenttype><releasedate>2013-08-18</releasedate><lastupdatedate>2014-06-02</lastupdatedate><samples>24</samples><assays>12</assays><arraydesign><id>11853</id><accession>A-AGIL-28</accession><name>Agilent Whole Human Genome Microarray 4x44K 014850 G4112F (85 cols x 532 rows)</name><count>12</count><legacy_id>1316855037</legacy_id></arraydesign><bioassaydatagroup><id/><name>rawData</name><bioassaydatacubes>12</bioassaydatacubes><arraydesignprovider/><dataformat>rawData</dataformat><bioassays>12</bioassays><isderived>0</isderived></bioassaydatagroup><bioassaydatagroup><id/><name>normalization</name><bioassaydatacubes>12</bioassaydatacubes><arraydesignprovider/><dataformat>normalization</dataformat><bioassays>12</bioassays><isderived>0</isderived></bioassaydatagroup><bioassaydatagroup><id/><name>processedData</name><bioassaydatacubes>12</bioassaydatacubes><arraydesignprovider/><dataformat>processedData</dataformat><bioassays>12</bioassays><isderived>0</isderived></bioassaydatagroup><bibliography><accession>23944633</accession><authors>Muso E, Okuzaki D, Kobayashi S, Iwasaki Y, Sakurai MA, Ito A, Nojima H</authors><title>Ficolin-1 is up-regulated in leukocytes and glomeruli from microscopic polyangiitis patients.</title><doi>10.3109/08916934.2013.822073</doi></bibliography><provider><contact>Daisuke Okuzaki</contact><role>submitter</role><email>dokuzaki@biken.osaka-u.ac.jp</email></provider><provider><contact>Hiroshi Nojima</contact><role/><email/></provider><description><id/><text>To search for new markers of active lesions that might help better understand the molecular basis of MPA and aid in its diagnosis, DNA microarray analysis was performed with peripheral blood mononuclear cells (PBMCs). A total of 12 sets of two color arrays were performed and each individual array included a target sample and a control sample.</text></description><protocol><id>833857</id><accession>P-GSE41744-4</accession></protocol><protocol><id>833856</id><accession>P-GSE41744-5</accession></protocol><protocol><id>833859</id><accession>P-GSE41744-2</accession></protocol><protocol><id>833858</id><accession>P-GSE41744-3</accession></protocol><protocol><id>833855</id><accession>P-GSE41744-1</accession></protocol><organism>Homo sapiens</organism><files><!--
This section is deprecated and unsupported.
Please use webservice located at:
    http://www.ebi.ac.uk/arrayexpress/xml/files
to obtain detailed information on files available for the experiment.
For more information, please go to:
    http://www.ebi.ac.uk/arrayexpress/help/programmatic_access.html
                --><raw name="E-GEOD-41744.raw.1.zip" count="true" celcount="0"/><fgem name="E-GEOD-41744.processed.1.zip" available="true"/><idf name="E-GEOD-41744.idf.txt"/><sdrf name="E-GEOD-41744.sdrf.txt"/></files></experiment><experiment><species>Homo sapiens</species><rawdatafiles available="true"/><processeddatafiles available="true"/><sampleattribute><category>disease status</category><value>control</value><value>Scleroderma associated interstitial lung disease</value><value>Usual Interstitial Pneumonia</value></sampleattribute><sampleattribute><category>organism</category><value>Homo sapiens</value></sampleattribute><sampleattribute><category>organism part</category><value>Pulmonary fibroblasts</value></sampleattribute><experimentalfactor><name>DISEASE STATUS</name><value>control</value><value>Scleroderma associated interstitial lung disease</value><value>Usual Interstitial Pneumonia</value></experimentalfactor><miamescores><reportersequencescore>1</reportersequencescore><protocolscore>1</protocolscore><factorvaluescore>1</factorvaluescore><derivedbioassaydatascore>1</derivedbioassaydatascore><measuredbioassaydatascore>1</measuredbioassaydatascore><overallscore>5</overallscore></miamescores><id>329290</id><accession>E-GEOD-40839</accession><secondaryaccession>GSE40839</secondaryaccession><name>Expression data from fibroblasts cultured from normal and fibrotic human lung tissue</name><experimenttype>transcription profiling by array</experimenttype><releasedate>2013-08-05</releasedate><lastupdatedate>2014-06-02</lastupdatedate><samples>21</samples><assays>21</assays><arraydesign><id>11043</id><accession>A-AFFY-33</accession><name>Affymetrix GeneChip Human Genome HG-U133A [HG-U133A]</name><count>21</count><legacy_id>302382080</legacy_id></arraydesign><bioassaydatagroup><id/><name>rawData</name><bioassaydatacubes>21</bioassaydatacubes><arraydesignprovider/><dataformat>rawData</dataformat><bioassays>21</bioassays><isderived>0</isderived></bioassaydatagroup><bioassaydatagroup><id/><name>normalization</name><bioassaydatacubes>21</bioassaydatacubes><arraydesignprovider/><dataformat>normalization</dataformat><bioassays>21</bioassays><isderived>0</isderived></bioassaydatagroup><bioassaydatagroup><id/><name>processedData</name><bioassaydatacubes>21</bioassaydatacubes><arraydesignprovider/><dataformat>processedData</dataformat><bioassays>21</bioassays><isderived>0</isderived></bioassaydatagroup><provider><contact>Carmel J Stock</contact><role/><email/></provider><provider><contact>Gisela E Lindahl</contact><role/><email/></provider><provider><contact>Athol U Wells</contact><role/><email/></provider><provider><contact>George Bou-Gharios</contact><role/><email/></provider><provider><contact>Christopher P Denton</contact><role/><email/></provider><provider><contact>Elisabetta A Renzoni</contact><role/><email/></provider><provider><contact>Carmel Stock</contact><role>submitter</role><email>c.stock@imperial.ac.uk</email></provider><provider><contact>Michael E Dusmet</contact><role/><email/></provider><provider><contact>Xu Shi-Wen</contact><role/><email/></provider><provider><contact>Andrew G Nicholson</contact><role/><email/></provider><provider><contact>David J Abraham</contact><role/><email/></provider><description><id/><text>Pulmonary fibrosis develops as a consequence of environmentally induced lung injury and/or an inherent disease susceptibility causing fibroblast activation, proliferation and extracellular matrix deposition. The study was undertaken to characterise global gene expression in pulmonary fibroblasts to better understand the mechanisms underlying the fibrotic fibroblast phenotype. Gene expression was evaluated in lung fibroblasts derived from ten controls (normal periphery of resected tumor), open lung biopsies from eight patients with interstitial lung disease associated with systemic sclerosis (fibrotic non specific interstitial pneumonia pattern on biopsy), and from three patients with usual interstitial pneumonia. Lung fibroblasts were grown to confluence in DMEM with 10% fetal calf serum. At confluence, lung fibroblasts were serum-deprived for 44 hours in the presence of fibroblast growth medium with the addition of 0.1% bovine serum albumin (Sigma).</text></description><protocol><id>818942</id><accession>P-GSE40839-1</accession></protocol><protocol><id>818946</id><accession>P-GSE40839-3</accession></protocol><protocol><id>818947</id><accession>P-GSE40839-2</accession></protocol><protocol><id>818945</id><accession>P-GSE40839-5</accession></protocol><protocol><id>818948</id><accession>P-GSE40839-4</accession></protocol><protocol><id>818944</id><accession>P-GSE40839-6</accession></protocol><protocol><id>818943</id><accession>P-GSE40839-7</accession></protocol><organism>Homo sapiens</organism><files><!--
This section is deprecated and unsupported.
Please use webservice located at:
    http://www.ebi.ac.uk/arrayexpress/xml/files
to obtain detailed information on files available for the experiment.
For more information, please go to:
    http://www.ebi.ac.uk/arrayexpress/help/programmatic_access.html
                --><raw name="E-GEOD-40839.raw.1.zip" count="true" celcount="0"/><fgem name="E-GEOD-40839.processed.1.zip" available="true"/><idf name="E-GEOD-40839.idf.txt"/><sdrf name="E-GEOD-40839.sdrf.txt"/></files></experiment><experiment><species>Homo sapiens</species><species>Mus musculus</species><rawdatafiles available="true"/><processeddatafiles available="true"/><sampleattribute><category>cell line</category><value>A549</value><value>M1</value></sampleattribute><sampleattribute><category>cell type</category><value>immortal kidney epithilium</value><value>lung epithilium</value></sampleattribute><sampleattribute><category>organism</category><value>Homo sapiens</value><value>Mus musculus</value></sampleattribute><experimentalfactor><name>CELL LINE</name><value>A549</value><value>M1</value></experimentalfactor><experimentalfactor><name>CELL TYPE</name><value>immortal kidney epithilium</value><value>lung epithilium</value></experimentalfactor><experimentalfactor><name>ORGANISM</name><value>Homo sapiens</value><value>Mus musculus</value></experimentalfactor><miamescores><reportersequencescore>0</reportersequencescore><protocolscore>1</protocolscore><factorvaluescore>1</factorvaluescore><derivedbioassaydatascore>1</derivedbioassaydatascore><measuredbioassaydatascore>1</measuredbioassaydatascore><overallscore>4</overallscore></miamescores><id>317393</id><accession>E-GEOD-48200</accession><secondaryaccession>GSE48200</secondaryaccession><name>Influenza A/Hong Kong/156/1997(H5N1) virus NS1 gene mutations F103L and M106I both increase IFN antagonism, virulence and cytoplasmic localization but differ in binding to RIG-I and CPSF30</name><experimenttype>transcription profiling by array</experimenttype><releasedate>2013-06-22</releasedate><lastupdatedate>2013-07-01</lastupdatedate><samples>36</samples><assays>36</assays><arraydesign><id>29206</id><accession>A-AFFY-130</accession><name>Affymetrix GeneChip Mouse Gene 1.0 ST Array [MoGene-1_0-st-v1]</name><count>18</count><legacy_id>1661650425</legacy_id></arraydesign><arraydesign><id>9595</id><accession>A-AFFY-141</accession><name>Affymetrix GeneChip Human Gene 1.0 ST Array [HuGene-1_0-st-v1]</name><count>18</count><legacy_id>1759805535</legacy_id></arraydesign><bioassaydatagroup><id/><name>rawData</name><bioassaydatacubes>36</bioassaydatacubes><arraydesignprovider/><dataformat>rawData</dataformat><bioassays>36</bioassays><isderived>0</isderived></bioassaydatagroup><bioassaydatagroup><id/><name>normalization</name><bioassaydatacubes>36</bioassaydatacubes><arraydesignprovider/><dataformat>normalization</dataformat><bioassays>36</bioassays><isderived>0</isderived></bioassaydatagroup><bioassaydatagroup><id/><name>processedData</name><bioassaydatacubes>36</bioassaydatacubes><arraydesignprovider/><dataformat>processedData</dataformat><bioassays>36</bioassays><isderived>0</isderived></bioassaydatagroup><provider><contact>Samar Dankar</contact><role/><email/></provider><provider><contact>Martin Pelchat</contact><role/><email/></provider><provider><contact>Earl G Brown</contact><role/><email/></provider><provider><contact>Earl Garnet Brown</contact><role>submitter</role><email>ebrown@uottawa.ca</email></provider><description><id/><text>Gene transcription effects of mutations in the infuenza virus A/Hong Kong/1/1968(H3N2) nonstructural 1 NS1 gene in infected human A549 (lung epithilium) cells Influenza A/Hong Kong/156/1997(H5N1) virus NS1 gene mutations F103L and M106I both increase IFN antagonism, virulence and cytoplasmic localization but differ in binding to RIG-I and CPSF30 (manuscript submitted to Virology Journal). Human cells were infected with influenza viruses mutants with specific gain of function mutations in the NS1 gene in order to assess the affects of each mutation on host gene expression. Human (A549) and mouse (M1) cells were infected at a multiplicity of infection of 2 (infectious viruses/cell) and incubated for 8 hr before collection of total RNA and microarray anlaysis using the Affymetrix platforms. Samples were compared in triplicate to mock PBS infected (uninfected) cells to detecte dysregulated genes for A/HK/1/1968(H3N2) wt, and the following NS1 gene mutants:  F103L, M106I, M106V, and F103L + M106I. Background: The genetic basis for avian to mammalian host switching in influenza A virus is largely unknown.  The human A/HK/156/1997(H5N1) virus that transmitted from poultry possesses NS1 gene mutations F103L + M106I that are virulence determinants in the mouse model of pneumonia; however their individual roles have not been determined.  The emergent A/Shanghai/1/2013(H7N9)-like viruses also possess these mutations which may contribute to their virulence and ability to switch species. Methods: NS1 mutant viruses were constructed by reverse genetics and site directed mutagenesis on human and mouse-adapted backbones.  Mouse infections assessed virulence, virus yield, tissue infection, and IFN induction. NS1 protein proprieties were assessed for subcellular distribution, IFN antagonism (mouse and human), CPSF30 and RIG-I domain binding, effect on host gene transcription (microarray); and the natural prevalence of 103L and 106I mutants was assessed. Results: Each of the F103L and M106I mutations contributes additively to virulence to reduce the lethal dose by &gt;800 and &gt;3,200 fold respectively by mediating alveolar tissue infection with &gt;100 fold increased infectious yields. The 106I NS1 mutant lost CPSF binding but the 103L mutant maintained binding that correlated with an increased general decrease in host gene expression in human but not mouse cells.  Each mutation positively modulated the inhibition of IFN induction in mouse cells and activation of the IFN-β promoter in human cells but not in combination in human cells indicating negative epistasis.  Each of the F103L and M106I mutations restored a defect in cytoplasmic localization of H5N1 NS1 in mouse cells.  Human H1N1 and H3N2 NS1 proteins bound to the CARD, helicase and RD RIG-I domains, whereas the H5N1 NS1 with the same consensus 103F and 106M mutations did not bind these domains, which was partially or totally restored by the F103L or M106I mutations respectively. Conclusions: The F103L and M106I mutations in the H5N1 NS1 protein each increased IFN antagonism and mediated interstitial pneumonia in mice that was associated with increased cytoplasmic localization and altered host factor binding. These mutations may contribute to the ability of previous HPAI H5N1 and recent LPAI H7N9 viruses to switch hosts and cause severe disease in mammals. Triplicate biological replicates of mock PBS treated (uninfected) cells to detecte dysregulated genes for A/HK/1/1968(H3N2) wt, and the following NS1 gene mutants:  F103L, M106I, M106V, and F103L + M106I. Cells were infected at a multiplicty of infection of 2 and cells were incubated for 8 hr at 37 C for 8 hrs before RNA extraction and analysis of 3 biological replicates relative to mock PBS infected cells.</text></description><protocol><id>791777</id><accession>P-GSE48200-6</accession></protocol><protocol><id>791776</id><accession>P-GSE48200-7</accession></protocol><protocol><id>791782</id><accession>P-GSE48200-8</accession></protocol><protocol><id>791781</id><accession>P-GSE48200-10</accession></protocol><protocol><id>791783</id><accession>P-GSE48200-9</accession></protocol><protocol><id>791780</id><accession>P-GSE48200-11</accession></protocol><protocol><id>791785</id><accession>P-GSE48200-2</accession></protocol><protocol><id>791784</id><accession>P-GSE48200-3</accession></protocol><protocol><id>791779</id><accession>P-GSE48200-4</accession></protocol><protocol><id>791778</id><accession>P-GSE48200-5</accession></protocol><protocol><id>791775</id><accession>P-GSE48200-1</accession></protocol><organism>Homo sapiens</organism><organism>Mus musculus</organism><files><!--
This section is deprecated and unsupported.
Please use webservice located at:
    http://www.ebi.ac.uk/arrayexpress/xml/files
to obtain detailed information on files available for the experiment.
For more information, please go to:
    http://www.ebi.ac.uk/arrayexpress/help/programmatic_access.html
                --><raw name="E-GEOD-48200.raw.1.zip" count="true" celcount="0"/><fgem name="E-GEOD-48200.processed.1.zip" available="true"/><idf name="E-GEOD-48200.idf.txt"/><sdrf name="E-GEOD-48200.sdrf.txt"/></files></experiment><experiment><species>Homo sapiens</species><rawdatafiles available="true"/><processeddatafiles available="true"/><sampleattribute><category>%emphysema f-950</category><value>  </value><value>0.001</value><value>0.004</value><value>0.006</value><value>0.007</value><value>0.008</value><value>0.009</value><value>0.01</value><value>0.012</value><value>0.013</value><value>0.014</value><value>0.015</value><value>0.016</value><value>0.02</value><value>0.026</value><value>0.03</value><value>0.031</value><value>0.032</value><value>0.033</value><value>0.038</value><value>0.041</value><value>0.042</value><value>0.046</value><value>0.051</value><value>0.052</value><value>0.055</value><value>0.059</value><value>0.061</value><value>0.063</value><value>0.065</value><value>0.068</value><value>0.07</value><value>0.075</value><value>0.08</value><value>0.083</value><value>0.089</value><value>0.09</value><value>0.097</value><value>0.098</value><value>0.1</value><value>0.101</value><value>0.102</value><value>0.111</value><value>0.121</value><value>0.123</value><value>0.126</value><value>0.131</value><value>0.136</value><value>0.141</value><value>0.142</value><value>0.146</value><value>0.15</value><value>0.151</value><value>0.168</value><value>0.169</value><value>0.172</value><value>0.173</value><value>0.174</value><value>0.175</value><value>0.182</value><value>0.184</value><value>0.193</value><value>0.195</value><value>0.196</value><value>0.2</value><value>0.203</value><value>0.204</value><value>0.211</value><value>0.216</value><value>0.228</value><value>0.241</value><value>0.255</value><value>0.256</value><value>0.26</value><value>0.267</value><value>0.275</value><value>0.282</value><value>0.284</value><value>0.286</value><value>0.289</value><value>0.3</value><value>0.307</value><value>0.308</value><value>0.313</value><value>0.32</value><value>0.323</value><value>0.33</value><value>0.331</value><value>0.333</value><value>0.347</value><value>0.35</value><value>0.353</value><value>0.356</value><value>0.358</value><value>0.362</value><value>0.4</value><value>0.405</value><value>0.416</value><value>0.419</value><value>0.43</value><value>0.439</value><value>0.443</value><value>0.457</value><value>0.469</value><value>0.478</value><value>0.491</value><value>0.497</value><value>0.5</value><value>0.513</value><value>0.543</value><value>0.56</value><value>0.605</value><value>0.633</value><value>0.634</value><value>0.641</value><value>0.649</value><value>0.69</value><value>0.7</value><value>0.746</value><value>0.777</value><value>0.782</value><value>0.793</value><value>0.8</value><value>0.821</value><value>0.864</value><value>0.879</value><value>0.891</value><value>0.9</value><value>0.974</value><value>1</value><value>1.1</value><value>1.139</value><value>1.173</value><value>1.187</value><value>1.216</value><value>1.247</value><value>1.282</value><value>1.3</value><value>1.4</value><value>1.431</value><value>1.465</value><value>1.5</value><value>1.506</value><value>1.512</value><value>1.523</value><value>1.7</value><value>1.704</value><value>1.8</value><value>1.82</value><value>1.9</value><value>1.903</value><value>10.048</value><value>10.5</value><value>10.7</value><value>10.72</value><value>11.4</value><value>11.563</value><value>11.616</value><value>11.7</value><value>11.725</value><value>11.759</value><value>12.6</value><value>13.525</value><value>13.886</value><value>14</value><value>14.2</value><value>14.325</value><value>14.493</value><value>14.5</value><value>14.9</value><value>15.9</value><value>16.3</value><value>16.4</value><value>16.906</value><value>17</value><value>17.813</value><value>18</value><value>2</value><value>2.073</value><value>2.1</value><value>2.2</value><value>2.291</value><value>2.3</value><value>2.436</value><value>2.471</value><value>2.5</value><value>2.544</value><value>2.6</value><value>2.789</value><value>20.1</value><value>20.3</value><value>20.4</value><value>21.1</value><value>21.6</value><value>21.7</value><value>23.3</value><value>23.6</value><value>23.7</value><value>24.7</value><value>25.4</value><value>25.5</value><value>25.8</value><value>26.1</value><value>26.3</value><value>26.7</value><value>26.9</value><value>27.5</value><value>27.7</value><value>28.2</value><value>28.9</value><value>29.4</value><value>29.5</value><value>29.7</value><value>3.197</value><value>3.311</value><value>3.5</value><value>3.6</value><value>3.623</value><value>3.7</value><value>3.719</value><value>3.767</value><value>30.1</value><value>30.3</value><value>31.3</value><value>31.664</value><value>31.7</value><value>31.9</value><value>33</value><value>33.5</value><value>35.1</value><value>35.6</value><value>36.6</value><value>37.8</value><value>37.954</value><value>38</value><value>38.5</value><value>39.5</value><value>4.03</value><value>4.1</value><value>4.104</value><value>4.2</value><value>4.232</value><value>4.3</value><value>4.4</value><value>4.6</value><value>4.7</value><value>4.959</value><value>40.046</value><value>41.5</value><value>41.7</value><value>41.796</value><value>41.9</value><value>42.5</value><value>43.3</value><value>43.7</value><value>43.768</value><value>44.4</value><value>44.8</value><value>45</value><value>45.3</value><value>46</value><value>46.3</value><value>46.559</value><value>48.5</value><value>48.8</value><value>48.9</value><value>5.6</value><value>5.7</value><value>5.934</value><value>50.1</value><value>51.431</value><value>53.4</value><value>56.335</value><value>58.6</value><value>59.7</value><value>59.8</value><value>6</value><value>6.021</value><value>6.168</value><value>6.2</value><value>6.3</value><value>6.392</value><value>6.406</value><value>6.5</value><value>6.664</value><value>6.86</value><value>61.7</value><value>62</value><value>7</value><value>7.241</value><value>7.246</value><value>7.3</value><value>7.511</value><value>7.7</value><value>7.8</value><value>71.6 (PTX)</value><value>8.16</value><value>8.162</value><value>8.555</value><value>8.7</value><value>8.8</value><value>8.889</value><value>9.018</value><value>9.3</value><value>9.647</value><value>9.945</value></sampleattribute><sampleattribute><category>%predicted dlco</category><value>  </value><value>100</value><value>101</value><value>102</value><value>103</value><value>104</value><value>105</value><value>107</value><value>108</value><value>11</value><value>112</value><value>113</value><value>115</value><value>117</value><value>122</value><value>128</value><value>13</value><value>14</value><value>144</value><value>15</value><value>16</value><value>17</value><value>18</value><value>20</value><value>21</value><value>22</value><value>23</value><value>24</value><value>25</value><value>26</value><value>27</value><value>28</value><value>29</value><value>30</value><value>31</value><value>32</value><value>33</value><value>34</value><value>35</value><value>36</value><value>37</value><value>38</value><value>39</value><value>40</value><value>41</value><value>42</value><value>43</value><value>44</value><value>45</value><value>46</value><value>47</value><value>48</value><value>49</value><value>50</value><value>51</value><value>52</value><value>53</value><value>54</value><value>55</value><value>56</value><value>57</value><value>58</value><value>59</value><value>60</value><value>61</value><value>62</value><value>63</value><value>64</value><value>65</value><value>66</value><value>67</value><value>68</value><value>69</value><value>70</value><value>71</value><value>72</value><value>73</value><value>74</value><value>75</value><value>76</value><value>77</value><value>78</value><value>79</value><value>80</value><value>81</value><value>82</value><value>83</value><value>84</value><value>85</value><value>86</value><value>87</value><value>88</value><value>89</value><value>9</value><value>90</value><value>91</value><value>92</value><value>93</value><value>94</value><value>95</value><value>96</value><value>97</value><value>98</value><value>99</value></sampleattribute><sampleattribute><category>%predicted fev1 post-bd</category><value>  </value><value>101</value><value>102</value><value>103</value><value>104</value><value>105</value><value>106</value><value>107</value><value>108</value><value>109</value><value>110</value><value>111</value><value>112</value><value>113</value><value>114</value><value>115</value><value>116</value><value>117</value><value>121</value><value>123</value><value>135</value><value>14</value><value>140</value><value>143</value><value>15</value><value>16</value><value>17</value><value>18</value><value>19</value><value>20</value><value>21</value><value>22</value><value>23</value><value>24</value><value>25</value><value>26</value><value>27</value><value>28</value><value>29</value><value>30</value><value>31</value><value>32</value><value>34</value><value>35</value><value>37</value><value>40</value><value>41</value><value>42</value><value>43</value><value>44</value><value>45</value><value>46</value><value>47</value><value>48</value><value>49</value><value>50</value><value>51</value><value>52</value><value>53</value><value>54</value><value>55</value><value>56</value><value>57</value><value>58</value><value>59</value><value>60</value><value>61</value><value>62</value><value>63</value><value>64</value><value>65</value><value>66</value><value>67</value><value>68</value><value>69</value><value>70</value><value>71</value><value>72</value><value>73</value><value>74</value><value>75</value><value>76</value><value>77</value><value>78</value><value>79</value><value>80</value><value>81</value><value>82</value><value>83</value><value>84</value><value>85</value><value>86</value><value>87</value><value>88</value><value>89</value><value>90</value><value>91</value><value>92</value><value>93</value><value>94</value><value>95</value><value>96</value><value>97</value><value>98</value><value>99</value></sampleattribute><sampleattribute><category>%predicted fev1 pre-bd</category><value>  </value><value>100</value><value>101</value><value>102</value><value>103</value><value>104</value><value>105</value><value>106</value><value>107</value><value>108</value><value>109</value><value>11</value><value>110</value><value>113</value><value>114</value><value>115</value><value>117</value><value>118</value><value>129</value><value>13</value><value>132</value><value>136</value><value>137</value><value>14</value><value>15</value><value>16</value><value>17</value><value>18</value><value>19</value><value>20</value><value>21</value><value>22</value><value>23</value><value>24</value><value>25</value><value>26</value><value>27</value><value>28</value><value>29</value><value>30</value><value>31</value><value>32</value><value>33</value><value>34</value><value>35</value><value>36</value><value>37</value><value>38</value><value>39</value><value>40</value><value>41</value><value>42</value><value>43</value><value>44</value><value>45</value><value>46</value><value>47</value><value>48</value><value>49</value><value>50</value><value>51</value><value>52</value><value>53</value><value>54</value><value>55</value><value>56</value><value>57</value><value>58</value><value>59</value><value>60</value><value>61</value><value>62</value><value>63</value><value>64</value><value>65</value><value>66</value><value>67</value><value>68</value><value>69</value><value>70</value><value>71</value><value>72</value><value>73</value><value>74</value><value>75</value><value>76</value><value>77</value><value>78</value><value>79</value><value>80</value><value>81</value><value>82</value><value>83</value><value>84</value><value>85</value><value>86</value><value>87</value><value>88</value><value>89</value><value>90</value><value>91</value><value>92</value><value>93</value><value>94</value><value>95</value><value>96</value><value>97</value><value>98</value><value>99</value></sampleattribute><sampleattribute><category>%predicted fvc post-bd</category><value>  </value><value>100</value><value>101</value><value>102</value><value>103</value><value>104</value><value>105</value><value>106</value><value>107</value><value>108</value><value>109</value><value>110</value><value>112</value><value>113</value><value>114</value><value>115</value><value>116</value><value>117</value><value>118</value><value>119</value><value>120</value><value>126</value><value>128</value><value>139</value><value>150</value><value>26</value><value>31</value><value>36</value><value>37</value><value>39</value><value>42</value><value>44</value><value>45</value><value>46</value><value>47</value><value>48</value><value>49</value><value>50</value><value>51</value><value>52</value><value>53</value><value>54</value><value>55</value><value>56</value><value>57</value><value>58</value><value>59</value><value>60</value><value>61</value><value>62</value><value>63</value><value>64</value><value>65</value><value>66</value><value>67</value><value>68</value><value>69</value><value>70</value><value>71</value><value>72</value><value>73</value><value>74</value><value>75</value><value>76</value><value>77</value><value>78</value><value>79</value><value>80</value><value>81</value><value>82</value><value>83</value><value>84</value><value>85</value><value>86</value><value>87</value><value>88</value><value>89</value><value>90</value><value>91</value><value>92</value><value>93</value><value>94</value><value>95</value><value>96</value><value>97</value><value>98</value><value>99</value></sampleattribute><sampleattribute><category>%predicted fvc pre-bd</category><value>  </value><value>100</value><value>101</value><value>102</value><value>103</value><value>104</value><value>105</value><value>106</value><value>107</value><value>108</value><value>109</value><value>110</value><value>111</value><value>112</value><value>113</value><value>114</value><value>116</value><value>117</value><value>119</value><value>121</value><value>122</value><value>13</value><value>142</value><value>146</value><value>21</value><value>23</value><value>24</value><value>25</value><value>27</value><value>28</value><value>32</value><value>33</value><value>34</value><value>35</value><value>36</value><value>37</value><value>38</value><value>39</value><value>40</value><value>41</value><value>42</value><value>43</value><value>44</value><value>45</value><value>46</value><value>47</value><value>48</value><value>49</value><value>50</value><value>51</value><value>52</value><value>53</value><value>54</value><value>55</value><value>56</value><value>57</value><value>58</value><value>59</value><value>60</value><value>61</value><value>62</value><value>63</value><value>64</value><value>65</value><value>66</value><value>67</value><value>68</value><value>69</value><value>70</value><value>71</value><value>72</value><value>73</value><value>74</value><value>75</value><value>76</value><value>77</value><value>78</value><value>79</value><value>80</value><value>81</value><value>82</value><value>83</value><value>84</value><value>85</value><value>86</value><value>87</value><value>88</value><value>89</value><value>90</value><value>91</value><value>92</value><value>93</value><value>94</value><value>95</value><value>96</value><value>97</value><value>98</value><value>99</value></sampleattribute><sampleattribute><category>age</category><value>23</value><value>24</value><value>26</value><value>28</value><value>32</value><value>34</value><value>35</value><value>37</value><value>38</value><value>39</value><value>40</value><value>41</value><value>42</value><value>43</value><value>44</value><value>45</value><value>46</value><value>47</value><value>48</value><value>49</value><value>50</value><value>51</value><value>52</value><value>53</value><value>54</value><value>55</value><value>56</value><value>57</value><value>58</value><value>59</value><value>60</value><value>61</value><value>62</value><value>63</value><value>64</value><value>65</value><value>66</value><value>67</value><value>68</value><value>69</value><value>70</value><value>71</value><value>72</value><value>73</value><value>74</value><value>75</value><value>76</value><value>77</value><value>78</value><value>79</value><value>80</value><value>81</value><value>82</value><value>84</value><value>86</value><value>87</value><value>91</value></sampleattribute><sampleattribute><category>disease state</category><value>Chronic Obstructive Lung Disease</value><value>control</value><value>interstitial lung disease</value></sampleattribute><sampleattribute><category>gold stage</category><value>  </value><value>0-At Risk</value><value>1-Mild COPD</value><value>2-Moderate COPD</value><value>3-Severe COPD</value><value>4-Very Severe COPD</value></sampleattribute><sampleattribute><category>ild subtype</category><value>  </value><value>1-ILD of known cause, hypersensitivity or associated w/ CVD</value><value>10-Fibrosis-Uncharacterized</value><value>2-UIP/IPF</value><value>3-NSIP</value><value>4-Desquamative interstitial pneumonia (DIP)</value><value>5-Respiratory bronchiolitis-interstitial lung disease (RB-ILD)</value><value>7-Cryptogenic Organizing Pneumonia (COP)</value><value>8-Acute interstitial pneumonia (AIP)</value><value>9-Hypersensitive Pneumonitis (HP)</value></sampleattribute><sampleattribute><category>organism</category><value>Homo sapiens</value></sampleattribute><sampleattribute><category>pneumocystis colonization</category><value>  </value><value>Negative</value><value>Positive</value></sampleattribute><sampleattribute><category>Sex</category><value>1-Male</value><value>2-Female</value></sampleattribute><sampleattribute><category>smoker?</category><value>  </value><value>1-Current</value><value>2-Ever (&gt;100)</value><value>3-Never</value></sampleattribute><experimentalfactor><name>%EMPHYSEMA F-950</name><value>0.001</value><value>0.004</value><value>0.006</value><value>0.007</value><value>0.008</value><value>0.009</value><value>0.01</value><value>0.012</value><value>0.013</value><value>0.014</value><value>0.015</value><value>0.016</value><value>0.02</value><value>0.026</value><value>0.03</value><value>0.031</value><value>0.032</value><value>0.033</value><value>0.038</value><value>0.041</value><value>0.042</value><value>0.046</value><value>0.051</value><value>0.052</value><value>0.055</value><value>0.059</value><value>0.061</value><value>0.063</value><value>0.065</value><value>0.068</value><value>0.07</value><value>0.075</value><value>0.08</value><value>0.083</value><value>0.089</value><value>0.09</value><value>0.097</value><value>0.098</value><value>0.1</value><value>0.101</value><value>0.102</value><value>0.111</value><value>0.121</value><value>0.123</value><value>0.126</value><value>0.131</value><value>0.136</value><value>0.141</value><value>0.142</value><value>0.146</value><value>0.15</value><value>0.151</value><value>0.168</value><value>0.169</value><value>0.172</value><value>0.173</value><value>0.174</value><value>0.175</value><value>0.182</value><value>0.184</value><value>0.193</value><value>0.195</value><value>0.196</value><value>0.2</value><value>0.203</value><value>0.204</value><value>0.211</value><value>0.216</value><value>0.228</value><value>0.241</value><value>0.255</value><value>0.256</value><value>0.26</value><value>0.267</value><value>0.275</value><value>0.282</value><value>0.284</value><value>0.286</value><value>0.289</value><value>0.3</value><value>0.307</value><value>0.308</value><value>0.313</value><value>0.32</value><value>0.323</value><value>0.33</value><value>0.331</value><value>0.333</value><value>0.347</value><value>0.35</value><value>0.353</value><value>0.356</value><value>0.358</value><value>0.362</value><value>0.4</value><value>0.405</value><value>0.416</value><value>0.419</value><value>0.43</value><value>0.439</value><value>0.443</value><value>0.457</value><value>0.469</value><value>0.478</value><value>0.491</value><value>0.497</value><value>0.5</value><value>0.513</value><value>0.543</value><value>0.56</value><value>0.605</value><value>0.633</value><value>0.634</value><value>0.641</value><value>0.649</value><value>0.69</value><value>0.7</value><value>0.746</value><value>0.777</value><value>0.782</value><value>0.793</value><value>0.8</value><value>0.821</value><value>0.864</value><value>0.879</value><value>0.891</value><value>0.9</value><value>0.974</value><value>1</value><value>1.1</value><value>1.139</value><value>1.173</value><value>1.187</value><value>1.216</value><value>1.247</value><value>1.282</value><value>1.3</value><value>1.4</value><value>1.431</value><value>1.465</value><value>1.5</value><value>1.506</value><value>1.512</value><value>1.523</value><value>1.7</value><value>1.704</value><value>1.8</value><value>1.82</value><value>1.9</value><value>1.903</value><value>10.048</value><value>10.5</value><value>10.7</value><value>10.72</value><value>11.4</value><value>11.563</value><value>11.616</value><value>11.7</value><value>11.725</value><value>11.759</value><value>12.6</value><value>13.525</value><value>13.886</value><value>14</value><value>14.2</value><value>14.325</value><value>14.493</value><value>14.5</value><value>14.9</value><value>15.9</value><value>16.3</value><value>16.4</value><value>16.906</value><value>17</value><value>17.813</value><value>18</value><value>2</value><value>2.073</value><value>2.1</value><value>2.2</value><value>2.291</value><value>2.3</value><value>2.436</value><value>2.471</value><value>2.5</value><value>2.544</value><value>2.6</value><value>2.789</value><value>20.1</value><value>20.3</value><value>20.4</value><value>21.1</value><value>21.6</value><value>21.7</value><value>23.3</value><value>23.6</value><value>23.7</value><value>24.7</value><value>25.4</value><value>25.5</value><value>25.8</value><value>26.1</value><value>26.3</value><value>26.7</value><value>26.9</value><value>27.5</value><value>27.7</value><value>28.2</value><value>28.9</value><value>29.4</value><value>29.5</value><value>29.7</value><value>3.197</value><value>3.311</value><value>3.5</value><value>3.6</value><value>3.623</value><value>3.7</value><value>3.719</value><value>3.767</value><value>30.1</value><value>30.3</value><value>31.3</value><value>31.664</value><value>31.7</value><value>31.9</value><value>33</value><value>33.5</value><value>35.1</value><value>35.6</value><value>36.6</value><value>37.8</value><value>37.954</value><value>38</value><value>38.5</value><value>39.5</value><value>4.03</value><value>4.1</value><value>4.104</value><value>4.2</value><value>4.232</value><value>4.3</value><value>4.4</value><value>4.6</value><value>4.7</value><value>4.959</value><value>40.046</value><value>41.5</value><value>41.7</value><value>41.796</value><value>41.9</value><value>42.5</value><value>43.3</value><value>43.7</value><value>43.768</value><value>44.4</value><value>44.8</value><value>45</value><value>45.3</value><value>46</value><value>46.3</value><value>46.559</value><value>48.5</value><value>48.8</value><value>48.9</value><value>5.6</value><value>5.7</value><value>5.934</value><value>50.1</value><value>51.431</value><value>53.4</value><value>56.335</value><value>58.6</value><value>59.7</value><value>59.8</value><value>6</value><value>6.021</value><value>6.168</value><value>6.2</value><value>6.3</value><value>6.392</value><value>6.406</value><value>6.5</value><value>6.664</value><value>6.86</value><value>61.7</value><value>62</value><value>7</value><value>7.241</value><value>7.246</value><value>7.3</value><value>7.511</value><value>7.7</value><value>7.8</value><value>71.6 (PTX)</value><value>8.16</value><value>8.162</value><value>8.555</value><value>8.7</value><value>8.8</value><value>8.889</value><value>9.018</value><value>9.3</value><value>9.647</value><value>9.945</value><value>not specified</value></experimentalfactor><experimentalfactor><name>%PREDICTED DLCO</name><value>100</value><value>101</value><value>102</value><value>103</value><value>104</value><value>105</value><value>107</value><value>108</value><value>11</value><value>112</value><value>113</value><value>115</value><value>117</value><value>122</value><value>128</value><value>13</value><value>14</value><value>144</value><value>15</value><value>16</value><value>17</value><value>18</value><value>20</value><value>21</value><value>22</value><value>23</value><value>24</value><value>25</value><value>26</value><value>27</value><value>28</value><value>29</value><value>30</value><value>31</value><value>32</value><value>33</value><value>34</value><value>35</value><value>36</value><value>37</value><value>38</value><value>39</value><value>40</value><value>41</value><value>42</value><value>43</value><value>44</value><value>45</value><value>46</value><value>47</value><value>48</value><value>49</value><value>50</value><value>51</value><value>52</value><value>53</value><value>54</value><value>55</value><value>56</value><value>57</value><value>58</value><value>59</value><value>60</value><value>61</value><value>62</value><value>63</value><value>64</value><value>65</value><value>66</value><value>67</value><value>68</value><value>69</value><value>70</value><value>71</value><value>72</value><value>73</value><value>74</value><value>75</value><value>76</value><value>77</value><value>78</value><value>79</value><value>80</value><value>81</value><value>82</value><value>83</value><value>84</value><value>85</value><value>86</value><value>87</value><value>88</value><value>89</value><value>9</value><value>90</value><value>91</value><value>92</value><value>93</value><value>94</value><value>95</value><value>96</value><value>97</value><value>98</value><value>99</value><value>not specified</value></experimentalfactor><experimentalfactor><name>%PREDICTED FEV1 POST-BD</name><value>101</value><value>102</value><value>103</value><value>104</value><value>105</value><value>106</value><value>107</value><value>108</value><value>109</value><value>110</value><value>111</value><value>112</value><value>113</value><value>114</value><value>115</value><value>116</value><value>117</value><value>121</value><value>123</value><value>135</value><value>14</value><value>140</value><value>143</value><value>15</value><value>16</value><value>17</value><value>18</value><value>19</value><value>20</value><value>21</value><value>22</value><value>23</value><value>24</value><value>25</value><value>26</value><value>27</value><value>28</value><value>29</value><value>30</value><value>31</value><value>32</value><value>34</value><value>35</value><value>37</value><value>40</value><value>41</value><value>42</value><value>43</value><value>44</value><value>45</value><value>46</value><value>47</value><value>48</value><value>49</value><value>50</value><value>51</value><value>52</value><value>53</value><value>54</value><value>55</value><value>56</value><value>57</value><value>58</value><value>59</value><value>60</value><value>61</value><value>62</value><value>63</value><value>64</value><value>65</value><value>66</value><value>67</value><value>68</value><value>69</value><value>70</value><value>71</value><value>72</value><value>73</value><value>74</value><value>75</value><value>76</value><value>77</value><value>78</value><value>79</value><value>80</value><value>81</value><value>82</value><value>83</value><value>84</value><value>85</value><value>86</value><value>87</value><value>88</value><value>89</value><value>90</value><value>91</value><value>92</value><value>93</value><value>94</value><value>95</value><value>96</value><value>97</value><value>98</value><value>99</value><value>not specified</value></experimentalfactor><experimentalfactor><name>%PREDICTED FEV1 PRE-BD</name><value>100</value><value>101</value><value>102</value><value>103</value><value>104</value><value>105</value><value>106</value><value>107</value><value>108</value><value>109</value><value>11</value><value>110</value><value>113</value><value>114</value><value>115</value><value>117</value><value>118</value><value>129</value><value>13</value><value>132</value><value>136</value><value>137</value><value>14</value><value>15</value><value>16</value><value>17</value><value>18</value><value>19</value><value>20</value><value>21</value><value>22</value><value>23</value><value>24</value><value>25</value><value>26</value><value>27</value><value>28</value><value>29</value><value>30</value><value>31</value><value>32</value><value>33</value><value>34</value><value>35</value><value>36</value><value>37</value><value>38</value><value>39</value><value>40</value><value>41</value><value>42</value><value>43</value><value>44</value><value>45</value><value>46</value><value>47</value><value>48</value><value>49</value><value>50</value><value>51</value><value>52</value><value>53</value><value>54</value><value>55</value><value>56</value><value>57</value><value>58</value><value>59</value><value>60</value><value>61</value><value>62</value><value>63</value><value>64</value><value>65</value><value>66</value><value>67</value><value>68</value><value>69</value><value>70</value><value>71</value><value>72</value><value>73</value><value>74</value><value>75</value><value>76</value><value>77</value><value>78</value><value>79</value><value>80</value><value>81</value><value>82</value><value>83</value><value>84</value><value>85</value><value>86</value><value>87</value><value>88</value><value>89</value><value>90</value><value>91</value><value>92</value><value>93</value><value>94</value><value>95</value><value>96</value><value>97</value><value>98</value><value>99</value><value>not specified</value></experimentalfactor><experimentalfactor><name>%PREDICTED FVC POST-BD</name><value>100</value><value>101</value><value>102</value><value>103</value><value>104</value><value>105</value><value>106</value><value>107</value><value>108</value><value>109</value><value>110</value><value>112</value><value>113</value><value>114</value><value>115</value><value>116</value><value>117</value><value>118</value><value>119</value><value>120</value><value>126</value><value>128</value><value>139</value><value>150</value><value>26</value><value>31</value><value>36</value><value>37</value><value>39</value><value>42</value><value>44</value><value>45</value><value>46</value><value>47</value><value>48</value><value>49</value><value>50</value><value>51</value><value>52</value><value>53</value><value>54</value><value>55</value><value>56</value><value>57</value><value>58</value><value>59</value><value>60</value><value>61</value><value>62</value><value>63</value><value>64</value><value>65</value><value>66</value><value>67</value><value>68</value><value>69</value><value>70</value><value>71</value><value>72</value><value>73</value><value>74</value><value>75</value><value>76</value><value>77</value><value>78</value><value>79</value><value>80</value><value>81</value><value>82</value><value>83</value><value>84</value><value>85</value><value>86</value><value>87</value><value>88</value><value>89</value><value>90</value><value>91</value><value>92</value><value>93</value><value>94</value><value>95</value><value>96</value><value>97</value><value>98</value><value>99</value><value>not specified</value></experimentalfactor><experimentalfactor><name>%PREDICTED FVC PRE-BD</name><value>100</value><value>101</value><value>102</value><value>103</value><value>104</value><value>105</value><value>106</value><value>107</value><value>108</value><value>109</value><value>110</value><value>111</value><value>112</value><value>113</value><value>114</value><value>116</value><value>117</value><value>119</value><value>121</value><value>122</value><value>13</value><value>142</value><value>146</value><value>21</value><value>23</value><value>24</value><value>25</value><value>27</value><value>28</value><value>32</value><value>33</value><value>34</value><value>35</value><value>36</value><value>37</value><value>38</value><value>39</value><value>40</value><value>41</value><value>42</value><value>43</value><value>44</value><value>45</value><value>46</value><value>47</value><value>48</value><value>49</value><value>50</value><value>51</value><value>52</value><value>53</value><value>54</value><value>55</value><value>56</value><value>57</value><value>58</value><value>59</value><value>60</value><value>61</value><value>62</value><value>63</value><value>64</value><value>65</value><value>66</value><value>67</value><value>68</value><value>69</value><value>70</value><value>71</value><value>72</value><value>73</value><value>74</value><value>75</value><value>76</value><value>77</value><value>78</value><value>79</value><value>80</value><value>81</value><value>82</value><value>83</value><value>84</value><value>85</value><value>86</value><value>87</value><value>88</value><value>89</value><value>90</value><value>91</value><value>92</value><value>93</value><value>94</value><value>95</value><value>96</value><value>97</value><value>98</value><value>99</value><value>not specified</value></experimentalfactor><experimentalfactor><name>AGE</name><value>23</value><value>24</value><value>26</value><value>28</value><value>32</value><value>34</value><value>35</value><value>37</value><value>38</value><value>39</value><value>40</value><value>41</value><value>42</value><value>43</value><value>44</value><value>45</value><value>46</value><value>47</value><value>48</value><value>49</value><value>50</value><value>51</value><value>52</value><value>53</value><value>54</value><value>55</value><value>56</value><value>57</value><value>58</value><value>59</value><value>60</value><value>61</value><value>62</value><value>63</value><value>64</value><value>65</value><value>66</value><value>67</value><value>68</value><value>69</value><value>70</value><value>71</value><value>72</value><value>73</value><value>74</value><value>75</value><value>76</value><value>77</value><value>78</value><value>79</value><value>80</value><value>81</value><value>82</value><value>84</value><value>86</value><value>87</value><value>91</value></experimentalfactor><experimentalfactor><name>DISEASE STATE</name><value>Chronic Obstructive Lung Disease</value><value>control</value><value>interstitial lung disease</value></experimentalfactor><experimentalfactor><name>GOLD STAGE</name><value>0-At Risk</value><value>1-Mild COPD</value><value>2-Moderate COPD</value><value>3-Severe COPD</value><value>4-Very Severe COPD</value><value>not specified</value></experimentalfactor><experimentalfactor><name>ILD SUBTYPE</name><value>1-ILD of known cause, hypersensitivity or associated w/ CVD</value><value>10-Fibrosis-Uncharacterized</value><value>2-UIP/IPF</value><value>3-NSIP</value><value>4-Desquamative interstitial pneumonia (DIP)</value><value>5-Respiratory bronchiolitis-interstitial lung disease (RB-ILD)</value><value>7-Cryptogenic Organizing Pneumonia (COP)</value><value>8-Acute interstitial pneumonia (AIP)</value><value>9-Hypersensitive Pneumonitis (HP)</value><value>not specified</value></experimentalfactor><experimentalfactor><name>PNEUMOCYSTIS COLONIZATION</name><value>Negative</value><value>not specified</value><value>Positive</value></experimentalfactor><experimentalfactor><name>SEX</name><value>1-Male</value><value>2-Female</value></experimentalfactor><experimentalfactor><name>SMOKER?</name><value>1-Current</value><value>2-Ever (&gt;100)</value><value>3-Never</value><value>not specified</value></experimentalfactor><miamescores><reportersequencescore>1</reportersequencescore><protocolscore>1</protocolscore><factorvaluescore>1</factorvaluescore><derivedbioassaydatascore>1</derivedbioassaydatascore><measuredbioassaydatascore>1</measuredbioassaydatascore><overallscore>5</overallscore></miamescores><id>311285</id><accession>E-GEOD-47460</accession><secondaryaccession>GSE47460</secondaryaccession><name>Gene expression profiling of chronic lung disease for the Lung Genomics Research Consortium</name><experimenttype>transcription profiling by array</experimenttype><releasedate>2013-05-30</releasedate><lastupdatedate>2014-06-03</lastupdatedate><samples>582</samples><assays>582</assays><arraydesign><id>11853</id><accession>A-AGIL-28</accession><name>Agilent Whole Human Genome Microarray 4x44K 014850 G4112F (85 cols x 532 rows)</name><count>153</count><legacy_id>1316855037</legacy_id></arraydesign><arraydesign><id>18943</id><accession>A-GEOD-14550</accession><name>Agilent-028004 SurePrint G3 Human GE 8x60K Microarray (Probe Name Version)</name><count>429</count></arraydesign><bioassaydatagroup><id/><name>rawData</name><bioassaydatacubes>582</bioassaydatacubes><arraydesignprovider/><dataformat>rawData</dataformat><bioassays>582</bioassays><isderived>0</isderived></bioassaydatagroup><bioassaydatagroup><id/><name>normalization</name><bioassaydatacubes>582</bioassaydatacubes><arraydesignprovider/><dataformat>normalization</dataformat><bioassays>582</bioassays><isderived>0</isderived></bioassaydatagroup><bioassaydatagroup><id/><name>processedData</name><bioassaydatacubes>582</bioassaydatacubes><arraydesignprovider/><dataformat>processedData</dataformat><bioassays>582</bioassays><isderived>0</isderived></bioassaydatagroup><provider><contact>John Tedrow</contact><role>submitter</role><email>jrtedrow@gmail.com</email></provider><provider><contact>Naftali Kaminski</contact><role/><email/></provider><provider><contact>David A Schwartz</contact><role/><email/></provider><provider><contact>Brenda J Guardela</contact><role/><email/></provider><provider><contact>John Tedrow</contact><role/><email/></provider><description><id/><text>Microarray data from total RNA extracted from whole lung homogenate from subjects undergoing thoracic surgery. These subjects were diagnosed as being controls or having interstitial lung disease or COPD as determined by clinical history, CT scan, and surgical pathology. There was no intervention, these are cross-sectional data.  All samples are from the Lung Tissue Research Consorium (LTRC and are indexed by their LTRC tissue label). These are 582 total subjects, 254 have interstitial lung disease, 220 have COPD, and 108 are controls, who went for surgery for the investigation of a nodule and have no chronic lung disease by CT or pathology.  Due to the number of samples, multipe batches of arrays were necessary, so 10% of the arrays were picked at random to have replicates throughout each batch to account for possible batch effects.  The feature extracted data was normalized using a pairwise cyclic loess approach, and the probes were collapsed to one probe per gene by selecting the probe with the highest average signal. Each sample is total RNA extracted from flash frozen human whole lung homogenate. Between the two platforms were analyzed. Samples are titled by source (LT=LTRC), 6-digit tissue label, lobe of extraction, and major disease state)</text></description><protocol><id>782886</id><accession>P-GSE47460-5</accession></protocol><protocol><id>782885</id><accession>P-GSE47460-1</accession></protocol><protocol><id>782889</id><accession>P-GSE47460-2</accession></protocol><protocol><id>782888</id><accession>P-GSE47460-3</accession></protocol><protocol><id>782887</id><accession>P-GSE47460-4</accession></protocol><organism>Homo sapiens</organism><files><!--
This section is deprecated and unsupported.
Please use webservice located at:
    http://www.ebi.ac.uk/arrayexpress/xml/files
to obtain detailed information on files available for the experiment.
For more information, please go to:
    http://www.ebi.ac.uk/arrayexpress/help/programmatic_access.html
                --><raw name="E-GEOD-47460.raw.10.zip E-GEOD-47460.raw.1.zip E-GEOD-47460.raw.2.zip E-GEOD-47460.raw.3.zip E-GEOD-47460.raw.4.zip E-GEOD-47460.raw.5.zip E-GEOD-47460.raw.6.zip E-GEOD-47460.raw.7.zip E-GEOD-47460.raw.8.zip E-GEOD-47460.raw.9.zip" count="true" celcount="0"/><fgem name="E-GEOD-47460.processed.1.zip" available="true"/><idf name="E-GEOD-47460.idf.txt"/><sdrf name="E-GEOD-47460.sdrf.txt"/></files></experiment><experiment><species>Homo sapiens</species><rawdatafiles available="true"/><processeddatafiles available="true"/><sampleattribute><category>age years</category><value>1.1</value><value>1.3</value><value>1.8</value><value>10.5</value><value>11.0</value><value>11.5</value><value>12.5</value><value>12.7</value><value>13.9</value><value>14.5</value><value>14.6</value><value>2.2</value><value>2.3</value><value>3.0</value><value>3.5</value><value>4.1</value><value>7.0</value><value>7.3</value><value>7.5</value><value>7.8</value><value>8.0</value><value>8.1</value><value>8.9</value><value>9.0</value><value>9.6</value></sampleattribute><sampleattribute><category>culture results</category><value>Negative</value><value>not performed</value><value>Positive</value></sampleattribute><sampleattribute><category>cxr findings</category><value>Adult-type disease with bilateral bronchopneumonic consolidation, lymph node disease</value><value>Adult-type disease with bilateral cavitation and unilateral bronchopneumonic consolidation</value><value>Adult-type disease with unilateral bronchopneumonic consolidation, lymph node disease with unilateral hyperinflation</value><value>Adult-type disease with unilateral cavitation and bilateral bronchopneumonic consolidation, lymph node disease with bronchial compression</value><value>Adult-type disease with unilateral cavitation, lymph node disease with lobar alveolar consolidation and unilateral hyperinflation</value><value>Ghon focus with bilateral bronchopneumonic consolidation, lymph node disease with bronchial compression and unilateral hyperinflation</value><value>Ghon focus with bilateral bronchopneumonic consolidation, lymph node disease with tracheal compression, pleural effusion</value><value>Ghon focus with cavitation and bilateral bronchopneumonic consolidation, lymph node disease with tracheal compression</value><value>Ghon focus with unilateral bronchopneumonic consolidation</value><value>No abnormalities observed</value></sampleattribute><sampleattribute><category>Organism</category><value>Homo sapiens</value></sampleattribute><sampleattribute><category>qft-git</category><value>Indeterminate</value><value>Negative</value><value>Positive</value></sampleattribute><sampleattribute><category>Sex</category><value>female</value><value>male</value></sampleattribute><sampleattribute><category>tuberculin skin test</category><value>10</value><value>11</value><value>13</value><value>14</value><value>15</value><value>18</value><value>20</value><value>3</value><value>6</value></sampleattribute><experimentalfactor><name>AGE YEARS</name><value>1.1</value><value>1.3</value><value>1.8</value><value>10.5</value><value>11.0</value><value>11.5</value><value>12.5</value><value>12.7</value><value>13.9</value><value>14.5</value><value>14.6</value><value>2.2</value><value>2.3</value><value>3.0</value><value>3.5</value><value>4.1</value><value>7.0</value><value>7.3</value><value>7.5</value><value>7.8</value><value>8.0</value><value>8.1</value><value>8.9</value><value>9.0</value><value>9.6</value></experimentalfactor><experimentalfactor><name>CULTURE RESULTS</name><value>Negative</value><value>not performed</value><value>Positive</value></experimentalfactor><experimentalfactor><name>CXR FINDINGS</name><value>Adult-type disease with bilateral bronchopneumonic consolidation, lymph node disease</value><value>Adult-type disease with bilateral cavitation and unilateral bronchopneumonic consolidation</value><value>Adult-type disease with unilateral bronchopneumonic consolidation, lymph node disease with unilateral hyperinflation</value><value>Adult-type disease with unilateral cavitation and bilateral bronchopneumonic consolidation, lymph node disease with bronchial compression</value><value>Adult-type disease with unilateral cavitation, lymph node disease with lobar alveolar consolidation and unilateral hyperinflation</value><value>Ghon focus with bilateral bronchopneumonic consolidation, lymph node disease with bronchial compression and unilateral hyperinflation</value><value>Ghon focus with bilateral bronchopneumonic consolidation, lymph node disease with tracheal compression, pleural effusion</value><value>Ghon focus with cavitation and bilateral bronchopneumonic consolidation, lymph node disease with tracheal compression</value><value>Ghon focus with unilateral bronchopneumonic consolidation</value><value>No abnormalities observed</value></experimentalfactor><experimentalfactor><name>QFT-GIT</name><value>Indeterminate</value><value>Negative</value><value>Positive</value></experimentalfactor><experimentalfactor><name>SEX</name><value>female</value><value>male</value></experimentalfactor><experimentalfactor><name>TUBERCULIN SKIN TEST</name><value>10</value><value>11</value><value>13</value><value>14</value><value>15</value><value>18</value><value>20</value><value>3</value><value>6</value><value>not specified</value></experimentalfactor><miamescores><reportersequencescore>0</reportersequencescore><protocolscore>0</protocolscore><factorvaluescore>1</factorvaluescore><derivedbioassaydatascore>1</derivedbioassaydatascore><measuredbioassaydatascore>1</measuredbioassaydatascore><overallscore>3</overallscore></miamescores><id>275254</id><accession>E-GEOD-41055</accession><secondaryaccession>GSE41055</secondaryaccession><name>A predictive signature gene set for discriminating active from latent TB in Warao Amerindian children</name><experimenttype>transcription profiling by array</experimenttype><releasedate>2013-02-05</releasedate><lastupdatedate>2013-02-11</lastupdatedate><samples>27</samples><assays>27</assays><arraydesign><id>30357</id><accession>A-AFFY-143</accession><name>Affymetrix GeneChip Human Exon 1.0 ST Array version 1, [HuEx-1_0-st-v1]</name><count>27</count><legacy_id>1762083787</legacy_id></arraydesign><bioassaydatagroup><id/><name>rawData</name><bioassaydatacubes>27</bioassaydatacubes><arraydesignprovider/><dataformat>rawData</dataformat><bioassays>27</bioassays><isderived>0</isderived></bioassaydatagroup><bioassaydatagroup><id/><name>normalization</name><bioassaydatacubes>27</bioassaydatacubes><arraydesignprovider/><dataformat>normalization</dataformat><bioassays>27</bioassays><isderived>0</isderived></bioassaydatagroup><bioassaydatagroup><id/><name>processedData</name><bioassaydatacubes>27</bioassaydatacubes><arraydesignprovider/><dataformat>processedData</dataformat><bioassays>27</bioassays><isderived>0</isderived></bioassaydatagroup><provider><contact>Aldert Zomer</contact><role>submitter</role><email>a.zomer@cukz.umcn.nl</email></provider><provider><contact>Aldert Zomer</contact><role/><email/></provider><provider><contact>Lilly Verhagen</contact><role/><email/></provider><description><id/><text>While blood transcriptional profiling has improved diagnosis and understanding of disease pathogenesis of adult tuberculosis (TB), no studies applying gene expression profiling of children with TB have been described so far. In this study, we have compared whole blood gene expression in childhood TB patients, as well as in healthy latently infected (LTBI) and uninfected (HC) children in a cohort of Warao Amerindians in the Delta Amacuro in Venezuela. We identified a 116-gene signature set by means of random forest analysis that showed an average prediction error of 11% for TB vs. LTBI and for TB vs. LTBI vs. HC in our dataset. Furthermore, a minimal set of only 9 genes showed a significant predictive value for all previously published adult studies using whole blood gene expression, with average prediction errors between 17% and 23%. Additionally, a minimal gene set of 42 genes with a comparable predictive value to the 116-gene set in both our dataset and the previously published literature cohorts for the comparsion of TB vs. LTBI vs. HC was identified. In order to identify a robust representative gene set that would hold stand among different ethnic populations, we selected ten genes that were highly discriminative between TB, LTBI and HC in all literature datasets as well as in our dataset. Functional annotation of these ten genes highlights a possible role for genes involved in calcium signaling and calcium metabolism as biomarkers for active TB. These ten genes were validated by quantitative real-time polymerase chain reaction in an additional cohort of 54 Warao Amerindian children with LTBI, HC and non-TB pneumonia. Decision tree analysis indicated that five of the ten genes were sufficient to diagnose 78% of the TB cases correctly with 100% specificity.   We conclude that our data justify the further exploration of our signature set as biomarkers to diagnose childhood TB. Furthermore, as the identification of different biomarkers in ethnically distinct cohorts is apparent, it is important to cross-validate newly identified markers in all available cohorts. In this study, 27 children 1 to 15 years of age with TB (n=9), LTBI (n=9) and HC (n=9) were recruited between May 2010 and December 2010. Tuberculin skin test (TST) and QuantiFERON-TB Gold In-Tube assay (QFT-GIT) were performed on all children. A sputum sample was collected from all children with expectoration and a gastric aspirate was taken from all children under 6 years of age. Children with active TB were diagnosed based on culture of M. tuberculosis (n=2) or on the basis of clinical, epidemiological and radiological features (n=7). The latter group were children with a TST = 10 mm or a positive QFT-GIT result who presented all of: persistent fever &gt;38°C objectively recorded daily for at least two weeks, persistent cough for more than three weeks, weight loss (&gt;5% reduction in weight compared with the highest weight recorded in last three months) or failure to thrive (documented crossing of percentile lines in the preceding three months), persistent lethargy or decrease in playfulness/activity reported by the parent and absence of clinical response on broad-spectrum antibiotics. Standard antero-posterior and lateral chest radiographs (CXRs) were taken from all children. Two independent experts, blinded to all clinical information, evaluated the CXRs and documented their findings on a standard report form. Where the two objective experts disagreed, a third expert was consulted and final consensus was achieved. A diagnosis of TB was only made when the CXR was consistent with TB9 and the child showed a positive clinical response to anti-TB treatment. Children were followed up clinically, radiologically and, in case of a negative TST at inclusion, by means of TST at six and 12 months after inclusion. LTBI was defined as a TST = 10mm and a positive QFT-GIT with a negative culture result on inclusion in the absence of radiological and clinical evidence of TB disease on inclusion as well as on t=6 and t=12 months. HC were children with a TST = 0 mm at inclusion and at t=6 and t=12 months. The HC had a negative QFT-GIT and a negative culture result at inclusion without radiological or clinical evidence of TB disease on inclusion nor on t=6 and t=12 months. TB patients were sampled before initiation of anti-TB treatment. Of three of the nine TB patients, a follow-up sample was taken when the patient was in anti-TB treatment for five months. All children were HIV-negative. 27 samples in total where analyzed,  active TB infection (TB, n=9), Latent TB infection (LTBI, n=9) and healthy controls (HC, n=9) . Gene expression values were log2-transformed and differentially expressed genes were identified based on log2 fold changes (M-values). P values were calculated with a Bayes-regularized one-way ANOVA. Random Forest recursive feature elimination was used to find a signature geneset capable of discrimination active TB from latent TB and from non-infected individuals.</text></description><protocol><id>707155</id><accession>P-GSE41055-2</accession></protocol><protocol><id>707150</id><accession>P-GSE41055-1</accession></protocol><protocol><id>707154</id><accession>P-GSE41055-4</accession></protocol><protocol><id>707156</id><accession>P-GSE41055-3</accession></protocol><protocol><id>707152</id><accession>P-GSE41055-7</accession></protocol><protocol><id>707153</id><accession>P-GSE41055-5</accession></protocol><protocol><id>707151</id><accession>P-GSE41055-6</accession></protocol><organism>Homo sapiens</organism><files><!--
This section is deprecated and unsupported.
Please use webservice located at:
    http://www.ebi.ac.uk/arrayexpress/xml/files
to obtain detailed information on files available for the experiment.
For more information, please go to:
    http://www.ebi.ac.uk/arrayexpress/help/programmatic_access.html
                --><raw name="E-GEOD-41055.raw.1.zip E-GEOD-41055.raw.2.zip E-GEOD-41055.raw.3.zip E-GEOD-41055.raw.4.zip" count="true" celcount="0"/><fgem name="E-GEOD-41055.processed.1.zip" available="true"/><idf name="E-GEOD-41055.idf.txt"/><sdrf name="E-GEOD-41055.sdrf.txt"/></files></experiment><experiment><species>Homo sapiens</species><rawdatafiles available="true"/><processeddatafiles available="true"/><sampleattribute><category>age</category><value>40-49y</value><value>50-59y</value><value>60-69y</value><value>70-79y</value><value>80-89y</value><value>not available</value></sampleattribute><sampleattribute><category>Organism</category><value>Homo sapiens</value></sampleattribute><sampleattribute><category>organism part</category><value>whole lung</value></sampleattribute><sampleattribute><category>sex</category><value>female</value><value>male</value><value>not available</value></sampleattribute><experimentalfactor><name>AGE</name><value>40-49y</value><value>50-59y</value><value>60-69y</value><value>70-79y</value><value>80-89y</value><value>not available</value></experimentalfactor><experimentalfactor><name>SEX</name><value>female</value><value>male</value><value>not available</value></experimentalfactor><miamescores><reportersequencescore>1</reportersequencescore><protocolscore>0</protocolscore><factorvaluescore>1</factorvaluescore><derivedbioassaydatascore>1</derivedbioassaydatascore><measuredbioassaydatascore>1</measuredbioassaydatascore><overallscore>4</overallscore></miamescores><id>266070</id><accession>E-GEOD-27430</accession><secondaryaccession>GSE27430</secondaryaccession><name>MicroRNA expression data in Idiopathic Pulmonary Fibrosis</name><experimenttype>transcription profiling by array</experimenttype><releasedate>2013-01-04</releasedate><lastupdatedate>2014-06-02</lastupdatedate><samples>25</samples><assays>25</assays><arraydesign><id>4071</id><accession>A-GEOD-8227</accession><name>Agilent-019118 Human miRNA Microarray 2.0 G4470B (GeneView version)</name><count>25</count><legacy_id>2102920264</legacy_id></arraydesign><bioassaydatagroup><id/><name>rawData</name><bioassaydatacubes>25</bioassaydatacubes><arraydesignprovider/><dataformat>rawData</dataformat><bioassays>25</bioassays><isderived>0</isderived></bioassaydatagroup><bioassaydatagroup><id/><name>normalization</name><bioassaydatacubes>25</bioassaydatacubes><arraydesignprovider/><dataformat>normalization</dataformat><bioassays>25</bioassays><isderived>0</isderived></bioassaydatagroup><bioassaydatagroup><id/><name>processedData</name><bioassaydatacubes>25</bioassaydatacubes><arraydesignprovider/><dataformat>processedData</dataformat><bioassays>25</bioassays><isderived>0</isderived></bioassaydatagroup><bibliography><accession>23043088</accession><authors>Milosevic J, Pandit K, Magister M, Rabinovich E, Ellwanger DC, Yu G, Vuga LJ, Weksler B, Benos PV, Gibson KF, McMillan M, Kahn M, Kaminski N</authors><title>Profibrotic Role of miR-154 in Pulmonary Fibrosis.</title><doi>10.1165/rcmb.2011-0377OC</doi></bibliography><provider><contact>Naftali Kaminski</contact><role/><email/></provider><provider><contact>Kusum Vijay Pandit</contact><role>submitter</role><email>panditkv@upmc.edu</email></provider><provider><contact>Kusum V Pandit</contact><role/><email/></provider><description><id/><text>Idiopathic pulmonary fibrosis (IPF) is an untreatable fibrotic lung disease characterized by fibroblast proliferation and epithelial mesenchymal transition. Using miRNA expression microarrays we identified 96 differentially expressed miRNA in IPF lungs which included let-7d, miR-30 family, miR-29 family and miR-154 family. Lung tissue samples for microarray analysis were obtained through the University of Pittsburgh Health Sciences Tissue Bank. 13 samples were obtained from surgical remnants of biopsies or lungs explanted from patients with IPF who underwent pulmonary transplant, and 12 control normal lung tissues obtained from the disease free margins with normal histology of lung cancer resection specimens. The morphologic diagnosis of IPF was based on typical microscopic findings consistent with usual interstitial pneumonia. Total RNA was labeled with Cy3 and hybridized on Agilent 8X15K microRNA array (Agilent Technologies, Santa Clara, CA). After 20 hours hybridization, arrays were washed and scanned according to the manufacturer’s protocol.</text></description><protocol><id>688824</id><accession>P-GSE27430-8</accession></protocol><protocol><id>688822</id><accession>P-GSE27430-7</accession></protocol><protocol><id>688825</id><accession>P-GSE27430-6</accession></protocol><protocol><id>688823</id><accession>P-GSE27430-5</accession></protocol><protocol><id>688827</id><accession>P-GSE27430-4</accession></protocol><protocol><id>688828</id><accession>P-GSE27430-3</accession></protocol><protocol><id>688826</id><accession>P-GSE27430-2</accession></protocol><protocol><id>688821</id><accession>P-GSE27430-1</accession></protocol><organism>Homo sapiens</organism><files><!--
This section is deprecated and unsupported.
Please use webservice located at:
    http://www.ebi.ac.uk/arrayexpress/xml/files
to obtain detailed information on files available for the experiment.
For more information, please go to:
    http://www.ebi.ac.uk/arrayexpress/help/programmatic_access.html
                --><raw name="E-GEOD-27430.raw.1.zip" count="true" celcount="0"/><fgem name="E-GEOD-27430.processed.1.zip" available="true"/><idf name="E-GEOD-27430.idf.txt"/><sdrf name="E-GEOD-27430.sdrf.txt"/></files></experiment><experiment><species>Homo sapiens</species><rawdatafiles available="true"/><processeddatafiles available="true"/><sampleattribute><category>Organism</category><value>Homo sapiens</value></sampleattribute><sampleattribute><category>organism part</category><value>blood</value></sampleattribute><miamescores><reportersequencescore>1</reportersequencescore><protocolscore>0</protocolscore><factorvaluescore>0</factorvaluescore><derivedbioassaydatascore>1</derivedbioassaydatascore><measuredbioassaydatascore>1</measuredbioassaydatascore><overallscore>3</overallscore></miamescores><id>265855</id><accession>E-GEOD-30385</accession><secondaryaccession>GSE30385</secondaryaccession><name>Differential gene expression between critically ill trauma patients who do and do not go on to develop ventilator-associated pneumonia</name><experimenttype>transcription profiling by array</experimenttype><releasedate>2013-01-01</releasedate><lastupdatedate>2014-06-02</lastupdatedate><samples>20</samples><assays>20</assays><arraydesign><id>10917</id><accession>A-AFFY-41</accession><name>Affymetrix GeneChip Human Genome Focus Array [HG-Focus]</name><count>20</count><legacy_id>327974795</legacy_id></arraydesign><bioassaydatagroup><id/><name>rawData</name><bioassaydatacubes>20</bioassaydatacubes><arraydesignprovider/><dataformat>rawData</dataformat><bioassays>20</bioassays><isderived>0</isderived></bioassaydatagroup><bioassaydatagroup><id/><name>normalization</name><bioassaydatacubes>20</bioassaydatacubes><arraydesignprovider/><dataformat>normalization</dataformat><bioassays>20</bioassays><isderived>0</isderived></bioassaydatagroup><bioassaydatagroup><id/><name>processedData</name><bioassaydatacubes>20</bioassaydatacubes><arraydesignprovider/><dataformat>processedData</dataformat><bioassays>20</bioassays><isderived>0</isderived></bioassaydatagroup><provider><contact>Martin A Croce</contact><role/><email/></provider><provider><contact>Timothy C Fabian</contact><role/><email/></provider><provider><contact>Joseph   Swanson</contact><role>submitter</role><email>jswanson@uthsc.edu</email></provider><provider><contact>G C Wood</contact><role/><email/></provider><provider><contact>Lisa E Tang</contact><role/><email/></provider><provider><contact>Lijing Xu</contact><role/><email/></provider><provider><contact>Bernd Meibohm</contact><role/><email/></provider><provider><contact>Ramin Homayouni</contact><role/><email/></provider><provider><contact>Joseph M Swanson</contact><role/><email/></provider><description><id/><text>Objective: Identify genes that are differentially expressed between critically ill trauma patients who go on to develop ventilator-associated pneumonia (VAP) compared to similar patients who do not develop VAP Using gene expression differences, develop a model that predicts which patients are at greater risk of developing VAP. Prospective observational study, analysis of gene expression in 20 patient samples, 10 that developed ventilator-associated pneumonia, 10 that did not</text></description><protocol><id>687220</id><accession>P-GSE30385-5</accession></protocol><protocol><id>687223</id><accession>P-GSE30385-3</accession></protocol><protocol><id>687218</id><accession>P-GSE30385-6</accession></protocol><protocol><id>687221</id><accession>P-GSE30385-4</accession></protocol><protocol><id>687217</id><accession>P-GSE30385-1</accession></protocol><protocol><id>687219</id><accession>P-GSE30385-7</accession></protocol><protocol><id>687222</id><accession>P-GSE30385-2</accession></protocol><organism>Homo sapiens</organism><files><!--
This section is deprecated and unsupported.
Please use webservice located at:
    http://www.ebi.ac.uk/arrayexpress/xml/files
to obtain detailed information on files available for the experiment.
For more information, please go to:
    http://www.ebi.ac.uk/arrayexpress/help/programmatic_access.html
                --><raw name="E-GEOD-30385.raw.1.zip" count="true" celcount="0"/><fgem name="E-GEOD-30385.processed.1.zip" available="true"/><idf name="E-GEOD-30385.idf.txt"/><sdrf name="E-GEOD-30385.sdrf.txt"/></files></experiment><experiment><species>Homo sapiens</species><rawdatafiles available="true"/><processeddatafiles available="true"/><sampleattribute><category>cell type</category><value>alveolar macrophage</value></sampleattribute><sampleattribute><category>individual</category><value>Subject 1</value><value>Subject 2</value><value>Subject 3</value><value>Subject 4</value><value>Subject 5</value><value>Subject 6</value><value>Subject 7</value></sampleattribute><sampleattribute><category>Organism</category><value>Homo sapiens</value></sampleattribute><sampleattribute><category>sex</category><value>male</value></sampleattribute><experimentalfactor><name>INDIVIDUAL</name><value>Subject 1</value><value>Subject 2</value><value>Subject 3</value><value>Subject 4</value><value>Subject 5</value><value>Subject 6</value><value>Subject 7</value></experimentalfactor><experimentalfactor><name>TREATMENT</name><value>LPS</value><value>saline</value></experimentalfactor><miamescores><reportersequencescore>1</reportersequencescore><protocolscore>1</protocolscore><factorvaluescore>1</factorvaluescore><derivedbioassaydatascore>1</derivedbioassaydatascore><measuredbioassaydatascore>1</measuredbioassaydatascore><overallscore>5</overallscore></miamescores><id>238295</id><accession>E-GEOD-40885</accession><secondaryaccession>GSE40885</secondaryaccession><name>Data expression in alveolar macrophages induced by lipopolysaccharide in humans</name><experimenttype>transcription profiling by array</experimenttype><releasedate>2012-09-15</releasedate><lastupdatedate>2012-09-24</lastupdatedate><samples>14</samples><assays>14</assays><arraydesign><id>11119</id><accession>A-AFFY-44</accession><name>Affymetrix GeneChip Human Genome U133 Plus 2.0 [HG-U133_Plus_2]</name><count>14</count><legacy_id>405156763</legacy_id></arraydesign><bioassaydatagroup><id/><name>rawData</name><bioassaydatacubes>14</bioassaydatacubes><arraydesignprovider/><dataformat>rawData</dataformat><bioassays>14</bioassays><isderived>0</isderived></bioassaydatagroup><bioassaydatagroup><id/><name>normalization</name><bioassaydatacubes>14</bioassaydatacubes><arraydesignprovider/><dataformat>normalization</dataformat><bioassays>14</bioassays><isderived>0</isderived></bioassaydatagroup><bioassaydatagroup><id/><name>processedData</name><bioassaydatacubes>14</bioassaydatacubes><arraydesignprovider/><dataformat>processedData</dataformat><bioassays>14</bioassays><isderived>0</isderived></bioassaydatagroup><bibliography><accession>22952057</accession><authors>Reynier F, De Vos AF, Hoogerwerf JJ, Bresser P, Van Der Zee JS, Paye M, Pachot A, Mougin B, Van Der Poll T</authors><title>Gene expression profiles in alveolar macrophages induced by lipopolysaccharide in humans.</title><doi>10.2119/molmed.2012.00230</doi></bibliography><provider><contact>Tom van der Poll</contact><role/><email/></provider><provider><contact>Paul Bresser</contact><role/><email/></provider><provider><contact>Alexandre Pachot</contact><role/><email/></provider><provider><contact>Bruno Mougin</contact><role/><email/></provider><provider><contact>Frederic Reynier</contact><role>submitter</role><email>frederic.reynier@biomerieux.com</email></provider><provider><contact>Jacobien J Hoogerwerf</contact><role/><email/></provider><provider><contact>Malick Paye</contact><role/><email/></provider><provider><contact>Jaring S van der Zee</contact><role/><email/></provider><provider><contact>Alex F de Vos</contact><role/><email/></provider><description><id/><text>Rationale: Lipopolysaccharide (LPS) is ubiquitous in the environment. Inhalation of LPS has been implicated in the pathogenesis and/or severity of several lung diseases, including pneumonia, chronic obstructive pulmonary disease and asthma. Alveolar macrophages are the main resident leukocytes exposed to inhaled antigens.   Objectives: To obtain insight into which innate immune pathways become activated within human alveolar macrophages upon exposure to LPS in vivo. In seven healthy humans sterile saline was instilled into a lung segment by bronchoscope, followed by instillation of LPS into the contralateral lung. Six hours later a bilateral bronchoalveolar lavage was performed and whole-genome transcriptional profiling was done (Affymetrix HG-U133 Plus 2.0) on purified alveolar macrophages, comparing cells exposed to saline or LPS from the same individuals.</text></description><protocol><id>633074</id><accession>P-GSE40885-7</accession></protocol><protocol><id>633071</id><accession>P-GSE40885-1</accession></protocol><protocol><id>633077</id><accession>P-GSE40885-2</accession></protocol><protocol><id>633076</id><accession>P-GSE40885-3</accession></protocol><protocol><id>633073</id><accession>P-GSE40885-4</accession></protocol><protocol><id>633075</id><accession>P-GSE40885-5</accession></protocol><protocol><id>633072</id><accession>P-GSE40885-6</accession></protocol><organism>Homo sapiens</organism><files><!--
This section is deprecated and unsupported.
Please use webservice located at:
    http://www.ebi.ac.uk/arrayexpress/xml/files
to obtain detailed information on files available for the experiment.
For more information, please go to:
    http://www.ebi.ac.uk/arrayexpress/help/programmatic_access.html
                --><raw name="E-GEOD-40885.raw.1.zip" count="true" celcount="0"/><fgem name="E-GEOD-40885.processed.1.zip" available="true"/><idf name="E-GEOD-40885.idf.txt"/><sdrf name="E-GEOD-40885.sdrf.txt"/></files></experiment><experiment><species>Homo sapiens</species><rawdatafiles available="true"/><processeddatafiles available="true"/><sampleattribute><category>age</category><value>41 y</value><value>45 y</value><value>46 y</value><value>47 y</value><value>48 y</value><value>49 y</value><value>50 y</value><value>51 y</value><value>52 y</value><value>53 y</value><value>54 y</value><value>55 y</value><value>56 y</value><value>57 y</value><value>58 y</value><value>59 y</value><value>60 y</value><value>61 y</value><value>62 y</value><value>63 y</value><value>64 y</value><value>65 y</value><value>66 y</value><value>67 y</value><value>68 y</value><value>69 y</value><value>70 y</value><value>71 y</value><value>72 y</value><value>73 y</value><value>74 y</value><value>75 y</value><value>76 y</value><value>77 y</value><value>78 y</value><value>80 y</value><value>83 y</value></sampleattribute><sampleattribute><category>disease state</category><value>Adenocarcinoma of Lung</value><value>amyloid of lung</value><value>granuloma of lung</value><value>hamartoma of lung</value><value>large cell carcinoma of lung</value><value>lung after resection of lung cancer</value><value>lung without lung cancer or non-cancerous nodule</value><value>neuroendocrine carcinoma of lung</value><value>pleural plaque of lung</value><value>pneumonia of lung</value><value>poorly differentiated non-small cell cancer of lung</value><value>sarcomatoid carcinoma of lung</value><value>Squamous cell carcinoma of lung</value><value>subpleural fibrosis of lung</value></sampleattribute><sampleattribute><category>individual</category><value>1</value><value>10</value><value>100</value><value>101</value><value>102</value><value>103</value><value>104</value><value>105</value><value>106</value><value>107</value><value>108</value><value>109</value><value>11</value><value>110</value><value>111</value><value>112</value><value>113</value><value>114</value><value>115</value><value>116</value><value>117</value><value>118</value><value>119</value><value>12</value><value>120</value><value>121</value><value>122</value><value>123</value><value>124</value><value>125</value><value>126</value><value>127</value><value>128</value><value>129</value><value>13</value><value>130</value><value>131</value><value>132</value><value>133</value><value>134</value><value>135</value><value>136</value><value>137</value><value>138</value><value>139</value><value>14</value><value>140</value><value>141</value><value>142</value><value>143</value><value>144</value><value>145</value><value>146</value><value>147</value><value>148</value><value>149</value><value>15</value><value>150</value><value>151</value><value>152</value><value>153</value><value>154</value><value>155</value><value>156</value><value>157</value><value>158</value><value>159</value><value>16</value><value>160</value><value>161</value><value>162</value><value>17</value><value>18</value><value>19</value><value>2</value><value>20</value><value>21</value><value>22</value><value>23</value><value>24</value><value>25</value><value>26</value><value>27</value><value>28</value><value>29</value><value>3</value><value>30</value><value>31</value><value>32</value><value>33</value><value>34</value><value>35</value><value>36</value><value>37</value><value>38</value><value>39</value><value>4</value><value>40</value><value>41</value><value>42</value><value>43</value><value>44</value><value>45</value><value>46</value><value>47</value><value>48</value><value>49</value><value>5</value><value>50</value><value>51</value><value>52</value><value>53</value><value>54</value><value>55</value><value>56</value><value>57</value><value>58</value><value>59</value><value>6</value><value>60</value><value>61</value><value>62</value><value>63</value><value>64</value><value>65</value><value>66</value><value>67</value><value>68</value><value>69</value><value>7</value><value>70</value><value>71</value><value>72</value><value>73</value><value>74</value><value>75</value><value>76</value><value>77</value><value>78</value><value>79</value><value>8</value><value>80</value><value>81</value><value>82</value><value>83</value><value>84</value><value>85</value><value>86</value><value>87</value><value>88</value><value>89</value><value>9</value><value>90</value><value>91</value><value>92</value><value>93</value><value>94</value><value>95</value><value>96</value><value>97</value><value>98</value><value>99</value></sampleattribute><sampleattribute><category>lung disease</category><value>Lung cancer (before surgical resection of lung cancer)</value><value>Non-cancerous lung nodule</value><value>None (after surgical resection of lung cancer)</value><value>None (no current or past lung cancer or non-cancerous nodule)</value></sampleattribute><sampleattribute><category>Organism</category><value>Homo sapiens</value></sampleattribute><sampleattribute><category>organism part</category><value>blood</value><value>Multiple</value></sampleattribute><sampleattribute><category>sample type</category><value>Human universal reference RNA from Ambion</value></sampleattribute><sampleattribute><category>sex</category><value>female</value><value>male</value><value>Mixed</value></sampleattribute><experimentalfactor><name>AGE</name><value>41 y</value><value>45 y</value><value>46 y</value><value>47 y</value><value>48 y</value><value>49 y</value><value>50 y</value><value>51 y</value><value>52 y</value><value>53 y</value><value>54 y</value><value>55 y</value><value>56 y</value><value>57 y</value><value>58 y</value><value>59 y</value><value>60 y</value><value>61 y</value><value>62 y</value><value>63 y</value><value>64 y</value><value>65 y</value><value>66 y</value><value>67 y</value><value>68 y</value><value>69 y</value><value>70 y</value><value>71 y</value><value>72 y</value><value>73 y</value><value>74 y</value><value>75 y</value><value>76 y</value><value>77 y</value><value>78 y</value><value>80 y</value><value>83 y</value><value>not specified</value></experimentalfactor><experimentalfactor><name>DISEASE STATE</name><value>Adenocarcinoma of Lung</value><value>amyloid of lung</value><value>granuloma of lung</value><value>hamartoma of lung</value><value>large cell carcinoma of lung</value><value>lung after resection of lung cancer</value><value>lung without lung cancer or non-cancerous nodule</value><value>neuroendocrine carcinoma of lung</value><value>not specified</value><value>pleural plaque of lung</value><value>pneumonia of lung</value><value>poorly differentiated non-small cell cancer of lung</value><value>sarcomatoid carcinoma of lung</value><value>Squamous cell carcinoma of lung</value><value>subpleural fibrosis of lung</value></experimentalfactor><experimentalfactor><name>INDIVIDUAL</name><value>1</value><value>10</value><value>100</value><value>101</value><value>102</value><value>103</value><value>104</value><value>105</value><value>106</value><value>107</value><value>108</value><value>109</value><value>11</value><value>110</value><value>111</value><value>112</value><value>113</value><value>114</value><value>115</value><value>116</value><value>117</value><value>118</value><value>119</value><value>12</value><value>120</value><value>121</value><value>122</value><value>123</value><value>124</value><value>125</value><value>126</value><value>127</value><value>128</value><value>129</value><value>13</value><value>130</value><value>131</value><value>132</value><value>133</value><value>134</value><value>135</value><value>136</value><value>137</value><value>138</value><value>139</value><value>14</value><value>140</value><value>141</value><value>142</value><value>143</value><value>144</value><value>145</value><value>146</value><value>147</value><value>148</value><value>149</value><value>15</value><value>150</value><value>151</value><value>152</value><value>153</value><value>154</value><value>155</value><value>156</value><value>157</value><value>158</value><value>159</value><value>16</value><value>160</value><value>161</value><value>162</value><value>17</value><value>18</value><value>19</value><value>2</value><value>20</value><value>21</value><value>22</value><value>23</value><value>24</value><value>25</value><value>26</value><value>27</value><value>28</value><value>29</value><value>3</value><value>30</value><value>31</value><value>32</value><value>33</value><value>34</value><value>35</value><value>36</value><value>37</value><value>38</value><value>39</value><value>4</value><value>40</value><value>41</value><value>42</value><value>43</value><value>44</value><value>45</value><value>46</value><value>47</value><value>48</value><value>49</value><value>5</value><value>50</value><value>51</value><value>52</value><value>53</value><value>54</value><value>55</value><value>56</value><value>57</value><value>58</value><value>59</value><value>6</value><value>60</value><value>61</value><value>62</value><value>63</value><value>64</value><value>65</value><value>66</value><value>67</value><value>68</value><value>69</value><value>7</value><value>70</value><value>71</value><value>72</value><value>73</value><value>74</value><value>75</value><value>76</value><value>77</value><value>78</value><value>79</value><value>8</value><value>80</value><value>81</value><value>82</value><value>83</value><value>84</value><value>85</value><value>86</value><value>87</value><value>88</value><value>89</value><value>9</value><value>90</value><value>91</value><value>92</value><value>93</value><value>94</value><value>95</value><value>96</value><value>97</value><value>98</value><value>99</value><value>not specified</value></experimentalfactor><experimentalfactor><name>LUNG DISEASE</name><value>Lung cancer (before surgical resection of lung cancer)</value><value>Non-cancerous lung nodule</value><value>None (after surgical resection of lung cancer)</value><value>None (no current or past lung cancer or non-cancerous nodule)</value><value>not specified</value></experimentalfactor><experimentalfactor><name>ORGANISM PART</name><value>blood</value><value>Multiple</value></experimentalfactor><experimentalfactor><name>SEX</name><value>female</value><value>male</value><value>Mixed</value></experimentalfactor><experimentalfactor><name>TIME</name><value>not specified</value><value>postop</value><value>preop</value></experimentalfactor><miamescores><reportersequencescore>1</reportersequencescore><protocolscore>1</protocolscore><factorvaluescore>1</factorvaluescore><derivedbioassaydatascore>1</derivedbioassaydatascore><measuredbioassaydatascore>1</measuredbioassaydatascore><overallscore>5</overallscore></miamescores><id>238387</id><accession>E-GEOD-40738</accession><secondaryaccession>GSE40738</secondaryaccession><name>Whole blood microRNA expression in human lung cancer</name><experimenttype>transcription profiling by array</experimenttype><releasedate>2012-09-11</releasedate><lastupdatedate>2014-05-02</lastupdatedate><samples>354</samples><assays>177</assays><arraydesign><id>22510</id><accession>A-GEOD-16016</accession><name>Exiqon miRCURY LNA microRNA array, 7th generation - hsa, mmu &amp; rno (miRBase 18.0)</name><count>177</count></arraydesign><bioassaydatagroup><id/><name>rawData</name><bioassaydatacubes>354</bioassaydatacubes><arraydesignprovider/><dataformat>rawData</dataformat><bioassays>354</bioassays><isderived>0</isderived></bioassaydatagroup><bioassaydatagroup><id/><name>normalization</name><bioassaydatacubes>177</bioassaydatacubes><arraydesignprovider/><dataformat>normalization</dataformat><bioassays>177</bioassays><isderived>0</isderived></bioassaydatagroup><bioassaydatagroup><id/><name>processedData</name><bioassaydatacubes>177</bioassaydatacubes><arraydesignprovider/><dataformat>processedData</dataformat><bioassays>177</bioassays><isderived>0</isderived></bioassaydatagroup><provider><contact>Santosh Kumar Patnaik</contact><role>submitter</role><email>drpatnaik@yahoo.com</email></provider><provider><contact>Sai Yendamuri</contact><role/><email/></provider><provider><contact>Anil Vachani</contact><role/><email/></provider><provider><contact>Santosh K Patnaik</contact><role/><email/></provider><provider><contact>Eric Kannisto</contact><role/><email/></provider><description><id/><text>Seventh generation Exiqon locked nucleic acid miRCURY LNA microarrays were used to profile the expression of microRNAs in whole blood of patients with lung cancer and of clinically relevant controls without the disease (individuals with non-cancerous lung nodule, at high risk for cancer because of heavy smoking, or with lung cancer treated by surgical resection). The goal was to examine if whole blood microRNAs can be used for developing a non-invasive assay to diagnose lung cancer. Using the PAXgene Blood miRNA kit (Qiagen, Valencia, CA, USA), total RNA was isolated from whole blood stabilized and stored in PAXgene Blood RNA tubes for 85 individuals with lung cancer, 59 individuals without the disease but at a high risk for the disease because of smoking, and 17 individuals with a non-cancerous pulmonary nodule. RNA was also isolated from 13 samples of blood of 12 of the lung cancer cases following surgery; blood samples were collected on two different days post-operatively for one of the cases (Sample names 157 and 160). The data-set here includes data (sample name 171) from a post-operative blood sample of an individual (who had the lung cancer removed by operation) for whom good array data was not obtained for RNA from a pre-operative blood sample. Two RNA samples were used to test technical duplicability of the microarray platform (pairs of sample names 59 &amp; 192, and 175 &amp; 182). Thus, a total of 162 unique individuals and 175 unique RNA samples are covered by this data-set. Isolated RNA was provided to Exiqon (Denmark) for microRNA quantification using microarrays. Quality and concentration of RNA in the samples was assessed by Nanodrop 2000 (Thermo Scientific, Wilmington, DE, USA) and Bioanalyzer 2100 (Agilent, Santa Clara, CA, USA) instruments. Sample RNA (500 ng) was labeled with the Cy3-like Hy3 dye, mixed with 500 ng of a human universal reference RNA (product number AM6000, Ambion, Austin, TX, USA) that was labeled with the Cy5-like Hy5 dye, and hybridized to 7th generation miRCURY locked nucleic acid oligonucleotide microarrays. Sixty-two artificial small RNAs were spiked-in each RNA sample before labeling. disease state: Lung cancer (before surgical resection of lung cancer): 1, 2, 4, 5, 6, 7, 8, 9, 10, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 61, 63, 64, 65, 67, 68, 69, 70, 81, 82, 85, 86, 87, 88, 89, 90, 101, 102, 103, 104, 105, 106, 107, 108, 109, 110, 111, 112, 121, 122, 123, 124, 125, 126, 127, 149, 151, 153, 154, 156, 158, 165, 167, 174, 175, 176, 177, 179, 180, 181, 183, 184, 186, 187, 188, 189, 193 disease state: Non-cancerous lung nodule: 128, 129, 130, 131, 133, 134, 135, 136, 137, 140, 141, 142, 144, 145, 146, 148, 182, 190 disease state: None (after surgical resection of lung cancer): 155, 157, 159, 160, 161, 162, 163, 164, 166, 169, 170, 171, 172, 173 disease state: None (no current or past lung cancer or non-cancerous nodule): 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 91, 92, 93, 94, 95, 96, 97, 98, 99, 100, 113, 114, 115, 116, 117, 118, 119, 120, 192 individual: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99, 100, 101, 102, 103, 104, 105, 106, 107, 108, 109, 110, 111, 112, 113, 114, 115, 116, 117, 118, 119, 120, 121, 122, 123, 124, 125, 126, 127, 128, 129, 130, 131, 132, 133, 134, 135, 136, 137, 138, 139, 140, 141, 142, 143, 144, 145, 146, 147, 148, 149, 150, 151, 152, 153, 154, 155, 156, 157, 158, 159, 160, 161, 162</text></description><protocol><id>633631</id><accession>P-GSE40738-4</accession></protocol><protocol><id>633627</id><accession>P-GSE40738-5</accession></protocol><protocol><id>633628</id><accession>P-GSE40738-6</accession></protocol><protocol><id>633626</id><accession>P-GSE40738-1</accession></protocol><protocol><id>633629</id><accession>P-GSE40738-2</accession></protocol><protocol><id>633630</id><accession>P-GSE40738-3</accession></protocol><organism>Homo sapiens</organism><files><!--
This section is deprecated and unsupported.
Please use webservice located at:
    http://www.ebi.ac.uk/arrayexpress/xml/files
to obtain detailed information on files available for the experiment.
For more information, please go to:
    http://www.ebi.ac.uk/arrayexpress/help/programmatic_access.html
                --><raw name="E-GEOD-40738.raw.1.zip E-GEOD-40738.raw.2.zip E-GEOD-40738.raw.3.zip" count="true" celcount="0"/><fgem name="E-GEOD-40738.processed.1.zip" available="true"/><idf name="E-GEOD-40738.idf.txt"/><sdrf name="E-GEOD-40738.sdrf.txt"/></files></experiment><experiment><species>Homo sapiens</species><rawdatafiles available="true"/><processeddatafiles available="true"/><sampleattribute><category>Organism</category><value>Homo sapiens</value></sampleattribute><sampleattribute><category>protocol</category><value>stimuated with gram-positive pneumonia patient 1224 plasma</value><value>stimuated with gram-positive pneumonia patient 1275 plasma</value><value>stimuated with gram-positive pneumonia patient 1287 plasma</value><value>stimuated with gram-positive pneumonia patient 1325 plasma</value><value>stimuated with gram-positive pneumonia patient 1344 plasma</value><value>stimuated with gram-positive pneumonia patient 1353 plasma</value><value>stimuated with gram-positive pneumonia patient 1382 plasma</value><value>stimuated with gram-positive pneumonia patient 1403 plasma</value><value>stimuated with gram-positive pneumonia patient 1410 plasma</value><value>stimuated with gram-positive pneumonia patient 1412 plasma</value><value>stimuated with HC1006 plasma</value><value>stimuated with HC1259 plasma</value><value>stimuated with HC1369 plasma</value><value>stimuated with HC1534 plasma</value><value>stimuated with HC1730 plasma</value><value>stimuated with HC217 plasma</value><value>stimuated with HC226 plasma</value><value>stimuated with HC2301 plasma</value><value>stimuated with HC233 plasma</value><value>stimuated with HC272 plasma</value><value>stimuated with HC285 plasma</value><value>stimuated with HC294 plasma</value><value>stimuated with HC295 plasma</value><value>stimuated with HC381 plasma</value><value>stimuated with HC385 plasma</value><value>stimuated with HC389 plasma</value><value>stimuated with HC390 plasma</value><value>stimuated with HC393 plasma</value></sampleattribute><sampleattribute><category>responder cell line</category><value>UPN727</value></sampleattribute><experimentalfactor><name>PROTOCOL</name><value>stimuated with gram-positive pneumonia patient 1224 plasma</value><value>stimuated with gram-positive pneumonia patient 1275 plasma</value><value>stimuated with gram-positive pneumonia patient 1287 plasma</value><value>stimuated with gram-positive pneumonia patient 1325 plasma</value><value>stimuated with gram-positive pneumonia patient 1344 plasma</value><value>stimuated with gram-positive pneumonia patient 1353 plasma</value><value>stimuated with gram-positive pneumonia patient 1382 plasma</value><value>stimuated with gram-positive pneumonia patient 1403 plasma</value><value>stimuated with gram-positive pneumonia patient 1410 plasma</value><value>stimuated with gram-positive pneumonia patient 1412 plasma</value><value>stimuated with HC1006 plasma</value><value>stimuated with HC1259 plasma</value><value>stimuated with HC1369 plasma</value><value>stimuated with HC1534 plasma</value><value>stimuated with HC1730 plasma</value><value>stimuated with HC217 plasma</value><value>stimuated with HC226 plasma</value><value>stimuated with HC2301 plasma</value><value>stimuated with HC233 plasma</value><value>stimuated with HC272 plasma</value><value>stimuated with HC285 plasma</value><value>stimuated with HC294 plasma</value><value>stimuated with HC295 plasma</value><value>stimuated with HC381 plasma</value><value>stimuated with HC385 plasma</value><value>stimuated with HC389 plasma</value><value>stimuated with HC390 plasma</value><value>stimuated with HC393 plasma</value></experimentalfactor><miamescores><reportersequencescore>1</reportersequencescore><protocolscore>1</protocolscore><factorvaluescore>1</factorvaluescore><derivedbioassaydatascore>1</derivedbioassaydatascore><measuredbioassaydatascore>1</measuredbioassaydatascore><overallscore>5</overallscore></miamescores><id>239407</id><accession>E-GEOD-35716</accession><secondaryaccession>GSE35716</secondaryaccession><name>Transcriptional Signatures as a Disease-Specific and Predictive Inflammatory Biomarker for Type 1 Diabetes [Pneu_S3S24_10Pneu_4HC]</name><experimenttype>transcription profiling by array</experimenttype><releasedate>2012-09-01</releasedate><lastupdatedate>2012-09-26</lastupdatedate><samples>28</samples><assays>28</assays><arraydesign><id>11119</id><accession>A-AFFY-44</accession><name>Affymetrix GeneChip Human Genome U133 Plus 2.0 [HG-U133_Plus_2]</name><count>28</count><legacy_id>405156763</legacy_id></arraydesign><bioassaydatagroup><id/><name>rawData</name><bioassaydatacubes>28</bioassaydatacubes><arraydesignprovider/><dataformat>rawData</dataformat><bioassays>28</bioassays><isderived>0</isderived></bioassaydatagroup><bioassaydatagroup><id/><name>normalization</name><bioassaydatacubes>28</bioassaydatacubes><arraydesignprovider/><dataformat>normalization</dataformat><bioassays>28</bioassays><isderived>0</isderived></bioassaydatagroup><bioassaydatagroup><id/><name>processedData</name><bioassaydatacubes>28</bioassaydatacubes><arraydesignprovider/><dataformat>processedData</dataformat><bioassays>28</bioassays><isderived>0</isderived></bioassaydatagroup><provider><contact>Scott J Pavletich</contact><role/><email/></provider><provider><contact>Shuang Jia</contact><role/><email/></provider><provider><contact>Jack Gorski</contact><role/><email/></provider><provider><contact>Melissa Reske</contact><role/><email/></provider><provider><contact>Xujing Wang</contact><role/><email/></provider><provider><contact>Martin J Hessner</contact><role/><email/></provider><provider><contact>Martin Hessner</contact><role>submitter</role><email>mhessner@mcw.edu</email></provider><provider><contact>Joanna Kramer</contact><role/><email/></provider><provider><contact>Mary K Dahmer</contact><role/><email/></provider><provider><contact>Mike W Quasney</contact><role/><email/></provider><provider><contact>Mary Kaldunski</contact><role/><email/></provider><description><id/><text>The complex milieu of inflammatory mediators associated with many diseases is often too dilute to directly measure in the periphery, necessitating development of more sensitive measurements suitable for mechanistic studies, earlier diagnosis, guiding selection of therapy, and monitoring interventions.  Previously, we determined that plasma of recent-onset (RO) Type 1 diabetes (T1D) patients induce a proinflammatory transcriptional signature in fresh peripheral blood mononuclear cells (PBMC) relative to that of unrelated healthy controls (HC).  Here, using an optimized cryopreserved PBMC-based protocol, we compared the signature found between unrelated healthy controls and patients with bacterial pneumonia. UPN727 cells were stimulated with either plasma from unrelated healthy controls (n=18) or plasma from patients with bacterial pneumonia (n=10). Gene expression analysis was perfromed in order to evaluate the transcriptional signature associated with bacterial pneumonia.</text></description><protocol><id>634768</id><accession>P-GSE35716-3</accession></protocol><protocol><id>634765</id><accession>P-GSE35716-2</accession></protocol><protocol><id>634766</id><accession>P-GSE35716-5</accession></protocol><protocol><id>634767</id><accession>P-GSE35716-4</accession></protocol><protocol><id>634761</id><accession>P-GSE35716-1</accession></protocol><protocol><id>634763</id><accession>P-GSE35716-7</accession></protocol><protocol><id>634764</id><accession>P-GSE35716-6</accession></protocol><protocol><id>634762</id><accession>P-GSE35716-8</accession></protocol><organism>Homo sapiens</organism><files><!--
This section is deprecated and unsupported.
Please use webservice located at:
    http://www.ebi.ac.uk/arrayexpress/xml/files
to obtain detailed information on files available for the experiment.
For more information, please go to:
    http://www.ebi.ac.uk/arrayexpress/help/programmatic_access.html
                --><raw name="E-GEOD-35716.raw.1.zip" count="true" celcount="0"/><fgem name="E-GEOD-35716.processed.1.zip" available="true"/><idf name="E-GEOD-35716.idf.txt"/><sdrf name="E-GEOD-35716.sdrf.txt"/></files></experiment><experiment><species>Homo sapiens</species><rawdatafiles available="true"/><processeddatafiles available="true"/><sampleattribute><category>Organism</category><value>Homo sapiens</value></sampleattribute><sampleattribute><category>protocol</category><value>stimuated with AutoB1S1 plasma</value><value>stimuated with AutoB1S2 plasma</value><value>stimuated with AutoB1S3 plasma</value><value>stimuated with AutoB3W1 plasma</value><value>stimuated with AutoB3W1+2 plasma</value><value>stimuated with gram-positive pneumonia patient 1224 plasma</value><value>stimuated with gram-positive pneumonia patient 1275 plasma</value><value>stimuated with gram-positive pneumonia patient 1287 plasma</value><value>stimuated with gram-positive pneumonia patient 1325 plasma</value><value>stimuated with gram-positive pneumonia patient 1344 plasma</value><value>stimuated with gram-positive pneumonia patient 1353 plasma</value><value>stimuated with gram-positive pneumonia patient 1382 plasma</value><value>stimuated with gram-positive pneumonia patient 1403 plasma</value><value>stimuated with gram-positive pneumonia patient 1410 plasma</value><value>stimuated with gram-positive pneumonia patient 1412 plasma</value><value>stimuated with HC1006 plasma</value><value>stimuated with HC1259 plasma</value><value>stimuated with HC1369 plasma</value><value>stimuated with HC1534 plasma</value><value>stimuated with HC1730 plasma</value><value>stimuated with HC217 plasma</value><value>stimuated with HC226 plasma</value><value>stimuated with HC2301 plasma</value><value>stimuated with HC233 plasma</value><value>stimuated with HC272 plasma</value><value>stimuated with HC285 plasma</value><value>stimuated with HC294 plasma</value><value>stimuated with HC295 plasma</value><value>stimuated with HC381 plasma</value><value>stimuated with HC385 plasma</value><value>stimuated with HC389 plasma</value><value>stimuated with HC390 plasma</value><value>stimuated with HC393 plasma</value><value>stimulated with 033S pre flu plasma</value><value>stimulated with 033T active flu plasma</value><value>stimulated with 1052A pre flu plasma</value><value>stimulated with 1052B active flu plasma</value><value>stimulated with 1090A pre flu plasma</value><value>stimulated with 1090B active flu plasma</value><value>stimulated with 121F pre flu plasma</value><value>stimulated with 121G active flu plasma</value><value>stimulated with 1223A pre flu plasma</value><value>stimulated with 1223B active flu plasma</value><value>stimulated with Auto250S10 plasma</value><value>stimulated with Auto250S12 plasma</value><value>stimulated with Auto250S14 plasma</value><value>stimulated with Auto250S15 plasma</value><value>stimulated with Auto250S7 plasma</value><value>stimulated with Auto250S8 plasma</value><value>stimulated with Auto250S9 plasma</value><value>stimulated with autologous plasma</value><value>stimulated with CF4017 plasma</value><value>stimulated with CF4024 plasma</value><value>stimulated with CF4026 plasma</value><value>stimulated with CF4045 plasma</value><value>stimulated with CF4047 plasma</value><value>stimulated with CF4087 plasma</value><value>stimulated with CF4088 plasma</value><value>stimulated with CF4091 plasma</value><value>stimulated with CF4107 plasma</value><value>stimulated with CF4133 plasma</value><value>stimulated with CF4138 plasma</value><value>stimulated with CF4157 plasma</value><value>stimulated with CF4184 plasma</value><value>stimulated with CF4256 plasma</value><value>stimulated with CF4265 plasma</value><value>stimulated with CF4271 plasma</value><value>stimulated with CF4285 plasma</value><value>stimulated with CF4297 plasma</value><value>stimulated with CF4304 plasma</value><value>stimulated with CF4305 plasma</value><value>stimulated with HC1006 plasma</value><value>stimulated with HC1089 plasma</value><value>stimulated with HC1142 plasma</value><value>stimulated with HC1249 plasma</value><value>stimulated with HC1259 plasma</value><value>stimulated with HC1265 plasma</value><value>stimulated with HC1271 plasma</value><value>stimulated with HC1301 plasma</value><value>stimulated with HC1365 plasma</value><value>stimulated with HC1369 plasma</value><value>stimulated with HC1534 plasma</value><value>stimulated with HC1543 plasma</value><value>stimulated with HC1601 plasma</value><value>stimulated with HC1678 plasma</value><value>stimulated with HC1730 plasma</value><value>stimulated with HC1777 plasma</value><value>stimulated with HC2074 plasma</value><value>stimulated with HC2146 plasma</value><value>stimulated with HC217 plasma</value><value>stimulated with HC223 plasma</value><value>stimulated with HC224 plasma</value><value>stimulated with HC226 plasma</value><value>stimulated with HC227 plasma</value><value>stimulated with HC2300 plasma</value><value>stimulated with HC2301 plasma</value><value>stimulated with HC2302 plasma</value><value>stimulated with HC233 plasma</value><value>stimulated with HC2369 plasma</value><value>stimulated with HC2593 plasma</value><value>stimulated with HC2614 plasma</value><value>stimulated with HC272 plasma</value><value>stimulated with HC2790 plasma</value><value>stimulated with HC285 plasma</value><value>stimulated with HC294 plasma</value><value>stimulated with HC295 plasma</value><value>stimulated with HC304 plasma</value><value>stimulated with HC305 plasma</value><value>stimulated with HC307 plasma</value><value>stimulated with HC308 plasma</value><value>stimulated with HC322 plasma</value><value>stimulated with HC375 plasma</value><value>stimulated with HC379 plasma</value><value>stimulated with HC381 plasma</value><value>stimulated with HC382 plasma</value><value>stimulated with HC384 plasma</value><value>stimulated with HC385 plasma</value><value>stimulated with HC388 plasma</value><value>stimulated with HC390 plasma</value><value>stimulated with HC394 plasma</value><value>stimulated with HCy1006 plasma</value><value>stimulated with HCy1837 plasma</value><value>stimulated with HCy217 plasma</value><value>stimulated with HCy226 plasma</value><value>stimulated with HCy2301 plasma</value><value>stimulated with HCy233 plasma</value><value>stimulated with HCy252 plasma</value><value>stimulated with HCy284 plasma</value><value>stimulated with HCy294 plasma</value><value>stimulated with HCy295 plasma</value><value>stimulated with HCy385 plasma</value><value>stimulated with HCy390 plasma</value><value>stimulated with HCy393 plasma</value><value>stimulated with LO1063 (timepoint 3) plasma</value><value>stimulated with LO1377 (timepoint 4) plasma</value><value>stimulated with LO1910 (timepoint 5) plasma</value><value>stimulated with LO2132 (timepoint 6) plasma</value><value>stimulated with LO3 (timepoint 1) plasma</value><value>stimulated with LO350 (timepoint 2) plasma</value><value>stimulated with LS1053 plasma</value><value>stimulated with LS1110 plasma</value><value>stimulated with LS1296 plasma</value><value>stimulated with LS264 plasma</value><value>stimulated with LS311 plasma</value><value>stimulated with LS35 plasma</value><value>stimulated with LS38 plasma</value><value>stimulated with LS59 plasma</value><value>stimulated with LS599 plasma</value><value>stimulated with LS66 plasma</value><value>stimulated with LS96 plasma</value><value>stimulated with RO1012 plasma</value><value>stimulated with RO1037 plasma</value><value>stimulated with RO1057 plasma</value><value>stimulated with RO1225 plasma</value><value>stimulated with RO1437 plasma</value><value>stimulated with RO1442 plasma</value><value>stimulated with RO1579 plasma</value><value>stimulated with RO159 plasma</value><value>stimulated with RO1707 plasma</value><value>stimulated with RO189 plasma</value><value>stimulated with RO1939 plasma</value><value>stimulated with RO1964 plasma</value><value>stimulated with RO1973 plasma</value><value>stimulated with RO1997 plasma</value><value>stimulated with RO201 plasma</value><value>stimulated with RO2024 plasma</value><value>stimulated with RO2109 plasma</value><value>stimulated with RO2130 plasma</value><value>stimulated with RO2185 plasma</value><value>stimulated with RO2312 plasma</value><value>stimulated with RO2348 plasma</value><value>stimulated with RO2359 plasma</value><value>stimulated with RO2366 plasma</value><value>stimulated with RO246 plasma</value><value>stimulated with RO2503 plasma</value><value>stimulated with RO253 plasma</value><value>stimulated with RO2559 plasma</value><value>stimulated with RO2598 plasma</value><value>stimulated with RO2676 plasma</value><value>stimulated with RO2751 plasma</value><value>stimulated with RO2808 plasma</value><value>stimulated with RO2903 plasma</value><value>stimulated with RO2936 plasma</value><value>stimulated with RO2944 plasma</value><value>stimulated with RO2953 plasma</value><value>stimulated with RO2991 plasma</value><value>stimulated with RO3040 plasma</value><value>stimulated with RO3045 plasma</value><value>stimulated with RO3052 plasma</value><value>stimulated with RO3087 plasma</value><value>stimulated with RO3139 plasma</value><value>stimulated with RO3153 plasma</value><value>stimulated with RO62 plasma</value><value>stimulated with RO930 plasma</value><value>stimulated with RO946 plasma</value><value>stimulated with RO972 plasma</value></sampleattribute><sampleattribute><category>responder cell line</category><value>UPN727</value></sampleattribute><experimentalfactor><name>PROTOCOL</name><value>stimuated with AutoB1S1 plasma</value><value>stimuated with AutoB1S2 plasma</value><value>stimuated with AutoB1S3 plasma</value><value>stimuated with AutoB3W1 plasma</value><value>stimuated with AutoB3W1+2 plasma</value><value>stimuated with gram-positive pneumonia patient 1224 plasma</value><value>stimuated with gram-positive pneumonia patient 1275 plasma</value><value>stimuated with gram-positive pneumonia patient 1287 plasma</value><value>stimuated with gram-positive pneumonia patient 1325 plasma</value><value>stimuated with gram-positive pneumonia patient 1344 plasma</value><value>stimuated with gram-positive pneumonia patient 1353 plasma</value><value>stimuated with gram-positive pneumonia patient 1382 plasma</value><value>stimuated with gram-positive pneumonia patient 1403 plasma</value><value>stimuated with gram-positive pneumonia patient 1410 plasma</value><value>stimuated with gram-positive pneumonia patient 1412 plasma</value><value>stimuated with HC1006 plasma</value><value>stimuated with HC1259 plasma</value><value>stimuated with HC1369 plasma</value><value>stimuated with HC1534 plasma</value><value>stimuated with HC1730 plasma</value><value>stimuated with HC217 plasma</value><value>stimuated with HC226 plasma</value><value>stimuated with HC2301 plasma</value><value>stimuated with HC233 plasma</value><value>stimuated with HC272 plasma</value><value>stimuated with HC285 plasma</value><value>stimuated with HC294 plasma</value><value>stimuated with HC295 plasma</value><value>stimuated with HC381 plasma</value><value>stimuated with HC385 plasma</value><value>stimuated with HC389 plasma</value><value>stimuated with HC390 plasma</value><value>stimuated with HC393 plasma</value><value>stimulated with 033S pre flu plasma</value><value>stimulated with 033T active flu plasma</value><value>stimulated with 1052A pre flu plasma</value><value>stimulated with 1052B active flu plasma</value><value>stimulated with 1090A pre flu plasma</value><value>stimulated with 1090B active flu plasma</value><value>stimulated with 121F pre flu plasma</value><value>stimulated with 121G active flu plasma</value><value>stimulated with 1223A pre flu plasma</value><value>stimulated with 1223B active flu plasma</value><value>stimulated with Auto250S10 plasma</value><value>stimulated with Auto250S12 plasma</value><value>stimulated with Auto250S14 plasma</value><value>stimulated with Auto250S15 plasma</value><value>stimulated with Auto250S7 plasma</value><value>stimulated with Auto250S8 plasma</value><value>stimulated with Auto250S9 plasma</value><value>stimulated with autologous plasma</value><value>stimulated with CF4017 plasma</value><value>stimulated with CF4024 plasma</value><value>stimulated with CF4026 plasma</value><value>stimulated with CF4045 plasma</value><value>stimulated with CF4047 plasma</value><value>stimulated with CF4087 plasma</value><value>stimulated with CF4088 plasma</value><value>stimulated with CF4091 plasma</value><value>stimulated with CF4107 plasma</value><value>stimulated with CF4133 plasma</value><value>stimulated with CF4138 plasma</value><value>stimulated with CF4157 plasma</value><value>stimulated with CF4184 plasma</value><value>stimulated with CF4256 plasma</value><value>stimulated with CF4265 plasma</value><value>stimulated with CF4271 plasma</value><value>stimulated with CF4285 plasma</value><value>stimulated with CF4297 plasma</value><value>stimulated with CF4304 plasma</value><value>stimulated with CF4305 plasma</value><value>stimulated with HC1006 plasma</value><value>stimulated with HC1089 plasma</value><value>stimulated with HC1142 plasma</value><value>stimulated with HC1249 plasma</value><value>stimulated with HC1259 plasma</value><value>stimulated with HC1265 plasma</value><value>stimulated with HC1271 plasma</value><value>stimulated with HC1301 plasma</value><value>stimulated with HC1365 plasma</value><value>stimulated with HC1369 plasma</value><value>stimulated with HC1534 plasma</value><value>stimulated with HC1543 plasma</value><value>stimulated with HC1601 plasma</value><value>stimulated with HC1678 plasma</value><value>stimulated with HC1730 plasma</value><value>stimulated with HC1777 plasma</value><value>stimulated with HC2074 plasma</value><value>stimulated with HC2146 plasma</value><value>stimulated with HC217 plasma</value><value>stimulated with HC223 plasma</value><value>stimulated with HC224 plasma</value><value>stimulated with HC226 plasma</value><value>stimulated with HC227 plasma</value><value>stimulated with HC2300 plasma</value><value>stimulated with HC2301 plasma</value><value>stimulated with HC2302 plasma</value><value>stimulated with HC233 plasma</value><value>stimulated with HC2369 plasma</value><value>stimulated with HC2593 plasma</value><value>stimulated with HC2614 plasma</value><value>stimulated with HC272 plasma</value><value>stimulated with HC2790 plasma</value><value>stimulated with HC285 plasma</value><value>stimulated with HC294 plasma</value><value>stimulated with HC295 plasma</value><value>stimulated with HC304 plasma</value><value>stimulated with HC305 plasma</value><value>stimulated with HC307 plasma</value><value>stimulated with HC308 plasma</value><value>stimulated with HC322 plasma</value><value>stimulated with HC375 plasma</value><value>stimulated with HC379 plasma</value><value>stimulated with HC381 plasma</value><value>stimulated with HC382 plasma</value><value>stimulated with HC384 plasma</value><value>stimulated with HC385 plasma</value><value>stimulated with HC388 plasma</value><value>stimulated with HC390 plasma</value><value>stimulated with HC394 plasma</value><value>stimulated with HCy1006 plasma</value><value>stimulated with HCy1837 plasma</value><value>stimulated with HCy217 plasma</value><value>stimulated with HCy226 plasma</value><value>stimulated with HCy2301 plasma</value><value>stimulated with HCy233 plasma</value><value>stimulated with HCy252 plasma</value><value>stimulated with HCy284 plasma</value><value>stimulated with HCy294 plasma</value><value>stimulated with HCy295 plasma</value><value>stimulated with HCy385 plasma</value><value>stimulated with HCy390 plasma</value><value>stimulated with HCy393 plasma</value><value>stimulated with LO1063 (timepoint 3) plasma</value><value>stimulated with LO1377 (timepoint 4) plasma</value><value>stimulated with LO1910 (timepoint 5) plasma</value><value>stimulated with LO2132 (timepoint 6) plasma</value><value>stimulated with LO3 (timepoint 1) plasma</value><value>stimulated with LO350 (timepoint 2) plasma</value><value>stimulated with LS1053 plasma</value><value>stimulated with LS1110 plasma</value><value>stimulated with LS1296 plasma</value><value>stimulated with LS264 plasma</value><value>stimulated with LS311 plasma</value><value>stimulated with LS35 plasma</value><value>stimulated with LS38 plasma</value><value>stimulated with LS59 plasma</value><value>stimulated with LS599 plasma</value><value>stimulated with LS66 plasma</value><value>stimulated with LS96 plasma</value><value>stimulated with RO1012 plasma</value><value>stimulated with RO1037 plasma</value><value>stimulated with RO1057 plasma</value><value>stimulated with RO1225 plasma</value><value>stimulated with RO1437 plasma</value><value>stimulated with RO1442 plasma</value><value>stimulated with RO1579 plasma</value><value>stimulated with RO159 plasma</value><value>stimulated with RO1707 plasma</value><value>stimulated with RO189 plasma</value><value>stimulated with RO1939 plasma</value><value>stimulated with RO1964 plasma</value><value>stimulated with RO1973 plasma</value><value>stimulated with RO1997 plasma</value><value>stimulated with RO201 plasma</value><value>stimulated with RO2024 plasma</value><value>stimulated with RO2109 plasma</value><value>stimulated with RO2130 plasma</value><value>stimulated with RO2185 plasma</value><value>stimulated with RO2312 plasma</value><value>stimulated with RO2348 plasma</value><value>stimulated with RO2359 plasma</value><value>stimulated with RO2366 plasma</value><value>stimulated with RO246 plasma</value><value>stimulated with RO2503 plasma</value><value>stimulated with RO253 plasma</value><value>stimulated with RO2559 plasma</value><value>stimulated with RO2598 plasma</value><value>stimulated with RO2676 plasma</value><value>stimulated with RO2751 plasma</value><value>stimulated with RO2808 plasma</value><value>stimulated with RO2903 plasma</value><value>stimulated with RO2936 plasma</value><value>stimulated with RO2944 plasma</value><value>stimulated with RO2953 plasma</value><value>stimulated with RO2991 plasma</value><value>stimulated with RO3040 plasma</value><value>stimulated with RO3045 plasma</value><value>stimulated with RO3052 plasma</value><value>stimulated with RO3087 plasma</value><value>stimulated with RO3139 plasma</value><value>stimulated with RO3153 plasma</value><value>stimulated with RO62 plasma</value><value>stimulated with RO930 plasma</value><value>stimulated with RO946 plasma</value><value>stimulated with RO972 plasma</value></experimentalfactor><miamescores><reportersequencescore>1</reportersequencescore><protocolscore>1</protocolscore><factorvaluescore>1</factorvaluescore><derivedbioassaydatascore>1</derivedbioassaydatascore><measuredbioassaydatascore>1</measuredbioassaydatascore><overallscore>5</overallscore></miamescores><id>242313</id><accession>E-GEOD-35713</accession><secondaryaccession>GSE35713</secondaryaccession><name>Transcriptional Signatures as a Disease-Specific and Predictive Inflammatory Biomarker for Type 1 Diabetes</name><experimenttype>transcription profiling by array</experimenttype><releasedate>2012-09-01</releasedate><lastupdatedate>2012-10-04</lastupdatedate><samples>203</samples><assays>203</assays><arraydesign><id>11119</id><accession>A-AFFY-44</accession><name>Affymetrix GeneChip Human Genome U133 Plus 2.0 [HG-U133_Plus_2]</name><count>203</count><legacy_id>405156763</legacy_id></arraydesign><bioassaydatagroup><id/><name>rawData</name><bioassaydatacubes>203</bioassaydatacubes><arraydesignprovider/><dataformat>rawData</dataformat><bioassays>203</bioassays><isderived>0</isderived></bioassaydatagroup><bioassaydatagroup><id/><name>normalization</name><bioassaydatacubes>203</bioassaydatacubes><arraydesignprovider/><dataformat>normalization</dataformat><bioassays>203</bioassays><isderived>0</isderived></bioassaydatagroup><bioassaydatagroup><id/><name>processedData</name><bioassaydatacubes>203</bioassaydatacubes><arraydesignprovider/><dataformat>processedData</dataformat><bioassays>203</bioassays><isderived>0</isderived></bioassaydatagroup><provider><contact>Martin Hessner</contact><role>submitter</role><email>mhessner@mcw.edu</email></provider><description><id/><text>This SuperSeries is composed of the following subset Series: GSE35711: Transcriptional Signatures as a Disease-Specific and Predictive Inflammatory Biomarker for Type 1 Diabetes [CF_S1S3_5Auto_20CF_10HC] GSE35712: Transcriptional Signatures as a Disease-Specific and Predictive Inflammatory Biomarker for Type 1 Diabetes [H1N1_S5_5Pre_5D0] GSE35716: Transcriptional Signatures as a Disease-Specific and Predictive Inflammatory Biomarker for Type 1 Diabetes [Pneu_S3S24_10Pneu_4HC] GSE35725: Transcriptional Signatures as a Disease-Specific and Predictive Inflammatory Biomarker for Type 1 Diabetes [T1D_114] Refer to individual Series</text></description><protocol><id>641398</id><accession>P-GSE35713-9</accession></protocol><protocol><id>641394</id><accession>P-GSE35713-3</accession></protocol><protocol><id>641396</id><accession>P-GSE35713-4</accession></protocol><protocol><id>641389</id><accession>P-GSE35713-1</accession></protocol><protocol><id>641397</id><accession>P-GSE35713-10</accession></protocol><protocol><id>641395</id><accession>P-GSE35713-11</accession></protocol><protocol><id>641399</id><accession>P-GSE35713-2</accession></protocol><protocol><id>641390</id><accession>P-GSE35713-7</accession></protocol><protocol><id>641391</id><accession>P-GSE35713-8</accession></protocol><protocol><id>641393</id><accession>P-GSE35713-5</accession></protocol><protocol><id>641392</id><accession>P-GSE35713-6</accession></protocol><organism>Homo sapiens</organism><files><!--
This section is deprecated and unsupported.
Please use webservice located at:
    http://www.ebi.ac.uk/arrayexpress/xml/files
to obtain detailed information on files available for the experiment.
For more information, please go to:
    http://www.ebi.ac.uk/arrayexpress/help/programmatic_access.html
                --><raw name="E-GEOD-35713.raw.1.zip E-GEOD-35713.raw.2.zip E-GEOD-35713.raw.3.zip E-GEOD-35713.raw.4.zip E-GEOD-35713.raw.5.zip E-GEOD-35713.raw.6.zip" count="true" celcount="0"/><fgem name="E-GEOD-35713.processed.1.zip" available="true"/><idf name="E-GEOD-35713.idf.txt"/><sdrf name="E-GEOD-35713.sdrf.txt"/></files></experiment><experiment><species>Homo sapiens</species><rawdatafiles available="false"/><processeddatafiles available="true"/><sampleattribute><category>day</category><value>1</value><value>2</value><value>3</value><value>4</value><value>5</value></sampleattribute><sampleattribute><category>ID</category><value>1</value><value>10</value><value>11</value><value>12</value><value>13</value><value>14</value><value>15</value><value>16</value><value>17</value><value>18</value><value>19</value><value>2</value><value>20</value><value>21</value><value>22</value><value>23</value><value>24</value><value>25</value><value>26</value><value>27</value><value>28</value><value>29</value><value>3</value><value>30</value><value>31</value><value>32</value><value>33</value><value>34</value><value>35</value><value>36</value><value>37</value><value>38</value><value>39</value><value>4</value><value>40</value><value>41</value><value>42</value><value>43</value><value>44</value><value>45</value><value>46</value><value>47</value><value>48</value><value>49</value><value>5</value><value>50</value><value>51</value><value>52</value><value>53</value><value>54</value><value>55</value><value>56</value><value>57</value><value>58</value><value>6</value><value>7</value><value>8</value><value>9</value></sampleattribute><sampleattribute><category>Organism</category><value>Homo sapiens</value></sampleattribute><sampleattribute><category>organism part</category><value>PAXgene whole blood</value></sampleattribute><sampleattribute><category>sample type</category><value>bacterial pneumonia</value><value>healthy control</value><value>influenza A pneumonia</value><value>mixed bacterial and influenza A pneumonia</value><value>systemic inflammatory response</value></sampleattribute><sampleattribute><category>sex</category><value>female</value><value>male</value></sampleattribute><experimentalfactor><name>DAY</name><value>1</value><value>2</value><value>3</value><value>4</value><value>5</value></experimentalfactor><experimentalfactor><name>ID</name><value>1</value><value>10</value><value>11</value><value>12</value><value>13</value><value>14</value><value>15</value><value>16</value><value>17</value><value>18</value><value>19</value><value>2</value><value>20</value><value>21</value><value>22</value><value>23</value><value>24</value><value>25</value><value>26</value><value>27</value><value>28</value><value>29</value><value>3</value><value>30</value><value>31</value><value>32</value><value>33</value><value>34</value><value>35</value><value>36</value><value>37</value><value>38</value><value>39</value><value>4</value><value>40</value><value>41</value><value>42</value><value>43</value><value>44</value><value>45</value><value>46</value><value>47</value><value>48</value><value>49</value><value>5</value><value>50</value><value>51</value><value>52</value><value>53</value><value>54</value><value>55</value><value>56</value><value>57</value><value>58</value><value>6</value><value>7</value><value>8</value><value>9</value></experimentalfactor><experimentalfactor><name>SAMPLE TYPE</name><value>bacterial pneumonia</value><value>healthy control</value><value>influenza A pneumonia</value><value>mixed bacterial and influenza A pneumonia</value><value>systemic inflammatory response</value></experimentalfactor><experimentalfactor><name>SEX</name><value>female</value><value>male</value></experimentalfactor><miamescores><reportersequencescore>1</reportersequencescore><protocolscore>1</protocolscore><factorvaluescore>1</factorvaluescore><derivedbioassaydatascore>1</derivedbioassaydatascore><measuredbioassaydatascore>0</measuredbioassaydatascore><overallscore>4</overallscore></miamescores><id>232269</id><accession>E-GEOD-40012</accession><secondaryaccession>GSE40012</secondaryaccession><name>Blood transcriptome of human bacterial and influenza A pneumonia</name><experimenttype>transcription profiling by array</experimenttype><releasedate>2012-08-14</releasedate><lastupdatedate>2012-08-20</lastupdatedate><samples>190</samples><assays>190</assays><arraydesign><id>13379</id><accession>A-MEXP-1171</accession><name>Illumina HumanHT-12 v3.0 Expression BeadChip</name><count>190</count><legacy_id>1633174974</legacy_id></arraydesign><bioassaydatagroup><id/><name>normalization</name><bioassaydatacubes>190</bioassaydatacubes><arraydesignprovider/><dataformat>normalization</dataformat><bioassays>190</bioassays><isderived>0</isderived></bioassaydatagroup><bioassaydatagroup><id/><name>processedData</name><bioassaydatacubes>190</bioassaydatacubes><arraydesignprovider/><dataformat>processedData</dataformat><bioassays>190</bioassays><isderived>0</isderived></bioassaydatagroup><provider><contact>Grant Parnell</contact><role>submitter</role><email>gpar3109@uni.sydney.edu.au</email></provider><provider><contact>Grant P Parnell</contact><role/><email/></provider><provider><contact>Benjamin M Tang</contact><role/><email/></provider><description><id/><text>Introduction: Diagnosis of severe influenza pneumonia remains challenging because of the lack of correlation between presence of influenza virus and patient’s clinical status. We conducted gene expression profiling in the whole blood of critically ill patients to identify a gene signature that would allow clinicians to distinguish influenza infection from other causes of severe respiratory failure (e.g. bacterial pneumonia, non-infective systemic inflammatory response syndrome).   Methods: Whole blood samples were collected from critically ill individuals and assayed on Illumina HT-12 gene expression beadarrays. Differentially expressed genes were determined by linear mixed model analysis and over-represented biological pathways determined using GeneGo MetaCore.   Results: The gene expression profile of H1N1 influenza A pneumonia was distinctly different from bacterial pneumonia and systemic inflammatory response syndrome. The influenza gene expression profile is characterized by up-regulation of genes from cell cycle regulation, apoptosis and DNA-damage response pathways. In contrast, no distinctive gene-expression signature was found in patients with bacterial pneumonia or systemic inflammatory response syndrome. The gene expression profile of influenza infection persisted through five days of follow-up. Furthermore, in patients with primary H1N1 influenza A infection who subsequently developed bacterial co-infection, the influenza gene-expression signature remained unaltered, despite the presence of a super-imposed bacterial infection.   Conclusions: The whole blood expression profiling data indicates that the host response to influenza pneumonia is distinctly different from that caused by bacterial pathogens. This information may speed up identification of the cause of infection in patients presenting with severe respiratory failure, allowing appropriate patient care to be undertaken more rapidly. Daily PAXgene samples for up to 5 days for; influenza A pneumonia patients (n=8),  bacterial pneumonia patients (n=16), mixed bacterial and influenza A pneumonia patients (n=3), systemic inflammatory response patients (SIRS, n=13). Days 1 and 5 PAXgene samples for healthy control individuals</text></description><protocol><id>620886</id><accession>P-GSE40012-3</accession></protocol><protocol><id>620885</id><accession>P-GSE40012-4</accession></protocol><protocol><id>620882</id><accession>P-GSE40012-5</accession></protocol><protocol><id>620884</id><accession>P-GSE40012-6</accession></protocol><protocol><id>620887</id><accession>P-GSE40012-2</accession></protocol><protocol><id>620883</id><accession>P-GSE40012-1</accession></protocol><organism>Homo sapiens</organism><files><!--
This section is deprecated and unsupported.
Please use webservice located at:
    http://www.ebi.ac.uk/arrayexpress/xml/files
to obtain detailed information on files available for the experiment.
For more information, please go to:
    http://www.ebi.ac.uk/arrayexpress/help/programmatic_access.html
                --><fgem name="E-GEOD-40012.processed.1.zip" available="true"/><idf name="E-GEOD-40012.idf.txt"/><sdrf name="E-GEOD-40012.sdrf.txt"/></files></experiment><experiment><species>Homo sapiens</species><rawdatafiles available="true"/><processeddatafiles available="false"/><sampleattribute><category>Age</category><value>23 years</value><value>30 years</value><value>42 years</value><value>49 years</value><value>70 years</value><value>74 years</value><value>77 years</value></sampleattribute><sampleattribute><category>BioSourceType</category><value>fresh_sample</value></sampleattribute><sampleattribute><category>ClinicalHistory</category><value>infection</value><value>preinfection</value></sampleattribute><sampleattribute><category>DevelopmentalStage</category><value>adult</value></sampleattribute><sampleattribute><category>DiseaseState</category><value>VAP - Ventilated associated pneumonia</value><value>VAT - Ventilated associated tracheobronchitis</value></sampleattribute><sampleattribute><category>Individual</category><value>10130098</value><value>10135357</value><value>10159733</value><value>10171128</value><value>10180455</value><value>10280811</value><value>11138012</value><value>11160634</value></sampleattribute><sampleattribute><category>InitialTimePoint</category><value>beginning_of_stage</value></sampleattribute><sampleattribute><category>Organism</category><value>Homo sapiens</value></sampleattribute><sampleattribute><category>OrganismPart</category><value>blood</value></sampleattribute><sampleattribute><category>provider</category><value>ICU Joan XXIII Hospital</value></sampleattribute><sampleattribute><category>Sex</category><value>female</value><value>male</value></sampleattribute><sampleattribute><category>TargetedCellType</category><value>blood cells</value></sampleattribute><experimentalfactor><name>CLINICAL_INFORMATION</name><value>infection</value><value>preinfection</value></experimentalfactor><experimentalfactor><name>DISEASE_STATE</name><value>VAP - Ventilated associated pneumonia</value><value>VAT - Ventilated associated tracheobronchitis</value></experimentalfactor><miamescores><reportersequencescore>1</reportersequencescore><protocolscore>1</protocolscore><factorvaluescore>1</factorvaluescore><derivedbioassaydatascore>0</derivedbioassaydatascore><measuredbioassaydatascore>1</measuredbioassaydatascore><overallscore>4</overallscore></miamescores><id>88422</id><accession>E-MEXP-3001</accession><name>Intubated patients developing Tracheobronchitis or Pneumonia have distinctive complement system gene expression signatures</name><experimenttype>transcription profiling by array</experimenttype><releasedate>2012-06-19</releasedate><lastupdatedate>2011-10-12</lastupdatedate><samples>56</samples><assays>56</assays><arraydesign><id>11853</id><accession>A-AGIL-28</accession><name>Agilent Whole Human Genome Microarray 4x44K 014850 G4112F (85 cols x 532 rows)</name><count>56</count><legacy_id>1316855037</legacy_id></arraydesign><bioassaydatagroup><id/><name>rawData</name><bioassaydatacubes>56</bioassaydatacubes><arraydesignprovider/><dataformat>rawData</dataformat><bioassays>56</bioassays><isderived>0</isderived></bioassaydatagroup><bioassaydatagroup><id/><name>scan</name><bioassaydatacubes>56</bioassaydatacubes><arraydesignprovider/><dataformat>scan</dataformat><bioassays>56</bioassays><isderived>0</isderived></bioassaydatagroup><provider><contact>Guillermo Lopez</contact><role>submitter</role><email>glopez@isciii.es</email></provider><experimentdesign>clinical history</experimentdesign><experimentdesign>co-expression</experimentdesign><experimentdesign>disease state</experimentdesign><experimentdesign>in vivo</experimentdesign><description><id/><text>The onset of an infection-specific transcriptional program precedes the clinical diagnosis in patients who developed Ventilator-associated pneumonia (VAP). Ventilator-associated tracheobronchitis (VAT) is another respiratory infection affecting<br/><br/>outcomes in intubated patients, but interactions between VAT and VAP remains unknown.</text></description><protocol><id>85035</id><accession>P-AGIL-29</accession></protocol><protocol><id>242599</id><accession>P-MTAB-17954</accession></protocol><protocol><id>85037</id><accession>P-AGIL-2</accession></protocol><protocol><id>85039</id><accession>P-AGIL-1</accession></protocol><organism>Homo sapiens</organism><files><!--
This section is deprecated and unsupported.
Please use webservice located at:
    http://www.ebi.ac.uk/arrayexpress/xml/files
to obtain detailed information on files available for the experiment.
For more information, please go to:
    http://www.ebi.ac.uk/arrayexpress/help/programmatic_access.html
                --><raw name="E-MEXP-3001.raw.1.zip E-MEXP-3001.raw.2.zip E-MEXP-3001.raw.3.zip" count="true" celcount="0"/><idf name="E-MEXP-3001.idf.txt"/><sdrf name="E-MEXP-3001.sdrf.txt"/></files></experiment><experiment><species>Homo sapiens</species><rawdatafiles available="true"/><processeddatafiles available="true"/><sampleattribute><category>infection (virus strain)</category><value>Influenza A/H1N1 virus isolated from a patient with fatal pneumonia during the first outbreak in Mexico City in April 2009.</value><value>Influenza seasonal virus A/PR/8/34 strain</value></sampleattribute><sampleattribute><category>Organism</category><value>Homo sapiens</value></sampleattribute><sampleattribute><category>sample</category><value>5 treated macrophages from five independent experiments were pooled.</value></sampleattribute><experimentalfactor><name>INFECTION (VIRUS STRAIN)</name><value>Influenza A/H1N1 virus isolated from a patient with fatal pneumonia during the first outbreak in Mexico City in April 2009.</value><value>Influenza seasonal virus A/PR/8/34 strain</value></experimentalfactor><miamescores><reportersequencescore>0</reportersequencescore><protocolscore>0</protocolscore><factorvaluescore>1</factorvaluescore><derivedbioassaydatascore>1</derivedbioassaydatascore><measuredbioassaydatascore>1</measuredbioassaydatascore><overallscore>3</overallscore></miamescores><id>212298</id><accession>E-GEOD-36012</accession><secondaryaccession>GSE36012</secondaryaccession><name>Genome-wide mRNA expression profiles induced by infection with the pandemic and seasonal influenza A viruses in macrophages</name><experimenttype>transcription profiling by array</experimenttype><releasedate>2012-06-09</releasedate><lastupdatedate>2012-06-21</lastupdatedate><samples>4</samples><assays>4</assays><arraydesign><id>9595</id><accession>A-AFFY-141</accession><name>Affymetrix GeneChip Human Gene 1.0 ST Array [HuGene-1_0-st-v1]</name><count>4</count><legacy_id>1759805535</legacy_id></arraydesign><bioassaydatagroup><id/><name>rawData</name><bioassaydatacubes>4</bioassaydatacubes><arraydesignprovider/><dataformat>rawData</dataformat><bioassays>4</bioassays><isderived>0</isderived></bioassaydatagroup><bioassaydatagroup><id/><name>normalization</name><bioassaydatacubes>4</bioassaydatacubes><arraydesignprovider/><dataformat>normalization</dataformat><bioassays>4</bioassays><isderived>0</isderived></bioassaydatagroup><bioassaydatagroup><id/><name>processedData</name><bioassaydatacubes>4</bioassaydatacubes><arraydesignprovider/><dataformat>processedData</dataformat><bioassays>4</bioassays><isderived>0</isderived></bioassaydatagroup><provider><contact>Annie Pardo</contact><role/><email/></provider><provider><contact>Irma Aguilar</contact><role/><email/></provider><provider><contact>Benjamin T Suratt</contact><role/><email/></provider><provider><contact>Elsy Canché-Pool</contact><role/><email/></provider><provider><contact>Carlos Cabello</contact><role/><email/></provider><provider><contact>Sandra Lorena Romero-Cordoba</contact><role>submitter</role><email>sromero_cordoba@hotmail.com</email></provider><provider><contact>Moisés Selman</contact><role/><email/></provider><provider><contact>Sandra Romero-Cordoba</contact><role/><email/></provider><provider><contact>Enrique Espinosa</contact><role/><email/></provider><provider><contact>Teresa Herrera</contact><role/><email/></provider><provider><contact>Blanca Ortiz-Quintero</contact><role/><email/></provider><provider><contact>Alfredo Hidalgo-Miranda</contact><role/><email/></provider><provider><contact>Lorena Orozco</contact><role/><email/></provider><provider><contact>Joaquin Zuñiga</contact><role/><email/></provider><provider><contact>Gustavo Ramírez</contact><role/><email/></provider><provider><contact>Andrew M Tager</contact><role/><email/></provider><provider><contact>Luis Jiménez-Alvarez</contact><role/><email/></provider><provider><contact>Alfredo Cruz-Lagunas</contact><role/><email/></provider><provider><contact>Martha Torres</contact><role/><email/></provider><provider><contact>Teresa Santos-Mendoza</contact><role/><email/></provider><description><id/><text>Infection with pandemic A/H1N1 influenza virus induces high levels of circulating and lung pro-inflammatory cytokines and chemokines in experimental models and humans. These inflammatory mediators contribute to poor clinical outcomes of this infection. To compare the regulation of inflammatory responses in seasonal versus pandemic influenza A virus infections, we analyzed the expression of mRNA by the human gene st 1.0 array (affymetrix). We identifed a number of differentially expressed genes by infection of the A/H1N1 compared to the seasonal virus. Gene ontology analysis of these genes found that most of them are involved in several aspects of immunity. These studies suggest that factors inherent in the pandemic A/H1N1 viral strain may augment the production of inflammatory mediators by inhibiting SOCS- 1 expression and that infection with this viral strain also modifies the expression of several immunity related genes and pathways . The experimental design consist in 1 pool and its replicate containing 5 independent experiments from treated macrophages with Influenza A/H1N1 virus, and 1 more pool and its replicate containing 5 independent experiments from treated macrophages with seasonal influenza A virus. By this way, the total number of the samples analyzed was 10 in 4 microarrays.</text></description><protocol><id>559342</id><accession>P-GSE36012-6</accession></protocol><protocol><id>559344</id><accession>P-GSE36012-7</accession></protocol><protocol><id>559339</id><accession>P-GSE36012-4</accession></protocol><protocol><id>559343</id><accession>P-GSE36012-5</accession></protocol><protocol><id>559341</id><accession>P-GSE36012-2</accession></protocol><protocol><id>559340</id><accession>P-GSE36012-3</accession></protocol><protocol><id>559338</id><accession>P-GSE36012-1</accession></protocol><organism>Homo sapiens</organism><files><!--
This section is deprecated and unsupported.
Please use webservice located at:
    http://www.ebi.ac.uk/arrayexpress/xml/files
to obtain detailed information on files available for the experiment.
For more information, please go to:
    http://www.ebi.ac.uk/arrayexpress/help/programmatic_access.html
                --><raw name="E-GEOD-36012.raw.1.zip" count="true" celcount="0"/><fgem name="E-GEOD-36012.processed.1.zip" available="true"/><idf name="E-GEOD-36012.idf.txt"/><sdrf name="E-GEOD-36012.sdrf.txt"/></files></experiment><experiment><species>Homo sapiens</species><rawdatafiles available="true"/><processeddatafiles available="true"/><sampleattribute><category>batch</category><value>1</value><value>2</value><value>3</value></sampleattribute><sampleattribute><category>diagnosis</category><value>HCV/sarcoid</value><value>Healthy</value><value>Hypersensitivity Pnemonitis</value><value>sarcoid vs. BO</value><value>sarcoidosis</value></sampleattribute><sampleattribute><category>dx</category><value>health</value><value>hp</value><value>sarc-hcv</value><value>sarc-vs-bo</value><value>sarc_high_lung_fx</value><value>sarc_low_lung_fx</value></sampleattribute><sampleattribute><category>ethnicity</category><value>Asian</value><value>Black</value><value>Latino</value><value>White</value></sampleattribute><sampleattribute><category>Organism</category><value>Homo sapiens</value></sampleattribute><sampleattribute><category>sex</category><value>F</value><value>M</value></sampleattribute><sampleattribute><category>years</category><value>31</value><value>32</value><value>34</value><value>35</value><value>37</value><value>39</value><value>40</value><value>41</value><value>42</value><value>43</value><value>44</value><value>45</value><value>46</value><value>47</value><value>48</value><value>49</value><value>50</value><value>51</value><value>53</value><value>54</value><value>55</value><value>56</value><value>57</value><value>58</value><value>59</value><value>60</value><value>61</value><value>62</value><value>63</value><value>66</value><value>67</value><value>70</value><value>73</value></sampleattribute><experimentalfactor><name>BATCH</name><value>1</value><value>2</value><value>3</value></experimentalfactor><experimentalfactor><name>DIAGNOSIS</name><value>HCV/sarcoid</value><value>Healthy</value><value>Hypersensitivity Pnemonitis</value><value>sarcoid vs. BO</value><value>sarcoidosis</value></experimentalfactor><experimentalfactor><name>DX</name><value>health</value><value>hp</value><value>sarc-hcv</value><value>sarc-vs-bo</value><value>sarc_high_lung_fx</value><value>sarc_low_lung_fx</value></experimentalfactor><experimentalfactor><name>ETHNICITY</name><value>Asian</value><value>Black</value><value>Latino</value><value>White</value></experimentalfactor><experimentalfactor><name>SEX</name><value>F</value><value>M</value></experimentalfactor><experimentalfactor><name>YEARS</name><value>31</value><value>32</value><value>34</value><value>35</value><value>37</value><value>39</value><value>40</value><value>41</value><value>42</value><value>43</value><value>44</value><value>45</value><value>46</value><value>47</value><value>48</value><value>49</value><value>50</value><value>51</value><value>53</value><value>54</value><value>55</value><value>56</value><value>57</value><value>58</value><value>59</value><value>60</value><value>61</value><value>62</value><value>63</value><value>66</value><value>67</value><value>70</value><value>73</value></experimentalfactor><miamescores><reportersequencescore>1</reportersequencescore><protocolscore>1</protocolscore><factorvaluescore>1</factorvaluescore><derivedbioassaydatascore>1</derivedbioassaydatascore><measuredbioassaydatascore>1</measuredbioassaydatascore><overallscore>5</overallscore></miamescores><id>225428</id><accession>E-GEOD-19314</accession><secondaryaccession>GSE19314</secondaryaccession><name>Sarcoidosis-specific markers from whole blood gene expression</name><experimenttype>transcription profiling by array</experimenttype><releasedate>2011-08-10</releasedate><lastupdatedate>2012-07-24</lastupdatedate><samples>66</samples><assays>66</assays><arraydesign><id>11119</id><accession>A-AFFY-44</accession><name>Affymetrix GeneChip Human Genome U133 Plus 2.0 [HG-U133_Plus_2]</name><count>66</count><legacy_id>405156763</legacy_id></arraydesign><bioassaydatagroup><id/><name>rawData</name><bioassaydatacubes>66</bioassaydatacubes><arraydesignprovider/><dataformat>rawData</dataformat><bioassays>66</bioassays><isderived>0</isderived></bioassaydatagroup><bioassaydatagroup><id/><name>normalization</name><bioassaydatacubes>66</bioassaydatacubes><arraydesignprovider/><dataformat>normalization</dataformat><bioassays>66</bioassays><isderived>0</isderived></bioassaydatagroup><bioassaydatagroup><id/><name>processedData</name><bioassaydatacubes>66</bioassaydatacubes><arraydesignprovider/><dataformat>processedData</dataformat><bioassays>66</bioassays><isderived>0</isderived></bioassaydatagroup><provider><contact>Prescott G Woodruff</contact><role/><email/></provider><provider><contact>Laura L Koth</contact><role/><email/></provider><provider><contact>Prescott Gurney Woodruff</contact><role>submitter</role><email>prescott.woodruff@ucsf.edu</email></provider><description><id/><text>We hypothesized that microarray analyses of whole blood gene expression would identify patterns of gene expression useful in the diagnosis for sacroidosis and identify inflammatory mediators relevant to the underlying pathophysiology. We analyzed whole blood RNA from 37 patients with sarcoidosis, 20 healthy controls and 6 patients with hypersensitivity pneumonitis using genome-wide expression microarrays. We developed a classification algorithm using a derivation and validation subset approach, analyzed the most discriminative gene expression changes, and confirmed selected expression changes using flow-cytometry.</text></description><protocol><id>604846</id><accession>P-GSE19314-1</accession></protocol><protocol><id>604849</id><accession>P-GSE19314-5</accession></protocol><protocol><id>604851</id><accession>P-GSE19314-4</accession></protocol><protocol><id>604850</id><accession>P-GSE19314-3</accession></protocol><protocol><id>604848</id><accession>P-GSE19314-2</accession></protocol><protocol><id>604847</id><accession>P-GSE19314-6</accession></protocol><organism>Homo sapiens</organism><files><!--
This section is deprecated and unsupported.
Please use webservice located at:
    http://www.ebi.ac.uk/arrayexpress/xml/files
to obtain detailed information on files available for the experiment.
For more information, please go to:
    http://www.ebi.ac.uk/arrayexpress/help/programmatic_access.html
                --><raw name="E-GEOD-19314.raw.1.zip E-GEOD-19314.raw.2.zip" count="true" celcount="0"/><fgem name="E-GEOD-19314.processed.1.zip" available="true"/><idf name="E-GEOD-19314.idf.txt"/><sdrf name="E-GEOD-19314.sdrf.txt"/></files></experiment><experiment><species>Homo sapiens</species><rawdatafiles available="false"/><processeddatafiles available="true"/><sampleattribute><category>Organism</category><value>Homo sapiens</value></sampleattribute><sampleattribute><category>tissue</category><value>Paxgene Whole Blood RNA Samples</value></sampleattribute><miamescores><reportersequencescore>1</reportersequencescore><protocolscore>0</protocolscore><factorvaluescore>0</factorvaluescore><derivedbioassaydatascore>1</derivedbioassaydatascore><measuredbioassaydatascore>0</measuredbioassaydatascore><overallscore>2</overallscore></miamescores><id>90405</id><accession>E-GEOD-20346</accession><secondaryaccession>GSE20346</secondaryaccession><name>Expression profiling of critically ill influenza and bacterial pneumonia patients, also influenza vaccination recipients</name><experimenttype>transcription profiling by array</experimenttype><releasedate>2011-06-30</releasedate><lastupdatedate>2011-07-12</lastupdatedate><samples>81</samples><assays>81</assays><arraydesign><id>13379</id><accession>A-MEXP-1171</accession><name>Illumina HumanHT-12 v3.0 Expression BeadChip</name><count>81</count><legacy_id>1633174974</legacy_id></arraydesign><bioassaydatagroup><id/><name>normalization</name><bioassaydatacubes>81</bioassaydatacubes><arraydesignprovider/><dataformat>normalization</dataformat><bioassays>81</bioassays><isderived>0</isderived></bioassaydatagroup><bioassaydatagroup><id/><name>processedData</name><bioassaydatacubes>81</bioassaydatacubes><arraydesignprovider/><dataformat>processedData</dataformat><bioassays>81</bioassays><isderived>0</isderived></bioassaydatagroup><provider><contact>Grant Parnell</contact><role>submitter</role><email>gpar3109@med.usyd.edu.au</email></provider><provider><contact>Benjamin Tang</contact><role/><email/></provider><provider><contact>Grant P Parnell</contact><role/><email/></provider><description><id/><text>Longitudinal Gene expression profiling of whole blood from critically ill influenza and bacterial pneumonia patients.  In addition before vs 7 days post influenza vaccination volunteer samples are assayed. 3 groups of samples.  First is bacterial pneumonia patients with 6 subjects sampled for up to 5 days.  Second group is severe influenza infection with 4 subjects sampled for up to 5 days.  Third group is influenza vaccination with 18 subjects sampled before and 7 days post vaccination.</text></description><protocol><id>249170</id><accession>P-GSE20346-3</accession></protocol><protocol><id>249172</id><accession>P-GSE20346-4</accession></protocol><protocol><id>249168</id><accession>P-GSE20346-1</accession></protocol><protocol><id>249169</id><accession>P-GSE20346-2</accession></protocol><protocol><id>249166</id><accession>P-GSE20346-7</accession></protocol><protocol><id>249171</id><accession>P-GSE20346-5</accession></protocol><protocol><id>249167</id><accession>P-GSE20346-6</accession></protocol><organism>Homo sapiens</organism><files><!--
This section is deprecated and unsupported.
Please use webservice located at:
    http://www.ebi.ac.uk/arrayexpress/xml/files
to obtain detailed information on files available for the experiment.
For more information, please go to:
    http://www.ebi.ac.uk/arrayexpress/help/programmatic_access.html
                --><fgem name="E-GEOD-20346.processed.1.zip" available="true"/><idf name="E-GEOD-20346.idf.txt"/><sdrf name="E-GEOD-20346.sdrf.txt"/></files></experiment><experiment><species>Homo sapiens</species><rawdatafiles available="true"/><processeddatafiles available="true"/><sampleattribute><category>age</category><value>40</value><value>49</value><value>53</value><value>54</value><value>59</value><value>63</value><value>70</value><value>72</value><value>76</value><value>81</value><value>87</value></sampleattribute><sampleattribute><category>cancer stage</category><value>IA</value><value>IB</value><value>IIA</value><value>IIB</value><value>IV</value><value>NO CANCER</value></sampleattribute><sampleattribute><category>cell type</category><value>large airway epithelial cells</value></sampleattribute><sampleattribute><category>disease state</category><value>Lung Cancer</value><value>No Lung Cancer</value></sampleattribute><sampleattribute><category>histology</category><value>adenocarcinoma</value><value>Chronic inflammation</value><value>Granuloma</value><value>Large Cell Carcinoma</value><value>Non-Small-Cell Carcinoma</value><value>normal</value><value>Organizing pneumonitis</value><value>Sarcoid</value><value>squamous cell carcinoma</value></sampleattribute><sampleattribute><category>Organism</category><value>Homo sapiens</value></sampleattribute><sampleattribute><category>packyears</category><value>15</value><value>21-42</value><value>24</value><value>40</value><value>48</value><value>50</value><value>75-100</value><value>90</value><value>&gt;20</value><value>&gt;60</value><value>NA</value></sampleattribute><sampleattribute><category>sex</category><value>female</value><value>male</value><value>NA</value></sampleattribute><sampleattribute><category>smoking status</category><value>Current</value><value>Former</value></sampleattribute><sampleattribute><category>years passed since quitting</category><value>20</value><value>22</value><value>30</value><value>5</value><value>7</value><value>8</value><value>less than 1</value></sampleattribute><experimentalfactor><name>AGE</name><value>40</value><value>49</value><value>53</value><value>54</value><value>59</value><value>63</value><value>70</value><value>72</value><value>76</value><value>81</value><value>87</value></experimentalfactor><experimentalfactor><name>CANCER STAGE</name><value>IA</value><value>IB</value><value>IIA</value><value>IIB</value><value>IV</value><value>NO CANCER</value></experimentalfactor><experimentalfactor><name>DISEASE STATE</name><value>Lung Cancer</value><value>No Lung Cancer</value></experimentalfactor><experimentalfactor><name>HISTOLOGY</name><value>adenocarcinoma</value><value>Chronic inflammation</value><value>Granuloma</value><value>Large Cell Carcinoma</value><value>Non-Small-Cell Carcinoma</value><value>normal</value><value>Organizing pneumonitis</value><value>Sarcoid</value><value>squamous cell carcinoma</value></experimentalfactor><experimentalfactor><name>PACKYEARS</name><value>15</value><value>21-42</value><value>24</value><value>40</value><value>48</value><value>50</value><value>75-100</value><value>90</value><value>&gt;20</value><value>&gt;60</value><value>NA</value></experimentalfactor><experimentalfactor><name>SEX</name><value>female</value><value>male</value><value>NA</value></experimentalfactor><experimentalfactor><name>SMOKING STATUS</name><value>Current</value><value>Former</value></experimentalfactor><experimentalfactor><name>YEARS PASSED SINCE QUITTING</name><value>20</value><value>22</value><value>30</value><value>5</value><value>7</value><value>8</value><value>less than 1</value><value>not specified</value></experimentalfactor><miamescores><reportersequencescore>0</reportersequencescore><protocolscore>0</protocolscore><factorvaluescore>1</factorvaluescore><derivedbioassaydatascore>1</derivedbioassaydatascore><measuredbioassaydatascore>1</measuredbioassaydatascore><overallscore>3</overallscore></miamescores><id>269340</id><accession>E-GEOD-28835</accession><secondaryaccession>GSE28835</secondaryaccession><name>Large airway epithelial cells from cigarette smokers with and without lung cancer undergoing flexible bronchoscopy in the operating room for resection of a suspicious lung nodule</name><experimenttype>transcription profiling by array</experimenttype><releasedate>2011-06-01</releasedate><lastupdatedate>2013-01-27</lastupdatedate><samples>13</samples><assays>13</assays><arraydesign><id>16542</id><accession>A-GEOD-13447</accession><name>Affymetrix GeneChip Human Genome U133A 2.0 Array [CDF: Ensembl v58, Hs133Av2_Hs_ENSG]</name><count>13</count></arraydesign><bioassaydatagroup><id/><name>rawData</name><bioassaydatacubes>13</bioassaydatacubes><arraydesignprovider/><dataformat>rawData</dataformat><bioassays>13</bioassays><isderived>0</isderived></bioassaydatagroup><bioassaydatagroup><id/><name>normalization</name><bioassaydatacubes>13</bioassaydatacubes><arraydesignprovider/><dataformat>normalization</dataformat><bioassays>13</bioassays><isderived>0</isderived></bioassaydatagroup><bioassaydatagroup><id/><name>processedData</name><bioassaydatacubes>13</bioassaydatacubes><arraydesignprovider/><dataformat>processedData</dataformat><bioassays>13</bioassays><isderived>0</isderived></bioassaydatagroup><bibliography><accession>21636547</accession><authors>Beane J, Vick J, Schembri F, Anderlind C, Gower A, Campbell J, Luo L, Zhang XH, Xiao J, Alekseyev YO, Wang S, Levy S, Massion PP, Lenburg M, Spira A</authors><title>Characterizing the impact of smoking and lung cancer on the airway transcriptome using RNA-Seq.</title><doi>10.1158/1940-6207.CAPR-11-0212</doi></bibliography><provider><contact>Avrum  Spira</contact><role>submitter</role><email>aspira@lung.bumc.bu.edu</email></provider><provider><contact>Jennifer Beane</contact><role/><email/></provider><description><id/><text>mRNA expression was assayed from bronchial epithelial cell samples from smokers with and without lung cancer.  A subset of the samples (2 of the lung cancer samples and 3 of the no cancer samples) were pooled and underwent whole transcriptome sequencing.  The goals were to compare whole transcriptome sequencing gene expression levels to gene expression levels derived from these samples run on the Affymetrix HGU133A 2.0 platform. Current and former smokers with cancer (n=8) and without cancer (n=5) undergoing flexible bronchoscopy in the operating room for resection of a suspicious lung nodule at Boston University Medical Center were recruited.  Patients were classified as having no lung cancer based on the pathological results from the lung biopsy.  Patients with no cancer were diagnosed with alternative benign diseases of the chest including organizing pneumonitis, sarcoidosis and chronic inflammation due to foreign body material.</text></description><protocol><id>694468</id><accession>P-GSE28835-3</accession></protocol><protocol><id>694469</id><accession>P-GSE28835-2</accession></protocol><protocol><id>694464</id><accession>P-GSE28835-1</accession></protocol><protocol><id>694467</id><accession>P-GSE28835-4</accession></protocol><protocol><id>694465</id><accession>P-GSE28835-5</accession></protocol><protocol><id>694466</id><accession>P-GSE28835-6</accession></protocol><organism>Homo sapiens</organism><files><!--
This section is deprecated and unsupported.
Please use webservice located at:
    http://www.ebi.ac.uk/arrayexpress/xml/files
to obtain detailed information on files available for the experiment.
For more information, please go to:
    http://www.ebi.ac.uk/arrayexpress/help/programmatic_access.html
                --><raw name="E-GEOD-28835.raw.1.zip" count="true" celcount="0"/><fgem name="E-GEOD-28835.processed.1.zip" available="true"/><idf name="E-GEOD-28835.idf.txt"/><sdrf name="E-GEOD-28835.sdrf.txt"/></files></experiment><experiment><species>Homo sapiens</species><rawdatafiles available="false"/><processeddatafiles available="true"/><sampleattribute><category>disease phase</category><value>control</value><value>early period</value><value>late period</value></sampleattribute><sampleattribute><category>mechanical ventilation</category><value>no</value><value>yes</value></sampleattribute><sampleattribute><category>Organism</category><value>Homo sapiens</value></sampleattribute><sampleattribute><category>patient</category><value>1</value><value>10</value><value>11</value><value>12</value><value>13</value><value>14</value><value>15</value><value>16</value><value>17</value><value>18</value><value>19</value><value>2</value><value>3</value><value>4</value><value>5</value><value>6</value><value>7</value><value>8</value><value>9</value><value>control</value></sampleattribute><sampleattribute><category>tissue</category><value>Blood</value></sampleattribute><sampleattribute><category>virus strain</category><value>none</value><value>Pandemic influenza (A/H1N1 new subtype)</value></sampleattribute><experimentalfactor><name>DISEASE PHASE</name><value>control</value><value>early period</value><value>late period</value></experimentalfactor><experimentalfactor><name>MECHANICAL VENTILATION</name><value>no</value><value>not specified</value><value>yes</value></experimentalfactor><experimentalfactor><name>PATIENT</name><value>1</value><value>10</value><value>11</value><value>12</value><value>13</value><value>14</value><value>15</value><value>16</value><value>17</value><value>18</value><value>19</value><value>2</value><value>3</value><value>4</value><value>5</value><value>6</value><value>7</value><value>8</value><value>9</value><value>control</value></experimentalfactor><experimentalfactor><name>VIRUS STRAIN</name><value>none</value><value>Pandemic influenza (A/H1N1 new subtype)</value></experimentalfactor><miamescores><reportersequencescore>1</reportersequencescore><protocolscore>0</protocolscore><factorvaluescore>1</factorvaluescore><derivedbioassaydatascore>1</derivedbioassaydatascore><measuredbioassaydatascore>0</measuredbioassaydatascore><overallscore>3</overallscore></miamescores><id>72263</id><accession>E-GEOD-21802</accession><secondaryaccession>GSE21802</secondaryaccession><name>Hosts responses in critical disease caused by pandemic H1N1</name><experimenttype>transcription profiling by array</experimenttype><releasedate>2011-05-05</releasedate><lastupdatedate>2012-03-27</lastupdatedate><samples>40</samples><assays>40</assays><arraydesign><id>13056</id><accession>A-MEXP-930</accession><name>Illumina Human-6 v2 Expression BeadChip</name><count>40</count><legacy_id>1549852481</legacy_id></arraydesign><bioassaydatagroup><id/><name>normalization</name><bioassaydatacubes>40</bioassaydatacubes><arraydesignprovider/><dataformat>normalization</dataformat><bioassays>40</bioassays><isderived>0</isderived></bioassaydatagroup><bioassaydatagroup><id/><name>processedData</name><bioassaydatacubes>40</bioassaydatacubes><arraydesignprovider/><dataformat>processedData</dataformat><bioassays>40</bioassays><isderived>0</isderived></bioassaydatagroup><bibliography><accession>20840779</accession><authors>Bermejo-Martin JF, Martin-Loeches I, Rello J, Antón A, Almansa R, Xu L, Lopez-Campos G, Pumarola T, Ran L, Ramirez P, Banner D, Ng DC, Socias L, Loza A, Andaluz D, Maravi E, Gómez-Sánchez MJ, Gordón M, Gallegos MC, Fernandez V, Aldunate S, León C, Merino P, Blanco J, Martin-Sanchez F, Rico L, Varillas D, Iglesias V, Marcos MÁ, Gandía F, Bobillo F, Nogueira B, Rojo S, Resino S, Castro C, Ortiz de Lejarazu R, Kelvin D</authors><title>Host adaptive immunity deficiency in severe pandemic influenza.</title><doi>10.1186/cc9259</doi></bibliography><provider><contact>David J Kelvin</contact><role/><email/></provider><provider><contact>Longsi Ran</contact><role>submitter</role><email>lran@uhnresearch.ca</email></provider><description><id/><text>Critical disease caused by the new 2009 pandemic influenza virus (nvH1N1) is a challenge for physicians and scientist. As evidenced in SARS and H5N1, the development of an effective immune response plays a key role to overcome viral diseases.  We studied host`s gene expression signatures, cytokine and antibody responses along the first week of hospitalization in 19 critically ill patients with primary nvH1N1 pneumonia and two degrees of respiratory involvement. Presence of comorbidities and absence of immunosuppresory conditions were the common antecedents in both groups. The most severe patients (n=12) showed persistant respiratory viral secretion, increased levels of pro-inflammatory cytokines and chemokines in serum, and elevated systemic levels of two immunosuppresory cytokines (IL-10 and IL-1ra). Both groups were able to produce specific antibodies against the virus. The average day for antibody production was day 9 in the course of the disease, defining an early period of innate immunity and a late period of adaptive immunity. The most severe group evidenced a poor expression of a set of MHC class II and T cell receptor (TCR) related genes participating in antigen presentation and cell mediated immune responses in the late phase. 7 patients of this group finally died. This findings evidence that, as observed in sepsis, severe H1N1 disease course with immunoparalysis, which could explain the poor control of the virus along with the increased incidence of bacterial superinfection observed in these patients. 19 patients attending to the participants ICUs with primary viral pneumonia during the acute phase of influenza virus illness with acute respiratory distress and unequivocal alveolar opacification involving two or more lobes with negative respiratory and blood bacterial cultures at admission were recruited from November the 1st to December the 31st 2009. Serial blood samples for plasma, serum and RNA were collected by using Serum, EDTA and PaxGene (BD®) venous blood vacuum collection following manufacturer instructions at day 1, 3/5 and 7 according to an unified protocol for all the participant ICUs. A pharyngeal sample was collected in paralel. RNA from blood was processed for gene expression analysis by using Sentrix Human-6 v2 Expression BeadChips (Illumina, San Diego, CA). RNA from blood obtained from 4 healthy controls was used for comparison purposes. Samples were distributed in four groups depending on whether or not the patients nedeed of mechanical ventilation, and on the early/late phase of the disease (before or after day 9 respectively).</text></description><protocol><id>204004</id><accession>P-GSE21802-2</accession></protocol><protocol><id>203999</id><accession>P-GSE21802-1</accession></protocol><protocol><id>204002</id><accession>P-GSE21802-4</accession></protocol><protocol><id>204003</id><accession>P-GSE21802-3</accession></protocol><protocol><id>204001</id><accession>P-GSE21802-6</accession></protocol><protocol><id>204000</id><accession>P-GSE21802-5</accession></protocol><organism>Homo sapiens</organism><files><!--
This section is deprecated and unsupported.
Please use webservice located at:
    http://www.ebi.ac.uk/arrayexpress/xml/files
to obtain detailed information on files available for the experiment.
For more information, please go to:
    http://www.ebi.ac.uk/arrayexpress/help/programmatic_access.html
                --><fgem name="E-GEOD-21802.processed.1.zip" available="true"/><idf name="E-GEOD-21802.idf.txt"/><sdrf name="E-GEOD-21802.sdrf.txt"/></files></experiment><experiment><species>Homo sapiens</species><rawdatafiles available="true"/><processeddatafiles available="true"/><sampleattribute><category>diagnosis</category><value>COP</value><value>FU</value><value>HP</value><value>normal</value><value>NSIP</value><value>RB-ILD</value><value>UIP/IPF</value></sampleattribute><sampleattribute><category>disease status</category><value>control</value><value>ILD patient</value></sampleattribute><sampleattribute><category>fvc-group</category><value>FVC1</value><value>FVC2</value><value>FVC3</value><value>normal</value></sampleattribute><sampleattribute><category>Organism</category><value>Homo sapiens</value></sampleattribute><sampleattribute><category>organism part</category><value>lung</value></sampleattribute><experimentalfactor><name>DIAGNOSIS</name><value>COP</value><value>FU</value><value>HP</value><value>normal</value><value>NSIP</value><value>RB-ILD</value><value>UIP/IPF</value></experimentalfactor><experimentalfactor><name>DISEASE STATUS</name><value>control</value><value>ILD patient</value></experimentalfactor><experimentalfactor><name>FVC-GROUP</name><value>FVC1</value><value>FVC2</value><value>FVC3</value><value>normal</value></experimentalfactor><miamescores><reportersequencescore>1</reportersequencescore><protocolscore>1</protocolscore><factorvaluescore>1</factorvaluescore><derivedbioassaydatascore>1</derivedbioassaydatascore><measuredbioassaydatascore>1</measuredbioassaydatascore><overallscore>5</overallscore></miamescores><id>269717</id><accession>E-GEOD-21394</accession><secondaryaccession>GSE21394</secondaryaccession><name>MicroRNA expression profiles of interstitial lung disease (ILD) patients</name><experimenttype>transcription profiling by array</experimenttype><releasedate>2011-04-19</releasedate><lastupdatedate>2014-06-02</lastupdatedate><samples>25</samples><assays>25</assays><arraydesign><id>4353</id><accession>A-GEOD-8936</accession><name>Agilent-019118 Human miRNA Microarray 2.0 G4470B (Probe Name version)</name><count>25</count><legacy_id>2102705896</legacy_id></arraydesign><bioassaydatagroup><id/><name>rawData</name><bioassaydatacubes>25</bioassaydatacubes><arraydesignprovider/><dataformat>rawData</dataformat><bioassays>25</bioassays><isderived>0</isderived></bioassaydatagroup><bioassaydatagroup><id/><name>normalization</name><bioassaydatacubes>25</bioassaydatacubes><arraydesignprovider/><dataformat>normalization</dataformat><bioassays>25</bioassays><isderived>0</isderived></bioassaydatagroup><bioassaydatagroup><id/><name>processedData</name><bioassaydatacubes>25</bioassaydatacubes><arraydesignprovider/><dataformat>processedData</dataformat><bioassays>25</bioassays><isderived>0</isderived></bioassaydatagroup><bibliography><accession>21241464</accession><authors>Cho JH, Gelinas R, Wang K, Etheridge A, Piper MG, Batte K, Dakhallah D, Price J, Bornman D, Zhang S, Marsh C, Galas D</authors><title>Systems biology of interstitial lung diseases: integration of mRNA and microRNA expression changes.</title><doi>10.1186/1755-8794-4-8</doi></bibliography><provider><contact>Kai Wang</contact><role/><email/></provider><provider><contact>Clay Marsh</contact><role/><email/></provider><provider><contact>Richard Gelinas</contact><role/><email/></provider><provider><contact>Ji-Hoon Cho</contact><role>submitter</role><email>jcho@systemsbiology.org</email></provider><provider><contact>Riscili Brent</contact><role/><email/></provider><provider><contact>Jennifer Price</contact><role/><email/></provider><provider><contact>Kara Batte</contact><role/><email/></provider><provider><contact>Alton Etheridge</contact><role/><email/></provider><provider><contact>David Galas</contact><role/><email/></provider><provider><contact>Ji-Hoon Cho</contact><role/><email/></provider><provider><contact>Dan Bornman</contact><role/><email/></provider><provider><contact>Melissa G Piper</contact><role/><email/></provider><provider><contact>Shile Zhang</contact><role/><email/></provider><description><id/><text>The mechanisms and molecular pathways underlying interstitial lung diseases (ILDs) are poorly understood. Systems biology approaches were used to identify perturbed networks in these disease states to gain a better understanding of the underlying mechanisms of disease. Through profiling genes and miRNAs, we found subsets of genes and miRNAs that distinguish different disease stages, ILDs from controls, and idiopathic pulmonary fibrosis (IPF) from non-specific interstitial pneumonitis (NSIP). Traditional pathway analysis revealed several disease-associated modules involving genes from the TGF-beta, Wnt, focal adhesion and smooth muscle actin pathways that may be involved in advancing fibrosis. A comprehensively integrative approach was used to construct a global gene regulatory network based on the perturbation of key regulatory elements, transcriptional factors and miRNAs. The data also demonstrated that several subnetworks were significantly associated with key molecules involved in the diseases. We present a broad overview of the disease at a molecular level and discuss several possibly key regulatory molecular circuits that could play central roles in facilitating the progression of ILDs. Lung tissue samples from thirty patients with IPF or related disorders were obtained from the Lung Tissue Research Consortium (www.ltrcpublic.org). Ten samples came from patients who had been diagnosed with usual interstitial pneumonia/ idiopathic pulmonary fibrosis (UIP/IPF), nine samples came from patients with non-specific interstitial pneumonia (NSIP), four from patients with uncharacterized fibrosis, and the remaining samples came from patients with other ILD variants. Biopsies from uninvolved lung tissue from lung cancer patients (5 samples) and from one lung transplant patient were used as controls for comparison with the ILD samples.</text></description><protocol><id>698023</id><accession>P-GSE21394-5</accession></protocol><protocol><id>698022</id><accession>P-GSE21394-6</accession></protocol><protocol><id>698026</id><accession>P-GSE21394-3</accession></protocol><protocol><id>698025</id><accession>P-GSE21394-4</accession></protocol><protocol><id>698021</id><accession>P-GSE21394-1</accession></protocol><protocol><id>698024</id><accession>P-GSE21394-2</accession></protocol><organism>Homo sapiens</organism><files><!--
This section is deprecated and unsupported.
Please use webservice located at:
    http://www.ebi.ac.uk/arrayexpress/xml/files
to obtain detailed information on files available for the experiment.
For more information, please go to:
    http://www.ebi.ac.uk/arrayexpress/help/programmatic_access.html
                --><raw name="E-GEOD-21394.raw.1.zip" count="true" celcount="0"/><fgem name="E-GEOD-21394.processed.1.zip" available="true"/><idf name="E-GEOD-21394.idf.txt"/><sdrf name="E-GEOD-21394.sdrf.txt"/></files></experiment><experiment><species>Homo sapiens</species><rawdatafiles available="true"/><processeddatafiles available="true"/><sampleattribute><category>diagnosis</category><value>COP</value><value>FU</value><value>HP</value><value>Normal</value><value>NSIP</value><value>RB-ILD</value><value>UIP/IPF</value></sampleattribute><sampleattribute><category>fvc-group</category><value>FVC1</value><value>FVC2</value><value>FVC3</value><value>Normal</value></sampleattribute><sampleattribute><category>Organism</category><value>Homo sapiens</value></sampleattribute><sampleattribute><category>tissue</category><value>lung</value></sampleattribute><experimentalfactor><name>DIAGNOSIS</name><value>COP</value><value>FU</value><value>HP</value><value>Normal</value><value>NSIP</value><value>RB-ILD</value><value>UIP/IPF</value></experimentalfactor><experimentalfactor><name>FVC-GROUP</name><value>FVC1</value><value>FVC2</value><value>FVC3</value><value>Normal</value></experimentalfactor><miamescores><reportersequencescore>1</reportersequencescore><protocolscore>0</protocolscore><factorvaluescore>1</factorvaluescore><derivedbioassaydatascore>1</derivedbioassaydatascore><measuredbioassaydatascore>1</measuredbioassaydatascore><overallscore>4</overallscore></miamescores><id>64389</id><accession>E-GEOD-21369</accession><secondaryaccession>GSE21369</secondaryaccession><name>Gene expression profiles of interstitial lung disease (ILD) patients</name><experimenttype>transcription profiling by array</experimenttype><releasedate>2011-03-24</releasedate><lastupdatedate>2012-03-27</lastupdatedate><samples>29</samples><assays>29</assays><arraydesign><id>11119</id><accession>A-AFFY-44</accession><name>Affymetrix GeneChip Human Genome U133 Plus 2.0 [HG-U133_Plus_2]</name><count>29</count><legacy_id>405156763</legacy_id></arraydesign><bioassaydatagroup><id/><name>rawData</name><bioassaydatacubes>29</bioassaydatacubes><arraydesignprovider/><dataformat>rawData</dataformat><bioassays>29</bioassays><isderived>0</isderived></bioassaydatagroup><bioassaydatagroup><id/><name>normalization</name><bioassaydatacubes>29</bioassaydatacubes><arraydesignprovider/><dataformat>normalization</dataformat><bioassays>29</bioassays><isderived>0</isderived></bioassaydatagroup><bioassaydatagroup><id/><name>processedData</name><bioassaydatacubes>29</bioassaydatacubes><arraydesignprovider/><dataformat>processedData</dataformat><bioassays>29</bioassays><isderived>0</isderived></bioassaydatagroup><bibliography><accession>21241464</accession><authors>Cho JH, Gelinas R, Wang K, Etheridge A, Piper MG, Batte K, Dakhallah D, Price J, Bornman D, Zhang S, Marsh C, Galas D</authors><title>Systems biology of interstitial lung diseases: integration of mRNA and microRNA expression changes.</title><doi>10.1186/1755-8794-4-8</doi></bibliography><provider><contact>Melissa G Piper</contact><role/><email/></provider><provider><contact>Shile Zhang</contact><role/><email/></provider><provider><contact>Dan Bornman</contact><role/><email/></provider><provider><contact>Clay Marsh</contact><role/><email/></provider><provider><contact>Riscili Brent</contact><role/><email/></provider><provider><contact>Richard Gelinas</contact><role/><email/></provider><provider><contact>Alton Etheridge</contact><role/><email/></provider><provider><contact>Kara Batte</contact><role/><email/></provider><provider><contact>Kai Wang</contact><role/><email/></provider><provider><contact>Ji-Hoon Cho</contact><role>submitter</role><email>jcho@systemsbiology.org</email></provider><provider><contact>Jennifer Price</contact><role/><email/></provider><provider><contact>David Galas</contact><role/><email/></provider><description><id/><text>The mechanisms and molecular pathways underlying interstitial lung diseases (ILDs) are poorly understood. Systems biology approaches were used to identify perturbed networks in these disease states to gain a better understanding of the underlying mechanisms of disease. Through profiling genes and miRNAs, we found subsets of genes and miRNAs that distinguish different disease stages, ILDs from controls, and idiopathic pulmonary fibrosis (IPF) from non-specific interstitial pneumonitis (NSIP).  Traditional pathway analysis revealed several disease-associated modules involving genes from the TGF-beta, Wnt, focal adhesion and smooth muscle actin pathways that may be involved in advancing fibrosis. A comprehensively integrative approach was used to construct a global gene regulatory network based on the perturbation of key regulatory elements, transcriptional factors and miRNAs.  The data also demonstrated that several subnetworks were significantly associated with key molecules involved in the diseases.  We present a broad overview of the disease at a molecular level and discuss several possibly key regulatory molecular circuits that could play central roles in facilitating the progression of ILDs. Lung tissue samples from 23 patients with IPF or related disorders were obtained from the Lung Tissue Research Consortium (www.ltrcpublic.org). 11 samples came from patients who had been diagnosed with usual interstitial pneumonia/ idiopathic pulmonary fibrosis (UIP/IPF), 5 samples came from patients with non-specific interstitial pneumonia (NSIP),  the remaining from patients with uncharacterized fibrosis and from patients with other ILD variants. B. Biopsies from uninvolved lung tissue from lung cancer patients (5 samples) and from one lung transplant patient were used as controls for comparison with the ILD samples.</text></description><protocol><id>186188</id><accession>P-GSE21369-6</accession></protocol><protocol><id>186187</id><accession>P-GSE21369-5</accession></protocol><protocol><id>186191</id><accession>P-GSE21369-2</accession></protocol><protocol><id>186186</id><accession>P-GSE21369-1</accession></protocol><protocol><id>186189</id><accession>P-GSE21369-4</accession></protocol><protocol><id>186190</id><accession>P-GSE21369-3</accession></protocol><organism>Homo sapiens</organism><files><!--
This section is deprecated and unsupported.
Please use webservice located at:
    http://www.ebi.ac.uk/arrayexpress/xml/files
to obtain detailed information on files available for the experiment.
For more information, please go to:
    http://www.ebi.ac.uk/arrayexpress/help/programmatic_access.html
                --><raw name="E-GEOD-21369.raw.1.zip" count="true" celcount="0"/><fgem name="E-GEOD-21369.processed.1.zip" available="true"/><idf name="E-GEOD-21369.idf.txt"/><sdrf name="E-GEOD-21369.sdrf.txt"/></files></experiment><experiment><species>Callicebus cupreus</species><species>Homo sapiens</species><rawdatafiles available="true"/><processeddatafiles available="true"/><sampleattribute><category>human donor</category><value>BSRI#1</value><value>BSRI#10</value><value>BSRI#11</value><value>BSRI#12</value><value>BSRI#13</value><value>BSRI#14</value><value>BSRI#15</value><value>BSRI#16</value><value>BSRI#17</value><value>BSRI#18</value><value>BSRI#2</value><value>BSRI#3</value><value>BSRI#4</value><value>BSRI#5</value><value>BSRI#6</value><value>BSRI#7</value><value>BSRI#8</value><value>BSRI#9</value></sampleattribute><sampleattribute><category>Organism</category><value>Callicebus cupreus</value><value>Homo sapiens</value></sampleattribute><sampleattribute><category>swab</category><value>lung swab</value><value>nasal swab</value></sampleattribute><sampleattribute><category>tissue</category><value>liver tissue</value><value>lung tissue</value></sampleattribute><experimentalfactor><name>HUMAN DONOR</name><value>BSRI#1</value><value>BSRI#10</value><value>BSRI#11</value><value>BSRI#12</value><value>BSRI#13</value><value>BSRI#14</value><value>BSRI#15</value><value>BSRI#16</value><value>BSRI#17</value><value>BSRI#18</value><value>BSRI#2</value><value>BSRI#3</value><value>BSRI#4</value><value>BSRI#5</value><value>BSRI#6</value><value>BSRI#7</value><value>BSRI#8</value><value>BSRI#9</value><value>not specified</value></experimentalfactor><experimentalfactor><name>ORGANISM</name><value>Callicebus cupreus</value><value>Homo sapiens</value></experimentalfactor><experimentalfactor><name>SWAB</name><value>lung swab</value><value>nasal swab</value><value>not specified</value></experimentalfactor><experimentalfactor><name>TISSUE</name><value>liver tissue</value><value>lung tissue</value><value>not specified</value></experimentalfactor><miamescores><reportersequencescore>1</reportersequencescore><protocolscore>1</protocolscore><factorvaluescore>1</factorvaluescore><derivedbioassaydatascore>1</derivedbioassaydatascore><measuredbioassaydatascore>1</measuredbioassaydatascore><overallscore>5</overallscore></miamescores><id>46381</id><accession>E-GEOD-26898</accession><secondaryaccession>GSE26898</secondaryaccession><name>Evidence for Zoonotic Transmission of a Novel Adenovirus Associated with a Fulminant Pneumonia Outbreak in a Titi Monkey Colony</name><experimenttype>transcription profiling by array</experimenttype><releasedate>2011-02-05</releasedate><lastupdatedate>2014-05-02</lastupdatedate><samples>22</samples><assays>22</assays><arraydesign><id>14973</id><accession>A-GEOD-11662</accession><name>Viro5AGL-60k [Probe name version]</name><count>22</count></arraydesign><bioassaydatagroup><id/><name>rawData</name><bioassaydatacubes>22</bioassaydatacubes><arraydesignprovider/><dataformat>rawData</dataformat><bioassays>22</bioassays><isderived>0</isderived></bioassaydatagroup><bioassaydatagroup><id/><name>normalization</name><bioassaydatacubes>22</bioassaydatacubes><arraydesignprovider/><dataformat>normalization</dataformat><bioassays>22</bioassays><isderived>0</isderived></bioassaydatagroup><bioassaydatagroup><id/><name>processedData</name><bioassaydatacubes>22</bioassaydatacubes><arraydesignprovider/><dataformat>processedData</dataformat><bioassays>22</bioassays><isderived>0</isderived></bioassaydatagroup><provider><contact>Charles Chiu</contact><role>submitter</role><email>charles.chiu@ucsf.edu</email></provider><provider><contact>Eunice C Chen</contact><role/><email/></provider><provider><contact>Charles Y Chiu</contact><role/><email/></provider><description><id/><text>We used the Virochip microarray to detect and discover a novel adenovirus, TMAdV (titi monkey adenovirus).  We used custom-commercial microarrays from Agilent Technologies.  The microarray platform GPL11662 consists of 62,976 probes, of which 19,058 probes are 70-mer viral oligonucleotides (the union of the V3 and V4 platforms -- please see Wang, et al., PNAS, 2002; Chiu, et al., Clin Infect Dis, 2006; Chiu, et al., PNAS, 2008). For this study, 4 experimental Virochip microarrays derived from tissue and swabs from affected titi monkeys were analyzed.  We also used 18 Virochip microarrays derived from sera from healthy random human blood donors as a negative background set for Z-score analysis (see Chiu, et al., Clin Infect Dis, 2006).  Raw Agilent microarray .txt files are background normalized and the 19,058 70-mer viral probes are then selected and displayed as columns in the processed data table.</text></description><protocol><id>146674</id><accession>P-GSE26898-1</accession></protocol><protocol><id>146682</id><accession>P-GSE26898-2</accession></protocol><protocol><id>146681</id><accession>P-GSE26898-3</accession></protocol><protocol><id>146679</id><accession>P-GSE26898-4</accession></protocol><protocol><id>146677</id><accession>P-GSE26898-9</accession></protocol><protocol><id>146675</id><accession>P-GSE26898-8</accession></protocol><protocol><id>146678</id><accession>P-GSE26898-7</accession></protocol><protocol><id>146676</id><accession>P-GSE26898-6</accession></protocol><protocol><id>146680</id><accession>P-GSE26898-5</accession></protocol><organism>Callicebus cupreus</organism><organism>Homo sapiens</organism><files><!--
This section is deprecated and unsupported.
Please use webservice located at:
    http://www.ebi.ac.uk/arrayexpress/xml/files
to obtain detailed information on files available for the experiment.
For more information, please go to:
    http://www.ebi.ac.uk/arrayexpress/help/programmatic_access.html
                --><raw name="E-GEOD-26898.raw.1.zip E-GEOD-26898.raw.2.zip E-GEOD-26898.raw.3.zip" count="true" celcount="0"/><fgem name="E-GEOD-26898.processed.1.zip" available="true"/><idf name="E-GEOD-26898.idf.txt"/><sdrf name="E-GEOD-26898.sdrf.txt"/></files></experiment><experiment><species>Homo sapiens</species><rawdatafiles available="true"/><processeddatafiles available="true"/><sampleattribute><category>cell type</category><value>differentiated type I-like alveolar epithelial cells</value></sampleattribute><sampleattribute><category>individual</category><value>donor 1</value><value>donor 2</value><value>donor 3</value></sampleattribute><sampleattribute><category>infection</category><value>mock</value><value>pdmH1N1 virus</value><value>seasonal H1N1 virus</value></sampleattribute><sampleattribute><category>Organism</category><value>Homo sapiens</value></sampleattribute><sampleattribute><category>time point</category><value>8h post-infection</value></sampleattribute><sampleattribute><category>tissue</category><value>lung</value></sampleattribute><experimentalfactor><name>INDIVIDUAL</name><value>donor 1</value><value>donor 2</value><value>donor 3</value></experimentalfactor><experimentalfactor><name>INFECTION</name><value>mock</value><value>pdmH1N1 virus</value><value>seasonal H1N1 virus</value></experimentalfactor><miamescores><reportersequencescore>0</reportersequencescore><protocolscore>0</protocolscore><factorvaluescore>1</factorvaluescore><derivedbioassaydatascore>1</derivedbioassaydatascore><measuredbioassaydatascore>1</measuredbioassaydatascore><overallscore>3</overallscore></miamescores><id>17437</id><accession>E-GEOD-24533</accession><secondaryaccession>GSE24533</secondaryaccession><name>Expression data of influenza A-infected human type I-like alveolar epithelial cells</name><experimenttype>transcription profiling by array</experimenttype><releasedate>2010-10-06</releasedate><submissiondate>2010-10-04</submissiondate><lastupdatedate>2011-06-10</lastupdatedate><samples>9</samples><assays>9</assays><arraydesign><id>9595</id><accession>A-AFFY-141</accession><name>Affymetrix GeneChip Human Gene 1.0 ST Array [HuGene-1_0-st-v1]</name><count>9</count><legacy_id>1759805535</legacy_id></arraydesign><bioassaydatagroup><id/><name>rawData</name><bioassaydatacubes>9</bioassaydatacubes><arraydesignprovider/><dataformat>rawData</dataformat><bioassays>9</bioassays><isderived>0</isderived></bioassaydatagroup><bioassaydatagroup><id/><name>processedData</name><bioassaydatacubes>9</bioassaydatacubes><arraydesignprovider/><dataformat>processedData</dataformat><bioassays>9</bioassays><isderived>0</isderived></bioassaydatagroup><bioassaydatagroup><id/><name>scan</name><bioassaydatacubes>9</bioassaydatacubes><arraydesignprovider/><dataformat>scan</dataformat><bioassays>9</bioassays><isderived>0</isderived></bioassaydatagroup><provider><contact>Robert E Hancock</contact><role/><email/></provider><provider><contact>Cheuk K Lo</contact><role/><email/></provider><provider><contact>Alan D Sihoe</contact><role/><email/></provider><provider><contact>Timothy K Cheung</contact><role/><email/></provider><provider><contact>Yi Guan</contact><role/><email/></provider><provider><contact>Renee W Chan</contact><role/><email/></provider><provider><contact>Suki M Lee</contact><role/><email/></provider><provider><contact>SMY Lee</contact><role>submitter</role><email>geo@ncbi.nlm.nih.gov</email></provider><provider><contact>Sara S Kang</contact><role/><email/></provider><provider><contact>J M Peiris</contact><role/><email/></provider><provider><contact>Jennifer L Gardy</contact><role/><email/></provider><provider><contact>Michael C Chan</contact><role/><email/></provider><description><id/><text>Pandemic influenza H1N1 (pdmH1N1) virus causes mild disease in humans but occasionally leads to severe complications and even death, especially in those who are pregnant or have underlying disease. Cytokine responses induced by pdmH1N1 viruses in vitro are comparable to other seasonal influenza viruses, suggesting the cytokine dysregulation as seen in H5N1 infection is not a feature of the pdmH1N1 virus. However, a comprehensive gene expression profile of pdmH1N1 in relevant primary human cells in vitro has not been reported. Type I alveolar epithelial cells are a key target cell in pdmH1N1 pneumonia. We carried out a comprehensive gene expression profiling using the Affymetrix microarray platform to compare the transcriptomes of primary human alveolar type I-like alveolar epithelial cells infected with pdmH1N1 or seasonal H1N1 virus. Primary type II alveolar epithelial cells were isolated from human non-malignant lung tissue of three patients who underwent lung resection, and cells were differentiated to type I-like before use. Type I-like alveolar epithelial cells were mock infected, or infected with pdmH1N1 or seasonal H1N1 viruses at a multiplicity of infection (MOI) of two. Total RNA was extracted from cells after 8h post-infection, and gene expression profiling was performed using an Affymetrix Human Gene 1.0 ST microarray platform.</text></description><protocol><id>54749</id><accession>P-GSE24533-4</accession></protocol><protocol><id>54751</id><accession>P-GSE24533-3</accession></protocol><protocol><id>54748</id><accession>P-GSE24533-2</accession></protocol><protocol><id>54742</id><accession>P-GSE24533-1</accession></protocol><protocol><id>54750</id><accession>P-GSE24533-5</accession></protocol><protocol><id>54745</id><accession>P-GSE24533-6</accession></protocol><protocol><id>54743</id><accession>P-GSE24533-7</accession></protocol><protocol><id>54747</id><accession>P-GSE24533-8</accession></protocol><protocol><id>54744</id><accession>P-GSE24533-10</accession></protocol><protocol><id>54746</id><accession>P-GSE24533-9</accession></protocol><organism>Homo sapiens</organism><files><!--
This section is deprecated and unsupported.
Please use webservice located at:
    http://www.ebi.ac.uk/arrayexpress/xml/files
to obtain detailed information on files available for the experiment.
For more information, please go to:
    http://www.ebi.ac.uk/arrayexpress/help/programmatic_access.html
                --><raw name="E-GEOD-24533.raw.1.zip" count="true" celcount="0"/><fgem name="E-GEOD-24533.processed.1.zip" available="true"/><idf name="E-GEOD-24533.idf.txt"/><sdrf name="E-GEOD-24533.sdrf.txt"/></files></experiment><experiment><species>Homo sapiens</species><rawdatafiles available="true"/><processeddatafiles available="true"/><sampleattribute><category>Age</category><value>32</value><value>33</value><value>46</value><value>59</value></sampleattribute><sampleattribute><category>Ethnicity</category><value>African American</value><value>Caucasian</value></sampleattribute><sampleattribute><category>Gender</category><value>male</value></sampleattribute><sampleattribute><category>Organism</category><value>Homo sapiens</value></sampleattribute><sampleattribute><category>VAP day</category><value>3</value><value>5</value><value>7</value></sampleattribute><experimentalfactor><name>AGE</name><value>32</value><value>33</value><value>46</value><value>59</value></experimentalfactor><experimentalfactor><name>ETHNICITY</name><value>African American</value><value>Caucasian</value></experimentalfactor><experimentalfactor><name>VAP DAY</name><value>3</value><value>5</value><value>7</value></experimentalfactor><miamescores><reportersequencescore>1</reportersequencescore><protocolscore>0</protocolscore><factorvaluescore>1</factorvaluescore><derivedbioassaydatascore>1</derivedbioassaydatascore><measuredbioassaydatascore>1</measuredbioassaydatascore><overallscore>4</overallscore></miamescores><id>186490</id><accession>E-GEOD-12838</accession><secondaryaccession>GSE12838</secondaryaccession><name>The Monocyte Advantage</name><experimenttype>transcription profiling by array</experimenttype><releasedate>2010-09-08</releasedate><lastupdatedate>2012-03-05</lastupdatedate><samples>60</samples><assays>60</assays><arraydesign><id>11119</id><accession>A-AFFY-44</accession><name>Affymetrix GeneChip Human Genome U133 Plus 2.0 [HG-U133_Plus_2]</name><count>60</count><legacy_id>405156763</legacy_id></arraydesign><bioassaydatagroup><id/><name>rawData</name><bioassaydatacubes>60</bioassaydatacubes><arraydesignprovider/><dataformat>rawData</dataformat><bioassays>60</bioassays><isderived>0</isderived></bioassaydatagroup><bioassaydatagroup><id/><name>normalization</name><bioassaydatacubes>60</bioassaydatacubes><arraydesignprovider/><dataformat>normalization</dataformat><bioassays>60</bioassays><isderived>0</isderived></bioassaydatagroup><bioassaydatagroup><id/><name>processedData</name><bioassaydatacubes>60</bioassaydatacubes><arraydesignprovider/><dataformat>processedData</dataformat><bioassays>60</bioassays><isderived>0</isderived></bioassaydatagroup><provider><contact>Douglas Oppedal</contact><role/><email/></provider><provider><contact>William Schierding</contact><role/><email/></provider><provider><contact>Buddy Brownstein</contact><role/><email/></provider><provider><contact>Jianhua Ruan</contact><role/><email/></provider><provider><contact>Weixiong Zhang</contact><role/><email/></provider><provider><contact>Sandra MacMillan</contact><role/><email/></provider><provider><contact>J Perren Cobb</contact><role>submitter</role><email>jpcobb@partners.org</email></provider><provider><contact>J P Cobb</contact><role/><email/></provider><provider><contact>David Dixon</contact><role/><email/></provider><description><id/><text>INTRO: The ongoing challenge of accurately diagnosing infection in the ICU motivates a search for novel molecular diagnostics. In the current study, we tested the hypothesis that the informational content of circulating leukocytes differs, thereby allowing one to rank leukocyte populations on their potential to contribute to RNA diagnostics for pneumonia. METHODS: Sixteen patients (10 male, 6 female) at risk for VAP were entered into our IRB-approved study that collects blood and clinical data every 48 hours for up to 21 days. Four of the sixteen patients developed VAP as diagnosed and treated by the attending ICU physician. Previously reported blood protocols were used to isolate buffy coat, enriched neutrophil, and enriched monocyte populations by using negative selection. Cellular purity was assessed by FACS for one of the 4 VAP patients. Genome-wide expression analysis was performed on RMA-normalized signal from Affymetrix U133 2.0 Plus GeneChips. EDGE software (FDR=0.10) was used to determine changes in mRNA abundance over time for each cell population. RESULTS: During the 5-day window in which each of the four patients (all males) developed VAP, significant changes in gene expression were observed (Table 2), but the information content (number of genes altered) varied across leukocyte populations. These differences were not due to signal variance (coefficient of variation, CV) or differences in the number of samples available for analysis. Moreover, only 0.6% of the monocyte gene list overlaps with the neutrophil list, arguing that neutrophil contamination of monocyte populations is insufficient to explain the 40-fold difference in gene number. CONCLUSIONS: Enriched monocyte populations from circulating blood provide far more genes for study of the host response to VAP than the other 2 cell populations studied. This information should be considered when designing blood gene expression profiling experiments in patients at risk for sepsis.   Keywords: time course Four patients over several timepoints measured three different cell types for VAP signal</text></description><protocol><id>496183</id><accession>P-GSE12838-6</accession></protocol><protocol><id>496184</id><accession>P-GSE12838-7</accession></protocol><protocol><id>496186</id><accession>P-GSE12838-4</accession></protocol><protocol><id>496185</id><accession>P-GSE12838-5</accession></protocol><protocol><id>496187</id><accession>P-GSE12838-2</accession></protocol><protocol><id>496188</id><accession>P-GSE12838-3</accession></protocol><protocol><id>496182</id><accession>P-GSE12838-1</accession></protocol><organism>Homo sapiens</organism><files><!--
This section is deprecated and unsupported.
Please use webservice located at:
    http://www.ebi.ac.uk/arrayexpress/xml/files
to obtain detailed information on files available for the experiment.
For more information, please go to:
    http://www.ebi.ac.uk/arrayexpress/help/programmatic_access.html
                --><raw name="E-GEOD-12838.raw.1.zip E-GEOD-12838.raw.2.zip E-GEOD-12838.raw.3.zip E-GEOD-12838.raw.4.zip" count="true" celcount="0"/><fgem name="E-GEOD-12838.processed.1.zip" available="true"/><idf name="E-GEOD-12838.idf.txt"/><sdrf name="E-GEOD-12838.sdrf.txt"/></files></experiment><experiment><species>Homo sapiens</species><species>Mus musculus</species><rawdatafiles available="true"/><processeddatafiles available="true"/><sampleattribute><category>15 meta-groups</category><value>blood neoplasm cell line</value><value>blood non neoplastic disease</value><value>breast cancer</value><value>germ cell neoplasm</value><value>leukemia</value><value>nervous system neoplasm</value><value>non breast carcinoma</value><value>non leukemic blood neoplasm</value><value>non neoplastic cell line</value><value>normal blood</value><value>normal solid tissue</value><value>other neoplasm</value><value>sarcoma</value><value>solid tissue neoplasm cell line</value><value>solid tissue non neoplastic disease</value></sampleattribute><sampleattribute><category>369 groups</category><value>293t-tva</value><value>600MPE breast cancer</value><value>a498 renal cell carcinoma</value><value>A549 lung adenocarcinoma</value><value>A673 Ewing tumor</value><value>ABC-1 lung adenocarcinoma</value><value>acute lymphoblastic leukemia</value><value>acute megakaryoblastic leukaemia</value><value>acute monoblastic and monocytic leukemia</value><value>acute myeloid leukemia</value><value>acute myelomonocytic leukemia</value><value>acute promyelocytic leukemia</value><value>acute quadriplegic myopathy</value><value>adipose tissue normal</value><value>adipose tissue polycystic ovarian syndrome</value><value>adipose-derived adult stem cells</value><value>adipose-derived adult stem cells cultured</value><value>airway epithelial cell</value><value>airway epithelial cell cystic fibrosis</value><value>alveolar rhabdomyosarcoma</value><value>AMO-1 myeloma</value><value>amygdala</value><value>AU565 breast carcinoma</value><value>B cell</value><value>B-cell lymphoma</value><value>B-cell lymphoma cell line</value><value>BeWo choriocarcinoma</value><value>bladder</value><value>bladder cancer</value><value>bladder mucosa</value><value>blood</value><value>blood transplant rejection</value><value>bone</value><value>bone hyperparathyroidis</value><value>brain</value><value>brain bipolar disorder</value><value>brain tumor</value><value>breast cancer</value><value>bronchial epithelia</value><value>bronchoalveolar lavage cell</value><value>bronchoalveolar lavage cell transplant rejection</value><value>BT20 breast cancer</value><value>BT474 breast cancer</value><value>BT483 breast cancer</value><value>BT549 breast cancer</value><value>C2C12 mouse muscle myoblast</value><value>caco2 colon adenocarcinoma</value><value>caki-1 renal cell carcinoma</value><value>CAL27 head neck squamous cell carcinoma</value><value>Calu-1 lung epidermoid carcinoma</value><value>Calu-3 lung adenocarcinoma</value><value>Calu-6 lung anaplastic carcinoma</value><value>CAMA1 breast cancer</value><value>caudate nucleus</value><value>caudate nucleus Huntingtons</value><value>CCL-153 fetal pulmonary fibroblast</value><value>ccrf-cem T-ALL</value><value>CD138+ plasma cell</value><value>CD138+ plasma cell monoclonal gammopathy</value><value>CD138+ plasma cell myeloma</value><value>CD33+ cells</value><value>CD34+ blood cell</value><value>CD34+ blood cell thymus</value><value>cerebellum</value><value>cerebellum Huntingtons</value><value>chondroblastoma</value><value>chondromyxoid fibroma</value><value>chondrosarcoma</value><value>chordoma</value><value>chronic myeloid leukemia</value><value>cirrhosis</value><value>CMK megakaryoblastic</value><value>colo205 colorectal adenocarcinoma</value><value>colon mucosa bowel disease</value><value>colorectal cancer</value><value>conjunctiva</value><value>connective tissue fibroblast</value><value>coronary artery smooth muscle cell</value><value>dedifferentiated chondrosarcoma</value><value>dendritic cell</value><value>DU 145 prostate carcinoma</value><value>ea.hy926 cell imortalized endothelial</value><value>EBC-1 lung squamous cell carcinoma</value><value>EKVX lung non small cell carcinoma</value><value>embryonal rhabdomyosarcoma</value><value>embryonic lung fibroblast</value><value>embryonic skin fibroblast</value><value>embryonic stem cell</value><value>endothelial cell</value><value>epidermis</value><value>epidermis dermatitis</value><value>erythrocyte</value><value>esophageal adenocarcinoma</value><value>esophagus Barretts</value><value>esophagus epithelium</value><value>EW24 Ewing sarcoma cell line</value><value>ewings sarcoma</value><value>fetal lung</value><value>fetal lung fibroblast</value><value>fibroblast Cockayne syndrome</value><value>fibromatosis</value><value>FM9514 human embryonic myoblast</value><value>FR4 multiple myeloma</value><value>frontal cortex</value><value>frontal cortex Huntingtons</value><value>ganglioneuroblastoma</value><value>ganglioneuroma</value><value>germ cell tumor</value><value>gingiva cell periodontitis</value><value>glioblastoma</value><value>glioblastoma cell line</value><value>granulocyte</value><value>H1 mesenchymal precursor</value><value>H9 mesenchymal precursor</value><value>HBL 100 breast cancer</value><value>HCC lung adenocarcinoma</value><value>HCC-2998 colon cancer</value><value>HCC1007 breast cancer</value><value>HCC1171 lung non small cell lung carcinoma</value><value>HCC1187 breast cancer</value><value>HCC1195 lung adenocarcinoma</value><value>HCC1359 lung large cell carcinoma</value><value>HCC1428 breast cancer</value><value>HCC15 lung squamous cell carcinoma</value><value>HCC1500 breast cancer</value><value>HCC1937 breast cancer</value><value>HCC2157 breast cancer</value><value>HCC2185 breast cancer</value><value>HCC227 lung adenocarcinoma</value><value>HCC2935 lung non-small cell lung cancer line</value><value>HCC3153 breast cancer</value><value>HCC366 non-small cell lung carcinoma</value><value>HCC38 breast cancer</value><value>HCC44 non-small cell lung carcinoma</value><value>HCC515 lung adenocarcinoma</value><value>HCC70 breast cancer</value><value>HCC78 lung non-small cell carcinoma</value><value>HCC827 lung adenocarcinoma</value><value>HCC95 lung non-small cell carcinoma</value><value>HCT-15 colorectal adenocarcinoma</value><value>HCT116 colorectal carcinoma</value><value>head and neck squamous cell carcinoma</value><value>heart</value><value>heart disease</value><value>HEK293 embryonic kidney</value><value>HEK293T embryonic kidney</value><value>HeLa cervical adenocarcinoma</value><value>HeLa cervical adenocarcinoma transfected</value><value>hematopoietic stem cell</value><value>Hep-2 larynx sqamous cell carcinoma</value><value>hepatocellular carcinoma</value><value>hI60 promyelocytic leukemia</value><value>hippocampus CA1</value><value>hippocampus CA1 Alzheimers</value><value>HMEC S1</value><value>HMEC184 breast cancer</value><value>HMT3522S1 breast cancer</value><value>HMT3522S1 breast epithelium</value><value>HOP 92 non-small cell lung carcinoma</value><value>HOP-62 lung adenocarcinoma</value><value>HS578T breast cancer cell line</value><value>ht-29 colorectal adenocarcinoma</value><value>human bronchial epithelial cell line</value><value>hypopharynx</value><value>hypothalamus</value><value>I-6 embryonic stem cell</value><value>IB3-1 adenovirus transformed bronchial epithelia</value><value>IGROV1 ovarian cancer </value><value>JEG3 placental choriocarcinoma </value><value>Jurkat T lymphocyte</value><value>k562 myelogenous leukaemia</value><value>Kaposi sarcoma</value><value>KELLY neuroblastoma</value><value>keratinocyte</value><value>kidney</value><value>kidney carcinoma</value><value>kidney epithelium</value><value>KM12 colon cancer</value><value>KM4 multiple myeloma</value><value>KS Y-1 Kaposis sarcoma AIDS associated</value><value>KS-IMM  Kaposis sarcoma non AIDS associated</value><value>LC-1F lung squamous cell</value><value>LC1/SQ lung squamous cell</value><value>LC2/AD non-small cell lung adenocarcinoma</value><value>leiomyosarcoma</value><value>leukocyte</value><value>leukocyte multiple organ failure</value><value>ligament cell periodontitis</value><value>lipoma</value><value>liposarcoma</value><value>liver</value><value>LK-2 lung squamous cell</value><value>LNCaP prostate cancer</value><value>LOXIMVI malignant amelanotic melanoma</value><value>Lu130 lung small cell cancer</value><value>LU134 lung small cell cancer</value><value>LU139 lung small cell cancer</value><value>LU165 lung small cell cancer</value><value>Lu65 lung non-small cell adenocarcinoma</value><value>lung</value><value>lung cancer</value><value>lung emphysema</value><value>lymph node</value><value>lymphocyte</value><value>lymphocyte asthma</value><value>M14 malignant melanoma</value><value>M70e hematopoietic</value><value>macrophage</value><value>malignant peripheral nerve sheath tumor</value><value>MALME-3M malignant melanoma</value><value>mcf-7aro breast epithelial adenocarcinoma</value><value>MCF10A breast epithelial fibrocystic disease</value><value>MCF10A-myc breast epithelial fibrocystic disease</value><value>MCF12A breast epithelial+M824</value><value>MCF7 breast epithelial adenocarcinoma</value><value>MDA-MB-134VI breast cancer</value><value>MDA-MB-175VII breast cancer</value><value>MDA-MB-231 breast cancer</value><value>MDA-MB-361 breast cancer</value><value>MDA-MB-415 breast cancer</value><value>MDA-MB-435 melanoma</value><value>MDA-MB-436 breast cancer</value><value>MDA-MB-453 breast cancer</value><value>MDA468 breast cancer</value><value>mesangial cell</value><value>mesenchymal stem cell</value><value>microvascular endothelial</value><value>MOLT4 T cell acute lymphoblastic leukemia</value><value>monocyte</value><value>monocyte familial hypercholesterolemia</value><value>monocyte multiple organ failure</value><value>mononuclear cell</value><value>mononuclear cell infection</value><value>monophasic synovial sarcoma</value><value>MRC5 fetal fibroblast </value><value>MS-1 lung small cell lung cancer</value><value>multiple myeloma</value><value>multipotent adult progenitor cell</value><value>myelogenous leukemia</value><value>myometrium</value><value>myxoid liposarcoma</value><value>NC-NC lymphoblastoid B cell</value><value>NCI-ADR-RES ovarian cancer</value><value>NCI-H226 lung squamous cell carcinoma</value><value>NCI-H322M lung small cell bronchioalveolar carcinoma</value><value>NCI-H460 lung large cell carcinoma</value><value>NCI-H522 lung adenocarcinoma</value><value>NCI-H929 myeloma</value><value>NCU-MM1 multiple myeloma</value><value>neuroblastoma</value><value>neurofibroma</value><value>oral squamous cell carcinoma</value><value>oropharynx</value><value>osteosarcoma</value><value>ovarian tumor</value><value>ovary</value><value>OVCAR-3 ovarian cancer</value><value>OVCAR-4 ovarian cancer</value><value>OVCAR-5 ovarian cancer</value><value>OVCAR-8 ovarian cancer</value><value>PC-1 lung squamous cell cancer</value><value>pc-10 lung sqamous cell cancer</value><value>pc3 prostate cancer</value><value>pc6 lung small cell cancer</value><value>pc7 lung non-small cell adenocarcinoma</value><value>PC9 lung non-small cell adenocarcinoma</value><value>placenta basal plate</value><value>plasma cell</value><value>plasma-cell leukemia</value><value>preadipocytes</value><value>precursor T lymphoblastic leukemia</value><value>prefrontal cortex</value><value>primary fibroblast</value><value>primary intervertebral disc</value><value>progeria syndrome fibroblast</value><value>prostate cancer</value><value>prostate gland</value><value>pterygium</value><value>QG-56 lung squamous cell cancer</value><value>regenerating cell periodontitis</value><value>renal cell carcinoma</value><value>RERF-LC-AI lung sqamous cell cancer</value><value>RERF-LC-KJ lung non-small cell adenocarcinoma</value><value>RERF-LC-MS lung non-small cell adenocarcinoma</value><value>RJ2.2.5 Burkitts lymphoma</value><value>RKO colon carcinoma</value><value>rpmi-8226 myeloma</value><value>RXF-393 renal cell carcinoma</value><value>sarcoma</value><value>SBC-5 lung small cell cancer</value><value>SBC3 lung small cell cancer</value><value>schwannoma</value><value>SF-268 glioblastoma</value><value>SF-539 glioma</value><value>sk-mel-28 melanoma</value><value>SK-N-AS neuroblastoma</value><value>SK-N-MC neuroblastoma</value><value>SK-N-SH neuroblastoma cell</value><value>SKBR3 breast adenocarcinoma</value><value>skeletal muscle</value><value>skeletal muscle diseased</value><value>skeletal muscle muscular dystrophy</value><value>Skgt4 esophageal cancer</value><value>skin</value><value>skin basal cell UV treated</value><value>SKMC fetal skeletal muscle myoblast</value><value>skmel5 melanoma</value><value>SKMM1 multiple myeloma</value><value>small intestine</value><value>smooth muscle</value><value>SN12C renal cell carcinoma</value><value>SNB-19 glioblastoma</value><value>SNB-75 astrocytoma</value><value>spindle cell tumor</value><value>SQ-5 lung sqamous cell cancer</value><value>squamous cell carcinoma of the oral cavity</value><value>SR lymphoma</value><value>ssMCF7 breast cancer</value><value>Su-dhl1 anaplastic large cell lymphoma</value><value>SUM1315MO2 breast cancer</value><value>SUM149PT breast cancer</value><value>SUM159PT breast cancer</value><value>SUM185PE breast cancer</value><value>SUM190PT breast cancer</value><value>SUM225CWN breast cancer</value><value>SUM44PE breast cancer</value><value>SUM52PE breast cancer</value><value>SW480 colon cancer primary tumor derived</value><value>T cell</value><value>T cell diseased</value><value>T47D breast ductal carcinoma</value><value>te85 osteosarcoma</value><value>TERV</value><value>testis</value><value>theca</value><value>theca polycystic ovarian syndrome</value><value>thymocyte</value><value>thyrocyte</value><value>thyroid adenocarcinoma</value><value>thyroid gland</value><value>TK-10</value><value>tonsil</value><value>trabecular meshwork cell</value><value>ts anaplastic large cell lymphoma</value><value>u-20s osteosarcoma</value><value>U251 glioblastoma</value><value>U937 lymphoma</value><value>UACC-257 melanoma</value><value>UACC-62 melanoma</value><value>UACC812 breast cancer</value><value>umbilical vein endothelial cell</value><value>universal reference</value><value>unknown gliobastoma</value><value>unknown lung adenocarcinoma</value><value>unknown lung cancer</value><value>unknown lung cell carcinoma</value><value>unknown lung large cell carcinoma</value><value>unknown lung mesothelioma </value><value>unknown lung neuroendocrine</value><value>unknown lung non small cell cancer</value><value>unknown lung small cell cancer</value><value>unknown lung squamous cell carcinoma</value><value>unknown small cell lung cancer</value><value>UO-31 renal cell carcinoma</value><value>uterine tumor</value><value>WI38 fetal fibroblast</value><value>ZR751 breast cancer</value><value>ZR7530 breast cancer</value><value>ZR75B breast cancer</value></sampleattribute><sampleattribute><category>4 meta-groups</category><value>cell line</value><value>disease</value><value>neoplasm</value><value>normal</value></sampleattribute><sampleattribute><category>Age</category><value>0,91</value><value>0.25 years</value><value>0.5 month</value><value>1</value><value>1 month</value><value>1.25 month</value><value>1.4 years</value><value>1.5 month</value><value>1.7 month</value><value>10</value><value>10 days to 12 days</value><value>10 month</value><value>11</value><value>11 month</value><value>11.4 years</value><value>12</value><value>12 month</value><value>12.1 years</value><value>12.3 years</value><value>13</value><value>13 month</value><value>13.4 years</value><value>13.8 years</value><value>13.9 years</value><value>14 month</value><value>14 weeks</value><value>14.1 years</value><value>15</value><value>15 month</value><value>15.2 years</value><value>15.5 years</value><value>16</value><value>16 month</value><value>16.7 years</value><value>16.9 years</value><value>17 month</value><value>17.3 years</value><value>17.4 years</value><value>17.8 years</value><value>17.9 years</value><value>18</value><value>18 month</value><value>18 weeks</value><value>18.2 years</value><value>18.3 years</value><value>19</value><value>19 month</value><value>19 weeks</value><value>19 years</value><value>19.7 years</value><value>19.9 years</value><value>2</value><value>2 month</value><value>2.5 month</value><value>2.9 years</value><value>20 month</value><value>20.3 years</value><value>20.6 years</value><value>21 weeks</value><value>22</value><value>22 month</value><value>22 weeks</value><value>23 month</value><value>23 weeks</value><value>24</value><value>24 weeks</value><value>25</value><value>26</value><value>27</value><value>28</value><value>28 month</value><value>28 To 40</value><value>29</value><value>29 years</value><value>3</value><value>3 month</value><value>3.6 years</value><value>30</value><value>30 years</value><value>31</value><value>32</value><value>32 years</value><value>33</value><value>33 month</value><value>34</value><value>34 years</value><value>35</value><value>36</value><value>36 month</value><value>36 years</value><value>37</value><value>37 weeks</value><value>38</value><value>39</value><value>39 weeks</value><value>39 years</value><value>4</value><value>4 month</value><value>4.1 years</value><value>4.2 years</value><value>4.5 years</value><value>4.6 years</value><value>4.9 years</value><value>40</value><value>40 weeks</value><value>41</value><value>42</value><value>43</value><value>44</value><value>44 years</value><value>45</value><value>45 years</value><value>46</value><value>46 years</value><value>47</value><value>48</value><value>48 years</value><value>49</value><value>49 years</value><value>5</value><value>5 month</value><value>5.2 years</value><value>5.6 years</value><value>5.7 years</value><value>50</value><value>51</value><value>51 years</value><value>52</value><value>52 years</value><value>53</value><value>54</value><value>55</value><value>55 years</value><value>56</value><value>57</value><value>58</value><value>58 years</value><value>59</value><value>59 years</value><value>6</value><value>6 month</value><value>6.2 years</value><value>6.3 years</value><value>6.7 years</value><value>6.8 years</value><value>6.9 years</value><value>60</value><value>60 month</value><value>61</value><value>61 years</value><value>62</value><value>63</value><value>64</value><value>65</value><value>66</value><value>66 years</value><value>67</value><value>68</value><value>69</value><value>7</value><value>7 month</value><value>7.7 years</value><value>7.8 years</value><value>7.9 years</value><value>70</value><value>71</value><value>72</value><value>73</value><value>74</value><value>75</value><value>76</value><value>77</value><value>78</value><value>79</value><value>8</value><value>8 month</value><value>8.6 years</value><value>8.9 years</value><value>80</value><value>82</value><value>83</value><value>83 years</value><value>84</value><value>85</value><value>86</value><value>9</value><value>9 month</value><value>9.9 years</value></sampleattribute><sampleattribute><category>Blood/NonBlood meta-groups</category><value>blood</value><value>non blood</value></sampleattribute><sampleattribute><category>CellLine</category><value>293t-tva</value><value>600MPE</value><value>a498</value><value>a549</value><value>A549/ATCC</value><value>A673</value><value>ABC-1</value><value>Ag10750</value><value>Ag11498</value><value>Ag11513</value><value>AMO-1</value><value>AU565</value><value>Bewo</value><value>BM-MSC</value><value>Breast cancer cell line</value><value>bronchial cell line</value><value>BT20</value><value>BT474</value><value>BT483</value><value>BT549</value><value>C2C12</value><value>caco-2</value><value>caki-1</value><value>cal 27</value><value>cal 27, transfected with pEGFPC1-nm23-H2</value><value>calu-1</value><value>calu-6</value><value>calu3</value><value>CAMA1</value><value>CCL-153</value><value>ccrf-cem</value><value>CMA-01</value><value>CMA-02</value><value>CMA-03</value><value>CMK</value><value>colo205</value><value>cultured</value><value>cultured  24 hours</value><value>cultured polyclonal CD31- ADASCs</value><value>du-145</value><value>ea.hy926 cell</value><value>EBC-1</value><value>EKVX</value><value>Embryonic cell line</value><value>es cells</value><value>ew24 cell line</value><value>ew24 cell line, lentivirus treated</value><value>FR4</value><value>glioblastoma cell line</value><value>gm00038c, fibroblast cell line</value><value>gm00316b, fibroblast cell line</value><value>gmo8398c, fibroblast cell line</value><value>GRANTA-519</value><value>H1</value><value>H1299</value><value>H1395</value><value>H1437</value><value>H157</value><value>H1648</value><value>H1666</value><value>H1672</value><value>H1770</value><value>H1819</value><value>H1975</value><value>H1993</value><value>H2009</value><value>H2087</value><value>H2122</value><value>H2126</value><value>H2347</value><value>H2882</value><value>H2887</value><value>H3255</value><value>H441</value><value>h460</value><value>H820</value><value>H9</value><value>HBL100</value><value>hcaSMC</value><value>HCC-2998</value><value>HCC1007</value><value>HCC1143</value><value>HCC1171</value><value>HCC1187</value><value>HCC1195</value><value>HCC1359</value><value>HCC1428</value><value>HCC15</value><value>HCC1500</value><value>HCC193</value><value>HCC1937</value><value>HCC2157</value><value>HCC2185</value><value>HCC227</value><value>HCC2935</value><value>HCC3153</value><value>HCC366</value><value>HCC38</value><value>HCC44</value><value>HCC515</value><value>HCC70</value><value>HCC78</value><value>HCC827</value><value>HCC95</value><value>hct-15</value><value>hct116</value><value>HEK293</value><value>HEK293T</value><value>HeLa</value><value>HeLa cells (Luciferase siRNA transfection)</value><value>HeLa cells (transfected with UPF1 siRNA 1)</value><value>HeLa cells (transfected with UPF1 siRNA 2)</value><value>HeLa cells (transfected with UPF1 siRNA 3)</value><value>HeLa Tet-On</value><value>Hep-2</value><value>HES2</value><value>hl60</value><value>Hmec-1</value><value>Hmec-1, TNF-stimulated</value><value>HOP-62</value><value>HOP-92</value><value>HS578T</value><value>ht-29</value><value>I-6 ES</value><value>ib3-1</value><value>igrov1</value><value>Immortalized normal cell</value><value>imr-90</value><value>ITM (modifierd imr-90)</value><value>ITM-E6E7 (modifierd imr-90)</value><value>ITM-E6E7-ST (modifierd imr-90)</value><value>ITM-ST (modifierd imr-90)</value><value>itv (modified imr-90)</value><value>Jeg3</value><value>JEKO-1 </value><value>Jurkat</value><value>Jurkat/A4</value><value>k562</value><value>KELLY</value><value>KM12</value><value>KM4</value><value>KMS11</value><value>KMS12</value><value>KMS20</value><value>KMS27</value><value>KMS28</value><value>KMS34</value><value>KS Y-1</value><value>KS-IMM</value><value>LC-1F</value><value>LC1/sq</value><value>LC2/ad</value><value>LK2 </value><value>lncap cells</value><value>lncap cells, DHT-treated</value><value>lncap cells, SARM-treated</value><value>LOXIMVI</value><value>lp1</value><value>LU135</value><value>LU139</value><value>LU165</value><value>lung cancer cell line</value><value>m-o7e cell line</value><value>M14</value><value>malme-3m</value><value>Mammary gland cell line</value><value>mcf-7aro cells</value><value>MCF10A</value><value>mcf10a-myc cells</value><value>MCF12A</value><value>mcf7</value><value>mcf7-lmo4-tetoff cells</value><value>mcf7-lmo4-tetoff cells, treated with doxycycline</value><value>MDA-MB-231</value><value>MDA-MB-435</value><value>MDA-N (MDA-MB435 trasfected by erbB2)</value><value>MDA468</value><value>MDAMB134VI</value><value>MDAMB175VII</value><value>MDAMB361</value><value>MDAMB415</value><value>MDAMB436</value><value>MDAMB453</value><value>MDAMB468</value><value>MOLT4</value><value>MRC5</value><value>MS-1</value><value>N231</value><value>NC-NC</value><value>NCEB-1 </value><value>NCI-ADR-RES</value><value>NCI-H226</value><value>NCI-H322M</value><value>NCI-H460</value><value>NCI-H522</value><value>NCI-H929</value><value>NCU-MM1</value><value>OVCAR-3</value><value>OVCAR-4</value><value>OVCAR-5</value><value>OVCAR-8</value><value>pc-10</value><value>pc-6</value><value>pc3</value><value>PC7</value><value>PC9</value><value>primary cell line</value><value>QG-56</value><value>REC</value><value>RERF LC-KJ </value><value>RERF-LC-AI </value><value>RJ2.2.5</value><value>RKO</value><value>rpmi-8226</value><value>RXF-393</value><value>SBC3</value><value>SF-268</value><value>SF-539</value><value>sk-mel-28</value><value>SK-N-AS</value><value>sk-n-mc cell line, lentivirus treated</value><value>sk-n-mc cell line; lentivirus treated</value><value>SK-N-SH</value><value>SKBR3</value><value>Skgt4</value><value>skmc myoblast</value><value>skmel5</value><value>SKMM1</value><value>SN12C</value><value>snb-19</value><value>SNB-75</value><value>SQ-5</value><value>SR</value><value>ssmcf7</value><value>Su-dhl1</value><value>SUM1315MO2</value><value>SUM149PT</value><value>SUM159PT</value><value>SUM185PE</value><value>SUM190PT</value><value>SUM225CWN</value><value>SUM44PE</value><value>SUM52PE</value><value>sw480</value><value>sw620</value><value>T47D</value><value>te85</value><value>TERV</value><value>TERV-AntiSenseB56</value><value>TERV-ST</value><value>TERV-ST110</value><value>TK-10</value><value>ts cell line</value><value>u-2os cells</value><value>U251</value><value>U937</value><value>UACC-257</value><value>UACC-62</value><value>UACC812</value><value>UO-31</value><value>WI38</value><value>ZR751</value><value>ZR7530</value><value>ZR75B</value></sampleattribute><sampleattribute><category>CellType</category><value>721 B lymphoblasts</value><value>adipocytes</value><value>adipose-derived adult stem cells (ADASCs)</value><value>Airway epithelial cells</value><value>aortic vascular smooth muscle cell</value><value>b cell</value><value>basal cell, UV treated</value><value>BDCA4+ dentritic cell</value><value>blast cell</value><value>blast cell, mononuclear cell</value><value>Breast epithelia</value><value>breast epithelia</value><value>bronchial epithelium</value><value>bronchoalveolar lavage cell</value><value>CB8+ T cell</value><value>CD138+ plasma cell</value><value>CD14+ monocyte</value><value>CD19+ B cell (neg. sel.)</value><value>CD33+ cells</value><value>CD34+ cell</value><value>CD34+ hematopoietic stem cell</value><value>CD34+ T cell</value><value>CD34+ umbilical cord blood cell</value><value>CD34+CD1a- thymocyte</value><value>CD34+CD38- thymocyte</value><value>CD3intCD4+CD8+ thymocyte</value><value>CD4+ lymphocyte</value><value>CD4+ T cell</value><value>CD8+ T cell</value><value>central memory 1 CD4+ T cell</value><value>central memory CD4+ T cell</value><value>clear cell</value><value>CXCR5(-)ICOS(-/lo) CD4+ T cell</value><value>CXCR5(hi)ICOS(hi) CD4+ T cell</value><value>CXCR5(lo)ICOS(int) CD4+ T cell</value><value>DP CD3+ thymocyte</value><value>DP CD3- thymocyte</value><value>effector memory CD4+ T cell</value><value>embryonic lung fibroblast</value><value>Embryonic stem cell</value><value>endothelial cell</value><value>epidermal keratinocyte, P-2 treatment</value><value>epidermis</value><value>epidermis and dermis</value><value>epithelial cell</value><value>epithelium</value><value>Erythrocyte</value><value>Esophageal cells</value><value>esophageal epithelium</value><value>fibroblast</value><value>fibroblast like</value><value>gingiva cell</value><value>granulocyte</value><value>hematopoietic stem cell</value><value>human embryonic kidney cell</value><value>human lymphoblastoid cell</value><value>immature-B cell</value><value>immortalized endothelial cell</value><value>intestinal epithelial cell</value><value>ISP CD4+ thymocyte</value><value>Keratinocyte, DMSO treatment</value><value>Keratinocyte, P-2 treatment</value><value>Keratinocyte, PP-2 treatment</value><value>Leukocyte</value><value>ligament cell</value><value>lung epithelia</value><value>lymphoblast</value><value>lymphocyte</value><value>Macrophage</value><value>megakaryoblast</value><value>mesangial cell</value><value>mesenchymal precursor</value><value>mesenchymal stem cell</value><value>Monocyte</value><value>monocyte</value><value>monocyte derived macrophage</value><value>mononuclear cell</value><value>mononuclear cell, blast cell</value><value>myoblast</value><value>naive CD4+ T cell</value><value>neuroblastoma cell</value><value>peripheral blood cell, after drinking grape juice</value><value>peripheral blood cell, after drinking water</value><value>peripheral blood cell, after drinking wine</value><value>peripheral blood cells, after drinking alcohol</value><value>peripheral blood mononuclear cell</value><value>plasma cell</value><value>pre-B-I cell</value><value>pre-B-II large cell</value><value>pre-B-II small cell</value><value>primary aortic smooth muscle cell</value><value>primary blood vessel endothelial cell</value><value>primary bone marrow CD34+ stem cell</value><value>primary bone marrow CD34- mesenchymal stem cell</value><value>primary embryonic fibroblast</value><value>primary lymphatic endothelial cell</value><value>primary microvascular endothelial cell</value><value>primary uterine smooth muscle cell</value><value>progenitor cell, hematopoietic stem cell</value><value>regenerating cell</value><value>smooth muscle cell</value><value>SP CD4+ thymocyte</value><value>SP CD8+ thymocyte</value><value>Syncytiotrophoblast</value><value>T cell</value><value>T lymphocyte</value><value>theca</value><value>Thyrocyte</value><value>thyroid follicular epithelial cell</value><value>trabecular meshwork</value><value>trabecular meshwork cell</value><value>trabecular meshwork cell, treated TFG-beta1</value><value>trabecular meshwork cell, treated TFG-beta2</value><value>umbilical vein endothelial cell</value></sampleattribute><sampleattribute><category>DataSource</category><value>E-AFMX-6</value><value>E-LGCL-5</value><value>E-MEXP-1006</value><value>E-MEXP-101</value><value>E-MEXP-114</value><value>E-MEXP-120</value><value>E-MEXP-121</value><value>E-MEXP-122</value><value>E-MEXP-149</value><value>E-MEXP-156</value><value>E-MEXP-167</value><value>E-MEXP-168</value><value>E-MEXP-170</value><value>E-MEXP-184</value><value>E-MEXP-214</value><value>E-MEXP-215</value><value>E-MEXP-216</value><value>E-MEXP-231</value><value>E-MEXP-232</value><value>E-MEXP-243</value><value>E-MEXP-271</value><value>E-MEXP-296</value><value>E-MEXP-303</value><value>E-MEXP-313</value><value>E-MEXP-325</value><value>E-MEXP-337</value><value>E-MEXP-340</value><value>E-MEXP-353</value><value>E-MEXP-360</value><value>E-MEXP-382</value><value>E-MEXP-384</value><value>E-MEXP-389</value><value>E-MEXP-391</value><value>E-MEXP-403</value><value>E-MEXP-413</value><value>E-MEXP-429</value><value>E-MEXP-433</value><value>E-MEXP-440</value><value>E-MEXP-445</value><value>E-MEXP-466</value><value>E-MEXP-480</value><value>E-MEXP-530</value><value>E-MEXP-548</value><value>E-MEXP-549</value><value>E-MEXP-562</value><value>E-MEXP-569</value><value>E-MEXP-583</value><value>E-MEXP-641</value><value>E-MEXP-66</value><value>E-MEXP-72</value><value>E-MEXP-750</value><value>E-MEXP-76</value><value>E-MEXP-83</value><value>E-MEXP-847</value><value>E-MEXP-872</value><value>E-MEXP-97</value><value>E-MIMR-11</value><value>E-MIMR-17</value><value>E-TABM-145</value><value>E-TABM-15</value><value>E-TABM-157</value><value>E-TABM-26</value><value>E-TABM-36</value><value>E-TABM-43</value><value>E-TABM-90</value><value>GSE1000</value><value>GSE1140</value><value>GSE1159</value><value>GSE1295</value><value>GSE1297</value><value>GSE1317</value><value>GSE1318</value><value>GSE1400</value><value>GSE1410</value><value>GSE1417</value><value>GSE1420</value><value>GSE1456</value><value>GSE1460</value><value>GSE1462</value><value>GSE1518</value><value>GSE1561</value><value>GSE1615</value><value>GSE1648</value><value>GSE1650</value><value>GSE1657</value><value>GSE1722</value><value>GSE1729</value><value>GSE1786</value><value>GSE1869</value><value>GSE1922</value><value>GSE1937</value><value>GSE2004</value><value>GSE2018</value><value>GSE2044</value><value>GSE2060</value><value>GSE2113</value><value>GSE2144</value><value>GSE2152</value><value>GSE2225</value><value>GSE2240</value><value>GSE2248</value><value>GSE2280</value><value>GSE2328</value><value>GSE2450</value><value>GSE2461</value><value>GSE2487</value><value>GSE2509</value><value>GSE2513</value><value>GSE2525</value><value>GSE2531</value><value>GSE2555</value><value>GSE2603</value><value>GSE2638</value><value>GSE2639</value><value>GSE2665</value><value>GSE2724</value><value>GSE2725</value><value>GSE2742</value><value>GSE2990</value><value>GSE3167</value><value>GSE3183</value><value>GSE3185</value><value>GSE3218</value><value>GSE3230</value><value>GSE3243</value><value>GSE3284</value><value>GSE3307</value><value>GSE3356</value><value>GSE3407</value><value>GSE3494</value><value>GSE3585</value><value>GSE3737</value><value>GSE3771</value><value>GSE3780</value><value>GSE3788</value><value>GSE3790</value><value>GSE3794</value><value>GSE3823</value><value>GSE3846</value><value>GSE3860</value><value>GSE4045</value><value>GSE4069</value><value>GSE4127</value><value>GSE4176</value><value>GSE4271</value><value>GSE4475</value><value>GSE4485</value><value>GSE4636</value><value>GSE4646</value><value>GSE4698</value><value>GSE473</value><value>GSE4780</value><value>GSE4817</value><value>GSE4824</value><value>GSE4917</value><value>GSE4922</value><value>GSE5007</value><value>GSE5090</value><value>GSE5258</value><value>GSE5370</value><value>GSE5392</value><value>GSE5418</value><value>GSE5457</value><value>GSE5580</value><value>GSE5667</value><value>GSE5720</value><value>GSE5967</value><value>GSE5999</value><value>GSE6008</value><value>GSE6011</value><value>GSE6015</value><value>GSE6029</value><value>GSE6082</value><value>GSE6184</value><value>GSE620</value><value>GSE6205</value><value>GSE6253</value><value>GSE6263</value><value>GSE6269</value><value>GSE6344</value><value>GSE6365</value><value>GSE6401</value><value>GSE6477</value><value>GSE648</value><value>GSE6532</value><value>GSE658</value><value>GSE659</value><value>GSE6596</value><value>GSE6691</value><value>GSE6740</value><value>GSE6786</value><value>GSE6914</value><value>GSE6932</value><value>GSE7007</value><value>GSE7009</value><value>GSE7035</value><value>GSE7123</value><value>GSE7138</value><value>GSE7144</value><value>GSE7382</value><value>GSE7454</value><value>GSE7529</value><value>GSE781</value><value>GSE973</value><value>GSE974</value><value>GSE994</value></sampleattribute><sampleattribute><category>DevelopmentalStage</category><value>adult</value><value>embryo</value><value>fetus</value></sampleattribute><sampleattribute><category>DiseaseStage</category><value>aggressive</value><value>chronic</value><value>early</value><value>grade 0</value><value>grade 1</value><value>grade 2</value><value>grade 3</value><value>grade 4</value><value>lymph node metastasis</value><value>metastatic</value><value>pre-LVAD</value><value>primary</value><value>relapsed</value><value>stage 1</value><value>stage 1A</value><value>stage 1C</value><value>stage 2</value><value>stage 2A</value><value>stage 2B</value><value>stage 2C</value><value>stage 3</value><value>stage 3B</value><value>stage 3C</value><value>stage 3D</value><value>stage 4</value><value>stage I</value><value>stage IA</value><value>stage II</value><value>Stage IIA</value><value>stage IIA</value><value>stage III</value><value>stage IIIA</value><value>stage IIIB</value><value>Stage IV</value><value>stage T1N0</value><value>stage T2N0</value><value>T3a</value><value>T3b</value><value>T4a</value><value>T4b</value></sampleattribute><sampleattribute><category>DiseaseState</category><value>abscess</value><value>acute lymphoblastic leukemia</value><value>acute lymphoblastic leukemia, chemotherapy response</value><value>acute monoblastic and monocytic leukemia</value><value>acute myeloid leukemia</value><value>acute myelomonocytic leukemia</value><value>acute promyelocytic leukemia</value><value>acute quadriplegic myopathy</value><value>acute rejection</value><value>adenocarcinoma</value><value>adenocarcinoma (poorly differenciated)</value><value>Aggressive, chronic myelogenous leukemia</value><value>AIDS-KS, HIV+, nodular (late) stage</value><value>AIDS-KS, KSHV-</value><value>alveolar rhabdomyosarcoma</value><value>alzheimers disease</value><value>Anaplastic large cell lymphoma</value><value>astrocytoma</value><value>atopic mild asthmatics</value><value>atopic severe asthma</value><value>atrial fibrillation</value><value>B-cell lymphoma</value><value>bacteremia</value><value>barretts esophagus</value><value>bipolar disorder</value><value>bladder tumor</value><value>bone tumor</value><value>brain tumor</value><value>Breast adenocarcinoma</value><value>breast cancer</value><value>breast cancer, adenovirus expressing GFP</value><value>breast cancer, inflammatory</value><value>breast epithelial carcinosarcoma</value><value>breast tumor</value><value>breast tumor, basal</value><value>breast tumor, luminal</value><value>breast tumor, normal like</value><value>calpainopathy</value><value>carcinoma (undifferenciated)</value><value>carcinoma in situ</value><value>carcinoma in situ, bladder tumor</value><value>cardiomyopathy</value><value>cardiomyopathy, calcifications</value><value>cellulitis</value><value>cervical carcinoma</value><value>chondroblastoma</value><value>chondromyxoid fibroma</value><value>chondrosarcoma</value><value>chordoma</value><value>choriocarcinoma </value><value>chronic myelogenous leukemia</value><value>chronic myelogenous leukemia, indolent</value><value>chronic myeloid leukemia</value><value>Classic-KS, HIV-, nodular (late) stage</value><value>clear cell carcinoma</value><value>cockayne syndrome</value><value>cololrectal tumor</value><value>colon adenocarcinoma</value><value>colon adenocarcinoma, acterial infection</value><value>colon cancer</value><value>colon cancer cells with intact PTEN</value><value>colon cancer cells with PTEn -/-</value><value>colon carcinoma</value><value>colon carcinoma (poory differenciated)</value><value>colorectal adenocarcinoma</value><value>common variable immunodeficiency</value><value>congestive heart failure</value><value>cystic fibrosis</value><value>cystoadenocarcinoma (poolry differentiated)</value><value>dedifferentiated chondrosarcoma</value><value>dermatitis</value><value>dermatomyositis</value><value>diffuse large B-cell lymphoma</value><value>Down syndrome, acute megakaryoblastic leukaemia</value><value>Down syndrome, transient myleoproliferative disorder</value><value>duchenne muscular dystrophy</value><value>embryonal rhabdomyosarcoma</value><value>Emery-Dreifuss muscular dystrophy</value><value>emphysema</value><value>endocarditis</value><value>Erythromyeloblastoid leukemia</value><value>esophageal cancer </value><value>Ewings Sarcoma</value><value>facioscapulohumeral muscular dystrophy</value><value>fibromatosis</value><value>follicular thyroid adenoma</value><value>follicular thyroid carcinoma</value><value>ganglioneuroblastoma</value><value>ganglioneuroblastoma intermixed</value><value>ganglioneuroma</value><value>germ cell tumor</value><value>glial neoplasm</value><value>glioblastoma</value><value>glioblastoma (undifferciated)</value><value>head and neck squamous cell carcinoma</value><value>heart transplant no rejection</value><value>heart transplant post-rejection</value><value>heart transplant rejection</value><value>hepatitis c</value><value>hepatocellular adenoma</value><value>hepatocellular carcinoma</value><value>hepatocellular carcinoma, no satellite nodules</value><value>hepatocellular carcinoma, satellite nodules</value><value>hereditary leiomyomatosis and renal cell cancer</value><value>hereditary spastic paraplegia</value><value>hiv infection</value><value>hiv; hiv infection; disease; conclusion; infection; disease progression</value><value>Huntingtons disease</value><value>hypernephroma</value><value>Hyperparathyroidism</value><value>Iatrogenic Kaposis sarcoma, KSHV-</value><value>infiltrating ductal carcinoma</value><value>inflammatory myopathy</value><value>influenza</value><value>irritable bowel syndrome</value><value>Ischemia</value><value>ischemic cardiomyopathy</value><value>juvenile dermatomyositis</value><value>KSHV infection, 14 days</value><value>KSHV infection, 2 days</value><value>KSHV infection, 7 days</value><value>large cell carcinoma</value><value>large cell-undifferentiated</value><value>leiomyosarcoma</value><value>lipoma</value><value>locally advanced breast carcinoma</value><value>lung adenocarcinoma</value><value>lung adenocarcinoma, ebv infection</value><value>Lung adenocarcinoma, gemcitabine treated, gemcitabine resistant</value><value>lung cancer</value><value>lung cancer, cytotoxicity</value><value>lung large cell carcinoma</value><value>Lung small cell cancer</value><value>Lung squamous cell cancer</value><value>lung squamous cell carcinoma</value><value>lymphoma</value><value>malaria</value><value>malaria (treated malaria)</value><value>malaria, experimentally infected</value><value>malignant amelanotic melanoma</value><value>malignant melanoma</value><value>malignant peripheral nerve sheath tumor</value><value>melanoma</value><value>meningioma</value><value>meningitis</value><value>meningitis infected</value><value>mesothelioma</value><value>metabolic syndrome</value><value>mitochondrial disorder</value><value>monoclonal gammopathy of unknown significance</value><value>Monocyte lymphoma</value><value>monophasic synovial sarcoma</value><value>multiple myeloma</value><value>myeloma</value><value>myocardial infarction</value><value>myositis</value><value>myxoid liposarcoma</value><value>NC-NC lymphoblastoid B cell line</value><value>NCU-MM1 multiple myeloma cell line</value><value>neuroblastoma</value><value>neuroblastoma-differentiating</value><value>neuroblastoma-poorly differentiated</value><value>neuroblastoma-undifferentiated</value><value>neurofibroma</value><value>no tendon xanthomas</value><value>non-small cell lung cancer</value><value>non-tumoral alcoholic cirrhosis</value><value>non-tumoral alcoholic non-cirrhotic liver</value><value>non-tumoral HBV cirrhosis</value><value>non-tumoral HBV non-cirrhotic liver</value><value>non-tumoral HCV cirrhosis</value><value>nonischemic cardiomyopathy</value><value>obesity</value><value>osteomyelitis</value><value>osteosarcoma</value><value>ovarian tumor</value><value>ovarian tumor, endometrioid</value><value>ovarian tumor, mucinosus</value><value>ovarian tumor, serous</value><value>periodontitis</value><value>placental choriocarcinoma </value><value>plasma-cell leukemia</value><value>pneumonia</value><value>pneumonia; empyema</value><value>pneumonia; influenza</value><value>polycystic ovarian syndrome</value><value>polymyositis</value><value>precursor T lymphoblastic leukemia</value><value>presymptomatic DMD</value><value>progeria syndrome</value><value>prostate adenocarcinoma</value><value>prostate cancer</value><value>prostate carcinoma</value><value>pterygium</value><value>renal cell carcinoma</value><value>renal clear cell carcinoma</value><value>respiratory distress</value><value>rhabdomyosarcoma </value><value>RJ2.2.5 Burkitts lymphoma cell line</value><value>rpmi-8226 S166myeloma</value><value>sarcoma</value><value>schwannoma</value><value>Seizure</value><value>septic arthiritis</value><value>septic arthritis</value><value>small cell bronchioalveolar carcinoma</value><value>small cell cancer</value><value>small cell lung cancer</value><value>smoldering myeloma</value><value>spindle cell carcinoma</value><value>spindle cell tumor</value><value>squamous cell cancer</value><value>squamous cell carcinoma</value><value>squamous cell carcinoma cell line, 2h after infection with fasX-mutant Streptococcus pyogenes</value><value>squamous cell carcinoma cell line, 4h after infection with fasX-mutant Streptococcus pyogenes</value><value>squamous cell carcinoma cell line, 4h after infection with wildtype Streptococcus pyogenes</value><value>squamous cell carcinoma cell line, 6h after infection with fasX-mutant Streptococcus pyogenes</value><value>squamous cell carcinoma cell line, 8h after infection with fasX-mutant Streptococcus pyogenes</value><value>squamous cell carcinoma cell line, 8h after infection with wildtype Streptococcus pyogenes</value><value>squamous cell carcinoma cell line, control sample without infection after 8h</value><value>T cell acute lymphoblastic leukemia</value><value>T cell lymphoblast-like cell line </value><value>tendon xanthomas</value><value>trauma</value><value>Trauma, multiple organ failure</value><value>ulcerative colitis</value><value>urinary tract infection</value><value>uterine fibroid</value><value>well-differentiated liposarcoma</value><value>X-linked agammaglobulinemia</value></sampleattribute><sampleattribute><category>Generalization 6 on reduced data</category><value>brain</value><value>cell line</value><value>hematopoietic system</value><value>incompletely differentiated</value><value>muscle</value><value>solid tissue</value></sampleattribute><sampleattribute><category>groups with 10 and more replicates</category><value>A549 lung adenocarcinoma</value><value>acute lymphoblastic leukemia</value><value>acute myeloid leukemia</value><value>acute promyelocytic leukemia</value><value>B cell</value><value>B-cell lymphoma</value><value>bladder cancer</value><value>blood</value><value>brain</value><value>brain bipolar disorder</value><value>brain tumor</value><value>breast cancer</value><value>bronchial epithelia</value><value>bronchoalveolar lavage cell</value><value>BT474 breast cancer</value><value>caco2 colon adenocarcinoma</value><value>Calu-3 lung adenocarcinoma</value><value>caudate nucleus</value><value>caudate nucleus Huntingtons</value><value>CD138+ plasma cell myeloma</value><value>cerebellum</value><value>cerebellum Huntingtons</value><value>chronic myeloid leukemia</value><value>colorectal cancer</value><value>embryonal rhabdomyosarcoma</value><value>embryonic lung fibroblast</value><value>embryonic skin fibroblast</value><value>epidermis dermatitis</value><value>ewings sarcoma</value><value>fetal lung fibroblast</value><value>FM9514 human embryonic myoblast</value><value>frontal cortex</value><value>frontal cortex Huntingtons</value><value>germ cell tumor</value><value>heart</value><value>heart disease</value><value>HEK293 embryonic kidney</value><value>HeLa cervical adenocarcinoma</value><value>HeLa cervical adenocarcinoma transfected</value><value>hematopoietic stem cell</value><value>Hep-2 larynx sqamous cell carcinoma</value><value>hepatocellular carcinoma</value><value>hI60 promyelocytic leukemia</value><value>ht-29 colorectal adenocarcinoma</value><value>hypothalamus</value><value>IB3-1 adenovirus transformed bronchial epithelia</value><value>INCaP prostate cancer</value><value>k562 myelogenous leukaemia</value><value>Kaposi sarcoma</value><value>kidney</value><value>leukocyte</value><value>lung cancer</value><value>lymph node</value><value>lymphocyte</value><value>macrophage</value><value>mcf-7aro breast epithelial adenocarcinoma</value><value>MCF7 breast epithelial adenocarcinoma</value><value>MDA-MB-231 breast cancer</value><value>MDA468 breast cancer</value><value>mesenchymal stem cell</value><value>MOLT4 T cell acute lymphoblastic leukemia</value><value>monocyte</value><value>mononuclear cell</value><value>mononuclear cell infection</value><value>myelogenous leukemia</value><value>myometrium</value><value>neuroblastoma</value><value>oral squamous cell carcinoma</value><value>ovarian tumor</value><value>pc3 prostate cancer</value><value>placenta basal plate</value><value>preadipocytes</value><value>precursor T lymphoblastic leukemia</value><value>primary intervertebral disc</value><value>prostate cancer</value><value>prostate gland</value><value>renal cell carcinoma</value><value>RKO colon carcinoma</value><value>skeletal muscle</value><value>skeletal muscle diseased</value><value>skeletal muscle muscular dystrophy</value><value>skmel5 melanoma</value><value>smooth muscle</value><value>ssMCF7 breast cancer</value><value>T cell</value><value>T cell diseased</value><value>T47D breast ductal carcinoma</value><value>thymocyte</value><value>thyroid adenocarcinoma</value><value>tonsil</value><value>ts anaplastic large cell lymphoma</value><value>umbilical vein endothelial cell</value><value>universal reference</value><value>unknown lung adenocarcinoma</value><value>unknown lung small cell cancer</value><value>uterine tumor</value></sampleattribute><sampleattribute><category>OperatorVariation</category><value>Adrian,P.,Bracken</value><value>Agnes,,Viale</value><value>Agnes,,Yong</value><value>Agnieszka,Maria,Lichanska</value><value>Akihiko,,Gemma</value><value>Alessandro,,Provenzani</value><value>Alex,,Tonks</value><value>Alexander,,Ploner</value><value>Alexei,,Gratchev</value><value>Andrea,Patricelli,Malizia</value><value>Andreas,,Klein</value><value>Andreas,S.,Barth</value><value>Andrey,,Mikhailov</value><value>Angela,,Hodges</value><value>Antonino,,Neri</value><value>Antonio,,Iavarone</value><value>Antti,,Kokko</value><value>Are,M,Holm</value><value>Avrum,,Spira</value><value>Beat,W,Schafer</value><value>BELEN,,PERAL</value><value>Benjamin,,Haibe-Kains</value><value>Bernhard,R.,Brehm</value><value>Carlos,,Moreno</value><value>Carol,,Westbrook</value><value>Catherine,,Klapperich</value><value>Chris,D,McCabe</value><value>Christian,Albert,Gleissner</value><value>Chun,,Zheng</value><value>Claire,,Hirst</value><value>Claire,,Mulligan</value><value>Cristina,,Battaglia</value><value>Damien,,Chaussabel</value><value>Daniel,,Hopkins</value><value>Daniel,,Yap</value><value>Dave,,Peck</value><value>David,Lawrence,Newsom</value><value>David,W,Burleigh</value><value>Dirk,,Koczan</value><value>Dmitri,A,Kazmin</value><value>Domenico,,Albino</value><value>Dorothee,,Viemann</value><value>Douglas,A,Plager</value><value>Edward,J,Oakeley</value><value>Elizabeth ,,Salomon</value><value>Eoin,P.,OGrady</value><value>Eric,,Hoffman</value><value>Eric,M,Blalock</value><value>Ernesto,,Yague</value><value>Fabien,,Petel</value><value>Florent,,Baty</value><value>Francesco,,Bertoni</value><value>Frank,,Weber</value><value>Garrett,,Frampton</value><value>Geoffrey,,Girnun</value><value>Gerd,,Mueller</value><value>Grindle,M,Suzanne</value><value>Herbert,,Mayer</value><value>Hsei-Wei,,Wang</value><value>IDDC,,Inflammation  the Host Response to Injury</value><value>J Peter,,Svensson</value><value>James,,Korkola</value><value>Jeff,,Lande</value><value>Jeff,,Shearstone</value><value>Jennifer,Rebecca,Wood</value><value>Jerry,M.,Wright</value><value>Jim,,Boonyaratanakornkit</value><value>Joel,S,Rozowsky</value><value>Joerg,,Schlingemann</value><value>Johanne,,Tremblay</value><value>John,A,Copland</value><value>John,C,Newman</value><value>John,R,Walker</value><value>Jorgen,,Olsen</value><value>JUNGSIK,,KIM</value><value>Justin,,Lamb</value><value>karen,,rodgers</value><value>Karin,,Pike-Overzet</value><value>Katherine,J,Martin</value><value>Katrine,B,Fronsdal</value><value>Kenro,,Kusumi</value><value>Kevin,K,Lin</value><value>Khaldoun,,Al-Romaih</value><value>L,,McArdle</value><value>Lance,David,Miller</value><value>Lars,DyrskjC8t,Andersen</value><value>Lawrence,Martin,Boyd</value><value>Lesley,,Jones, Angela Hodges</value><value>Lizi,,Wu</value><value>Luc,,Girard</value><value>Maja,,Herak Bosnar</value><value>Malin,,Lindstedt</value><value>Manolis,G,Gialitakis</value><value>Manon,,Von Buelow</value><value>Manuel,,Collado</value><value>Marc,E.,Lenburg</value><value>Marcelo,,Viegas</value><value>Marco,,Crimi</value><value>Marek,,Basler</value><value>Maria,,Traka</value><value>maria,g,borrello</value><value>Mario,,Pescatori</value><value>Marjan,,Boerma</value><value>Marta,,Artieda</value><value>Martin,,Hyrcza</value><value>Maryanne,,Vahey</value><value>Marzia,,Dolcino</value><value>Menno,C,van Zelm</value><value>Michael,,Hummel</value><value>Michelle,,Kittleson</value><value>mike,j,hubank</value><value>Milton,W,Taylor</value><value>Myeong,S,Lee</value><value>Myriam,,Alcalay</value><value>Nikolai,N.,Khodarev</value><value>Norma,Carmen,Gutierrez</value><value>Oliver,,Frank</value><value>Olivier,,Delattre</value><value>Ontario Genomics Innovation Centre,,OGIC</value><value>Paolo,,Fardin</value><value>paul,,spellman</value><value>Per-Arne,,Svensson</value><value>Peter,,Connolly</value><value>Pierre,,Close</value><value>Priti,,Hegde</value><value>Rachel,,van Haaften</value><value>Rafael,,Fonseca</value><value>Ramaswamy,,Narayanan</value><value>Rebekah,K,ODonnell</value><value>Rehannah,H,Borup</value><value>Renate,,Kirschner-Schwabe</value><value>Richard,,Iggo</value><value>Richard,Steven,Mitchell</value><value>Roberto,,Piva</value><value>Roel,,Verhaak</value><value>Roland,J,Mayer</value><value>Rork,,Kuick</value><value>Ruprecht,,Kuner</value><value>Sabine,,Bahn</value><value>Sakari,,Vanharanta</value><value>Sangeeta,,English</value><value>Scott,A.,Ness</value><value>Sek Won,,Kong</value><value>Shane,P,Duggan</value><value>Shiuan,,Chen</value><value>Shlomit,,Radom-Aizik</value><value>Shula,,Blum</value><value>Sjur,,Reppe</value><value>Stefan,,Wolfl</value><value>Stephen,,Henderson</value><value>Susan,,Fisher</value><value>Susan,B,Connolly</value><value>Suzanne,,Conzen</value><value>Tal,,Shay</value><value>Thierry,,Pedron</value><value>Thomas,,Cappola</value><value>Thomas,,Hermann</value><value>Thomas,D.,Wu</value><value>Uma,T,Shankavaram</value><value>William,E,Evans</value><value>Xinmin,,Zhang</value><value>Yan,,Lu</value><value>Yong Wee,,Wong</value></sampleattribute><sampleattribute><category>Organism</category><value>Homo sapiens</value><value>Mus musculus</value></sampleattribute><sampleattribute><category>OrganismPart</category><value>Abdominus</value><value>adipose tissue</value><value>adipose tissue from abdomen</value><value>adipose tissue from abdomen and thigh</value><value>adrenal gland</value><value>amygdala</value><value>aorta</value><value>atrial myocardium</value><value>bladder</value><value>bladder mucosa</value><value>Blood</value><value>blood</value><value>bone</value><value>bone marrow</value><value>brain</value><value>brain caudate nucleus</value><value>brain cerebellum</value><value>brain, frontal cortex, primary motor cortex, Brodmanns Area 4</value><value>brain, frontal cortex, superior frontal cortex, Brodmanns Area 9</value><value>brain, prefrontal cortex</value><value>bronchial epithelia</value><value>bronchial epithelia, current smoker</value><value>bronchial epithelia, former smoker</value><value>cardiac ventricle</value><value>caudate nucleus</value><value>cerebellum</value><value>cervix</value><value>chest wall</value><value>colon</value><value>colon mucosa</value><value>conjunctiva</value><value>connective tissue</value><value>Cord blood</value><value>coronary artery</value><value>distal right femur</value><value>Epidermis</value><value>esophagus</value><value>extracranial</value><value>eye</value><value>fetal blood</value><value>fetal lung</value><value>gingiva</value><value>heart</value><value>hippocampal CA1 tissue</value><value>human microvascular endothelial cell </value><value>human universal reference</value><value>hypopharynx</value><value>hypothalamus</value><value>iliac fossa</value><value>kidney</value><value>larynx</value><value>larynx </value><value>left calf</value><value>left femur</value><value>left fibula</value><value>left foot</value><value>left forearm</value><value>left knee</value><value>left leg</value><value>left thigh</value><value>left tibia</value><value>left ventricle, heart</value><value>left ventricular myocardium</value><value>Leukocyte</value><value>liver</value><value>lower back</value><value>lung</value><value>lung transplant</value><value>lymph node</value><value>mammary gland</value><value>mandible</value><value>mediastinum</value><value>Mesagnium</value><value>muscle</value><value>myocardium (left ventricular)</value><value>myometrium</value><value>neuroendocrine</value><value>oral</value><value>Oral cavity</value><value>oropharynx</value><value>ovary</value><value>palatine tonsil</value><value>peroneal nerve</value><value>placenta</value><value>placenta basal plate</value><value>pleura</value><value>prostate</value><value>proximal epiphysis of left tibia</value><value>proximal epiphysis of right fibula</value><value>quadriceps muscle</value><value>ray of foot</value><value>rib cage</value><value>right axilla</value><value>right buttock</value><value>right calf</value><value>right elbow</value><value>right femur</value><value>right humerus</value><value>right knee</value><value>right latissimus dorsi</value><value>right leg</value><value>right shoulder</value><value>right thigh</value><value>right tibia</value><value>right upper arm</value><value>sacrum</value><value>skeletal muscle</value><value>skin</value><value>skin (arm)</value><value>skin (leg)</value><value>Small intestine</value><value>smooth muscle</value><value>spine disc</value><value>T2 vertebra</value><value>T5 vertebra</value><value>testis</value><value>thymus</value><value>thyroid</value><value>tibia</value><value>tongue</value><value>tonsil</value><value>Trachea</value><value>umbilical cord blood</value><value>umbilical vein</value><value>universal reference</value><value>uterine tube</value><value>uterus</value><value>vastus lateralis</value><value>Whole embryo</value><value>yolk sac</value></sampleattribute><sampleattribute><category>Sex</category><value>female</value><value>hermaphrodite</value><value>male</value><value>mixed sex</value><value>unknown sex</value></sampleattribute><experimentalfactor><name>15 meta-groups</name><value>blood neoplasm cell line</value><value>blood non neoplastic disease</value><value>breast cancer</value><value>germ cell neoplasm</value><value>leukemia</value><value>nervous system neoplasm</value><value>non breast carcinoma</value><value>non leukemic blood neoplasm</value><value>non neoplastic cell line</value><value>normal blood</value><value>normal solid tissue</value><value>other neoplasm</value><value>sarcoma</value><value>solid tissue neoplasm cell line</value><value>solid tissue non neoplastic disease</value></experimentalfactor><experimentalfactor><name>369 groups</name><value>293t-tva</value><value>600MPE breast cancer</value><value>a498 renal cell carcinoma</value><value>A549 lung adenocarcinoma</value><value>A673 Ewing tumor</value><value>ABC-1 lung adenocarcinoma</value><value>acute lymphoblastic leukemia</value><value>acute megakaryoblastic leukaemia</value><value>acute monoblastic and monocytic leukemia</value><value>acute myeloid leukemia</value><value>acute myelomonocytic leukemia</value><value>acute promyelocytic leukemia</value><value>acute quadriplegic myopathy</value><value>adipose tissue normal</value><value>adipose tissue polycystic ovarian syndrome</value><value>adipose-derived adult stem cells</value><value>adipose-derived adult stem cells cultured</value><value>airway epithelial cell</value><value>airway epithelial cell cystic fibrosis</value><value>alveolar rhabdomyosarcoma</value><value>AMO-1 myeloma</value><value>amygdala</value><value>AU565 breast carcinoma</value><value>B cell</value><value>B-cell lymphoma</value><value>B-cell lymphoma cell line</value><value>BeWo choriocarcinoma</value><value>bladder</value><value>bladder cancer</value><value>bladder mucosa</value><value>blood</value><value>blood transplant rejection</value><value>bone</value><value>bone hyperparathyroidis</value><value>brain</value><value>brain bipolar disorder</value><value>brain tumor</value><value>breast cancer</value><value>bronchial epithelia</value><value>bronchoalveolar lavage cell</value><value>bronchoalveolar lavage cell transplant rejection</value><value>BT20 breast cancer</value><value>BT474 breast cancer</value><value>BT483 breast cancer</value><value>BT549 breast cancer</value><value>C2C12 mouse muscle myoblast</value><value>caco2 colon adenocarcinoma</value><value>caki-1 renal cell carcinoma</value><value>CAL27 head neck squamous cell carcinoma</value><value>Calu-1 lung epidermoid carcinoma</value><value>Calu-3 lung adenocarcinoma</value><value>Calu-6 lung anaplastic carcinoma</value><value>CAMA1 breast cancer</value><value>caudate nucleus</value><value>caudate nucleus Huntingtons</value><value>CCL-153 fetal pulmonary fibroblast</value><value>ccrf-cem T-ALL</value><value>CD138+ plasma cell</value><value>CD138+ plasma cell monoclonal gammopathy</value><value>CD138+ plasma cell myeloma</value><value>CD33+ cells</value><value>CD34+ blood cell</value><value>CD34+ blood cell thymus</value><value>cerebellum</value><value>cerebellum Huntingtons</value><value>chondroblastoma</value><value>chondromyxoid fibroma</value><value>chondrosarcoma</value><value>chordoma</value><value>chronic myeloid leukemia</value><value>cirrhosis</value><value>CMK megakaryoblastic</value><value>colo205 colorectal adenocarcinoma</value><value>colon mucosa bowel disease</value><value>colorectal cancer</value><value>conjunctiva</value><value>connective tissue fibroblast</value><value>coronary artery smooth muscle cell</value><value>dedifferentiated chondrosarcoma</value><value>dendritic cell</value><value>DU 145 prostate carcinoma</value><value>ea.hy926 cell imortalized endothelial</value><value>EBC-1 lung squamous cell carcinoma</value><value>EKVX lung non small cell carcinoma</value><value>embryonal rhabdomyosarcoma</value><value>embryonic lung fibroblast</value><value>embryonic skin fibroblast</value><value>embryonic stem cell</value><value>endothelial cell</value><value>epidermis</value><value>epidermis dermatitis</value><value>erythrocyte</value><value>esophageal adenocarcinoma</value><value>esophagus Barretts</value><value>esophagus epithelium</value><value>EW24 Ewing sarcoma cell line</value><value>ewings sarcoma</value><value>fetal lung</value><value>fetal lung fibroblast</value><value>fibroblast Cockayne syndrome</value><value>fibromatosis</value><value>FM9514 human embryonic myoblast</value><value>FR4 multiple myeloma</value><value>frontal cortex</value><value>frontal cortex Huntingtons</value><value>ganglioneuroblastoma</value><value>ganglioneuroma</value><value>germ cell tumor</value><value>gingiva cell periodontitis</value><value>glioblastoma</value><value>glioblastoma cell line</value><value>granulocyte</value><value>H1 mesenchymal precursor</value><value>H9 mesenchymal precursor</value><value>HBL 100 breast cancer</value><value>HCC lung adenocarcinoma</value><value>HCC-2998 colon cancer</value><value>HCC1007 breast cancer</value><value>HCC1171 lung non small cell lung carcinoma</value><value>HCC1187 breast cancer</value><value>HCC1195 lung adenocarcinoma</value><value>HCC1359 lung large cell carcinoma</value><value>HCC1428 breast cancer</value><value>HCC15 lung squamous cell carcinoma</value><value>HCC1500 breast cancer</value><value>HCC1937 breast cancer</value><value>HCC2157 breast cancer</value><value>HCC2185 breast cancer</value><value>HCC227 lung adenocarcinoma</value><value>HCC2935 lung non-small cell lung cancer line</value><value>HCC3153 breast cancer</value><value>HCC366 non-small cell lung carcinoma</value><value>HCC38 breast cancer</value><value>HCC44 non-small cell lung carcinoma</value><value>HCC515 lung adenocarcinoma</value><value>HCC70 breast cancer</value><value>HCC78 lung non-small cell carcinoma</value><value>HCC827 lung adenocarcinoma</value><value>HCC95 lung non-small cell carcinoma</value><value>HCT-15 colorectal adenocarcinoma</value><value>HCT116 colorectal carcinoma</value><value>head and neck squamous cell carcinoma</value><value>heart</value><value>heart disease</value><value>HEK293 embryonic kidney</value><value>HEK293T embryonic kidney</value><value>HeLa cervical adenocarcinoma</value><value>HeLa cervical adenocarcinoma transfected</value><value>hematopoietic stem cell</value><value>Hep-2 larynx sqamous cell carcinoma</value><value>hepatocellular carcinoma</value><value>hI60 promyelocytic leukemia</value><value>hippocampus CA1</value><value>hippocampus CA1 Alzheimers</value><value>HMEC S1</value><value>HMEC184 breast cancer</value><value>HMT3522S1 breast cancer</value><value>HMT3522S1 breast epithelium</value><value>HOP 92 non-small cell lung carcinoma</value><value>HOP-62 lung adenocarcinoma</value><value>HS578T breast cancer cell line</value><value>ht-29 colorectal adenocarcinoma</value><value>human bronchial epithelial cell line</value><value>hypopharynx</value><value>hypothalamus</value><value>I-6 embryonic stem cell</value><value>IB3-1 adenovirus transformed bronchial epithelia</value><value>IGROV1 ovarian cancer </value><value>JEG3 placental choriocarcinoma </value><value>Jurkat T lymphocyte</value><value>k562 myelogenous leukaemia</value><value>Kaposi sarcoma</value><value>KELLY neuroblastoma</value><value>keratinocyte</value><value>kidney</value><value>kidney carcinoma</value><value>kidney epithelium</value><value>KM12 colon cancer</value><value>KM4 multiple myeloma</value><value>KS Y-1 Kaposis sarcoma AIDS associated</value><value>KS-IMM  Kaposis sarcoma non AIDS associated</value><value>LC-1F lung squamous cell</value><value>LC1/SQ lung squamous cell</value><value>LC2/AD non-small cell lung adenocarcinoma</value><value>leiomyosarcoma</value><value>leukocyte</value><value>leukocyte multiple organ failure</value><value>ligament cell periodontitis</value><value>lipoma</value><value>liposarcoma</value><value>liver</value><value>LK-2 lung squamous cell</value><value>LNCaP prostate cancer</value><value>LOXIMVI malignant amelanotic melanoma</value><value>Lu130 lung small cell cancer</value><value>LU134 lung small cell cancer</value><value>LU139 lung small cell cancer</value><value>LU165 lung small cell cancer</value><value>Lu65 lung non-small cell adenocarcinoma</value><value>lung</value><value>lung cancer</value><value>lung emphysema</value><value>lymph node</value><value>lymphocyte</value><value>lymphocyte asthma</value><value>M14 malignant melanoma</value><value>M70e hematopoietic</value><value>macrophage</value><value>malignant peripheral nerve sheath tumor</value><value>MALME-3M malignant melanoma</value><value>mcf-7aro breast epithelial adenocarcinoma</value><value>MCF10A breast epithelial fibrocystic disease</value><value>MCF10A-myc breast epithelial fibrocystic disease</value><value>MCF12A breast epithelial+M824</value><value>MCF7 breast epithelial adenocarcinoma</value><value>MDA-MB-134VI breast cancer</value><value>MDA-MB-175VII breast cancer</value><value>MDA-MB-231 breast cancer</value><value>MDA-MB-361 breast cancer</value><value>MDA-MB-415 breast cancer</value><value>MDA-MB-435 melanoma</value><value>MDA-MB-436 breast cancer</value><value>MDA-MB-453 breast cancer</value><value>MDA468 breast cancer</value><value>mesangial cell</value><value>mesenchymal stem cell</value><value>microvascular endothelial</value><value>MOLT4 T cell acute lymphoblastic leukemia</value><value>monocyte</value><value>monocyte familial hypercholesterolemia</value><value>monocyte multiple organ failure</value><value>mononuclear cell</value><value>mononuclear cell infection</value><value>monophasic synovial sarcoma</value><value>MRC5 fetal fibroblast </value><value>MS-1 lung small cell lung cancer</value><value>multiple myeloma</value><value>multipotent adult progenitor cell</value><value>myelogenous leukemia</value><value>myometrium</value><value>myxoid liposarcoma</value><value>NC-NC lymphoblastoid B cell</value><value>NCI-ADR-RES ovarian cancer</value><value>NCI-H226 lung squamous cell carcinoma</value><value>NCI-H322M lung small cell bronchioalveolar carcinoma</value><value>NCI-H460 lung large cell carcinoma</value><value>NCI-H522 lung adenocarcinoma</value><value>NCI-H929 myeloma</value><value>NCU-MM1 multiple myeloma</value><value>neuroblastoma</value><value>neurofibroma</value><value>oral squamous cell carcinoma</value><value>oropharynx</value><value>osteosarcoma</value><value>ovarian tumor</value><value>ovary</value><value>OVCAR-3 ovarian cancer</value><value>OVCAR-4 ovarian cancer</value><value>OVCAR-5 ovarian cancer</value><value>OVCAR-8 ovarian cancer</value><value>PC-1 lung squamous cell cancer</value><value>pc-10 lung sqamous cell cancer</value><value>pc3 prostate cancer</value><value>pc6 lung small cell cancer</value><value>pc7 lung non-small cell adenocarcinoma</value><value>PC9 lung non-small cell adenocarcinoma</value><value>placenta basal plate</value><value>plasma cell</value><value>plasma-cell leukemia</value><value>preadipocytes</value><value>precursor T lymphoblastic leukemia</value><value>prefrontal cortex</value><value>primary fibroblast</value><value>primary intervertebral disc</value><value>progeria syndrome fibroblast</value><value>prostate cancer</value><value>prostate gland</value><value>pterygium</value><value>QG-56 lung squamous cell cancer</value><value>regenerating cell periodontitis</value><value>renal cell carcinoma</value><value>RERF-LC-AI lung sqamous cell cancer</value><value>RERF-LC-KJ lung non-small cell adenocarcinoma</value><value>RERF-LC-MS lung non-small cell adenocarcinoma</value><value>RJ2.2.5 Burkitts lymphoma</value><value>RKO colon carcinoma</value><value>rpmi-8226 myeloma</value><value>RXF-393 renal cell carcinoma</value><value>sarcoma</value><value>SBC-5 lung small cell cancer</value><value>SBC3 lung small cell cancer</value><value>schwannoma</value><value>SF-268 glioblastoma</value><value>SF-539 glioma</value><value>sk-mel-28 melanoma</value><value>SK-N-AS neuroblastoma</value><value>SK-N-MC neuroblastoma</value><value>SK-N-SH neuroblastoma cell</value><value>SKBR3 breast adenocarcinoma</value><value>skeletal muscle</value><value>skeletal muscle diseased</value><value>skeletal muscle muscular dystrophy</value><value>Skgt4 esophageal cancer</value><value>skin</value><value>skin basal cell UV treated</value><value>SKMC fetal skeletal muscle myoblast</value><value>skmel5 melanoma</value><value>SKMM1 multiple myeloma</value><value>small intestine</value><value>smooth muscle</value><value>SN12C renal cell carcinoma</value><value>SNB-19 glioblastoma</value><value>SNB-75 astrocytoma</value><value>spindle cell tumor</value><value>SQ-5 lung sqamous cell cancer</value><value>squamous cell carcinoma of the oral cavity</value><value>SR lymphoma</value><value>ssMCF7 breast cancer</value><value>Su-dhl1 anaplastic large cell lymphoma</value><value>SUM1315MO2 breast cancer</value><value>SUM149PT breast cancer</value><value>SUM159PT breast cancer</value><value>SUM185PE breast cancer</value><value>SUM190PT breast cancer</value><value>SUM225CWN breast cancer</value><value>SUM44PE breast cancer</value><value>SUM52PE breast cancer</value><value>SW480 colon cancer primary tumor derived</value><value>T cell</value><value>T cell diseased</value><value>T47D breast ductal carcinoma</value><value>te85 osteosarcoma</value><value>TERV</value><value>testis</value><value>theca</value><value>theca polycystic ovarian syndrome</value><value>thymocyte</value><value>thyrocyte</value><value>thyroid adenocarcinoma</value><value>thyroid gland</value><value>TK-10</value><value>tonsil</value><value>trabecular meshwork cell</value><value>ts anaplastic large cell lymphoma</value><value>u-20s osteosarcoma</value><value>U251 glioblastoma</value><value>U937 lymphoma</value><value>UACC-257 melanoma</value><value>UACC-62 melanoma</value><value>UACC812 breast cancer</value><value>umbilical vein endothelial cell</value><value>universal reference</value><value>unknown gliobastoma</value><value>unknown lung adenocarcinoma</value><value>unknown lung cancer</value><value>unknown lung cell carcinoma</value><value>unknown lung large cell carcinoma</value><value>unknown lung mesothelioma </value><value>unknown lung neuroendocrine</value><value>unknown lung non small cell cancer</value><value>unknown lung small cell cancer</value><value>unknown lung squamous cell carcinoma</value><value>unknown small cell lung cancer</value><value>UO-31 renal cell carcinoma</value><value>uterine tumor</value><value>WI38 fetal fibroblast</value><value>ZR751 breast cancer</value><value>ZR7530 breast cancer</value><value>ZR75B breast cancer</value></experimentalfactor><experimentalfactor><name>4 groups from blood to incompletely diff</name><value>blood</value><value>connective</value><value>incompletely differentiated</value><value>the rest</value></experimentalfactor><experimentalfactor><name>4 meta-groups</name><value>cell line</value><value>disease</value><value>neoplasm</value><value>normal</value></experimentalfactor><experimentalfactor><name>6 meta-groups</name><value>brain</value><value>cell line</value><value>hematopoietic system</value><value>incompletely differentiated</value><value>muscle</value><value>solid tissue</value><value>Unspecified</value></experimentalfactor><experimentalfactor><name>96 groups</name><value>A549 lung adenocarcinoma</value><value>acute lymphoblastic leukemia</value><value>acute myeloid leukemia</value><value>acute promyelocytic leukemia</value><value>B cell</value><value>B-cell lymphoma</value><value>bladder cancer</value><value>blood</value><value>brain</value><value>brain bipolar disorder</value><value>brain tumor</value><value>breast cancer</value><value>bronchial epithelia</value><value>bronchoalveolar lavage cell</value><value>BT474 breast cancer</value><value>caco2 colon adenocarcinoma</value><value>Calu-3 lung adenocarcinoma</value><value>caudate nucleus</value><value>caudate nucleus Huntingtons</value><value>CD138+ plasma cell myeloma</value><value>cerebellum</value><value>cerebellum Huntingtons</value><value>chronic myeloid leukemia</value><value>colorectal cancer</value><value>embryonal rhabdomyosarcoma</value><value>embryonic lung fibroblast</value><value>embryonic skin fibroblast</value><value>epidermis dermatitis</value><value>ewings sarcoma</value><value>fetal lung fibroblast</value><value>FM9514 human embryonic myoblast</value><value>frontal cortex</value><value>frontal cortex Huntingtons</value><value>germ cell tumor</value><value>heart</value><value>heart disease</value><value>HEK293 embryonic kidney</value><value>HeLa cervical adenocarcinoma</value><value>HeLa cervical adenocarcinoma transfected</value><value>hematopoietic stem cell</value><value>Hep-2 larynx sqamous cell carcinoma</value><value>hepatocellular carcinoma</value><value>hI60 promyelocytic leukemia</value><value>ht-29 colorectal adenocarcinoma</value><value>hypothalamus</value><value>IB3-1 adenovirus transformed bronchial epithelia</value><value>INCaP prostate cancer</value><value>k562 myelogenous leukaemia</value><value>Kaposi sarcoma</value><value>kidney</value><value>leukocyte</value><value>lung cancer</value><value>lymph node</value><value>lymphocyte</value><value>macrophage</value><value>mcf-7aro breast epithelial adenocarcinoma</value><value>MCF7 breast epithelial adenocarcinoma</value><value>MDA-MB-231 breast cancer</value><value>MDA468 breast cancer</value><value>mesenchymal stem cell</value><value>MOLT4 T cell acute lymphoblastic leukemia</value><value>monocyte</value><value>mononuclear cell</value><value>mononuclear cell infection</value><value>myelogenous leukemia</value><value>myometrium</value><value>neuroblastoma</value><value>oral squamous cell carcinoma</value><value>ovarian tumor</value><value>pc3 prostate cancer</value><value>placenta basal plate</value><value>preadipocytes</value><value>precursor T lymphoblastic leukemia</value><value>primary intervertebral disc</value><value>prostate cancer</value><value>prostate gland</value><value>renal cell carcinoma</value><value>RKO colon carcinoma</value><value>skeletal muscle</value><value>skeletal muscle diseased</value><value>skeletal muscle muscular dystrophy</value><value>skmel5 melanoma</value><value>smooth muscle</value><value>ssMCF7 breast cancer</value><value>T cell</value><value>T cell diseased</value><value>T47D breast ductal carcinoma</value><value>thymocyte</value><value>thyroid adenocarcinoma</value><value>tonsil</value><value>ts anaplastic large cell lymphoma</value><value>umbilical vein endothelial cell</value><value>universal reference</value><value>unknown lung adenocarcinoma</value><value>unknown lung small cell cancer</value><value>Unspecified</value><value>uterine tumor</value></experimentalfactor><experimentalfactor><name>Blood-NonBlood meta-groups</name><value>blood</value><value>non blood</value></experimentalfactor><miamescores><reportersequencescore>1</reportersequencescore><protocolscore>1</protocolscore><factorvaluescore>1</factorvaluescore><derivedbioassaydatascore>1</derivedbioassaydatascore><measuredbioassaydatascore>1</measuredbioassaydatascore><overallscore>5</overallscore></miamescores><id>131258</id><accession>E-MTAB-62</accession><name>Human gene expression atlas of 5372 samples representing 369 different cell and tissue types, disease states and cell lines</name><experimenttype>transcription profiling by array</experimenttype><releasedate>2010-08-04</releasedate><lastupdatedate>2014-05-02</lastupdatedate><samples>5372</samples><assays>5372</assays><arraydesign><id>11043</id><accession>A-AFFY-33</accession><name>Affymetrix GeneChip Human Genome HG-U133A [HG-U133A]</name><count>5372</count><legacy_id>302382080</legacy_id></arraydesign><bioassaydatagroup><id/><name>rawData</name><bioassaydatacubes>5372</bioassaydatacubes><arraydesignprovider/><dataformat>rawData</dataformat><bioassays>5372</bioassays><isderived>0</isderived></bioassaydatagroup><bioassaydatagroup><id/><name>processedDataMatrix</name><bioassaydatacubes>1</bioassaydatacubes><arraydesignprovider/><dataformat>processedDataMatrix</dataformat><bioassays>1</bioassays><isderived>1</isderived></bioassaydatagroup><bibliography><accession>23552467</accession><authors>Rettew AN, Young ED, Lev DC, Kleinerman ES, Abdul-Karim FW, Getty PJ, Greenfield EM.</authors><title>Multiple receptor tyrosine kinases promote the in vitro phenotype of metastatic human osteosarcoma cell lines.</title><doi>10.1038/oncsis.2012.34</doi><pages>e34</pages><publication>Oncogenesis</publication><volume>1</volume><year>2012</year></bibliography><bibliography><accession>22977115</accession><authors>Bezginov A, Clark GW, Charlebois RL, Dar VU, Tillier ER.</authors><title>Coevolution reveals a network of human proteins originating with multicellularity.</title><doi>10.1093/molbev/mss218</doi><issue>2</issue><pages>332-346</pages><publication>Mol Biol Evol</publication><volume>30</volume><year>2013</year></bibliography><bibliography><accession>20379172</accession><authors>Lukk M, Kapushesky M, Nikkilä J, Parkinson H, Goncalves A, Huber W, Ukkonen E, Brazma A.</authors><title>A global map of human gene expression</title><doi>10.1038/nbt0410-322</doi><issue>4</issue><pages>322-4</pages><publication>Nat Biotechnol.</publication><volume>28</volume><uri>http://www.nature.com/nbt/journal/v28/n4/full/nbt0410-322.html</uri></bibliography><bibliography><accession>23563154</accession><authors>Lahti L, Torrente A, Elo LL, Brazma A, Rung J.</authors><title>A fully scalable online pre-processing algorithm for short oligonucleotide microarray atlases.</title><doi>10.1093/nar/gkt229</doi><issue>10</issue><pages>e110</pages><publication>Nucleic Acids Res</publication><volume>41</volume><year>2013</year></bibliography><provider><contact>Margus Lukk</contact><role>submitter</role><email>margus.lukk@cruk.cam.ac.uk</email></provider><experimentdesign>co-expression</experimentdesign><experimentdesign>data integration</experimentdesign><description><id/><text>The experiment contains systematically annotated and consistently normalized human gene expression data matrix of 5372 samples integrated from 206 public experiments of a HG-U133A array platform. The dataset is a subset of a larger pool of 9004 samples gathered from ArrayExpress and GEO websites and checked for quality assessment and suitability for data co-analysis as described by Bolstad et al 2005. The sample annotations have been subject to semiautomatic curation and manual generalization of 369 biological groups which have been additionally organized into blood/non-blood, 14 and 15 meta-classes.</text></description><protocol><id>323128</id><accession>P-MTAB-2072</accession></protocol><organism>Homo sapiens</organism><organism>Mus musculus</organism><files><!--
This section is deprecated and unsupported.
Please use webservice located at:
    http://www.ebi.ac.uk/arrayexpress/xml/files
to obtain detailed information on files available for the experiment.
For more information, please go to:
    http://www.ebi.ac.uk/arrayexpress/help/programmatic_access.html
                --><raw name="E-MTAB-62.raw.100.zip E-MTAB-62.raw.102.zip E-MTAB-62.raw.103.zip E-MTAB-62.raw.104.zip E-MTAB-62.raw.105.zip E-MTAB-62.raw.106.zip E-MTAB-62.raw.109.zip E-MTAB-62.raw.110.zip E-MTAB-62.raw.111.zip E-MTAB-62.raw.112.zip E-MTAB-62.raw.113.zip E-MTAB-62.raw.116.zip E-MTAB-62.raw.119.zip E-MTAB-62.raw.19.zip E-MTAB-62.raw.1.zip E-MTAB-62.raw.21.zip E-MTAB-62.raw.25.zip E-MTAB-62.raw.27.zip E-MTAB-62.raw.28.zip E-MTAB-62.raw.32.zip E-MTAB-62.raw.35.zip E-MTAB-62.raw.42.zip E-MTAB-62.raw.45.zip E-MTAB-62.raw.46.zip E-MTAB-62.raw.49.zip E-MTAB-62.raw.4.zip E-MTAB-62.raw.50.zip E-MTAB-62.raw.54.zip E-MTAB-62.raw.55.zip E-MTAB-62.raw.56.zip E-MTAB-62.raw.58.zip E-MTAB-62.raw.62.zip E-MTAB-62.raw.63.zip E-MTAB-62.raw.64.zip E-MTAB-62.raw.73.zip E-MTAB-62.raw.75.zip E-MTAB-62.raw.79.zip E-MTAB-62.raw.81.zip E-MTAB-62.raw.82.zip E-MTAB-62.raw.85.zip E-MTAB-62.raw.88.zip E-MTAB-62.raw.93.zip E-MTAB-62.raw.94.zip E-MTAB-62.raw.96.zip E-MTAB-62.raw.97.zip E-MTAB-62.raw.101.zip E-MTAB-62.raw.107.zip E-MTAB-62.raw.108.zip E-MTAB-62.raw.10.zip E-MTAB-62.raw.114.zip E-MTAB-62.raw.115.zip E-MTAB-62.raw.117.zip E-MTAB-62.raw.118.zip E-MTAB-62.raw.11.zip E-MTAB-62.raw.120.zip E-MTAB-62.raw.121.zip E-MTAB-62.raw.12.zip E-MTAB-62.raw.13.zip E-MTAB-62.raw.14.zip E-MTAB-62.raw.15.zip E-MTAB-62.raw.16.zip E-MTAB-62.raw.17.zip E-MTAB-62.raw.18.zip E-MTAB-62.raw.20.zip E-MTAB-62.raw.22.zip E-MTAB-62.raw.23.zip E-MTAB-62.raw.24.zip E-MTAB-62.raw.26.zip E-MTAB-62.raw.29.zip E-MTAB-62.raw.2.zip E-MTAB-62.raw.30.zip E-MTAB-62.raw.31.zip E-MTAB-62.raw.33.zip E-MTAB-62.raw.34.zip E-MTAB-62.raw.36.zip E-MTAB-62.raw.37.zip E-MTAB-62.raw.38.zip E-MTAB-62.raw.39.zip E-MTAB-62.raw.3.zip E-MTAB-62.raw.40.zip E-MTAB-62.raw.41.zip E-MTAB-62.raw.43.zip E-MTAB-62.raw.44.zip E-MTAB-62.raw.47.zip E-MTAB-62.raw.48.zip E-MTAB-62.raw.51.zip E-MTAB-62.raw.52.zip E-MTAB-62.raw.53.zip E-MTAB-62.raw.57.zip E-MTAB-62.raw.59.zip E-MTAB-62.raw.5.zip E-MTAB-62.raw.60.zip E-MTAB-62.raw.61.zip E-MTAB-62.raw.65.zip E-MTAB-62.raw.66.zip E-MTAB-62.raw.67.zip E-MTAB-62.raw.68.zip E-MTAB-62.raw.69.zip E-MTAB-62.raw.6.zip E-MTAB-62.raw.70.zip E-MTAB-62.raw.71.zip E-MTAB-62.raw.72.zip E-MTAB-62.raw.74.zip E-MTAB-62.raw.76.zip E-MTAB-62.raw.77.zip E-MTAB-62.raw.78.zip E-MTAB-62.raw.7.zip E-MTAB-62.raw.80.zip E-MTAB-62.raw.83.zip E-MTAB-62.raw.84.zip E-MTAB-62.raw.86.zip E-MTAB-62.raw.87.zip E-MTAB-62.raw.89.zip E-MTAB-62.raw.8.zip E-MTAB-62.raw.90.zip E-MTAB-62.raw.91.zip E-MTAB-62.raw.92.zip E-MTAB-62.raw.95.zip E-MTAB-62.raw.98.zip E-MTAB-62.raw.99.zip E-MTAB-62.raw.9.zip" count="true" celcount="0"/><fgem name="E-MTAB-62.processed.2.zip" available="true"/><idf name="E-MTAB-62.idf.txt"/><sdrf name="E-MTAB-62.sdrf.txt"/></files></experiment><experiment><species>Homo sapiens</species><rawdatafiles available="true"/><processeddatafiles available="true"/><sampleattribute><category>cause of death</category><value>acute alcohol poisoning</value><value>alcohol intoxication</value><value>atherosclerotic cardiovascular disease</value><value>atherosclerotic coronary heart disease</value><value>bleeding oesophageal varices</value><value>cardiomyopathy</value><value>consequences of cirrhosis</value><value>coronary artery atheroma</value><value>coronary thrombosis</value><value>dilated cardiomyopathy</value><value>ischemic heart disease</value><value>ischemic heart disease, emphysema</value><value>mixed drug toxicity, chronic alcoholism</value><value>respiratory arrest</value><value>respiratory failure, pneumonia</value><value>sepsis</value><value>suicide by hanging</value></sampleattribute><sampleattribute><category>Organism</category><value>Homo sapiens</value></sampleattribute><sampleattribute><category>sample</category><value>non smoking alcoholic_array 13422319</value><value>non smoking alcoholic_array 13422331</value><value>non smoking alcoholic_array 13438004</value><value>non smoking alcoholic_array 13438007</value><value>non smoking alcoholic_array 13465600</value><value>non smoking non alcoholic_array 13422304</value><value>non smoking non alcoholic_array 13427605</value><value>non smoking non alcoholic_array 13427609</value><value>non smoking non alcoholic_array 13427615</value><value>non smoking non alcoholic_array 13438118</value><value>pool of individual samples</value><value>smoking alcoholic_array 13422306</value><value>smoking alcoholic_array 13422330</value><value>smoking alcoholic_array 13427608</value><value>smoking alcoholic_array 13433288</value><value>smoking alcoholic_array 13433290</value><value>smoking non alcoholic_array 13422301</value><value>smoking non alcoholic_array 13422318</value><value>smoking non alcoholic_array 13427606</value><value>smoking non alcoholic_array 13427607</value><value>smoking non alcoholic_array 13465604</value></sampleattribute><sampleattribute><category>sex</category><value>female</value><value>male</value></sampleattribute><experimentalfactor><name>CAUSE OF DEATH</name><value>acute alcohol poisoning</value><value>alcohol intoxication</value><value>atherosclerotic cardiovascular disease</value><value>atherosclerotic coronary heart disease</value><value>bleeding oesophageal varices</value><value>cardiomyopathy</value><value>consequences of cirrhosis</value><value>coronary artery atheroma</value><value>coronary thrombosis</value><value>dilated cardiomyopathy</value><value>ischemic heart disease</value><value>ischemic heart disease, emphysema</value><value>mixed drug toxicity, chronic alcoholism</value><value>not specified</value><value>respiratory arrest</value><value>respiratory failure, pneumonia</value><value>sepsis</value><value>suicide by hanging</value></experimentalfactor><experimentalfactor><name>SAMPLE</name><value>non smoking alcoholic_array 13422319</value><value>non smoking alcoholic_array 13422331</value><value>non smoking alcoholic_array 13438004</value><value>non smoking alcoholic_array 13438007</value><value>non smoking alcoholic_array 13465600</value><value>non smoking non alcoholic_array 13422304</value><value>non smoking non alcoholic_array 13427605</value><value>non smoking non alcoholic_array 13427609</value><value>non smoking non alcoholic_array 13427615</value><value>non smoking non alcoholic_array 13438118</value><value>pool of individual samples</value><value>smoking alcoholic_array 13422306</value><value>smoking alcoholic_array 13422330</value><value>smoking alcoholic_array 13427608</value><value>smoking alcoholic_array 13433288</value><value>smoking alcoholic_array 13433290</value><value>smoking non alcoholic_array 13422301</value><value>smoking non alcoholic_array 13422318</value><value>smoking non alcoholic_array 13427606</value><value>smoking non alcoholic_array 13427607</value><value>smoking non alcoholic_array 13465604</value></experimentalfactor><experimentalfactor><name>SEX</name><value>female</value><value>male</value><value>not specified</value></experimentalfactor><miamescores><reportersequencescore>0</reportersequencescore><protocolscore>1</protocolscore><factorvaluescore>1</factorvaluescore><derivedbioassaydatascore>1</derivedbioassaydatascore><measuredbioassaydatascore>1</measuredbioassaydatascore><overallscore>4</overallscore></miamescores><id>36808</id><accession>E-GEOD-20568</accession><secondaryaccession>GSE20568</secondaryaccession><name>Genes associated with alcohol abuse and nicotine addiction in the human nucleus accumbens</name><experimenttype>transcription profiling by array</experimenttype><releasedate>2010-07-01</releasedate><lastupdatedate>2014-05-01</lastupdatedate><samples>40</samples><assays>20</assays><arraydesign><id>11553</id><accession>A-GEOD-10117</accession><name>UHN_human_single-spotted 19k cDNA array_version 8</name><count>20</count><legacy_id>2507738364</legacy_id></arraydesign><bioassaydatagroup><id/><name>rawData</name><bioassaydatacubes>20</bioassaydatacubes><arraydesignprovider/><dataformat>rawData</dataformat><bioassays>20</bioassays><isderived>0</isderived></bioassaydatagroup><bioassaydatagroup><id/><name>normalization</name><bioassaydatacubes>20</bioassaydatacubes><arraydesignprovider/><dataformat>normalization</dataformat><bioassays>20</bioassays><isderived>0</isderived></bioassaydatagroup><bioassaydatagroup><id/><name>processedData</name><bioassaydatacubes>20</bioassaydatacubes><arraydesignprovider/><dataformat>processedData</dataformat><bioassays>20</bioassays><isderived>0</isderived></bioassaydatagroup><bibliography><accession>20477762</accession><authors>Flatscher-Bader T, Harrison E, Matsumoto I, Wilce PA</authors><title>Genes associated with alcohol abuse and tobacco smoking in the human nucleus accumbens and ventral tegmental area.</title><doi>10.1111/j.1530-0277.2010.01207.x</doi></bibliography><provider><contact>Erin Harrison</contact><role/><email/></provider><provider><contact>Traute Flatscher-Bader</contact><role/><email/></provider><provider><contact>Traute Flatscher-Bader</contact><role>submitter</role><email>t.flatscher-bader@uq.edu.au</email></provider><provider><contact>Peter A Wilce</contact><role/><email/></provider><provider><contact>Izuru Matsumoto</contact><role/><email/></provider><description><id/><text>Background:  The incidence of alcohol and tobacco co-abuse is as high as 80%.  The molecular mechanism underlying this comorbidity is virtually unknown but interactions between these drugs have important implications for the development of, and recovery from drug dependence.  Methods:  We investigated the effects of chronic tobacco and alcohol abuse and the interaction of the two behaviours on global gene expression in the human nucleus accumbens using cDNA microarrays and 20 alcoholic and control cases, with and without smoking comorbidity.  Changes in gene expression were established by two-way ANOVA.  Unsupervised hierarchical clustering was utilized to probe the strength of the data sets. Results:  Subjecting the data sets derived from microarray gene expression screening to unsupervised hierarchical clustering tied the cases into distinct groups.  When considering all alcohol-responsive genes, alcoholics were separated from non alcoholics with the exception of one control case.  All smokers were distinguished from non smokers based on similarity in expression of smoking-sensitive genes. In the nucleus accumbens, alcohol-responsive genes were associated with transcription, lipid metabolism and signalling.  Smoking-sensitive genes were predominantly assigned to functional groups concerned with RNA processing and the endoplasmic reticulum.  Both drugs influenced the expression of genes involved in matrix remodelling, proliferation and cell morphogenesis.  Additionally, a gene set encoding proteins involved in the canonical pathway ‘regulation of the actin cytoskeleton’ was induced in response to alcohol and tobacco co-abuse and included.  Conclusions:  The region-specific modulation of alcohol-sensitive gene expression by smoking may have important consequences for alcohol-induced aberrations within the mesolimbic dopaminergic system. The data set contained individual RNA samples extracted from the nucleus accumbens from 5 non smoking non drinking control case, 5 non smoking alcoholics, 5 non drinking smokers, and 5 smoking alcoholics. An aliquot if each sample was combined to generate a reference pool. Each sample was amplified individually and labelled with Cy3 in the process, the reference samples was amplified and labelled with Cy5. Each sample was hybridised competitively against the reference sample to 1 array.</text></description><protocol><id>109870</id><accession>P-GSE20568-7</accession></protocol><protocol><id>109874</id><accession>P-GSE20568-5</accession></protocol><protocol><id>109869</id><accession>P-GSE20568-6</accession></protocol><protocol><id>109871</id><accession>P-GSE20568-3</accession></protocol><protocol><id>109873</id><accession>P-GSE20568-4</accession></protocol><protocol><id>109868</id><accession>P-GSE20568-1</accession></protocol><protocol><id>109872</id><accession>P-GSE20568-2</accession></protocol><organism>Homo sapiens</organism><files><!--
This section is deprecated and unsupported.
Please use webservice located at:
    http://www.ebi.ac.uk/arrayexpress/xml/files
to obtain detailed information on files available for the experiment.
For more information, please go to:
    http://www.ebi.ac.uk/arrayexpress/help/programmatic_access.html
                --><raw name="E-GEOD-20568.raw.1.zip" count="true" celcount="0"/><fgem name="E-GEOD-20568.processed.1.zip" available="true"/><idf name="E-GEOD-20568.idf.txt"/><sdrf name="E-GEOD-20568.sdrf.txt"/></files></experiment><experiment><species>Homo sapiens</species><rawdatafiles available="true"/><processeddatafiles available="true"/><sampleattribute><category>Organism</category><value>Homo sapiens</value></sampleattribute><miamescores><reportersequencescore>1</reportersequencescore><protocolscore>0</protocolscore><factorvaluescore>0</factorvaluescore><derivedbioassaydatascore>1</derivedbioassaydatascore><measuredbioassaydatascore>1</measuredbioassaydatascore><overallscore>3</overallscore></miamescores><id>760</id><accession>E-GEOD-10921</accession><secondaryaccession>GSE10921</secondaryaccession><name>Gene expression in lung fibroblasts</name><experimenttype>transcription profiling by array</experimenttype><releasedate>2010-06-21</releasedate><submissiondate>2008-03-24</submissiondate><lastupdatedate>2012-03-27</lastupdatedate><samples>7</samples><assays>7</assays><arraydesign><id>5652</id><accession>A-GEOD-4191</accession><name>CodeLink UniSet Human I Bioarray</name><count>7</count><legacy_id>2001712010</legacy_id></arraydesign><bioassaydatagroup><id/><name>rawData</name><bioassaydatacubes>7</bioassaydatacubes><arraydesignprovider/><dataformat>rawData</dataformat><bioassays>7</bioassays><isderived>0</isderived></bioassaydatagroup><bioassaydatagroup><id/><name>processedData</name><bioassaydatacubes>7</bioassaydatacubes><arraydesignprovider/><dataformat>processedData</dataformat><bioassays>7</bioassays><isderived>0</isderived></bioassaydatagroup><bioassaydatagroup><id/><name>scan</name><bioassaydatacubes>7</bioassaydatacubes><arraydesignprovider/><dataformat>scan</dataformat><bioassays>7</bioassays><isderived>0</isderived></bioassaydatagroup><bibliography><accession>19251946</accession><authors>Vuga LJ, Ben-Yehudah A, Kovkarova-Naumovski E, Oriss T, Gibson KF, Feghali-Bostwick C, Kaminski N</authors><title>WNT5A is a regulator of fibroblast proliferation and resistance to apoptosis.</title></bibliography><provider><contact>Louis Justine Vuga</contact><role>submitter</role><email>Vugalj@upmc.edu</email></provider><provider><contact>Louis J Vuga</contact><role/><email/></provider><provider><contact>Naftali Kaminski</contact><role/><email/></provider><description><id/><text>Pulmonary fibrosis is a chronic, progressive, and lethal interstitial lung disease. It is characterized by extracellular matrix deposition, fibroblast proliferation, and accumulation. Fibroblasts from normal or UIP histology were cultured and analyzed. Keywords: Fibroblasts from normal histology lung tissue or UIP histology lung tissue Five samples of primary human lung fibroblasts were obtained from explanted lungs of patients with Usual Interstitial Pneumonia (UIP) at the University of Pittsburgh Medical Center (Pittsburgh, PA, USA) and three samples of primary normal human lung fibroblasts were acquired from normal histololgy lung tissues of organ donors. The experimental protocol was approved by the University of Pittsburgh Institutional Reviews Board (IRB). Total RNA was extracted and used as a template to generate double-stranded cDNA and biotin-labeled cRNA, as recommended by the manufacturer of the arrays. Fragmented cRNA was hybridized to Codelink Uniset I slides. After hybridization, arrays were washed and stained with streptavidin-AlexaFluor 647. The arrays were scanned using a Genepix 4000B microarray scanner. Images were analyzed using Codelink expression II analysis suite, and visually inspected for defects and quality control parameters as recommended by the manufacturer.</text></description><protocol><id>5491</id><accession>P-GSE10921-7</accession></protocol><protocol><id>5487</id><accession>P-GSE10921-8</accession></protocol><protocol><id>5489</id><accession>P-GSE10921-3</accession></protocol><protocol><id>5490</id><accession>P-GSE10921-4</accession></protocol><protocol><id>5486</id><accession>P-GSE10921-5</accession></protocol><protocol><id>5488</id><accession>P-GSE10921-6</accession></protocol><protocol><id>5485</id><accession>P-GSE10921-1</accession></protocol><protocol><id>5492</id><accession>P-GSE10921-2</accession></protocol><organism>Homo sapiens</organism><files><!--
This section is deprecated and unsupported.
Please use webservice located at:
    http://www.ebi.ac.uk/arrayexpress/xml/files
to obtain detailed information on files available for the experiment.
For more information, please go to:
    http://www.ebi.ac.uk/arrayexpress/help/programmatic_access.html
                --><raw name="E-GEOD-10921.raw.1.zip" count="true" celcount="0"/><fgem name="E-GEOD-10921.processed.1.zip" available="true"/><idf name="E-GEOD-10921.idf.txt"/><sdrf name="E-GEOD-10921.sdrf.txt"/><biosamples><png name="E-GEOD-10921.biosamples.png"/><svg name="E-GEOD-10921.biosamples.svg"/></biosamples></files></experiment><experiment><species>Homo sapiens</species><rawdatafiles available="true"/><processeddatafiles available="true"/><sampleattribute><category>BioSourceProvider</category><value>Health Science Research Resources Bank, Tokyo, Japan</value></sampleattribute><sampleattribute><category>Organism</category><value>Homo sapiens</value></sampleattribute><miamescores><reportersequencescore>1</reportersequencescore><protocolscore>0</protocolscore><factorvaluescore>0</factorvaluescore><derivedbioassaydatascore>1</derivedbioassaydatascore><measuredbioassaydatascore>1</measuredbioassaydatascore><overallscore>3</overallscore></miamescores><id>26749</id><accession>E-GEOD-9077</accession><secondaryaccession>GSE9077</secondaryaccession><name>Expression profiles of immortal lung fibroblasts</name><experimenttype>transcription profiling by array</experimenttype><releasedate>2010-05-22</releasedate><submissiondate>2007-09-17</submissiondate><lastupdatedate>2012-03-27</lastupdatedate><samples>17</samples><assays>17</assays><arraydesign><id>3165</id><accession>A-GEOD-1928</accession><name>CodeLink Human 20K ver4.1</name><count>7</count><legacy_id>1835075212</legacy_id></arraydesign><arraydesign><id>11119</id><accession>A-AFFY-44</accession><name>Affymetrix GeneChip Human Genome U133 Plus 2.0 [HG-U133_Plus_2]</name><count>6</count><legacy_id>405156763</legacy_id></arraydesign><arraydesign><id>11480</id><accession>A-MEXP-1125</accession><name>Agilent Whole Human Genome Microarray 4x44K 014850 G4112F (266 cols x 170 rows)</name><count>4</count><legacy_id>1599794162</legacy_id></arraydesign><bioassaydatagroup><id/><name>rawData</name><bioassaydatacubes>17</bioassaydatacubes><arraydesignprovider/><dataformat>rawData</dataformat><bioassays>17</bioassays><isderived>0</isderived></bioassaydatagroup><bioassaydatagroup><id/><name>processedData</name><bioassaydatacubes>17</bioassaydatacubes><arraydesignprovider/><dataformat>processedData</dataformat><bioassays>17</bioassays><isderived>0</isderived></bioassaydatagroup><bioassaydatagroup><id/><name>scan</name><bioassaydatacubes>17</bioassaydatacubes><arraydesignprovider/><dataformat>scan</dataformat><bioassays>17</bioassays><isderived>0</isderived></bioassaydatagroup><bibliography><accession>18716925</accession><authors>Hiyama K, Tanimoto K, Nishimura Y, Tsugane M, Fukuba I, Sotomaru Y, Hiyama E, Nishiyama M</authors><title>Exploration of the genes responsible for unlimited proliferation of immortalized lung fibroblasts.</title></bibliography><provider><contact>Eiso Hiyama</contact><role>submitter</role><email>eiso@hiroshima-u.ac.jp</email></provider><provider><contact>Masahiko Nishiyama</contact><role/><email/></provider><provider><contact>Keiji Tanimoto</contact><role/><email/></provider><provider><contact>Keiko Hiyama</contact><role>submitter</role><email>khiyama@hiroshima-u.ac.jp</email></provider><description><id/><text>Activation of telomerase often endows cancer cells, but rarely normal somatic cells, with immortality. Especially, fetal lung fibroblasts are known to be hardly immortalized by TERT overexpression. We here established an immortal non-transformed lung fibroblast cell line only by TERT transfection, as well as an immortal transformed cell line by transfection of TERT and SV40 early antigens. Comparing the expression profiles of these cell lines with those of mortal cell strains with elongated lifespan after TERT transfection, 51 genes, including 19 upregulated and 32 downregulated, were explored to be the candidates responsible for regulation of cellular proliferation of lung fibroblasts. These included the genes previously reported to be involved in cellular proliferation, transformation, or self-renewal capacity, and those highly expressed in lung tissues obtained from patients with idiopathic pulmonary fibrosis or hypersensitivity pneumonitis. This set of lung fibrobrast cell lines/strains of identical genetic background with different proliferative capacity, mortal and immortal non-transformed fibroblasts may become useful model cells for research on lung fibroblast growth regulation and the candidate genes explored in this study may provide promising biomarkers or molecular targets of pulmonary fibrosis. Keywords: Cell type comparison We analyzed 6 arrays with Affymetrix, 4 arrays with Agilent, and 7 arrays with CodeLink oligonucleotide microarrays for lung fibroblasts with various lifespan with or without transfection of TERT and/or SV40 early antigens.</text></description><protocol><id>74943</id><accession>P-GSE9077-22</accession></protocol><protocol><id>74938</id><accession>P-GSE9077-7</accession></protocol><protocol><id>74941</id><accession>P-GSE9077-21</accession></protocol><protocol><id>74937</id><accession>P-GSE9077-8</accession></protocol><protocol><id>74935</id><accession>P-GSE9077-9</accession></protocol><protocol><id>74942</id><accession>P-GSE9077-20</accession></protocol><protocol><id>74934</id><accession>P-GSE9077-5</accession></protocol><protocol><id>74939</id><accession>P-GSE9077-11</accession></protocol><protocol><id>74940</id><accession>P-GSE9077-10</accession></protocol><protocol><id>74936</id><accession>P-GSE9077-6</accession></protocol><protocol><id>74945</id><accession>P-GSE9077-13</accession></protocol><protocol><id>74932</id><accession>P-GSE9077-3</accession></protocol><protocol><id>74947</id><accession>P-GSE9077-12</accession></protocol><protocol><id>74930</id><accession>P-GSE9077-4</accession></protocol><protocol><id>74933</id><accession>P-GSE9077-15</accession></protocol><protocol><id>74929</id><accession>P-GSE9077-1</accession></protocol><protocol><id>74946</id><accession>P-GSE9077-14</accession></protocol><protocol><id>74928</id><accession>P-GSE9077-2</accession></protocol><protocol><id>74931</id><accession>P-GSE9077-18</accession></protocol><protocol><id>74944</id><accession>P-GSE9077-19</accession></protocol><protocol><id>74949</id><accession>P-GSE9077-16</accession></protocol><protocol><id>74948</id><accession>P-GSE9077-17</accession></protocol><organism>Homo sapiens</organism><files><!--
This section is deprecated and unsupported.
Please use webservice located at:
    http://www.ebi.ac.uk/arrayexpress/xml/files
to obtain detailed information on files available for the experiment.
For more information, please go to:
    http://www.ebi.ac.uk/arrayexpress/help/programmatic_access.html
                --><raw name="E-GEOD-9077.raw.1.zip" count="true" celcount="0"/><fgem name="E-GEOD-9077.processed.1.zip" available="true"/><idf name="E-GEOD-9077.idf.txt"/><sdrf name="E-GEOD-9077.sdrf.txt"/></files></experiment><experiment><species>Homo sapiens</species><rawdatafiles available="true"/><processeddatafiles available="true"/><sampleattribute><category>Organism</category><value>Homo sapiens</value></sampleattribute><miamescores><reportersequencescore>1</reportersequencescore><protocolscore>0</protocolscore><factorvaluescore>0</factorvaluescore><derivedbioassaydatascore>1</derivedbioassaydatascore><measuredbioassaydatascore>1</measuredbioassaydatascore><overallscore>3</overallscore></miamescores><id>36779</id><accession>E-GEOD-13316</accession><secondaryaccession>GSE13316</secondaryaccession><name>miRNA expression data in idiopathic pulmonary fibrosis</name><experimenttype>transcription profiling by array</experimenttype><releasedate>2010-04-23</releasedate><lastupdatedate>2012-03-27</lastupdatedate><samples>20</samples><assays>20</assays><arraydesign><id>29806</id><accession>A-GEOD-6955</accession><name>Agilent Human miRNA Microarray, Version 1</name><count>20</count><legacy_id>2102374937</legacy_id></arraydesign><bioassaydatagroup><id/><name>rawData</name><bioassaydatacubes>20</bioassaydatacubes><arraydesignprovider/><dataformat>rawData</dataformat><bioassays>20</bioassays><isderived>0</isderived></bioassaydatagroup><bioassaydatagroup><id/><name>normalization</name><bioassaydatacubes>20</bioassaydatacubes><arraydesignprovider/><dataformat>normalization</dataformat><bioassays>20</bioassays><isderived>0</isderived></bioassaydatagroup><bioassaydatagroup><id/><name>processedData</name><bioassaydatacubes>20</bioassaydatacubes><arraydesignprovider/><dataformat>processedData</dataformat><bioassays>20</bioassays><isderived>0</isderived></bioassaydatagroup><bibliography><accession>20395557</accession><authors>Pandit KV, Corcoran D, Yousef H, Yarlagadda M, Tzouvelekis A, Gibson KF, Konishi K, Yousem SA, Singh M, Handley D, Richards T, Selman M, Watkins SC, Pardo A, Ben-Yehudah A, Bouros D, Eickelberg O, Ray P, Benos PV, Kaminski N</authors><title>Inhibition and role of let-7d in idiopathic pulmonary fibrosis.</title><doi>10.1164/rccm.200911-1698OC</doi></bibliography><provider><contact>David Corcoran</contact><role/><email/></provider><provider><contact>Panayiotis V Benos</contact><role/><email/></provider><provider><contact>Naftali Kaminski</contact><role/><email/></provider><provider><contact>Kusum Vijay Pandit</contact><role>submitter</role><email>panditkv@upmc.edu</email></provider><provider><contact>Kusum V Pandit</contact><role/><email/></provider><description><id/><text>Idiopathic pulmonary fibrosis (IPF) is an untreatable fibrotic lung disease characterized by fibroblast proliferation and epithelial mesenchymal transition. The expression and role of microRNAs (miRNA) has not been studied in IPF. Using miRNA expression microarrays we identified 46 differentially expressed miRNA in IPF lungs which included let-7d and the miR-30 family.  Keywords: miRNA expression Lung tissue samples for microarray analysis were obtained through the University of Pittsburgh Health Sciences Tissue Bank. Ten samples were obtained from surgical remnants of biopsies or lungs explanted from patients with IPF who underwent pulmonary transplant, and ten control normal lung tissues obtained from the disease free margins with normal histology of lung cancer resection specimens. The morphologic diagnosis of IPF was based on typical microscopic findings consistent with usual interstitial pneumonia. Total RNA was labeled with Cy3 and hybridized on Agilent 8X15K microRNA array (Agilent Technologies, Santa Clara, CA). After 20 hours hybridization, arrays were washed and scanned according to the manufacturer’s protocol.</text></description><protocol><id>109521</id><accession>P-GSE13316-4</accession></protocol><protocol><id>109516</id><accession>P-GSE13316-1</accession></protocol><protocol><id>109517</id><accession>P-GSE13316-5</accession></protocol><protocol><id>109518</id><accession>P-GSE13316-2</accession></protocol><protocol><id>109520</id><accession>P-GSE13316-3</accession></protocol><protocol><id>109519</id><accession>P-GSE13316-6</accession></protocol><organism>Homo sapiens</organism><files><!--
This section is deprecated and unsupported.
Please use webservice located at:
    http://www.ebi.ac.uk/arrayexpress/xml/files
to obtain detailed information on files available for the experiment.
For more information, please go to:
    http://www.ebi.ac.uk/arrayexpress/help/programmatic_access.html
                --><raw name="E-GEOD-13316.raw.1.zip" count="true" celcount="0"/><fgem name="E-GEOD-13316.processed.1.zip" available="true"/><idf name="E-GEOD-13316.idf.txt"/><sdrf name="E-GEOD-13316.sdrf.txt"/></files></experiment><experiment><species>Homo sapiens</species><rawdatafiles available="true"/><processeddatafiles available="true"/><sampleattribute><category>Age</category><value>57 years</value><value>61 years</value><value>64 years</value><value>68 years</value><value>70 years</value><value>72 years</value><value>73 years</value><value>74 years</value><value>75 years</value><value>77 years</value><value>78 years</value><value>80 years</value><value>82 years</value><value>83 years</value><value>93 years</value></sampleattribute><sampleattribute><category>BioSourceType</category><value>frozen_sample</value></sampleattribute><sampleattribute><category>ClinicalHistory</category><value>Cause of death: heart attack</value><value>Cause of death: heart failure</value><value>Cause of death: myocardial infarction</value><value>Cause of death: pancreatic cancer</value><value>Disease duration: 10 years; Cause of death: cachexia following swallowing disturbances</value><value>Disease duration: 11 years; Cause of death: pneumonia in a dehydrated and cachexic patient</value><value>Disease duration: 12 years; Cause of death: bronchopneumonia</value><value>Disease duration: 12 years; Cause of death: sepsis, due to an urinary tract infection, and cachexia</value><value>Disease duration: 13 years; Cause of death: cachexia and dehydration</value><value>Disease duration: 14 years; Cause of death: infection of lungs</value><value>Disease duration: 15 years; Cause of death: aspiration pneumonia</value><value>Disease duration: 15 years; Cause of death: dehydration</value><value>Disease duration: 16 years; Cause of death: acute cardiac arrest</value><value>Disease duration: 2 years; Cause of death: euthanasia</value><value>Disease duration: 3 years; Cause of death: cachexia and dehydration</value><value>Disease duration: 3 years; Cause of death: pneumonia / cachexia</value><value>Disease duration: 3 years; Cause of death: respiratory insufficience</value><value>Disease duration: 4 years; Cause of death: complications secondary to a cerebro vasculair accident</value><value>Disease duration: 4 years; Cause of death: septic with a urinary infection</value><value>Disease duration: 6 years; Cause of death: bleeding of the stomach</value><value>Disease duration: 6 years; Cause of death: myocardial infarction</value><value>Disease duration: 6 years; Cause of death: pneumonia and cachexia by PSP</value><value>Disease duration: 7 years; Cause of death: dehydration and vascular insufficiency</value><value>Disease duration: 7 years; Cause of death: pulmonary arrest</value><value>Disease duration: 7 years; Cause of death: unknown</value><value>Disease duration: 8 years; Cause of death: aspiration pneumonia</value><value>Disease duration: 8 years; Cause of death: cachexia and dehydration</value><value>Disease duration: 8 years; Cause of death: lungdisorder with fever for 4 weeks</value><value>Disease duration: 9 years; Cause of death: dehydration and respiratory insufficiency</value><value>Disease duration: more than 7 years; Cause of death: general deterioration</value></sampleattribute><sampleattribute><category>ClinicalInformation</category><value>post mortem delay 3:25</value><value>post mortem delay 3:35</value><value>post mortem delay 3:45</value><value>post mortem delay 3:55</value><value>post mortem delay 4:15</value><value>post mortem delay 4:20</value><value>post mortem delay 4:40</value><value>post mortem delay 4:50</value><value>post mortem delay 5:00</value><value>post mortem delay 5:10</value><value>post mortem delay 5:15</value><value>post mortem delay 5:20</value><value>post mortem delay 5:30</value><value>post mortem delay 5:43</value><value>post mortem delay 5:48</value><value>post mortem delay 6:15</value><value>post mortem delay 6:45</value><value>post mortem delay 7:40</value><value>post mortem delay 7:55</value><value>post mortem delay 8:10</value><value>post mortem delay 8:55</value></sampleattribute><sampleattribute><category>DevelopmentalStage</category><value>adult</value></sampleattribute><sampleattribute><category>DiseaseStaging</category><value>Braak stage 0</value><value>Braak stage 1</value><value>Braak stage 2</value><value>Braak stage 6</value><value>Constantinides type A</value><value>Constantinides type C1</value></sampleattribute><sampleattribute><category>DiseaseState</category><value>Alzheimer's disease</value><value>normal</value><value>Pick's disease</value><value>Progressive supranuclear palsy</value></sampleattribute><sampleattribute><category>Haplotype</category><value>APOE haplotype: 32; MAPT haplotype: H1/H1</value><value>APOE haplotype: 33; MAPT haplotype: H1/H1</value><value>APOE haplotype: 33; MAPT haplotype: H1/H2</value><value>APOE haplotype: 42; MAPT haplotype: H1/H1</value><value>APOE haplotype: 43; MAPT haplotype: H1/H1</value><value>APOE haplotype: 43; MAPT haplotype: H1/H2</value><value>APOE haplotype: 44; MAPT haplotype: H1/H1</value><value>APOE haplotype: 44; MAPT haplotype: H1/H2</value><value>APOE haplotype:33; MAPT haplotype: H1/H2</value><value>APOE haplotype:43; MAPT haplotype: H1/H1</value><value>APOE haplotype:43; MAPT haplotype: H2/H2</value></sampleattribute><sampleattribute><category>Individual</category><value>00-044</value><value>00-066</value><value>00-086</value><value>00-096</value><value>00-099</value><value>00-140</value><value>00-142</value><value>01-021</value><value>01-028</value><value>01-091</value><value>02-062</value><value>03-049</value><value>89-073</value><value>95-069</value><value>95-086</value><value>95-099</value><value>96-012</value><value>96-064</value><value>96-094</value><value>96-098</value><value>96-119</value><value>97-051</value><value>97-072</value><value>98-029</value><value>98-075</value><value>98-101</value><value>98-119</value><value>98-159</value><value>98-163</value><value>99-050</value><value>99-116</value></sampleattribute><sampleattribute><category>Organism</category><value>Homo sapiens</value></sampleattribute><sampleattribute><category>OrganismPart</category><value>medial temporal lobe</value></sampleattribute><sampleattribute><category>provider</category><value>The Netherlands Brain Bank</value></sampleattribute><sampleattribute><category>Sex</category><value>female</value><value>male</value></sampleattribute><experimentalfactor><name>DISEASE_STAGE</name><value>Braak stage 0</value><value>Braak stage 1</value><value>Braak stage 2</value><value>Braak stage 6</value><value>Constantinides type A</value><value>Constantinides type C1</value><value>stage unknown</value></experimentalfactor><experimentalfactor><name>DISEASE_STATE</name><value>Alzheimer's disease</value><value>normal</value><value>Pick's disease</value><value>Progressive supranuclear palsy</value></experimentalfactor><miamescores><reportersequencescore>1</reportersequencescore><protocolscore>1</protocolscore><factorvaluescore>1</factorvaluescore><derivedbioassaydatascore>1</derivedbioassaydatascore><measuredbioassaydatascore>1</measuredbioassaydatascore><overallscore>5</overallscore></miamescores><id>142257</id><accession>E-MEXP-2280</accession><name>Transcription profiling of patients with four neurodegenerative disorders distinguishes tauopathies and identifies shared molecular pathways</name><experimenttype>transcription profiling by array</experimenttype><releasedate>2010-01-14</releasedate><lastupdatedate>2014-05-02</lastupdatedate><samples>31</samples><assays>31</assays><arraydesign><id>11119</id><accession>A-AFFY-44</accession><name>Affymetrix GeneChip Human Genome U133 Plus 2.0 [HG-U133_Plus_2]</name><count>31</count><legacy_id>405156763</legacy_id></arraydesign><bioassaydatagroup><id/><name>rawData</name><bioassaydatacubes>31</bioassaydatacubes><arraydesignprovider/><dataformat>rawData</dataformat><bioassays>31</bioassays><isderived>0</isderived></bioassaydatagroup><bioassaydatagroup><id/><name>processedDataMatrix</name><bioassaydatacubes>1</bioassaydatacubes><arraydesignprovider/><dataformat>processedDataMatrix</dataformat><bioassays>1</bioassays><isderived>1</isderived></bioassaydatagroup><bibliography><accession>19714246</accession><authors>Bronner IF, Bochdanovits Z, Rizzu P, Kamphorst W, Ravid R, van Swieten JC, Heutink P</authors><title>Comprehensive mRNA expression profiling distinguishes tauopathies and identifies shared molecular pathways</title></bibliography><provider><contact>Iraad F Bronner</contact><role>submitter</role><email>ibronner@mrc-lmb.cam.ac.uk</email></provider><experimentdesign>co-expression</experimentdesign><experimentdesign>disease state</experimentdesign><experimentdesign>replicate</experimentdesign><description><id/><text>We have constructed genome wide expression profiles from snap frozen post-mortem tissue from the medial temporal lobe of patients with four neurodegenerative disorders (5 AD, 5 PSP, 5 PiD and 5 FTD patients) and 5 control subjects. All patients were matched for age, gender, ApoE-? and MAPT (tau) haplotype. From all groups a total of 790 probes were shown to be differently expressed when compared to control individuals. The results from these experiments were then used to investigate the correlations between clinical, pathological and molecular findings. From the 790 identified probes we extracted a gene set of 166 probes whose expression could discriminate between these disorders and normal ageing. This gene set can be further developed into an accurate microarray-based classification test. Furthermore, from this dataset we extracted a disease specific set of genes and identified two aging related transcription factors (FOXO1A and FOXO3A) as possible drug targets related to neurodegenerative disease.</text></description><protocol><id>344719</id><accession>P-MTAB-4952</accession></protocol><protocol><id>344720</id><accession>P-MTAB-4951</accession></protocol><organism>Homo sapiens</organism><files><!--
This section is deprecated and unsupported.
Please use webservice located at:
    http://www.ebi.ac.uk/arrayexpress/xml/files
to obtain detailed information on files available for the experiment.
For more information, please go to:
    http://www.ebi.ac.uk/arrayexpress/help/programmatic_access.html
                --><raw name="E-MEXP-2280.raw.1.zip" count="true" celcount="0"/><fgem name="E-MEXP-2280.processed.1.zip" available="true"/><idf name="E-MEXP-2280.idf.txt"/><sdrf name="E-MEXP-2280.sdrf.txt"/></files></experiment><experiment><species>Homo sapiens</species><rawdatafiles available="true"/><processeddatafiles available="true"/><sampleattribute><category>age</category><value>0.04 year</value><value>0.08 year</value><value>0.1 year</value><value>0.13 year</value><value>0.25 year</value><value>0.38 year</value><value>0.5 month</value><value>0.5 year</value><value>0.58 year</value><value>0.91 year</value><value>1 month</value><value>1 year</value><value>1.08 year</value><value>1.25 month</value><value>1.3 year</value><value>1.33 year</value><value>1.5 month</value><value>1.7 month</value><value>1.75 year</value><value>10 month</value><value>10 year</value><value>11 month</value><value>11 year</value><value>12 year</value><value>13 month</value><value>13 year</value><value>14 year</value><value>15 month</value><value>15 year</value><value>16 month</value><value>16 year</value><value>17 month</value><value>18 month</value><value>18 year</value><value>19 month</value><value>2 month</value><value>2 year</value><value>2.5 month</value><value>2.5 year</value><value>20 month</value><value>22 month</value><value>23 month</value><value>24 year</value><value>3 month</value><value>3 year</value><value>3.5 year</value><value>36 year</value><value>4 month</value><value>4 year</value><value>4.5 year</value><value>5 month</value><value>6 month</value><value>6 year</value><value>7 month</value><value>7 year</value><value>7.5 year</value><value>8 month</value><value>8 year</value><value>9 month</value><value>9 year</value><value>9.5 year</value></sampleattribute><sampleattribute><category>cell type</category><value>mononuclear</value></sampleattribute><sampleattribute><category>clinical information</category><value>Acyclovir</value><value>Amoxicillin</value><value>Ampicillin/Ceftriaxone</value><value>Ampicillin/ceftriaxone</value><value>Ampicillin/Gentamicin</value><value>Ampicillin/Gentamicin/Ceftriaxone</value><value>Cefazolin</value><value>Cefazolin/Rifampin</value><value>Ceftriaxone</value><value>Ceftriaxone/Acyclovir/Oseltamivir</value><value>Ceftriaxone/Azithromycin</value><value>Ceftriaxone/Clindamycin</value><value>Ceftriaxone/Gentamicin</value><value>Ceftriaxone/Oseltamivir</value><value>Ceftriaxone/Vancomycin</value><value>Ceftriaxone/Vancomycin/Oseltamivir</value><value>Cefuroxime</value><value>Cefuroxime/Clindamycin</value><value>Cefuroxime/Oseltamivir</value><value>Clindamycin</value><value>Clindamycin/Doxycycline</value><value>Clindamycin/Rifampin</value><value>Gentamicin</value><value>Gentamicin/Ampicillin</value><value>Nafcillin</value><value>None</value><value>Oseltamivir</value><value>Oxacillin</value><value>Oxacillin/Clindamycin</value><value>Oxacillin/Gentamicin/Rifampin</value><value>Oxacillin/Rifampin</value><value>Oxacillin/Tobramycin</value><value>Vancomycin</value><value>Vancomycin/Cefazolin</value><value>Vancomycin/Cefazolin/Gentamicin</value><value>Vancomycin/Ceftriaxone</value><value>Vancomycin/Clindamycin/Rifampin</value><value>Vancomycin/Gentamicin</value><value>Vancomycin/Rifampin</value><value>Vancomycin/Rifampin/Linezolid</value></sampleattribute><sampleattribute><category>disease state</category><value>abcess</value><value>bacteremia</value><value>bacteremia/septic arthritis/osteomyelitis</value><value>bacteremia/suppurative arthritis</value><value>cellulitis</value><value>disseminated</value><value>disseminated/pneumonia</value><value>encephalitis</value><value>endocarditis/bacteremia</value><value>fever</value><value>fever/seizure</value><value>fever/URI</value><value>fever/URI Sxs</value><value>hip abcess/bacteremia</value><value>lung abcess</value><value>meningitis</value><value>meningitis/bacteremia</value><value>normal</value><value>osteomyelitis</value><value>osteomyelitis/bacteremia</value><value>osteomyelitis/bacteremia/pneumonia</value><value>osteomyelitis/suppurative arthritis</value><value>osteomyelitis/suppurative arthritis/bacteremia</value><value>pneumonia</value><value>pneumonia/bacteremia</value><value>pneumonia/empyema</value><value>pyelonephritis</value><value>respiratory distress</value><value>seizures</value><value>septic arthritis/bacteremia</value><value>septic arthritis/osteomyelitis/bacteremia</value><value>septic athritis</value><value>skin/soft tissue abscess</value><value>skin/soft tissue abscess/bacteremia</value><value>suppurative arthritis</value><value>urinary tract infection</value><value>urinary tract infection/bacteremia</value></sampleattribute><sampleattribute><category>ethnicity</category><value>Asian</value><value>Black</value><value>Caucasian</value><value>Hispanic</value><value>Other</value></sampleattribute><sampleattribute><category>infection</category><value>E. coli</value><value>Influenza A</value><value>Influenza B</value><value>methicillin-resistant Staphylococcus aureus</value><value>methicillin-sensitive Staphylococcus aureus</value><value>S. pneumoniae</value></sampleattribute><sampleattribute><category>Organism</category><value>Homo sapiens</value></sampleattribute><sampleattribute><category>organism part</category><value>peripheral blood</value></sampleattribute><sampleattribute><category>sex</category><value>female</value><value>male</value></sampleattribute><experimentalfactor><name>disease state</name><value>abcess</value><value>bacteremia</value><value>bacteremia/septic arthritis/osteomyelitis</value><value>bacteremia/suppurative arthritis</value><value>cellulitis</value><value>disseminated</value><value>disseminated/pneumonia</value><value>encephalitis</value><value>endocarditis/bacteremia</value><value>fever</value><value>fever/seizure</value><value>fever/URI</value><value>fever/URI Sxs</value><value>hip abcess/bacteremia</value><value>lung abcess</value><value>meningitis</value><value>meningitis/bacteremia</value><value>normal</value><value>osteomyelitis</value><value>osteomyelitis/bacteremia</value><value>osteomyelitis/bacteremia/pneumonia</value><value>osteomyelitis/suppurative arthritis</value><value>osteomyelitis/suppurative arthritis/bacteremia</value><value>pneumonia</value><value>pneumonia/bacteremia</value><value>pneumonia/empyema</value><value>pyelonephritis</value><value>respiratory distress</value><value>seizures</value><value>septic arthritis/bacteremia</value><value>septic arthritis/osteomyelitis/bacteremia</value><value>septic athritis</value><value>skin/soft tissue abscess</value><value>skin/soft tissue abscess/bacteremia</value><value>suppurative arthritis</value><value>urinary tract infection</value><value>urinary tract infection/bacteremia</value></experimentalfactor><experimentalfactor><name>infection</name><value>E. coli</value><value>Influenza A</value><value>Influenza B</value><value>methicillin-resistant Staphylococcus aureus</value><value>methicillin-sensitive Staphylococcus aureus</value><value>S. pneumoniae</value><value>Unspecified</value></experimentalfactor><miamescores><reportersequencescore>1</reportersequencescore><protocolscore>0</protocolscore><factorvaluescore>1</factorvaluescore><derivedbioassaydatascore>1</derivedbioassaydatascore><measuredbioassaydatascore>1</measuredbioassaydatascore><overallscore>4</overallscore></miamescores><id>191283</id><accession>E-GEOD-6269</accession><secondaryaccession>GSE6269</secondaryaccession><name>Transcription profiling by array of human blood leukocytes from patients infected with various pathogens</name><experimenttype>transcription profiling by array</experimenttype><releasedate>2009-03-13</releasedate><lastupdatedate>2014-05-02</lastupdatedate><samples>143</samples><assays>143</assays><arraydesign><id>11043</id><accession>A-AFFY-33</accession><name>Affymetrix GeneChip Human Genome HG-U133A [HG-U133A]</name><count>97</count><legacy_id>302382080</legacy_id></arraydesign><arraydesign><id>12172</id><accession>A-MEXP-691</accession><name>Illumina Human-6 v1 Expression BeadChip</name><count>24</count><legacy_id>1334201749</legacy_id></arraydesign><arraydesign><id>11119</id><accession>A-AFFY-44</accession><name>Affymetrix GeneChip Human Genome U133 Plus 2.0 [HG-U133_Plus_2]</name><count>22</count><legacy_id>405156763</legacy_id></arraydesign><bioassaydatagroup><id/><name>rawData</name><bioassaydatacubes>143</bioassaydatacubes><arraydesignprovider/><dataformat>rawData</dataformat><bioassays>143</bioassays><isderived>0</isderived></bioassaydatagroup><bioassaydatagroup><id/><name>normalization</name><bioassaydatacubes>143</bioassaydatacubes><arraydesignprovider/><dataformat>normalization</dataformat><bioassays>143</bioassays><isderived>0</isderived></bioassaydatagroup><bioassaydatagroup><id/><name>processedData</name><bioassaydatacubes>143</bioassaydatacubes><arraydesignprovider/><dataformat>processedData</dataformat><bioassays>143</bioassays><isderived>0</isderived></bioassaydatagroup><bioassaydatagroup><id/><name>scan</name><bioassaydatacubes>143</bioassaydatacubes><arraydesignprovider/><dataformat>scan</dataformat><bioassays>143</bioassays><isderived>0</isderived></bioassaydatagroup><bibliography><accession>17105821</accession><authors>Ramilo O, Allman W, Chung W, Mejias A, Ardura M, Glaser C, Wittkowski KM, Piqueras B, Banchereau J, Palucka AK, Chaussabel D</authors><title>Gene expression patterns in blood leukocytes discriminate patients with acute infections.</title><doi>10.1182/blood-2006-02-002477</doi></bibliography><provider><contact>Damien Chaussabel</contact><role>submitter</role><email>damienc@baylorhealth.edu</email></provider><description><id/><text>Each infectious agent represents a unique combination of pathogen-associated molecular patterns that interact with specific pattern-recognition receptors expressed on immune cells. Therefore, we surmised that the blood immune cells of individuals with different infections might bear discriminative transcriptional signatures. Gene expression profiles were obtained for 131 peripheral blood samples from pediatric patients with acute infections caused by influenza A virus, Gram-negative (Escherichia coli) or Gram-positive (Staphylococcus aureus and Streptococcus pneumoniae) bacteria. Thirty-five genes were identified that best discriminate patients with influenza A virus infection from patients with either E coli or S pneumoniae infection. These genes classified with 95% accuracy (35 of 37 samples) an independent set of patients with either influenza A, E coli, or S pneumoniae infection. A different signature discriminated patients with E coli versus S aureus infections with 85% accuracy (34 of 40). Furthermore, distinctive gene expression patterns were observed in patients presenting with respiratory infections of different etiologies. Thus, microarray analyses of patient peripheral blood leukocytes might assist in the differential diagnosis of infectious diseases. Experiment Overall Design: Entire study included 144 samples. Only 143 are included in this series because the CHP/CEL file was not available for sample PBMC_Healthy_INF295.</text></description><protocol><id>507945</id><accession>P-G6269-3</accession></protocol><protocol><id>51</id><accession>P-AFFY-6</accession></protocol><protocol><id>507943</id><accession>P-G6269-1</accession></protocol><protocol><id>507944</id><accession>P-G6269-2</accession></protocol><organism>Homo sapiens</organism><files><!--
This section is deprecated and unsupported.
Please use webservice located at:
    http://www.ebi.ac.uk/arrayexpress/xml/files
to obtain detailed information on files available for the experiment.
For more information, please go to:
    http://www.ebi.ac.uk/arrayexpress/help/programmatic_access.html
                --><raw name="E-GEOD-6269.raw.1.zip E-GEOD-6269.raw.2.zip E-GEOD-6269.raw.3.zip" count="true" celcount="0"/><fgem name="E-GEOD-6269.processed.1.zip" available="true"/><idf name="E-GEOD-6269.idf.txt"/><sdrf name="E-GEOD-6269.sdrf.txt"/></files></experiment><experiment><species>Homo sapiens</species><rawdatafiles available="true"/><processeddatafiles available="true"/><sampleattribute><category>albumin</category><value>  </value><value>0</value><value>23</value><value>39</value><value>43</value></sampleattribute><sampleattribute><category>anatomic_location</category><value>  </value><value>ascending colon</value><value>descending colon</value><value>sigmoid colon</value><value>terminal ileum</value></sampleattribute><sampleattribute><category>aza at present</category><value>  </value><value>FALSE</value><value>TRUE</value></sampleattribute><sampleattribute><category>aza tolerant</category><value>  </value><value>FALSE</value><value>TRUE</value></sampleattribute><sampleattribute><category>aza treated</category><value>  </value><value>NO</value><value>unknown</value><value>YES</value></sampleattribute><sampleattribute><category>birth date</category><value>  </value><value>07/28/1060</value><value>1/1/54</value><value>1/10/35</value><value>1/10/37</value><value>1/10/59</value><value>1/12/60</value><value>1/18/44</value><value>1/19/56</value><value>1/2/72</value><value>1/27/58</value><value>1/29/55</value><value>1/29/86</value><value>1/5/43</value><value>1/7/57</value><value>1/9/47</value><value>1/9/63</value><value>10/10/57</value><value>10/16/44</value><value>10/18/39</value><value>10/26/64</value><value>10/29/77</value><value>10/3/50</value><value>10/5/63</value><value>11/1/43</value><value>11/10/44</value><value>11/12/28</value><value>11/20/53</value><value>11/22/48</value><value>11/27/61</value><value>11/4/67</value><value>11/9/58</value><value>12/21/50</value><value>12/27/57</value><value>2/17/25</value><value>2/2/29</value><value>2/21/38</value><value>2/9/57</value><value>3/13/54</value><value>3/14/58</value><value>3/14/77</value><value>3/17/78</value><value>3/19/81</value><value>3/27/80</value><value>3/31/67</value><value>4/10/41</value><value>4/12/56</value><value>4/13/52</value><value>4/17/28</value><value>4/23/65</value><value>4/29/47</value><value>4/30/52</value><value>4/4/87</value><value>4/8/59</value><value>5/10/36</value><value>5/16/64</value><value>5/21/51</value><value>5/22/21</value><value>5/29/87</value><value>5/30/76</value><value>5/6/54</value><value>5/6/60</value><value>6/15/74</value><value>6/25/62</value><value>6/25/77</value><value>6/27/36</value><value>6/28/48</value><value>6/28/56</value><value>6/30/65</value><value>6/8/79</value><value>7/10/61</value><value>7/17/43</value><value>7/25/59</value><value>7/29/84</value><value>7/5/81</value><value>8/12/40</value><value>8/14/59</value><value>8/15/43</value><value>8/16/74</value><value>8/16/85</value><value>8/17/71</value><value>8/17/81</value><value>8/3/76</value><value>8/30/33</value><value>9/10/59</value><value>9/14/28</value><value>9/20/78</value><value>9/27/24</value><value>9/27/38</value><value>9/29/46</value><value>9/30/70</value><value>9/5/62</value><value>9/5/82</value><value>9/9/36</value></sampleattribute><sampleattribute><category>blood obtained</category><value>  </value><value>FALSE</value><value>TRUE</value></sampleattribute><sampleattribute><category>calprotectin</category><value>  </value><value>0</value><value>700</value></sampleattribute><sampleattribute><category>casenote review date</category><value>  </value><value>12/16/04</value><value>12/7/04</value><value>12/9/04</value><value>3/4/05</value><value>3/7/05</value><value>5/30/05</value><value>5/31/05</value><value>6/1/05</value><value>6/3/05</value><value>7/7/05</value><value>8/15/05</value><value>8/3/05</value><value>9/14/05</value><value>9/30/05</value></sampleattribute><sampleattribute><category>category</category><value>  </value><value>0</value><value>DISEASE IN REMISSION</value><value>FAILURE OF THERAPY</value><value>NEW</value></sampleattribute><sampleattribute><category>crp</category><value>  </value><value>0</value><value>19</value><value>20</value><value>3</value></sampleattribute><sampleattribute><category>current medication</category><value>  </value><value>6MP 50mg</value><value>Asacol</value><value>Asacol 1.2g Asprin 75mg Amilodipine 10mg</value><value>Asacol 1.2g daily</value><value>Asacol 1.6g/ day</value><value>Asacol 2.4g co-codamol</value><value>Asacol 2.4g/d</value><value>Asacol 400mg BD</value><value>Asacol 800mg BD</value><value>Asacol 800mg bd Azathioprine 100mg</value><value>Asacol 800mg BD, Colifoam Enemas Daily</value><value>Asacol 800mg BD, Simvastatin</value><value>Asacol 800mg BFZ 2.5mg Metformin Simvastatin</value><value>asacol 800mg TDS Asprin coproxamol</value><value>Asacol 800mg TDS, Predfoam</value><value>Asacol Fybogel Amitriptiline</value><value>Asacol Predfoam Lanzoprazole</value><value>Asacol Prednisolone 5 Omeprazole Warfarin Cal VitD</value><value>Atenolol Pravastatin Asprin Adalat BFZ Balsalizide</value><value>Aza 150mg Atenolol Atorvastatin BFZ Clopidogril</value><value>AZA 150mg/d, Mesalazine 800mg TDS</value><value>AZA 200mg, Insulin, Asprin, Atenolol, Simvastatin</value><value>Azathioprine 150mg Asacol 1.6g Ca Vit D B12</value><value>Azathioprine 150mg Salazopyrine</value><value>Azathioprine 200mg Pentaza 1g TDS</value><value>Azathioprine 75mg Fosomax 70mg</value><value>Becotide inhaler</value><value>Bumetanide Asprin Lisinopril Colifoam</value><value>Clomiprimine</value><value>Cp-tenedone, Enalapril, Loperamide.</value><value>Enalapril Zantac</value><value>Frusemide, Codine Phosphate</value><value>Loperamide</value><value>Mesalazine 800mg B, Prednisolone Supps</value><value>Mesalazine 800mg TDS</value><value>metranidazole 400mg TDS Prednisolone</value><value>Minicycline</value><value>Movicol 1 sachet daily</value><value>naproxen</value><value>NONE</value><value>None</value><value>none</value><value>OCP</value><value>Omep 20mg Losartan 50mg Bisoprolol 5mg Prav 40mg</value><value>Omeprazole 20mg</value><value>paracetamol</value><value>Pentaza</value><value>Pentaza 1g BD</value><value>Pentaza 2g BD</value><value>pentaza 2g D</value><value>Pentaza 3g/d</value><value>Pentaza 500mg TDS</value><value>Pred 10mg, AZA150mg, ADCAL D3</value><value>PRED 7MG, ATENOLOL 100MG, ASPRIN 75MG, SIMVASTATI</value><value>Predfoam Adcal D3 Alendronate</value><value>Prednisolone 10mg Heparin Questran Gabapentin FA</value><value>Prednisolone 20mg Asacol 2.4g</value><value>Prednisolone 20mg Balsalazide</value><value>Prednisolone 25mg/d, Pentaza 1g BD, Fosomax weekly</value><value>prednisolone 40mg heparin clarithromycin</value><value>Prednisolone 5ng Balsalazide Lansoperazole</value><value>Prednisolone 7mg Asacol Adcal Seretide Fe SO4</value><value>Prednisolone ciproxin mesalazine fosomax Fe SO4</value><value>Salazopyrin BFZ Losartan Thyroxine Doxazosin</value><value>Salazopyrin Folic acid</value><value>Salubtamol, Bricanyl</value><value>Seratide Bricanyl BFZ</value><value>Sulphasalazine 1.2g Colifoam</value><value>Sulphasalazine 3g/d, Folic Acid 5mg/d, HRT, DF118</value><value>Sulphasalazine Asprin Metoprolol Atorvastatin</value><value>Venlafaxine</value></sampleattribute><sampleattribute><category>diagnosis date</category><value>  </value><value>1/1/58</value><value>1/1/69</value><value>1/1/75</value><value>1/1/77</value><value>1/1/79</value><value>1/1/80</value><value>1/1/81</value><value>1/1/82</value><value>1/1/87</value><value>1/1/89</value><value>1/1/90</value><value>1/1/92</value><value>1/1/93</value><value>1/1/95</value><value>1/1/98</value><value>1/10/61</value><value>1/10/74</value><value>1/10/79</value><value>1/13/04</value><value>1/14/05</value><value>1/18/05</value><value>11/1/00</value><value>11/11/91</value><value>11/13/95</value><value>11/19/02</value><value>12/10/01</value><value>12/12/64</value><value>12/14/04</value><value>12/3/03</value><value>2/2/83</value><value>3/15/04</value><value>3/16/05</value><value>3/22/04</value><value>3/23/93</value><value>3/24/90</value><value>3/25/95</value><value>3/29/05</value><value>5/10/05</value><value>5/30/94</value><value>6/1/00</value><value>6/1/88</value><value>6/16/03</value><value>6/2/03</value><value>6/2/05</value><value>6/20/86</value><value>6/25/04</value><value>6/6/05</value><value>6/7/79</value><value>7/4/03</value><value>8/1/02</value><value>8/16/02</value><value>8/18/88</value><value>8/20/66</value><value>8/24/05</value><value>8/26/97</value><value>8/30/04</value><value>9/1/01</value><value>9/29/95</value><value>9/4/97</value></sampleattribute><sampleattribute><category>diagnosis hep flex</category><value>  </value><value>BOTH</value><value>unknown</value></sampleattribute><sampleattribute><category>diagnosis recto sigmoid</category><value>  </value><value>BOTH</value><value>HISTOLOGICAL</value><value>unknown</value></sampleattribute><sampleattribute><category>diagnosis rectum</category><value>  </value><value>BOTH</value><value>HISTOLOGICAL</value><value>unknown</value></sampleattribute><sampleattribute><category>diagnosis splen flex</category><value>  </value><value>BOTH</value><value>HISTOLOGICAL</value><value>unknown</value></sampleattribute><sampleattribute><category>diagnosis total</category><value>  </value><value>BOTH</value><value>unknown</value></sampleattribute><sampleattribute><category>disease</category><value>  </value><value>normal</value><value>UC</value></sampleattribute><sampleattribute><category>dlg5 133a</category><value>  </value><value>0</value><value>11</value></sampleattribute><sampleattribute><category>esr</category><value>  </value><value>0</value><value>14</value><value>15</value><value>17</value></sampleattribute><sampleattribute><category>ethnicity</category><value>  </value><value>Asian</value><value>Caucasian</value><value>JEWISH</value></sampleattribute><sampleattribute><category>family history</category><value>  </value><value>FALSE</value><value>TRUE</value></sampleattribute><sampleattribute><category>followup hep flex</category><value>  </value><value>BOTH</value><value>unknown</value></sampleattribute><sampleattribute><category>followup recto sigmoid</category><value>  </value><value>BOTH</value><value>HISTOLOGICAL</value><value>unknown</value></sampleattribute><sampleattribute><category>followup rectum</category><value>  </value><value>BOTH</value><value>COLONOSCOPIC</value><value>unknown</value></sampleattribute><sampleattribute><category>followup splen flex</category><value>  </value><value>BOTH</value><value>unknown</value></sampleattribute><sampleattribute><category>followup total</category><value>  </value><value>BOTH</value><value>unknown</value></sampleattribute><sampleattribute><category>hb</category><value>  </value><value>0</value><value>110</value><value>121</value><value>147</value><value>93</value></sampleattribute><sampleattribute><category>ibd affected relatives</category><value>  </value><value>0</value><value>1</value><value>2</value></sampleattribute><sampleattribute><category>igr2096</category><value>  </value><value>0</value><value>11</value><value>12</value><value>22</value></sampleattribute><sampleattribute><category>igr2198</category><value>  </value><value>11</value><value>12</value><value>22</value></sampleattribute><sampleattribute><category>igr2230</category><value>  </value><value>11</value><value>12</value><value>22</value></sampleattribute><sampleattribute><category>indictation for procedure</category><value>  </value><value>abdominal pain</value><value>Abdominal pain, upper GI symptoms.</value><value>Altered bowel habbit, ? UC 1974, never on Bx.</value><value>Altered bowel habit</value><value>Altered bowel habit, Alcohol excess</value><value>bloody diahorrea</value><value>Diarrhoea</value><value>Diarrhoea PR bleeding</value><value>Diarrhoea predominant IBS</value><value>Diarrhoea, Also has Prostate Ca</value><value>Diarrhoea, Blastocytitis on stool cultures.</value><value>Diarrhoea, now settled, Mum has UC</value><value>FH Colon Ca</value><value>FH Colon Cancer</value><value>FH Colon cancer</value><value>FH of CD, Path Increased lymphiod in TI Bx.</value><value>FH of Colon Cancer</value><value>FH of Crohn's disease, Symtom free at procedure</value><value>IBS Type symptoms</value><value>IBS type symptoms</value><value>Pseudomembranous Colitis</value><value>Recurrant abcess, ?IBD</value><value>RIF pain, persistent anaemia.</value><value>Weight loss, altered bowel habbit.</value></sampleattribute><sampleattribute><category>inflammation_status</category><value>  </value><value>Inflamed</value><value>Uninflamed</value></sampleattribute><sampleattribute><category>joint problems</category><value>  </value><value>FALSE</value><value>TRUE</value></sampleattribute><sampleattribute><category>last followup date</category><value>  </value><value>1/11/05</value><value>1/14/05</value><value>1/25/05</value><value>1/31/05</value><value>1/6/05</value><value>10/1/04</value><value>10/14/04</value><value>10/8/04</value><value>11/1/04</value><value>11/12/04</value><value>11/14/04</value><value>11/15/04</value><value>11/16/04</value><value>11/18/04</value><value>11/26/04</value><value>11/5/04</value><value>11/9/04</value><value>12/10/04</value><value>12/14/04</value><value>12/16/04</value><value>12/3/04</value><value>12/7/04</value><value>2/1/05</value><value>2/11/05</value><value>2/18/05</value><value>2/3/05</value><value>3/10/05</value><value>3/16/05</value><value>3/22/05</value><value>3/26/05</value><value>3/29/05</value><value>3/3/05</value><value>4/29/05</value><value>4/8/05</value><value>5/24/05</value><value>5/31/05</value><value>6/14/05</value><value>6/2/05</value><value>6/5/03</value><value>6/6/05</value><value>6/7/05</value><value>6/9/05</value><value>7/19/05</value><value>7/22/05</value><value>7/5/05</value><value>7/8/05</value><value>8/24/05</value><value>9/14/05</value><value>9/20/05</value><value>9/30/04</value></sampleattribute><sampleattribute><category>neutrophils</category><value>  </value><value>0</value><value>16</value><value>3</value><value>4</value><value>5</value></sampleattribute><sampleattribute><category>nod 1007 fs</category><value>  </value><value>0</value><value>11</value><value>12</value></sampleattribute><sampleattribute><category>nod 702</category><value>  </value><value>0</value><value>11</value></sampleattribute><sampleattribute><category>nod 908</category><value>  </value><value>0</value><value>11</value><value>12</value></sampleattribute><sampleattribute><category>octn1</category><value>  </value><value>11</value><value>12</value><value>22</value></sampleattribute><sampleattribute><category>octn2</category><value>  </value><value>0</value><value>11</value><value>12</value><value>22</value></sampleattribute><sampleattribute><category>organism</category><value>Homo sapiens</value></sampleattribute><sampleattribute><category>other illnesses</category><value>  </value><value>? MS never proven</value><value>Arthritis Depression Alcohol excess</value><value>asthma</value><value>Asthma Eczema</value><value>Asthma Hypertension</value><value>Breast Cancer</value><value>CENTRAL RETINAL VEIN OCCLUSION 01/04</value><value>Coeliac disease 1991</value><value>COPD-Previous severe pneumonia</value><value>Hypercholesteremia Prev CABG</value><value>Hypertension Diverticular disease</value><value>Hypertension Hashimoto's Thyroditis</value><value>IHD Angina</value><value>IHD Deaf</value><value>ISCHEAMIC HEART DISEASE</value><value>MI 1986, Prostate cancer 1994</value><value>Migraines</value><value>NONE</value><value>None</value><value>none</value><value>Polymyalgia rheumatica</value><value>Prostate cancer 1985, Previous DVT's on warfarin</value><value>Scarlet Fever 1964</value><value>TURP</value><value>Type 2 DM 02/2004.-Gout.</value><value>Type 2 DM.</value><value>Vaginal Prolapse-Angina</value></sampleattribute><sampleattribute><category>patient</category><value>  </value><value>101</value><value>102</value><value>103</value><value>104</value><value>105</value><value>106</value><value>107</value><value>108</value><value>109</value><value>110</value><value>111</value><value>112</value><value>113</value><value>114</value><value>115</value><value>116</value><value>117</value><value>119</value><value>120</value><value>121</value><value>122</value><value>124</value><value>125</value><value>126</value><value>127</value><value>128</value><value>133</value><value>134</value><value>135</value><value>136</value><value>201</value><value>202</value><value>203</value><value>204</value><value>205</value><value>206</value><value>207</value><value>208</value><value>209</value><value>210</value><value>211</value><value>212</value><value>213</value><value>214</value><value>215</value><value>216</value><value>217</value><value>218</value><value>219</value><value>220</value><value>221</value><value>222</value><value>223</value><value>224</value><value>225</value><value>226</value><value>227</value><value>228</value><value>229</value><value>230</value><value>231</value><value>232</value><value>233</value><value>234</value><value>235</value><value>236</value><value>237</value><value>238</value><value>239</value><value>240</value><value>241</value><value>242</value><value>243</value><value>244</value><value>245</value><value>249</value><value>250</value><value>251</value><value>253</value><value>254</value><value>255</value><value>256</value><value>257</value><value>258</value><value>259</value><value>260</value><value>261</value><value>262</value><value>263</value><value>265</value><value>266</value><value>267</value><value>270</value></sampleattribute><sampleattribute><category>procedure date</category><value>  </value><value>1/11/05</value><value>1/14/05</value><value>1/18/05</value><value>1/25/05</value><value>1/27/05</value><value>1/28/05</value><value>1/31/05</value><value>1/6/05</value><value>10/1/04</value><value>10/14/04</value><value>10/15/04</value><value>10/19/04</value><value>10/8/04</value><value>11/1/04</value><value>11/12/04</value><value>11/15/04</value><value>11/16/04</value><value>11/18/04</value><value>11/2/04</value><value>11/25/04</value><value>11/26/04</value><value>11/5/04</value><value>11/9/04</value><value>12/10/04</value><value>12/14/04</value><value>12/16/04</value><value>12/2/04</value><value>12/21/04</value><value>12/3/04</value><value>12/7/04</value><value>2/1/05</value><value>2/10/05</value><value>2/11/05</value><value>2/18/05</value><value>2/3/05</value><value>3/1/05</value><value>3/16/05</value><value>3/22/05</value><value>3/29/05</value><value>3/3/05</value><value>4/1/05</value><value>4/29/05</value><value>4/8/05</value><value>5/13/05</value><value>5/24/05</value><value>5/31/05</value><value>6/14/05</value><value>6/2/05</value><value>6/6/05</value><value>6/7/05</value><value>6/9/05</value><value>7/12/05</value><value>7/19/05</value><value>7/20/05</value><value>7/22/05</value><value>7/28/05</value><value>7/5/05</value><value>7/8/05</value><value>8/15/05</value><value>8/24/05</value><value>9/30/04</value></sampleattribute><sampleattribute><category>run_date</category><value>  </value><value>1-25-01</value><value>11-15-01</value><value>5-25-01</value><value>6-2-01</value><value>8-9-01</value></sampleattribute><sampleattribute><category>sample type</category><value>  </value><value>total RNA from 10 human cell lines</value></sampleattribute><sampleattribute><category>sex</category><value>  </value><value>female</value><value>male</value><value>unknown</value></sampleattribute><sampleattribute><category>smoking amount</category><value>  </value><value>0-4</value><value>15-24</value><value>25+</value><value>5-14</value><value>unknown</value></sampleattribute><sampleattribute><category>smoking start date</category><value>  </value><value>1/1/03</value><value>1/1/50</value><value>1/1/58</value><value>1/1/70</value><value>1/1/71</value><value>1/1/85</value><value>1/10/62</value></sampleattribute><sampleattribute><category>smoking status</category><value>  </value><value>current</value><value>ex</value><value>never</value><value>unknown</value></sampleattribute><sampleattribute><category>smoking stop date</category><value>  </value><value>1/1/01</value><value>1/1/03</value><value>1/1/04</value><value>1/1/52</value><value>1/1/57</value><value>1/1/72</value><value>1/1/74</value><value>1/1/86</value><value>1/1/90</value><value>1/1/94</value><value>1/1/95</value><value>1/1/97</value><value>1/1/99</value><value>2/1/05</value><value>3/1/03</value><value>3/15/75</value><value>5/1/03</value></sampleattribute><sampleattribute><category>symptoms onset date</category><value>  </value><value>1/1/00</value><value>1/1/03</value><value>1/1/05</value><value>1/1/58</value><value>1/1/59</value><value>1/1/68</value><value>1/1/73</value><value>1/1/75</value><value>1/1/77</value><value>1/1/79</value><value>1/1/80</value><value>1/1/81</value><value>1/1/87</value><value>1/1/89</value><value>1/1/90</value><value>1/1/92</value><value>1/1/93</value><value>1/1/94</value><value>1/1/95</value><value>1/1/97</value><value>1/1/98</value><value>1/1/99</value><value>1/10/95</value><value>1/14/05</value><value>10/1/00</value><value>10/1/03</value><value>10/1/95</value><value>11/1/90</value><value>11/1/92</value><value>11/4/04</value><value>12/1/63</value><value>12/10/01</value><value>2/1/88</value><value>2/19/66</value><value>2/5/04</value><value>3/1/00</value><value>3/1/04</value><value>3/1/82</value><value>3/1/88</value><value>3/1/90</value><value>3/12/02</value><value>4/1/05</value><value>5/1/02</value><value>5/1/05</value><value>6/1/04</value><value>6/1/87</value><value>6/19/03</value><value>6/24/97</value><value>7/1/02</value><value>8/1/03</value><value>8/1/04</value><value>8/2/04</value><value>8/24/97</value><value>9/1/85</value><value>9/25/03</value></sampleattribute><sampleattribute><category>uc flare up</category><value>  </value><value>FALSE</value><value>TRUE</value></sampleattribute><sampleattribute><category>ucss</category><value>  </value><value>0</value><value>1</value><value>10</value><value>12</value><value>15</value><value>2</value><value>3</value><value>4</value><value>5</value><value>6</value><value>7</value><value>8</value><value>9</value></sampleattribute><sampleattribute><category>wcc</category><value>  </value><value>0</value><value>17</value><value>5</value><value>6</value><value>8</value></sampleattribute><miamescores><reportersequencescore>1</reportersequencescore><protocolscore>1</protocolscore><factorvaluescore>0</factorvaluescore><derivedbioassaydatascore>1</derivedbioassaydatascore><measuredbioassaydatascore>1</measuredbioassaydatascore><overallscore>4</overallscore></miamescores><id>317254</id><accession>E-GEOD-11223</accession><secondaryaccession>GSE11223</secondaryaccession><secondaryaccession>GDS3268</secondaryaccession><name>Colon biopsies from UC patients and healthy controls</name><experimenttype>transcription profiling by array</experimenttype><releasedate>2008-06-17</releasedate><lastupdatedate>2014-06-02</lastupdatedate><samples>404</samples><assays>202</assays><arraydesign><id>29705</id><accession>A-AGIL-11</accession><name>Agilent Whole Human Genome Oligo Microarray 012391 G4112A</name><count>202</count><legacy_id>376314681</legacy_id></arraydesign><bioassaydatagroup><id/><name>rawData</name><bioassaydatacubes>202</bioassaydatacubes><arraydesignprovider/><dataformat>rawData</dataformat><bioassays>202</bioassays><isderived>0</isderived></bioassaydatagroup><bioassaydatagroup><id/><name>normalization</name><bioassaydatacubes>202</bioassaydatacubes><arraydesignprovider/><dataformat>normalization</dataformat><bioassays>202</bioassays><isderived>0</isderived></bioassaydatagroup><bioassaydatagroup><id/><name>processedData</name><bioassaydatacubes>202</bioassaydatacubes><arraydesignprovider/><dataformat>processedData</dataformat><bioassays>202</bioassays><isderived>0</isderived></bioassaydatagroup><bibliography><accession>18523026</accession><authors>Noble CL, Abbas AR, Cornelius J, Lees CW, Ho GT, Toy K, Modrusan Z, Pal N, Zhong F, Chalasani S, Clark H, Arnott ID, Penman ID, Satsangi J, Diehl L</authors><title>Regional variation in gene expression in the healthy colon is dysregulated in ulcerative colitis.</title><doi>10.1136/gut.2008.148395</doi></bibliography><provider><contact>Zora Modrusan</contact><role/><email/></provider><provider><contact>Charles W Lees</contact><role/><email/></provider><provider><contact>Navneet Pal</contact><role/><email/></provider><provider><contact>Ian D Arnott</contact><role/><email/></provider><provider><contact>Alexander R Abbas</contact><role/><email/></provider><provider><contact>Fiona Zhong</contact><role/><email/></provider><provider><contact>Ian D Penman</contact><role/><email/></provider><provider><contact>Alex Abbas</contact><role>submitter</role><email>abbas@gene.com</email></provider><provider><contact>Lauri Diehl</contact><role/><email/></provider><provider><contact>Hilary F Clark</contact><role/><email/></provider><provider><contact>Gwo-Tzer Ho</contact><role/><email/></provider><provider><contact>Jennine Cornelius</contact><role/><email/></provider><provider><contact>Sreedevi Chalasani</contact><role/><email/></provider><provider><contact>Jack Satsangi</contact><role/><email/></provider><provider><contact>Karen Toy</contact><role/><email/></provider><provider><contact>Colin L Noble</contact><role/><email/></provider><description><id/><text>Transcriptional profiling of colon epithelial biopsies from ulcerative colitis patients and healthy control donors. Study aims to survey and analyze variation from disease in different GI regions. Keywords: disease state analysis Biopsies from a variety of anatomic locations, from patients of various treatment status or healthy controls.</text></description><protocol><id>790780</id><accession>P-GSE11223-5</accession></protocol><protocol><id>790782</id><accession>P-GSE11223-3</accession></protocol><protocol><id>790781</id><accession>P-GSE11223-4</accession></protocol><protocol><id>790779</id><accession>P-GSE11223-1</accession></protocol><protocol><id>790783</id><accession>P-GSE11223-2</accession></protocol><organism>Homo sapiens</organism><files><!--
This section is deprecated and unsupported.
Please use webservice located at:
    http://www.ebi.ac.uk/arrayexpress/xml/files
to obtain detailed information on files available for the experiment.
For more information, please go to:
    http://www.ebi.ac.uk/arrayexpress/help/programmatic_access.html
                --><raw name="E-GEOD-11223.raw.10.zip E-GEOD-11223.raw.11.zip E-GEOD-11223.raw.1.zip E-GEOD-11223.raw.2.zip E-GEOD-11223.raw.3.zip E-GEOD-11223.raw.4.zip E-GEOD-11223.raw.5.zip E-GEOD-11223.raw.6.zip E-GEOD-11223.raw.7.zip E-GEOD-11223.raw.8.zip E-GEOD-11223.raw.9.zip" count="true" celcount="0"/><fgem name="E-GEOD-11223.processed.1.zip" available="true"/><idf name="E-GEOD-11223.idf.txt"/><sdrf name="E-GEOD-11223.sdrf.txt"/></files></experiment><experiment><species>Homo sapiens</species><rawdatafiles available="true"/><processeddatafiles available="true"/><sampleattribute><category>Organism</category><value>Homo sapiens</value></sampleattribute><miamescores><reportersequencescore>1</reportersequencescore><protocolscore>0</protocolscore><factorvaluescore>0</factorvaluescore><derivedbioassaydatascore>1</derivedbioassaydatascore><measuredbioassaydatascore>1</measuredbioassaydatascore><overallscore>3</overallscore></miamescores><id>22619</id><accession>E-GEOD-6377</accession><secondaryaccession>GSE6377</secondaryaccession><name>Transcription profiling of human  patients suffering FROM bacterial infections TO investigate plasticity  OF THE systemic inflammatory response TO acute infection during critical  illness</name><experimenttype>transcription profiling by array</experimenttype><releasedate>2008-04-09</releasedate><submissiondate>2006-11-27</submissiondate><lastupdatedate>2011-06-10</lastupdatedate><samples>99</samples><assays>99</assays><arraydesign><id>10917</id><accession>A-AFFY-41</accession><name>Affymetrix GeneChip Human Genome Focus Array [HG-Focus]</name><count>99</count><legacy_id>327974795</legacy_id></arraydesign><bioassaydatagroup><id/><name>rawData</name><bioassaydatacubes>99</bioassaydatacubes><arraydesignprovider/><dataformat>rawData</dataformat><bioassays>99</bioassays><isderived>0</isderived></bioassaydatagroup><bioassaydatagroup><id/><name>scan</name><bioassaydatacubes>99</bioassaydatacubes><arraydesignprovider/><dataformat>scan</dataformat><bioassays>99</bioassays><isderived>0</isderived></bioassaydatagroup><bioassaydatagroup><id/><name>processedDataMatrix</name><bioassaydatacubes>1</bioassaydatacubes><arraydesignprovider/><dataformat>processedDataMatrix</dataformat><bioassays>1</bioassays><isderived>1</isderived></bioassaydatagroup><provider><contact>J Perren Cobb</contact><role>submitter</role><email>cobb@wustl.edu</email></provider><experimentdesign>unknown experiment type</experimentdesign><description><id/><text>Diagnosis of acute infection in the critically ill remains a challenge. Changes in physiologic parameters and existing molecular diagnostics are not specific and microbiologic confirmation of infection can take days. As cellular first responders, preclinical studies indicate that circulating leukocytes are activated in response to bacterial infection, manifesting infection-specific transcriptional programs.  We hypothesized that circulating leukocyte transcriptional profiles can be used to diagnose infection and monitor response to therapy in the critically ill. Experiment Overall Design: A translational research approach was employed.  Fifteen mice underwent intratracheal (i.t.) injections of live P. aeruginosa, P. aeruginosa endotoxin, live S. pneumoniae, or normal saline. At 24 hours after injury, GeneChip microarray analysis of circulating buffy coat RNA identified 219 genes that distinguished between the pulmonary insults and differences in 7-day mortality. Similarly, buffy coat microarray expression profiles were generated from 20 mechanically ventilated patients every two days for up to three weeks; 11 of these patients developed pneumonia.  Principal components analysis of the expression levels of the human orthologs for the mouse genes resulted in gene expression trajectories that describe the cohort of 11 patients as they develop, are treated for, and convalesce from ventilator-associated pneumonia (VAP).  When the VAP microarray profiles were analyzed independently, 85 genes were identified with consistent changes in abundance during the seven days bracketing the diagnosis of VAP.  The estimated prediction accuracy in this small patient cohort was 91%.  The abundance of select transcripts was validated using real-time PCR. Principal components analysis of the average microarray-measured abundances of these genes defined a general trajectory (riboleukogram) for the onset of acute infection in this patient population. Individual riboleukograms demonstrated that the onset and course of infection are specific for each individual, but as patients recover from infection the riboleukograms converge.  The gene ontologies of the co-expression networks indicate that leukocyte chemokines and granule maturation are especially informative for pneumonia diagnostics.</text></description><protocol><id>64464</id><accession>P-6377-1</accession></protocol><protocol><id>51</id><accession>P-AFFY-6</accession></protocol><protocol><id>64465</id><accession>P-6377-2</accession></protocol><protocol><id>64463</id><accession>P-6377-3</accession></protocol><organism>Homo sapiens</organism><files><!--
This section is deprecated and unsupported.
Please use webservice located at:
    http://www.ebi.ac.uk/arrayexpress/xml/files
to obtain detailed information on files available for the experiment.
For more information, please go to:
    http://www.ebi.ac.uk/arrayexpress/help/programmatic_access.html
                --><raw name="E-GEOD-6377.raw.1.zip" count="true" celcount="0"/><fgem name="E-GEOD-6377.processed.1.zip" available="true"/><idf name="E-GEOD-6377.idf.txt"/><sdrf name="E-GEOD-6377.sdrf.txt"/></files></experiment><experiment><species>Homo sapiens</species><rawdatafiles available="true"/><processeddatafiles available="false"/><sampleattribute><category>Age</category><value>20</value><value>21</value><value>21.5</value><value>24</value><value>25</value><value>26</value><value>29</value><value>30</value><value>31</value><value>32</value><value>34</value><value>35</value><value>40</value><value>41</value><value>42</value><value>44</value><value>45</value><value>46</value><value>47</value><value>48</value><value>49</value><value>50</value><value>51</value><value>52</value><value>53</value><value>56</value><value>57</value><value>58</value><value>59</value><value>60</value><value>62</value><value>63</value><value>64</value><value>66</value><value>67</value><value>68</value><value>69</value><value>70</value><value>71</value><value>73</value><value>74</value><value>75</value><value>76</value><value>77</value><value>78</value><value>80</value><value>81</value><value>82</value><value>84</value><value>85</value><value>86</value><value>87</value><value>90</value><value>96</value></sampleattribute><sampleattribute><category>BioSourceType</category><value>frozen_sample</value></sampleattribute><sampleattribute><category>ClinicalHistory</category><value>Cause of death: accidental drowning</value><value>Cause of death: acute alcohol intoxication</value><value>Cause of death: acute liver failure</value><value>Cause of death: acute pulmonary oedema</value><value>Cause of death: aortic aneurism</value><value>Cause of death: bronchopenumonia</value><value>Cause of death: bronchopneumonia</value><value>Cause of death: cardiac</value><value>Cause of death: cardiorespiratory failure</value><value>Cause of death: cardiovascular accident</value><value>Cause of death: chronic ischaemic heart disease</value><value>Cause of death: coronary artery occlusion</value><value>Cause of death: gastrointestinal bleed</value><value>Cause of death: haemathorax</value><value>Cause of death: haemopericardium</value><value>Cause of death: intra-abominal sepsis</value><value>Cause of death: ischaemic heart disease</value><value>Cause of death: left ventricular failure</value><value>Cause of death: motor vehicle accident</value><value>Cause of death: multiple injuries</value><value>Cause of death: multiple organ failure</value><value>Cause of death: mycocardial infarction</value><value>Cause of death: n/a</value><value>Cause of death: pelvic carcinoma</value><value>Cause of death: perforated duodenal</value><value>Cause of death: peritonitis</value><value>Cause of death: pneumonia</value><value>Cause of death: pulmonary disease</value><value>Cause of death: pulmonary emblous</value><value>Cause of death: pulmonary embolism</value><value>Cause of death: pulmonary embolus</value><value>Cause of death: pulmonary infarction</value><value>Cause of death: pulmonary oedema</value><value>Cause of death: pulmonary tuberculosis</value><value>Cause of death: ruptured aortic aneurism</value><value>Cause of death: sudden accident</value><value>Cause of death: suicide</value><value>Cause of death: unknown</value><value>Cause of death: unknown </value><value>Post-mortem interval: 10 hours</value><value>Post-mortem interval: 10.7 hours</value><value>Post-mortem interval: 100 hours</value><value>Post-mortem interval: 11 hours</value><value>Post-mortem interval: 12 hours</value><value>Post-mortem interval: 13 hours</value><value>Post-mortem interval: 13.1 hours</value><value>Post-mortem interval: 14 hours</value><value>Post-mortem interval: 14.2 hours</value><value>Post-mortem interval: 15.4 hours</value><value>Post-mortem interval: 16 hours</value><value>Post-mortem interval: 17.8 hours</value><value>Post-mortem interval: 18.5 hours</value><value>Post-mortem interval: 18.8 hours</value><value>Post-mortem interval: 19 hours</value><value>Post-mortem interval: 19.2 hours</value><value>Post-mortem interval: 19.3 hours</value><value>Post-mortem interval: 20 hours</value><value>Post-mortem interval: 20.5 hours</value><value>Post-mortem interval: 20.7 hours</value><value>Post-mortem interval: 21 hours</value><value>Post-mortem interval: 21.1 hours</value><value>Post-mortem interval: 21.5 hours</value><value>Post-mortem interval: 21.8 hours</value><value>Post-mortem interval: 22 hours</value><value>Post-mortem interval: 23 hours</value><value>Post-mortem interval: 23.3 hours</value><value>Post-mortem interval: 24 hours</value><value>Post-mortem interval: 25 hours</value><value>Post-mortem interval: 26 hours</value><value>Post-mortem interval: 26.4 hours</value><value>Post-mortem interval: 27 hours</value><value>Post-mortem interval: 27.7 hours</value><value>Post-mortem interval: 28 hours</value><value>Post-mortem interval: 28.7 hours</value><value>Post-mortem interval: 29 hours</value><value>Post-mortem interval: 29.5 hours</value><value>Post-mortem interval: 30 hours</value><value>Post-mortem interval: 31 hours</value><value>Post-mortem interval: 32 hours</value><value>Post-mortem interval: 35 hours</value><value>Post-mortem interval: 36 hours</value><value>Post-mortem interval: 37 hours</value><value>Post-mortem interval: 38 hours</value><value>Post-mortem interval: 40 hours</value><value>Post-mortem interval: 42 hours</value><value>Post-mortem interval: 44 hours</value><value>Post-mortem interval: 45 hours</value><value>Post-mortem interval: 48 hours</value><value>Post-mortem interval: 50 hours</value><value>Post-mortem interval: 51 hours</value><value>Post-mortem interval: 52 hours</value><value>Post-mortem interval: 53 hours</value><value>Post-mortem interval: 60 hours</value><value>Post-mortem interval: 61 hours</value><value>Post-mortem interval: 67 hours</value><value>Post-mortem interval: 7 hours</value><value>Post-mortem interval: 7.2 hours</value><value>Post-mortem interval: 70 hours</value><value>Post-mortem interval: 8 hours</value><value>Post-mortem interval: 81 hours</value><value>Post-mortem interval: 84 hours</value><value>Post-mortem interval: 85 hours</value><value>Post-mortem interval: 9.2 hours</value><value>Post-mortem interval: 91 hours</value><value>Post-mortem interval: 96 hours</value><value>Post-mortem interval: 97 hours</value></sampleattribute><sampleattribute><category>ClinicalTreatment</category><value>Antipsychotics: atypical</value><value>Antipsychotics: none</value><value>Antipsychotics: typical</value><value>Antipsychotics: unknown</value></sampleattribute><sampleattribute><category>DiseaseState</category><value>reference</value><value>schizophrenia</value></sampleattribute><sampleattribute><category>Organism</category><value>Homo sapiens</value></sampleattribute><sampleattribute><category>OrganismPart</category><value>brain</value></sampleattribute><sampleattribute><category>provider</category><value>Harvard Brain Tissue Resource center</value><value>Maudsley Institute of Psychiatry</value><value>Stanley Brain Consortium</value></sampleattribute><sampleattribute><category>Sex</category><value>female</value><value>male</value></sampleattribute><sampleattribute><category>TimeUnit</category><value>seconds</value><value>years</value></sampleattribute><experimentalfactor><name>clinical treatment</name><value>atypical antipsychotics</value><value>no antipsychotics</value><value>typical antipsychotics</value><value>unknown antipsychotics</value></experimentalfactor><experimentalfactor><name>disease state</name><value>reference</value><value>schizophrenia</value></experimentalfactor><miamescores><reportersequencescore>1</reportersequencescore><protocolscore>1</protocolscore><factorvaluescore>1</factorvaluescore><derivedbioassaydatascore>0</derivedbioassaydatascore><measuredbioassaydatascore>1</measuredbioassaydatascore><overallscore>4</overallscore></miamescores><id>30412</id><accession>E-MEXP-857</accession><name>Transcription profiling of brain samples from human control and schizophrenia patients who were treated with either typical, atypical or no antipsychotic medication</name><experimenttype>transcription profiling by array</experimenttype><releasedate>2007-12-06</releasedate><submissiondate>2006-09-13</submissiondate><lastupdatedate>2014-05-02</lastupdatedate><samples>110</samples><assays>16</assays><arraydesign><id>372</id><accession>A-MEXP-143</accession><name>KTH H. sapiens 30.5k cDNA array v1</name><count>4</count><legacy_id>393920089</legacy_id></arraydesign><arraydesign><id>371</id><accession>A-MEXP-114</accession><name>KTH H. sapiens 29.8k cDNA v2</name><count>12</count><legacy_id>361239053</legacy_id></arraydesign><bioassaydatagroup><id/><name>rawData</name><bioassaydatacubes>16</bioassaydatacubes><arraydesignprovider/><dataformat>rawData</dataformat><bioassays>16</bioassays><isderived>0</isderived></bioassaydatagroup><bioassaydatagroup><id/><name>scan</name><bioassaydatacubes>16</bioassaydatacubes><arraydesignprovider/><dataformat>scan</dataformat><bioassays>16</bioassays><isderived>0</isderived></bioassaydatagroup><bibliography><accession>17822540</accession><authors>Peter Saetre; Lina Emilsson; Elin Axelsson; Johan Kreuger; Eva Lindholm; Elena Jazin</authors><title>Inflammation-related genes up-regulated in schizophrenia brains</title><pages>46</pages><publication>BMC Psychiatry</publication><volume>7</volume><year>2007</year><uri>http://dx.doi.org/10.1186/1471-244X-7-46</uri></bibliography><provider><contact>Elin Axelsson</contact><role/><email/></provider><provider><contact>Eva Lindholm</contact><role/><email/></provider><provider><contact>Lina Emilsson</contact><role/><email/></provider><provider><contact>Peter Saetre</contact><role/><email/></provider><provider><contact>Elena E Jazin</contact><role>submitter</role><email>elena.jazin@ebc.uu.se</email></provider><provider><contact>Johan Kreuger</contact><role/><email/></provider><experimentdesign>clinical history</experimentdesign><experimentdesign>co-expression</experimentdesign><experimentdesign>disease state</experimentdesign><description><id/><text> Multiple studies have shown that brain gene expression is disturbed in subjects suffering from schizophrenia. However, disentangling disease effects from alterations caused by neuroleptics is a challenging task. <br/> To address the issues of disease heterogeneity and the effect of antipsychotic medication, we use a large collection of 110 brain autopsy samples, subdivided according to the type of antipsychotic medication received. We use global and high-resolution mRNA quantification techniques to analyse gene expression in brain tissues. We also analyse transcription in-vitro, in cell lines before and after treatment with cytokines.<br/> Results. We show that inflammation-related genes are up regulated in all groups of patients, including those not treated at the time of death. In particular, four co-expressed genes that are inducible by inflammatory cytokines showed increased mRNA levels, namely IFITM2, IFITM3, SERPINA3, and GBP1 (p-values from qPCR ? 0.01). We also show that these genes are expressed in oligodendrocyte and endothelial cell lines, and transcription is inducible by inflammatory cytokines in both cell lines. Our results give molecular support to the inflammatory theory of schizophrenia and suggest that inflammatory cytokines may stimulate transcription in endothelial brain cells during schizophrenia progression. Unexpectedly, inflammation-related genes may also have a role in myelin producing cells, since they are also inducible by cytokines in oligodendrocyte cell lines. Our findings encourage future research to explore whether anti-inflammatory agents can be used in combination with traditional antipsychotics for a more efficient treatment of schizophrenia.</text></description><protocol><id>89141</id><accession>P-MEXP-32418</accession></protocol><protocol><id>89146</id><accession>P-MEXP-32142</accession></protocol><protocol><id>89142</id><accession>P-MEXP-32682</accession></protocol><protocol><id>89144</id><accession>P-MEXP-32141</accession></protocol><protocol><id>89143</id><accession>P-MEXP-32139</accession></protocol><protocol><id>89145</id><accession>P-MEXP-32140</accession></protocol><protocol><id>89147</id><accession>P-MEXP-32879</accession></protocol><organism>Homo sapiens</organism><files><!--
This section is deprecated and unsupported.
Please use webservice located at:
    http://www.ebi.ac.uk/arrayexpress/xml/files
to obtain detailed information on files available for the experiment.
For more information, please go to:
    http://www.ebi.ac.uk/arrayexpress/help/programmatic_access.html
                --><raw name="E-MEXP-857.raw.1.zip" count="true" celcount="0"/><idf name="E-MEXP-857.idf.txt"/><sdrf name="E-MEXP-857.sdrf.txt"/></files></experiment><experiment><species>Homo sapiens</species><rawdatafiles available="false"/><processeddatafiles available="true"/><sampleattribute><category>CellType</category><value>fibroblast</value></sampleattribute><sampleattribute><category>DevelopmentalStage</category><value>fetus</value></sampleattribute><sampleattribute><category>DiseaseState</category><value>idiopathic pulmonary fibrosis</value><value>normal</value><value>scleroderma-associated pulmonary fibrosis</value></sampleattribute><sampleattribute><category>Organism</category><value>Homo sapiens</value></sampleattribute><sampleattribute><category>OrganismPart</category><value>lung</value></sampleattribute><experimentalfactor><name>Compound</name><value>none</value><value>TGF beta</value></experimentalfactor><experimentalfactor><name>DiseaseState</name><value>idiopathic pulmonary fibrosis</value><value>normal</value><value>scleroderma-associated pulmonary fibrosis</value></experimentalfactor><miamescores><reportersequencescore>1</reportersequencescore><protocolscore>0</protocolscore><factorvaluescore>1</factorvaluescore><derivedbioassaydatascore>1</derivedbioassaydatascore><measuredbioassaydatascore>0</measuredbioassaydatascore><overallscore>3</overallscore></miamescores><id>14967</id><accession>E-GEOD-1724</accession><secondaryaccession>GSE1724</secondaryaccession><secondaryaccession>GDS1012</secondaryaccession><name>Transcription profiling of human lung fibroblasts isolated from pulmonary fibrosis patients and treated with TGF beta</name><experimenttype>transcription profiling by array</experimenttype><releasedate>2007-08-04</releasedate><submissiondate>2004-09-02</submissiondate><lastupdatedate>2011-06-10</lastupdatedate><samples>18</samples><assays>18</assays><arraydesign><id>11048</id><accession>A-AFFY-1</accession><name>Affymetrix GeneChip Human Genome U95Av2 [HG_U95Av2]</name><count>18</count><legacy_id>5728564</legacy_id></arraydesign><bioassaydatagroup><id/><name>scan</name><bioassaydatacubes>18</bioassaydatacubes><arraydesignprovider/><dataformat>scan</dataformat><bioassays>18</bioassays><isderived>0</isderived></bioassaydatagroup><bioassaydatagroup><id/><name>processedDataMatrix</name><bioassaydatacubes>1</bioassaydatacubes><arraydesignprovider/><dataformat>processedDataMatrix</dataformat><bioassays>1</bioassays><isderived>1</isderived></bioassaydatagroup><provider><contact>Elisabetta Augusta Renzoni</contact><role>submitter</role><email>e.renzoni@imperial.ac.uk</email></provider><experimentdesign>co-expression</experimentdesign><experimentdesign>compound treatment</experimentdesign><experimentdesign>disease state</experimentdesign><description><id/><text>The response to a 4 hour treatment with TGFbeta (4 ng/ml) was evaluated in lung fibroblasts derived from three controls (normal periphery of resected tumor), open lung biopsies from three patients with idiopathic pulmonary fibrosis (usual interstitial pneumonia pattern on biopsy) and from three patients with fibrosing alveolitis associated with systemic sclerosis (fibrotic non specific interstitial pneumonia pattern on biopsy). Lung fibroblasts were grown to confluence in DMEM with 10% fetal calf serum. At confluence, lung fibroblasts were serum-deprived overnight, and exposed to either 4 ng/ml of activated TGF-ß1 (R&amp;D Systems) or serum-free culture medium with 0.1% BSA for four hours.</text></description><organism>Homo sapiens</organism><files><!--
This section is deprecated and unsupported.
Please use webservice located at:
    http://www.ebi.ac.uk/arrayexpress/xml/files
to obtain detailed information on files available for the experiment.
For more information, please go to:
    http://www.ebi.ac.uk/arrayexpress/help/programmatic_access.html
                --><fgem name="E-GEOD-1724.processed.1.zip" available="true"/><idf name="E-GEOD-1724.idf.txt"/><sdrf name="E-GEOD-1724.sdrf.txt"/></files></experiment></experiments>